<<

ll cts

inksp roduto a l p ith W websho LGC Standards Pharmacopoeial reference standards 2014

For standards with CofA see our catalogue: Pharmaceutical impurities and primary reference standards

LGC Quality – ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043 Pharmaceutical impurities

Code LGC Standards Product Pharmaceutical impuritiesA anddiphenine Hydrochloride CAS No. CS Price Unit MM1172.00 primary reference standards 2014Adiphenine Hydrochloride Adrenaline Tartrate 50-42-0

MM0614.00 A 250mg O O N Adrenaline Tartrate HCl

MM0614.02 L-Adrenaline 51-42-3 MM0614.13 A Imp. C 500mg OH OH (EP) as Hydrochloride: 1-(3,4-Di- H OH N O hydroxyphenyl)-2-(methylamino)ethanone OH OH OH O Hydrochloride (Adrenalone Hydrochloride) 51-43-4 OH

A OH 500mg OH MM0614.01 (1R)-1-(3,4-Dihydroxyphenyl)-2- H N methylaminoethanesulphonic Acid 62-13-5 OH (Adrenaline

A O -Sulphonate) 100mg OH H N HCl OH 78995-75-2 A OH 100mg O S OH O H MM0566.00 N Alanine OH

MM0567.00 Imp. A (Pharmeuropa): (2 (Aspartic Acid) 56-41-7 S)-2-Aminobutanedioic Acid NH A 500mg 2 Albendazole OH 56-84-8 O A O NH MM0382.00 500mg 2 Albendazole OH OH

O MM0382.01 Imp. A (EP): 5-(Propylsulphanyl)-1H- benzimidazol-2-amine 54965-21-8 MM0382.02 Imp. B (EP): Methyl [5-Propylsulphinyl)- A 500mg 1H-benzimidazol-2-yl]carbamate H O N 80983-36-4 O S N MM0382.03 N H Imp. C (EP): Methyl [5-Propylsulphonyl)- A 100mg 1H-benzimidazol-2-yl]carbamate H 54029-12-8 N S NH2 MM0382.04 N Imp. D A (EP): 5-(Propylsulphonyl) -1H- 100mg H O N benzimidazol-2-amine O S N 75184-71-3 N H MM2500.00 O Imp. E A 100mg (EP): Methyl (1H-Benzimidazol-2- H O N yl)carbamate (Carbendazim) O 80983-34-2 S N N H OO A A 100mg H lfuzosin Hydrochloride N

S NH 10605-21-7 N 2 OO A 100mg H O MM0085.04 ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043 N Imp. B O LGC Quality – (EP): 2-Chloro-6,7-dimethoxyquinazolin- N Request your4-amine copy now! N H MM1004.04 Imp. D (EP) as Dihydrochloride: N-(4-Amino-6,7- dimethoxyquinazolin-2-yl)-N-methylpropane-1,3- 23680-84-4 diamine Dihydrochloride O Visit us at www.lgcstandards.com A N 100mg Cl

O N

NH n/a 2 A 50mg O N NN H 2 O N HCl Print_LGC_Katalog_MM_2013-11-27_NoHyperlink_v04j.pdf 6 NH Also available from LGC Standards: 2 2

‘Pharmaceutical impurities and primary reference standards 20146’ A comprehensive catalogue of more than 3,000 pharmaceutical impurities and 20/01/2014 15:55:39 primary reference standards manufactured by LGC. Contact your local LGC Standards office for your free copy, or download a PDF version of this catalogue at www.lgcstandards.com.

Visit us at www.lgcstandards.com @LGCStdsPharma

LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043

© LGC Limited, 2014. All rights reserved. LGC Standards is part of the LGC Group. 3970/LB/0514 With links to all webshop products

Introduction

@LGCStdsPharma www.lgcstandards.com Buy pharmaceutical reference materials online

56,000 one reference intuitive your search standard materials engine

Our website offers the+ most comprehensive source of= reference materials - now available for ONLINE ordering.

Anyone can browse product information online, simply visit: www.lgcstandards.com

To view pricing and to place an order, please register at: www.lgcstandards.com/register

For further information visit www.lgcstandards.com

or contact your local office.

LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043

© LGC Limited, 2013. All rights reserved. LGC Standards is part of the LGC Group. 3664/LB/0713

3677_standards_webshop_ad_v4.indd 1 1/14/2014 5:40:43 PM Contents

Introduction ���������������������������������������������������������������������������������������������������������������������������������������� 6

European Pharmacopoeia ��������������������������������������������������������������������������������������������������������������� 11

United States Pharmacopoeia ��������������������������������������������������������������������������������������������������������� 77

British Pharmacopoeia and others ����������������������������������������������������������������������������������������������� 161

Complementary products ������������������������������������������������������������������������������������������������������������� 189

Email: [email protected] | Website: www.lgcstandards.com 5

3970_1Pharma_catalogue_internal_pages_v2.indd 5 6/12/2014 12:04:33 PM Introduction Welcome to the new edition of our pharmacopoeial reference standards catalogue.

About LGC Standards LGC Standards has successfully established a global reputation for the production of impurities and working standards, and as a single source for the supply of pharmacopeia reference materials. Our menu of custom services, including custom synthesis of impurities and metabolites, characterisation, certification, packaging and distribution, adds value to the scientific support we provide to our pharmaceutical customers. Our relationships with the world’s leading pharmacopoeias and their range of Chemical Reference Substances (CRS) and Reference Standards (RS), combined with in-house production of primary reference standards and pharmaceutical impurities, enable us to meet our customers’ specific needs. LGC Standards is also the exclusive European distributor for ATCC cultures and bio products. LGC Standards’ extensive network of sales offices and distribution centres means we offer the widest range of reference materials from one single source for rapid delivery. Our staff can provide scientific and technical guidance, including shipping and customs advice, in the local language. Our range of products also includes reference materials for clinical and forensic applications, , environmental analysis, physical properties determination, and food and beverage analysis. For more information about our range of services, or to receive any of our catalogues, please refer to our website www.lgcstandards.com or contact your local office.

About LGC LGC is an international life sciences measurement and testing company, which builds upon leading positions in sustainably growing markets. LGC provides reference materials, proficiency testing, genomics and analytical products and services which underpin the safety, health and security of the public to customers in the Pharmaceutical, Agricultural Bioscience, Food and Environment, Government and Academia, Security and Sports markets. With headquarters in Teddington, South West London, LGC employs over 2,000 staff, operating out of 22 countries worldwide. Its operations are extensively accredited to international quality standards such as ISO/IEC 17025 and ISO Guide 34. With a history dating back to 1842, LGC has been home to the UK Government Chemist for more than 100 years. It is the designated UK National Measurement Institute for Chemical and Bioanalytical measurement, providing metrology research, calibration and testing. LGC was privatised in 1996 and is now majority-owned by funds managed by Bridgepoint. For more information, please visit www.lgcgroup.com

6 Email: [email protected] | Website: www.lgcstandards.com

3970_1Pharma_catalogue_internal_pages_v2.indd 6 6/12/2014 12:04:33 PM About the catalogue This catalogue comprises the reference standards from the major pharmacopoeias, plus ready to use reagents as they are outlined in the chapters 2 and 4 of the European Pharmacopoeia and further complementary products.

For our own range of primary and impurity reference standards, please refer to the current catalogue “Pharmaceutical impurities and primary reference standards”. It is also available for download from our website.

The information provided in this catalogue as regards compendial articles is based on the ‘official’ pharmacopoeial lists and is correct at the time of print. Original descriptions and spellings used by the producers are retained.

Pharmaceutical reference substances

Certification The products described in this catalogue include pharmacopeial reference substances for use in pharmaceutical analysis. Pharmacopeial CRS and RS should be distinguished from certified reference materials (CRM), which are produced in conformity with the ISO guides 30 to 35, and supplied with a detailed certification document. Pharmacopeial reference substances are produced for a specific purpose, and the manufacturers follow rigorous protocols to ensure the reference substance is fit for the intended purpose. The ‘certification’ processes follow the basic requirements of the relevant ISO REMCO guides, but are modified by the pharmacopoeias to reflect the particular demands of the associated pharmacopeial monograph. Details are given in the introduction to each section listing the various CRS/RS collections in this catalogue.

Shelf life, storage, expiry dates and unit sizes Pharmacopeial CRS and RS should be purchased when required and not stored for a prolonged period. Pack sizes are designed to allow a limited number of replicate analyses, as required by Good Analytical Practice, but the opened pack should not be kept for future use. Please check all individual storage temperature requirements and note that the substances should be kept away from humidity and light (unless otherwise stated). Specific lot numbers or letters are allocated to all pharmacopeial reference substances, but no expiry dates are set. New lots are normally prepared well in advance of the expected ‘sell-out’ of the current lot. Please note that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. When a certain batch of a CRS/RS is withdrawn from sale because the lot has depleted a final expiry date is given, by which any material of the expiring lot held by users must be used. Parallel to that the new lot comes into distribution. This means that for a period of time both expiring and new lot are ‘official’. Lot information is available from LGC Standards.

Email: [email protected] | Website: www.lgcstandards.com 7

3970_1Pharma_catalogue_internal_pages_v2.indd 7 6/12/2014 12:04:33 PM If a material is withdrawn by the producer, then all stocks held by the users are no longer valid and expire immediately. Should this occur, LGC Standards will inform all customers who have purchased the withdrawn substance recently from LGC Standards. Please note that such a situation is outside LGC Standards’ control and products are not refundable. Once opened, the pharmacopoeias can no longer guarantee the stability of the material and any of the CRS/BRP and RS not used should be disposed of and not kept for future use.

Impurity standards Impurities in a pharmaceutical substance can change the effects and side effects of a drug significantly. Therefore, it is important to have an accurate detection of impurities. The pharmaceutical monographs regulate the legal definition, the analysis and the limits of impurities of a given substance. An official but limited range of impurity standards is available from the main pharmacopoeias where required in the monograph.

Approximately 3,000 other impurity standards are listed in the catalogue ‘Pharmaceutical impurities and primary reference standards’ which has been published separately and is available via your local LGC Standards office or via download from our website.

These materials are produced at our facility in Luckenwalde near Berlin, Germany, and are supplied with a full certificate of analysis. Our impurity reference standards are intended for the identification and control of impurities in drug substances and drug preparations, as well as for method development and validation.

Controlled substances A number of the pharmaceutical substances, such as and tranquillisers, described in this catalogue are so called controlled substances. The purchase, possession and use of controlled substances are subject to national and international regulations designed to limit their abuse. It is the responsibility of the customer to obtain any authorisation necessary to both purchase and possess controlled substances, complying with the laws of the importing country, before ordering. Customers wishing to obtain controlled substances must contact their LGC Standards sales office before ordering, and clarify with the sales specialists the relevant national requirements, the associated charges and consequential delivery times. All orders for controlled substances must be provided in writing and signed by an authorised person. The orders must be accompanied with the original import permit and/or possession permit.

8 Email: [email protected] | Website: www.lgcstandards.com

3970_1Pharma_catalogue_internal_pages_v2.indd 8 6/12/2014 12:04:33 PM Use, safety and handling Please read any documents supplied with the product before opening or using it. Particular attention must be paid to instructions referring to pre-mixing, addition of diluent to lyophilised materials and to the minimum size of sample to be used. The latter point is particularly important as it has normally been set by the producer after considering fully the homogeneity testing data obtained as a part of the certification exercise. The use of smaller than recommended samples is one of the most common sources of error. Some pharmaceutical substances are toxic and require special handling. Virtually all pharmaceutical reference substances have a pharmacological and/or biological activity. We therefore recommend that all the products described in this catalogue should be handled as if they were bio-active, toxic or infective, and that opened packs should only be handled by trained laboratory personnel. We also strongly recommend to read the information provided by material safety data sheets coming with the products. All pharmaceutical reference substances and standards are for laboratory analytical use only and not for use in humans.

General ordering information Prices and delivery procedures are available from your local LGC Standards office. For products requiring special delivery procedures (cooled shipping, special licensing, controlled substances) additional charges may be applied. Please note that once delivered to the customer, reference substances are not returnable. Customers requiring assistance with the purchase, use or application of a particular reference substance should contact LGC Standards where technical staff are available to advise on the use and suitability of the products.

Email: [email protected] | Website: www.lgcstandards.com 9

3970_1Pharma_catalogue_internal_pages_v2.indd 9 6/12/2014 12:04:33 PM Notes

10 Email: [email protected] | Website: www.lgcstandards.com

3970_1Pharma_catalogue_internal_pages_v2.indd 10 6/12/2014 12:04:33 PM With links to all webshop products

European Pharmacopoeia

@LGCStdsPharma www.lgcstandards.com Looking for the one impurity? LGC Standards custom synthesis

LGC Standards custom synthesis can provide you with research material for nearly every pharmaceutical impurity you want!

LGC Standards custom synthesis is a special service to customers who need a specific standard which is not available in our catalogue range. All kinds of standards are possible – from ordinary pharmacopoeial impurities to stable- isotope-labelled metabolites – with the desired purity and characterisation, in batch scales from milligramme to kilogramme.

Visit us at www.lgcstandards.com

LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043

© LGC Limited, 2013. All rights reserved. LGC Standards is part of the LGC Group. 3664/LB/0713

3677_pharma_custom_syn_ad_v4.indd 1 1/14/2014 11:20:56 AM Introduction

European Pharmacopoeia (EP) (from page 15)

Background European Pharmacopoeia reference substances and preparations are selected and verified by the EP laboratories as being suitable for the use as prescribed in the relevant monograph of the European Pharmacopoeia. Any reference substance, spectra or preparation required for a new EP monograph, shall be available as soon as the monograph comes into force. Since chemical reference substances (CRS) and biological reference preparations (BRP) are officially certified by the European Pharmacopoeia Commission, it should be noted that neither certificates of analysis nor data not relevant to the use of the products as defined by the EP monograph are provided with the reference product or substance.

Relationship with other pharmacopoeias in Europe Many of the member countries of the European Pharmacopoeia Commission have adopted the EP in full, and their monographs require only EP CRS/BRP. When an EP monograph is adopted by the pharmacopoeia of a member state of the Council of Europe then any reference material that may have been available from a national pharmacopoeia, e.g. BP or PF, will usually be discontinued in favour of the EP reference substance. However, a number of member countries of the EP Commission maintain national pharmacopoeial monographs, especially for finished dosage forms, which require the use of separate reference substances. A separate chapter in this catalogue includes lists of the reference substances produced for the British, French and International pharmacopoeia monographs. The International Pharmacopoeia (IP) reference substances are described in the section referring to the WHO (World Health Organization).

Storage, shelf life, expiry dates and size units European Pharmacopoeia CRS/BRP are subject to regular inspection and repeated analysis by EP scientific staff. Each EP CRS/BRP is, on receipt by the customer, fit for the intended use. No expiry date is indicated on the reference materials because the products or substances comply with the requirements of the corresponding monograph and are monitored regularly. When batches are to be changed, LGC Standards can provide you with the date on which the previous lot will no longer be official. In specific cases for reasons related to filling or labeling, sub-batches are obtained from the same batch of bulk material. However, all the necessary precautions are taken in order to guarantee that the quality and specifications of the sub-batches do not differ from one to another. Please note, that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. EP recommends only sufficient material should be purchased for immediate use and that unopened vials should be stored in the dark unless otherwise stated. Whilst most EP CRS/BRP can be shipped at ambient temperature, certain items have to be maintained at controlled temperatures at all times and are subject to special shipping charges and storage conditions (details are available on request).

Email: [email protected] | Website: www.lgcstandards.com 13

3970_2Pharma_catalogue_internal_EU_pharma_v1.indd 13 6/12/2014 3:33:20 PM Where no drying conditions are stated, the substance is to be used as received. Once opened, EP can no longer guarantee the stability of the CRS/BRP, and any material not used should be disposed of and not kept for future use.

Validation of secondary standards All secondary in-house working standards have to be validated against the corresponding EP CRS/BRP. Please make sure that the secondary material is used only for the same official purposes for which the primary pharmacopoeial material was designed.

Proper use For information on the use of the substances please refer to the monograph and leaflets accompanying the material, or contact your local LGC Standards office.

Toxicity The potential toxicity of certain reference substances is such that special precautions should be taken to avoid contact. Such substances should be manipulated in a glove box. If this is not possible, gloves, eye protection and a mask should be worn. Following the guidelines suggested by the EP does not replace the need to carry out a full hazard assessment. Biological and blood products should be regarded as potentially hazardous to health and therefore used and disposed of according to established laboratory safety procedures.

Controlled substances The EP product range contains substances subject to controlled substance regulations schedules. Special ordering procedures apply, so please contact LGC Standards for details and costs.

14 Email: [email protected] | Website: www.lgcstandards.com

3970_2Pharma_catalogue_internal_EU_pharma_v1.indd 14 6/12/2014 3:33:20 PM European Pharmacopoeia European Pharmacopoeia standards

Code Product Unit EPY0000053 17 alpha-dihydroequilin 10 mg EPY0000173 4-Aminobenzoic acid 60 mg EPA0460000 7-Aminodesacetoxycephalosporanic acid 20 mg EPY0001552 Abacavir for peak identification 10 mg EPY0001551 Abacavir for system suitability 10 mg EPY0001561 Abacavir sulfate 20 mg EPY0000055 Acamprosate - Reference Spectrum unit Acamprosate impurity A 50 mg EPY0000116 3-aminopropane-1-sulphonic acid EPY0000500 Acarbose 94.7 mg EPY0000354 Acarbose for identification 10 mg EPY0000427 Acarbose for peak identification 20 mg EPA0040000 Acebutolol hydrochloride 50 mg Acebutolol impurity B 10 mg N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl) EPY0000359 amino]propoxy]phenyl]acetamide (diacetolol) Acebutolol impurity C 20 mg EPY0000127 N-(3-acetyl-4-hydroxyphenyl)butanamide Acebutolol impurity I 0.004 mg EPY0000128 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl)butanamide EPY0000056 Aceclofenac - Reference Spectrum unit EPY0001094 Aceclofenac for peak identification 10 mg Aceclofenac impurity F benzyl 20 mg EPY0000085 [[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy] Aceclofenac impurity H 10 mg EPY0000086 [[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]oxy] EPY0000810 Acemetacin 100 mg Acemetacin impurity A 10 mg EPY0000811 4-chlorobenzoic acid EPY0000842 Acemetacine impurity mixture 0.06 mg EPA0070000 Acesulfame potassium 50 mg Acesulfame potassium impurity 50 mg EPA0070020 B 5-chloro-6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide EPA0100000 Acetazolamide 100 mg EPY0001084 Acetazolamide for system suitability 0.0068 mg EPY0000002 Acetylcholine chloride 50 mg EPA0150000 Acetylcysteine 50 mg Acetylcysteine impurity C 10 mg EPA0152000 N,N'-diacetyl-L-cystine Acetylcysteine impurity D 10 mg EPA0153000 N,S-diacetyl-L-cysteine EPA0200000 Acetylsalicylic acid 15 mg EPY0001460 Acetylsalicylic acid for peak identification (10.26 mg) 10 mg EPY0001462 Acetylsulfadiazine 0.002 mg EPA0220000 Aciclovir 75 mg EPY0001271 Aciclovir for peak identification 1 0.3 mg EPY0001269 Aciclovir for peak identification 2 0.004 mg EPY0001264 Aciclovir for system suitability 10 mg EPA0225000 Acitretin 100 mg EPY0001543 Actaea racemosa for assay CRS 300 mg EPY0001463 Actaea racemosa HRS 1200 mg EPY0001464 Actaea rasemosa dry extract for system suitability HRS 1200 mg EPY0001121 Adapalene 100 mg

Edition 2014 Visit us at www.lgcstandards.com 15

European Pharmacopoeia

Code Product Unit EPY0001119 Adapalene for peak identification 2.022 mg Adapalene impurity C 6 mg EPY0001120 1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane EPA0230000 Adenine 50 mg EPA0230200 Adenosine 50 mg EPY0000110 Adipic acid 50 mg EPY0000882 Adrenaline 5 mg EPY0000740 Adrenaline impurity mixture 0.005 mg EPA0300000 Adrenaline tartrate 100 mg EPY0000707 Adrenaline tartrate with impurity A 15 mg EPY0000883 Adrenaline with impurity F 10 mg EPY0000728 Agnus castus fruit standardised dry extract 200 mg EPA0325000 Alanine 60 mg EPA0325100 Albendazole 50 mg EPA0325200 Alcuronium chloride 50 mg EPA0325450 Alfacalcidol 5 mg EPA0325451 Alfacalcidol - Reference Spectrum unit EPY0001601 Alfacalcidol for system suitability 2.5 mg EPA1225000 Alfadex 150 mg EPA0325500 hydrochloride - Reference Spectrum unit EPY0000832 Alfuzosin for system suitability 10 mg EPA0325800 Alfuzosin hydrochloride 10 mg EPY0001581 Alimemazine for system suitability 5 mg EPY0001583 Alimemazine hemitartrate 15 mg EPA0349000 Allantoin 60 mg EPA0350000 Allopurinol 100 mg Allopurinol impurity A 10 mg EPA0350010 5-amino-1H-pyrazole-4-carboxamide Allopurinol impurity B 10 mg EPA0350020 5-formylamino-1H-pyrazole-4-carboxamide Allopurinol impurity C 10 mg EPA0350030 5-(4H-1,2,4-triazol-4-yl)1H-pyrazole-4-carboxamide Allopurinol impurity D 15 mg EPA0350040 ethyl 5-amino-1H-pyrazole-4-carboxylate Allopurinol impurity E 20 mg EPA0350050 ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate EPY0000383 All-rac-alpha-tocopherol for peak identification 50 mg EPY0000384 All-rac-alpha-tocopheryl acetate for peak identification 30 mg EPA0351000 Allylstrychnine 10 mg EPY0000235 Almagate 25 mg EPY0000255 Almagate - Reference Spectrum unit EPA1220000 Alpha-apo-oxytetracycline 20 mg EPT1550000 alpha-Tocopherol 500 mg EPT1600000 alpha-Tocopheryl acetate 500 mg EPA0357000 Alprazolam 100 mg EPA0360000 Alprenolol hydrochloride 100 mg EPY0000054 Alprostadil 50 mg EPY0000606 Altizide 150 mg Altizide impurity B 15 mg EPY0000843 3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene EPY0000687 Alverine citrate 5 mg EPY0000595 Alverine for peak identification 0.125 mg Alverine impurity D 10 mg EPY0000607 N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine

16 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPA0363000 Amantadine hydrochloride 100 mg EPA0363700 Ambroxol hydrochloride 125 mg EPA0900000 Amfetamine sulfate - Reference Spectrum unit EPA0365000 Amidotrizoic acid dihydrate 100 mg EPY0001461 Amidotrizoic acid for system suitability 0.08 mg EPA0368000 Amikacin 200 mg EPY0001117 Amikacin for system suitability 10 mg Amikacin impurity I 20 mg EPY0001467 (2S)-4-amino-2-hydroxybutanoic acid EPA0365900 Amikacin sulfate 200 mg EPA0370000 hydrochloride 100 mg Amiloride impurity A 20 mg EPY0000020 methyl-3,5-diamino-6-chloropyrazine-2-carboxylate EPA0420000 Aminocaproic acid 50 mg EPA0496000 125 mg Aminoglutethimide impurity A 20 mg (3RS)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; EPA0496005 (3-aminoglutethimide) Aminoglutethimide impurity D 10 mg EPA0496020 3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione) (azoglutethimide) EPA0575000 Amiodarone hydrochloride 100 mg Amiodarone impurity D 20 mg EPY0000129 (2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone Amiodarone impurity E 20 mg EPY0000130 (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone EPA0590000 Amisulpride 10 mg EPY0001534 Amisulpride for system suitability (1.0015 mg) 1 mg EPY0000563 Amitriptyline hydrochloride 10 mg EPY0000049 Amlodipine besilate 150 mg EPY0001067 Amlodipine for peak identification 10 mg Amlodipine impurity A 15 mg 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2- EPY0001068 yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Amlodipine impurity B 15 mg 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2- EPY0001069 (methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate Amlodipine impurity G 15mg EPY0001070 dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate EPY0000302 Ammonio methacrylate copolymer (type A) - Reference Spectrum unit EPY0000303 Ammonio methacrylate copolymer (type B) - Reference Spectrum unit EPY0000433 Ammonium glycyrrhizate 70 mg EPA0650000 Amobarbital 500 mg EPA0700000 Amobarbital sodium 500 mg EPA0800000 Amoxicillin trihydrate 100 mg EPY0001521 Amoxicillin trihydrate for performance verification 5 g EPY0000005 Amphotericin B 100 mg EPY0001361 Amphotericin B for microbiological assay 100 mg EPY0001014 Amphotericin B for peak identification 10 mg EPA1000000 Ampicillin (anhydrous) 250 mg EPA1100000 Ampicillin trihydrate 150 mg EPY0001244 Amylmetacresol 285 mg EPY0001245 Amylmetacresol for peak identification 10 mg EPY0001522 100 mg Anastrozole impurity E 10 mg EPY0001531 2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile) EPY0001386 Angelica dahuria root 160 mg

Edition 2014 Visit us at www.lgcstandards.com 17

European Pharmacopoeia

Code Product Unit EPY0001385 Angelica pubescent root 500 mg EPA1200000 Anhydrotetracycline hydrochloride 15 mg EPY0001466 Anhydrous Docetaxel 15 mg EPA1210000 Antazoline hydrochloride 50 mg EPY0001465 Apomorphine hydrochloride hemihydrate 15 mg EPY0001471 Apomorphine impurity B ( sulfate) (Morphinhemisulfat-Pentahemihydrat) 40 mg EPY0001154 Aprotinin for system suitability 2.7 mg EPA1250000 Aprotinin solution BRP 0.5 mL EPY0000806 Arbutin 100 mg EPA1270000 Arginine 50 mg EPY0000304 Arginine aspartate 20 mg EPA1271000 Arginine hydrochloride 60 mg EPY0001649 Aripiprazole 170 mg Aripiprazole impurity F 10 mg EPY0001650 7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]-3,4-dihydroquinolein-2(1H)-one EPY0001323 Aristolochia 140 mg EPY0001175 Aristolochic acid for system suitability 1 mg EPY0001185 Aristolochic acid I 11 mg EPY0000079 Articaine hydrochloride 100 mg Articaine impurity A 15 mg EPY0000080 methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2-carboxylate Articaine impurity E 10 mg methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl] EPY0000081 amino]thiophene-2-carboxylate EPA1300000 Ascorbic acid (Vitamin C) 100 mg Ascorbic acid impurity C 20 mg EPY0001024 D-sorbosonic acid Ascorbic acid impurity D 10 mg EPY0001170 methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate) EPY0000800 Ascorbyl palmitate 10 mg EPY0000305 Asparagine monohydrate 60 mg EPA1320000 Aspartame 40 mg Aspartame impurity A 10 mg EPA1321000 2-(5-benzyl-3,6-dioxopiperazin-2-yl)acetic acid (diketopiperazine) EPA1330000 Aspartic acid 50 mg EPY0001171 Astragaloside IV 40 mg EPA1340000 Atenolol 100 mg EPY0001089 Atenolol for system suitability 5 mg EPY0001587 for impurity A identification 10 mg EPY0001586 Atomoxetine hydrochloride 110 mg Atomoxetine impurity B 10 mg EPY0001588 (3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1- amine Atomoxetine impurity D 5 mg EPY0001589 (3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1- amine EPY0001327 Atorvastatin calcium trihydrate 150 mg Atorvastatin impurity A 10 mg EPY0001328 desfluoroatorvastatin Atorvastatin impurity B 10 mg EPY0001329 3-epi-atorvastatin Atorvastatin impurity C 10 mg EPY0001330 fluoroatorvastatin Atorvastatin impurity D 10 mg EPY0001331 3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide Atorvastatin impurity E 10 mg EPY0001332 ent-atorvastatin EPY0001572 Atovaquone 270 mg

18 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0001573 Atovaquone for system suitability 10 mg EPY0000424 Atracurium besilate 120 mg EPY0000503 Atracurium for impurity F identification 5 mg EPY0000504 Atracurium for peak identification 5 mg EPY0000878 30 mg EPY0000845 Atropine for peak identification 0.25 mg Atropine impurity B 10mg EPY0000816 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate (noratropine) EPA1400000 Atropine sulphate 50 mg EPY0000029 Azaperone 50 mg EPA1500000 Azathioprine 100 mg Azathioprine impurity A 10 mg EPY0001240 1-methyl-4-nitro-1H-imidazol-5-amine Azathioprine impurity G 5 mg EPY0001246 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine (thiamiprine) EPY0000326 Azelastine hydrochloride 25 mg Azelastine impurity B 5 mg EPY0000327 1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane Azelastine impurity D 5 mg EPY0000328 4-(4-chlorobenzyl)phthalazin-1(2H)-one Azelastine impurity E 5 mg EPY0000329 3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one EPY0000306 Azithromycin 200 mg EPY0000637 Azithromycin for peak identification 15 mg EPY0000641 Azithromycin for system suitability 0.05 mg Azithromycin impurity A 10 mg EPY0000307 6-demethylazithromycin EPB0070000 Bacampicillin hydrochloride 120 mg EPB0100000 Bacitracin 150 mg EPB0200000 50 mg Baclofen impurity A 50 mg EPB0200050 (RS)-4-amino-3-(4-chlorophenyl) lactam EPY0001273 10 mg EPB0250000 Bambuterol hydrochloride 100 mg EPB0300000 Barbital 500 mg EPY0001525 Basic butylated methacrylate copolymer 20 mg EPY0000295 Basic butylated methacrylate copolymer - Reference Spectrum unit EPB0305000 dipropionate anhydrous 150 mg EPY0000469 Beclometasone dipropionate for peak identification 10 mg EPY0000352 Beclometasone dipropionate for system suitability 15 mg EPY0001073 Beclometasone dipropionate impurities F and N 0.052 mg EPY0000351 Beclometasone dipropionate monohydrate 10 mg EPY0001607 Belamcanda chinensis rhizome HRS 110 mg EPY0001038 Benazepril for system suitability 0.016 mg EPY0001025 Benazepril hydrochloride 160 mg Benazepril impurity A 10 mg [(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-1- EPY0001026 benzazepin-1-yl]acetic acid EPB0400000 Bendroflumethiazide 100 mg Bendroflumethiazide impurity A 5 mg EPY0000564 4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide EPB0470000 Benperidol 100 mg EPY0001079 Benserazide for peak identification 10 mg EPB0477000 Benserazide hydrochloride 50 mg

Edition 2014 Visit us at www.lgcstandards.com 19

European Pharmacopoeia

Code Product Unit Benserazide impurity A 20 mg EPB0477010 (RS)-2-amino-3-hydroxypropanohydrazide Benserazide impurity C 10 mg EPY0001071 (2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]propanohydrazide EPY0001064 Benzaldehyde 150 mg EPY0001060 Benzalkonium chloride for system suitability 20 mg Benzarone 10 mg EPB0490000 (2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone EPB0500000 Benzathine 200 mg EPY0000775 Benzbromarone 10 mg EPB0550000 Benzethonium chloride 100 mg EPB0600000 Benzocaine 50 mg EPY0001470 30 mg EPY0000647 Benzophenone 40 mg EPY0000167 Benzyl 50 mg EPB0670000 Benzyl benzoate - Reference Spectrum unit EPB0700000 Benzylpenicillin potassium 100 mg EPB0900000 Benzylpenicillin sodium 200 mg EPY0001149 Berberine chloride 20 mg EPA1230000 Beta-apo-oxytetracycline 20 mg EPB0950000 Betadex 200 mg EPY0000391 Betahistine dihydrochloride 50 mg EPB0990000 Betahistine mesilate 100 mg EPB1000000 75 mg EPB1030000 100 mg EPY0001416 Betamethasone dipropionate for peak identification 10 mg EPY0001418 Betamethasone dipropionate for system suitability 10 mg EPB1040000 Betamethasone diproprionate 150 mg EPB1045000 Betamethasone sodium phosphate 100 mg EPY0001027 for system suitability 25 mg EPY0001065 Betamethasone valerate impurity mixture 0.018 mg EPB1054000 Betamethasone-17-valerate 100 mg EPB1055000 Betamethasone-21-valerate 15 mg EPY0001615 Beta-sitosterol 25 mg EPY0001360 Betaxolol for peak identification 15 mg EPB1103000 Betaxolol hydrochloride 60 mg Betaxolol impurity A 10 mg EPB1103100 (2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)-amino]propan-2-ol Betaxolol impurity C 5 mg EPY0001354 2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane EPB1115000 Bezafibrate 100 mg EPY0001444 100 mg EPY0001448 Bicalutamide for system suitability 15 mg EPY0001078 Bicisate labelling kit 24 mg EPB1110000 Bifonazole 100 mg EPY0001421 Bifonazole for system suitability 10 mg EPY0001059 Bilberry dry extract 250 mg EPB1116000 Biotin (Vitamin H) 20 mg EPB1120000 Biperiden hydrochloride 60 mg Biperiden impurity A 20 mg (1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol EPB1121000 (endo form) EPB1140000 Bisacodyl 50 mg EPY0000608 Bisacodyl for peak identification 10 mg

20 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0000694 Bisacodyl for system suitability 5 mg Bisoprolol for peak identification 1 mg Bisoprolol for system suitability method A CRS has been renamed as Bisoprolol for peak EPY0000877 identification CRS Bisoprolol for system suitability 1 mg Bisoprolol for system suitability method B CRS has been renamed as Bisoprolol for system EPY0000813 suitability CRS EPY0000812 Bisoprolol fumarate 50 mg EPB1141000 Bleomycin sulfate 7 mg EPY0000434 Boldine 30 mg EPB1142000 Bordetella pertussis mouse antiserum BRP 0.5 mg EPY0001634 Brimonidine for system suitability 1.3 mg EPY0001658 Brimonidine tartrate 5 mg EPB1143000 60 mg EPY0000645 Bromazepam for system suitability Controlled Substance 10 mg EPB1145000 Bromhexine hydrochloride 100 mg Bromhexine impurity C 15 mg EPY0000200 N-(2-aminobenzyl)-N-methylcyclohexanamine EPB1150000 Bromocriptine mesilate 30 mg EPY0000677 Bromocriptine mesilate for system suitability 5 mg EPB1152000 Bromperidol 100 mg EPB1152050 Bromperidol decanoate 60 mg EPB1153000 Brompheniramine maleate 100 mg EPY0000468 Brotizolam 10 mg Brotizolam impurity B 10 mg 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine EPY0000470 (demethylbrotizolam) EPB1155000 Brucella melitensis Rev. 1 strain BRP 1 mL EPB1157300 110 mg EPY0001148 Budesonide for system suitability 10 mg EPB1156000 Bufexamac 100 mg EPY0001529 Buflomedil for peak identification 0.45 mg EPB1157400 Buflomedil hydrochloride 100 mg Buflomedil impurity B 20 mg EPB1157410 4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one EPB1158000 Bumetanide 150 mg Bumetanide impurity A 5 mg EPY0000309 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid Bumetanide impurity B 5 mg EPY0000310 3-amino-4-phenoxy-5-sulphamoylbenzoic acid EPB1160000 Bupivacaine hydrochloride 100 mg Bupivacaine impurity B 20 mg EPY0000088 (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Bupivacaine impurity E 20 mg EPY0000089 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide Bupivacaine impurity F 70 mg EPY0001575 2,6-dimethylaniline EPY0001108 10 mg EPY0001122 Buprenorphine for system suitability Controlled Substance 10 mg EPY0001109 Buprenorphine hydrochloride 10 mg EPB1168000 Buserelin 2 mg EPY0000471 Buspirone for system suitability 2 mg EPY0000131 Buspirone hydrochloride 5 mg EPB1170000 Busulfan 50 mg EPY0001487 Butyl methacrylate 100 mg EPY0001304 Butyl methanesulfonate 30 µl

Edition 2014 Visit us at www.lgcstandards.com 21

European Pharmacopoeia

Code Product Unit EPB1217000 Butyl parahydroxybenzoate 100 mg Butyl parahydroxybenzoate impurity E 15 mg EPY0001357 2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate) EPB1212000 Butylhydroxyanisole 60 mg EPB1215000 Butylhydroxytoluene Plastic additive 07 50 mg EPY0000472 Cabergoline 100 mg EPC0100000 70 mg EPY0000787 Caffeine for system suitability 10 mg EPC0166000 Calcifediol 5 mg EPC0166001 Calcifediol - Reference Spectrum unit EPY0000499 Calcipotriol (anhydrous) - Reference Spectrum unit EPY0000473 Calcipotriol monohydrate 10 mg EPY0000474 Calcipotriol monohydrate - Reference Spectrum unit EPC0200000 Calcitonin (salmon) 2x1 mg EPY0000632 Calcitonin-Gly 0.4 mL EPC0225000 Calcitriol 10 mg EPC0226000 Calcitriol - Reference Spectrum unit EPC0249000 Calcium ascorbate - Reference Spectrum unit EPC0250000 Calcium folinate 130 mg EPC0299000 Calcium glucoheptonate 60 mg EPC0300000 Calcium gluconate 100 mg EPC0340000 Calcium levulinate dihydrate 250 mg EPC0350000 Calcium oxalate monohydrate 500 mg EPC0400000 Calcium pantothenate 60 mg EPC0405000 (racemic) 50 mg EPY0001388 Candesartan cilexetil 60 mg EPY0001387 Candesartan cilexetil for peak identification 10 mg EPY0001389 Candesartan cilexetil for system suitability 10 mg EPC0410000 50 mg EPY0001642 Capecitabine 150 mg Capecitabine impurity A 5 mg 4-amino-1-(5-deoxy-ß-D-ribofuranosyl)-5-fluoropyrimidin-2(1H)-one (5'-deoxy-5- EPY0001643 fluorocytidine) Capecitabine impurity B 5 mg EPY0001644 1-(5-deoxy-ß-D-ribofuranosyl)-5-fluoropyrimidin-2,4(1H,3H)-dione (5'-deoxy-5-fluorocytidine) Capecitabine impurity D 10 mg (2RS)-2-methylbutyl [1-(5-deoxy-ß-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4- EPY0001645 yl]carbamate EPC0426000 Caprylic acid 100 mg EPY0000671 50 mg EPC0430000 Captopril 10 mg EPY0001182 Captopril for system suitability 20 mg Captopril impurity B 10 mg EPY0001219 (2S) 1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2-carboxylic acid Captopril impurity C 10 mg EPY0001220 (2RS)-2-methyl-3-sulphanylpropanoic acid Captopril impurity D 10 mg EPY0001221 (2RS)-3-bromo-2-methylpropanoic acid Captopril impurity E 10 mg EPY0000435 (2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid Captopril impurity J 10 mg (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]pyrrolidine-2-carboxylic acid EPY0001450 (acetylcaptopril) EPY0000113 Carbachol 50 mg EPC0450000 200 mg

22 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Carbamazepine impurity A 10 mg EPY0000033 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide(10,11-dihydrocarbamazepine) EPC0451000 Carbasalate calcium - Reference Spectrum unit Carbasalate impurity B 5 mg EPY0001161 2-[[2-(acetyloxy)benzoyl]oxy]benzoic acid (acetylsalicylsalicylic acid) EPC0455000 Carbenicillin sodium 50 mg EPC0460000 Carbidopa 50 mg EPC0465000 120 mg EPC0470000 Carbocisteine 60 mg EPC0499900 dioxide - Reference Spectrum unit EPC0550000 Carboplatin - Reference Spectrum unit EPY0000475 Carboprost trometamol 40 mg EPY0000536 Carboprost trometamol - Reference Spectrum unit EPY0000035 Carisoprodol 50 mg Carisoprodol impurity A 10 mg EPY0000036 (2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate EPY0001214 Carmellose 10 mg EPC0580004 Carmustine - Reference Spectrum unit Carmustine impurity A 20 mg EPC0580010 1,3-bis(2-chloroethyl)urea EPY0000884 Carprofen for system suitability 5 mg EPY0000846 Carprofen for veterinary use 30 mg EPY0000193 Carteolol for system suitability 30 mg EPY0000192 Carteolol hydrochloride - Reference Spectrum unit EPY0001427 Carvedilol 50 mg EPY0000075 Carvedilol - Reference Spectrum unit EPY0001426 Carvedilol for system suitability 10 mg Carvedilol impurity C 15 mg EPY0000103 (2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy) propan-2-ol EPC0600000 Casein BRP 100 g EPC0630000 Cefaclor 450 mg EPC0650000 Cefadroxil 250mg EPC0675000 Cefalexin monohydrate 150 mg EPY0000505 Cefalotin for impurity B identification 10 mg EPC0682000 Cefalotin sodium 100 mg EPC0682300 Cefamandole nafate 125 mg EPY0000240 Cefapirin sodium 100 mg Cefatrizine impurity A 60 mg 7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8-oxo-5-thia-1- EPC0682410 azabicyclo[4.2.O]oct-2-ene-2-carboxylic acid(7-ACA triazole) EPC0682400 Cefatrizine propylene glycol 150 mg EPC0682800 Cefazolin 150 mg EPY0000633 Cefepime dihydrochloride monohydrate 150 mg EPY0000634 Cefepime dihydrochloride monohydrate for system suitability 15 mg Cefepime impurity E 10 mg (6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene- EPY0001336 2-carboxylate EPC0684000 Cefixime 200 mg EPC0684750 Cefoperazone dihydrate 100 mg EPC0684800 Cefoperazone sodium - Reference Spectrum unit EPY0000420 Cefotaxime acid 80 mg EPY0000506 Cefotaxime for peak identification 10 mg EPC0685000 Cefotaxime sodium 30 mg EPC0688000 Cefoxitin sodium 100 mg

Edition 2014 Visit us at www.lgcstandards.com 23

European Pharmacopoeia

Code Product Unit EPY0001496 Cefoxitin sodium for peak identification 15 mg EPY0001305 Cefpodoxime proxetil 70 mg EPY0001318 Cefpodoxime proxetil for impurity H identification 10 mg EPY0001306 Cefpodoxime proxetil for peak identification 10 mg EPY0001371 Cefprozil 120 mg EPY0001367 Cefprozil for peak identification 10 mg Cefprozil impurity A 20 mg EPY0001372 (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid (p-hydroxyphenylglycine) EPY0001368 Cefprozil impurity mixture 10 mg EPC0690000 Cefradine 300 mg EPY0000568 Cefradine for peak identification 15 mg EPY0001174 Cefradine impurity mixture 0.04 mg EPC0690500 Ceftazidime 200 mg EPY0001111 Ceftazidime for peak identification 10 mg Ceftriaxone impurity A 10 mg EPC0692000 E-isomer EPC0691000 Ceftriaxone sodium 100 mg EPC0694990 Cefuroxime axetil 60 mg EPC0695000 Cefuroxime sodium 150 mg EPY0001445 Celecoxib 200 mg Celecoxib impurity A 10 mg EPY0001446 4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Celecoxib impurity B 10 mg EPY0001447 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide EPY0000239 Celiprolol for peak identification 20 mg EPY0000311 Celiprolol hydrochloride 10 mg Celiprolol impurity I 0.02 mg EPY0000312 1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea EPY0000784 Cellulose acetate 40 mg EPY0001585 Cellulose acetate butyrate 60 mg EPY0001054 Cellulose acetate 10 mg EPC0700000 Cephaeline hydrochloride 15 mg EPC0980650 Cetirizine dihydrochloride 100 mg EPY0001197 Cetirizine for peak identification 1.01 mg Cetirizine impurity A 10 mg EPC0980651 (RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine EPC0984100 Cetostearyl isononanoate - Reference Spectrum unit EPC0990000 Cetyl alcohol 250 mg EPY0000073 Cetyl palmitate 15 60 mg EPY0000074 Cetyl palmitate 95 50 mg EPC1000000 Cetylpyridinium chloride 20 mg EPC1050000 Chenodeoxycholic acid 125 mg EPY0000104 Chitosan hydrochloride 30 mg EPC1100000 Chlorambucil 100 mg EPY0001298 Chlorambucil for system suitability 10 mg EPY0001299 Chlorambucil with impurity G 10 mg EPC1200000 Chloramphenicol 500 mg EPC1300000 Chloramphenicol dipalmitate 100 mg EPC1350000 Chloramphenicol disodium disuccinate 25 mg EPC1400000 Chloramphenicol palmitate isomer 100 mg EPC1425000 Chloramphenicol sodium succinate 1500 mg EPC1435000 Chlorcyclizine hydrochloride 100 mg EPC1450000 Chlordiazepoxide Controlled Substance 2x50 mg

24 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPC1500000 Chlordiazepoxide hydrochloride 100 mg Chlordiazepoxide impurity A 10 mg EPY0000476 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide EPC1510000 Chlorhexidine 50 mg EPC1520000 Chlorhexidine diacetate 10 mg EPC1540000 Chlorhexidine dihydrochloride 50 mg EPC1530000 Chlorhexidine for performance test 50 mg EPY0001545 Chlorhexidine for system suitability 15 mg EPY0001653 acetate 120 mg EPY0001638 for system suitability 10 mg EPY0001656 Chlormadinone acetate impurity G 20 mg EPY0000569 Chlorogenic acid 25 mg EPC1650000 Chloroquine sulphate 200 mg EPC1700000 Chlorothiazide 100 mg Chlorphenamine impurity A 0.01mg EPY0000436 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile Chlorphenamine impurity C 10 mg EPY0000437 (3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine EPC1800000 Chlorphenamine maleate 100 mg EPC1900000 hydrochloride 200 mg Chlorpromazine impurity A 15 mg 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- amine S-oxide EPY0000507 (chlorpromazine sulphoxide) Chlorpromazine impurity D 10 mg EPY0000479 3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (demethylchlorpromazine) Chlorpromazine impurity E 10 mg EPY0000508 2-chloro-10H-phenothiazine Chlorpromazine impurity F 2 mg EPY0001449 3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine EPC1905000 Chlorpropamide 100 mg Chlorpropamide impurity B 50 mg EPC1905020 1,3-Dipropylurea EPC1915000 Chlorprothixene hydrochloride 50 mg EPC1950000 Chlortalidone 150 mg EPY0000779 Chlortalidone for peak identification 1.017 mg EPY0001451 Chlortetracycline for system suitability 20 mg EPC2000000 Chlortetracycline hydrochloride 100 mg EPC2100000 Cholecalciferol 480 mg EPC2150000 Cholecalciferol for system suitability 1 mL EPC2155000 100 mg EPC2158000 Cholic acid 60 mg EPY0000280 Chondroitin sulfate sodium 250 mg EPY0000593 Chondroitin sulfate sodium (marine) 100 mg EPC2160000 Chymotrypsin BRP 100 mg EPY0001553 150 mg Ciclesonide containing impurity A 15 mg (2'S)-2'-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4',5':16,17]pregna-1,4-diene- EPY0001554 21-yl 2-methylpropanoate (S-epimer of ciclesonide) Ciclesonide impurity B 10 mg (2'R)-2'-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4',5':16,17]pregna-1,4-diene-3,20- EPY0001555 dione Ciclesonide impurity C 10 mg (2’R)-2’-[(1RS)-cyclohex-3-enyl]-11b-hydroxy-3,20-dioxo-16bH- EPY0001556 [1,3]dioxolo[4’,5’:16,17]pregna-1,4-diene-21-yl 2-methylpropanoate EPY0000040 Ciclopirox 100 mg

Edition 2014 Visit us at www.lgcstandards.com 25

European Pharmacopoeia

Code Product Unit Ciclopirox impurity A 40 mg EPC2162701 (RS)-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid Ciclopirox impurity B 20 mg EPC2162702 6-cyclohexyl-4-methyl-2H-pyran-2-one EPC2162700 Ciclopirox olamine 150 mg EPC2163000 Ciclosporin 120 mg EPY0000361 Ciclosporin for system suitability 5 mg EPY0001651 Cilastatin for system suitability 1 5 mg EPY0001652 Cilastatin for system suitability 2 5 mg EPC2170000 Cilastatin sodium 10 mg EPC2174000 Cilazapril 50 mg Cilazapril impurity A 25 mg 1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]amino]- EPC2174002 10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate Cilazapril impurity D 10 mg (1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10-oxo-octahydro-6H- EPC2174005 pyridazino[1,2a][1,2]diazepine-1-carboxylic acid EPC2175000 50 mg EPY0001130 Cimetidine for peak identification 10 mg EPY0001146 Cimetidine for system suitability 0.5085 mg EPC2175500 Cimetidine hydrochloride 100 mg EPC2177000 Cinchocaine hydrochloride 60 mg EPY0000176 Cineole 180 mg EPC2180000 Cinnarizine 100 mg EPY0000362 Ciprofibrate 5 mg EPY0000363 Ciprofibrate for system suitability 5 mg EPY0000198 20 mg EPC2190000 Ciprofloxacin hydrochloride 100 mg EPY0000199 Ciprofloxacin hydrochloride for peak identification 10 mg Ciprofloxacin impurity A 25 mg 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo--3-carboxylic acid EPC2190050 (fluoroquinolonic acid) EPC2210000 Cisplatin 100 mg Cisplatin impurity A 15 mg EPY0001018 trans-diamminedichloroplatinium (II) Cisplatin impurity B 15 mg EPY0001019 amminetrichloroplatinate (-) EPY0000855 Citalopram for system suitability (0.065 mg) 0.06 mg EPY0001008 Citalopram hydrobromide 5 mg EPY0001007 Citalopram hydrochloride 5 mg EPA1202000 Citric acid (anhydrous) 50 mg EPC2219000 Citric acid monohydrate 50 mg EPY0000639 Cladribine 50 mg EPY0000609 Cladribine for peak identification 10 mg Cladribine impurity C 5 mg EPY0000610 2-chloro-7H-purin-6-amine EPY0000320 Clarithromycin 160 mg EPY0000321 Clarithromycin for peak identification 40 mg EPY0001193 Clazuril 10 mg EPY0000269 Clazuril for system suitability 10 mg EPC2221000 Clebopride malate 100 mg EPY0001613 Clemastine for system suitability 0.165 mg EPC2223000 Clemastine Fumarate 100 mg EPC2248000 Clenbuterol hydrochloride 30 mg

26 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Clenbuterol impurity B 10 mg EPC2248010 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanone (clenbuterol ketone) EPC2250000 Clindamycin hydrochloride 200 mg EPC2269000 Clindamycin phosphate 250 mg EPY0000364 Clioquinol 5 mg EPY0000205 Clobazam - Reference Spectrum unit Clobazam impurity A 10 mg EPY0000241 7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5--2,4-dione EPY0000570 for peak identification 2 mg Clobetasol impurity J 0.4 mg (17R)-4'-chloro-5'-ethyl-9-fluoro-11ß-hydroxy-16ß-methylspiro[androsta-1,4-diene-17,2'(3'H)- EPY0000571 furan]-3,3'-dione (17 alpha-spiro compound) EPY0000559 40 mg EPC2285000 butyrate 50 mg EPY0001137 for system suitability 30 mg EPY0000888 Clodronate disodium tetrahydrate 5 mg Clodronate impurity D 5 mg EPY0000885 (chloromethylene)bis(phosphonic acid) EPY0000313 Clofazimine 150 mg EPY0000358 Clofazimine for system suitability 10 mg EPC2300000 Clofibrate 0.5 mL EPC2320000 citrate 50 mg EPC2332000 Clomifene citrate for performance test 50 mg EPC2360000 Clomipramine hydrochloride 100 mg Clomipramine impurity C 10 mg EPY0000132 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Clomipramine impurity D 10 mg 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl) EPY0000133 N,N-dimethylpropan-1-amine Clomipramine impurity F 5 mg EPY0000134 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine EPC2385000 50 mg EPY0000286 Clonazepam - Reference Spectrum unit Clonazepam impurity B 5 mg EPC2385015 3-Amino-4-(2-chlorophenyl)-6-nitro-1H-quinolin-2-one EPC2400000 Clonidine hydrochloride 100 mg Clonidine impurity B 20 mg EPY0000801 1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H- EPY0000833 Clopamide 40 mg EPY0000848 Clopamide for system suitability 10 mg EPY0001334 Clopidogrel for system suitability 100 mg EPY0001333 Clopidogrel hydrogen sulfate 60 mg Clopidogrel impurity A 10 mg EPY0001335 (2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid EPY0000393 Closantel for system suitability 20 mg EPY0000392 Closantel sodium dihydrate 20 mg Clostridia (multi-component) rabbit antiserum 1 mg EPC2424400 (for vaccines-vet.use) BRP Clostridium tetani guinea pig antiserum 1 mg EPC2424500 (for vaccines - vet.use) BRP Clostridium tetani guinea pig antiserum 3x1 mg EPC2424550 (for vaccines-human use) BRP Clostridium tetani rabbit antiserum 1 mg EPC2425600 (for vaccines - vet.use) BRP EPC2430000 100 mg EPY0000849 Clotrimazole for peak identification 1 mg

Edition 2014 Visit us at www.lgcstandards.com 27

European Pharmacopoeia

Code Product Unit Clotrimazole impurity E 15 mg EPY0000818 (2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) EPC2450000 Cloxacillin sodium 200 mg EPC2460000 Clozapine 60 mg EPY0000758 Clozapine for peak identification 0.41 mg EPY0001472 Coagulation Factors V, VIII, XI and XIII plasma 2x1 mg EPY0000162 hydrochloride - Reference Spectrum unit EPC2480000 Cocoyl caprylocaprate 40 mg EPY0000722 Controlled Substance 20 mg EPC2500000 Codeine - Reference Spectrum unit EPC2500100 Codeine hydrochloride dihydrate - Reference Spectrum unit Codeine impurity A 15 mg 7,8-didehydro-4,5α-epoxy-3,6α-dimethoxy-17-methylmorphinan EPY0000334 (o-methylcodeine) Controlled Substance EPC2510000 Codergocrine mesilate 60 mg EPY0001500 Coix seed HRS 1300 mg EPC2580000 15 mg EPY0000209 Colchicine for system suitability 10 mg EPY0000374 Colestyramine 10 mg EPC2600000 Colistimethate sodium 20 mg EPY0000277 Colistin sulfate 25 mg EPC2700000 Colistin sulfate for microbiological assay 25 mg EPC2725000 Copovidone - Reference Spectrum unit EPC2800000 acetate 250 mg EPC2900000 Cotton wool standard for neps 1000 mg EPY0000438 Coumarin 80 mg EPY0001053 Crospovidone 5 mg EPC2970000 Crotamiton 100 mg Crotamiton impurity A 70 mg EPC2970005 N-ethyl-N-(2-methylphenyl)but-3-enamide EPY0001061 Cyanidin chloride 25 mg EPC3000000 Cyanocobalamin 20 mg EPC3090000 Cyclizine hydrochloride 50 mg Cyclizine impurity A 15 mg EPY0000886 1-methylpiperazine Cyclizine impurity B 10 mg EPY0000887 diphenylmethanol (benzhydrol) EPC3200000 Cyclobenzaprine hydrochloride 100 mg EPC3230000 Cyclohexa-1,4-dienylglycine 15 mg EPY0001088 Cyclopentolate for system suitability 60 mg EPC3245000 Cyclopentolate hydrochloride 2x50 mg EPC3250000 Cyclophosphamide 50 mg EPC3280000 hydrochloride 30 mg Cyproheptadine impurity C 5 mg EPY0001095 5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol EPC3283000 acetate 30 mg EPY0001390 for peak identification 5 mg EPY0001223 Cyproterone impurity mixture 0.01 mg EPC3290000 Cysteine hydrochloride monohydrate 100 mg EPC3300000 Cystine 100 mg EPC3350000 Cytarabine 150 mg EPY0001620 2,4-Dichlorobenzyl alcohol 250 mg EPY0001621 2,4-Dichlorobenzyl alcohol impurity A 25 mg

28 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit 2,4-Dichlorobenzyl alcohol impurity C 25 mg EPY0001622 3,4-Dichlorobenzyl alcohol EPY0000019 4-D-Ser- 0.1 mg EPY0000733 Dacarbazine 20 mg Dacarbazine impurity A 20 mg EPY0000734 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2-azahypoxanthine) Dacarbazine impurity B 10 mg EPY0000735 5-amino-1H-imidazole-carboxamide D-alpha-(4-Hydroxy-phenyl) 50 mg EPH1430000 (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A EPD0070000 Dalteparin sodium 250 mg EPY0000600 Danaparoid sodium 10 mg EPD0100000 Dapsone 100 mg EPD0125000 Daunorubicin hydrochloride 120 mg Daunorubicinone 10 mg EPD0120000 Daunorubicin aglycone EPD0160000 Deferoxamine mesilate 30 mg Dehydrohexetidine 2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4- 50 mg EPD0201000 yl]methyl]hexan-1-amine EPC0640000 Delta-3-Cefaclor 20 mg EPY0000611 Dembrexine hydrochloride monohydrate 10 mg EPD0300000 Demeclocycline hydrochloride 100 mg EPY0000228 Demethylflumazenil - Reference Spectrum unit EPD0406200 Deptropine citrate 60 mg EPD0430000 Dequalinium chloride 50 mg EPD0431000 Dequalinium chloride for performance test 50 mg EPY0001321 Dermatan sulfate and oversulfated chondroitin sulfate 1 mL EPD0480000 Desacetylvinblastine 2x1 mg EPY0000879 Desflurance - Reference Spectrum unit impurity A 1 mL EPY0000807 1,1'-oxybis(1,2,2,2-tetrafluoroethane) EPD0500000 Desipramine hydrochloride 100 mg EPD0600000 Deslanoside 150 mg EPY0001584 Desloratadine 100 mg EPY0001582 Desloratadine for system suitability 5 mg EPD0630000 Desmethylmetrifonate 30 mg EPD0650000 Desmopressin 0.94 mg EPY0000509 50 mg EPY0000510 Desogestrel for system suitability 10 mg EPD0400000 Desoxycortone acetate 100 mg EPY0000001 Detomidine hydrochloride 100 mg Detomidine impurity B 20 mg EPD0660020 (RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol EPD0700000 50 mg EPD0710000 100 mg Dexamethasone acetate impurity E 0.013 mg EPY0001169 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl acetate EPY0001593 Dexamethasone for peak identification 10 mg EPY0001177 Dexamethasone for system suitability 10 mg EPY0000538 Dexamethasone isonicotinate 10 mg EPY0000511 Dexamethasone isonicotinate for impurity C identification 10 mg EPD0718000 Dexamethasone pivalate 50 mg EPD0720000 Dexamethasone sodium phosphate 100 mg EPY0001477 Dexamethasone sodium phosphate for peak identification 10 mg

Edition 2014 Visit us at www.lgcstandards.com 29

European Pharmacopoeia

Code Product Unit EPD0720800 Dexchlorpheniramine maleate 60 mg EPD0730000 Dexpanthenol 5 mg EPD0731000 Dextran 25 mg EPD0731005 Dextran 1 50 mg EPD0734000 Dextran 10 for calibration 50 mg EPD0737000 Dextran 250 for calibration 50 mg EPD0733000 Dextran 4 for calibration 50 mg EPD0735000 Dextran 40 for calibration 50 mg EPD0738000 Dextran 40 for performance test 50 mg EPD0739000 Dextran 60/70 for performance test 50 mg EPD0736000 Dextran 70 for calibration 50 mg EPD0732000 Dextran Vo 10 mg EPY0000744 Dextranomer 50 mg EPD0740000 hydrobromide 100 mg Dextromethorphan impurity A 5 mg EPY0000261 ent-3-methoxymorphinan EPY0001150 for system suitability Controlled Substance 5 mg EPY0001058 Dextropropoxyphene hydrochloride Controlled Substance 10 mg EPP3760020 D-His Protirelin 0.1 mg EPB1168020 D-His-Buserelin 0.5 mg EPY0001595 Diacerein 150 mg EPY0001596 Diacerein impurity B 20 mg EPY0001597 Diacerein impurity mixture 0.014 mg EPY0000454 Diacetylfluorescein 100 mg EPD0940000 30 mg EPY0000596 Diazepam for system suitability Controlled Substance 0.5 mg EPD0950000 Diazoxide 50 mg EPD0970000 Dibenzocycloheptene 20 mg EPD1000000 Dibenzosuberone 30 mg EPY0000480 Dibrompropamidine diisetionate 10 mg EPY0000481 Dibrompropamidine for system suitability 20 mg EPD1010000 Dibutyl phthalate 1 mL EPY0000275 Dichlorodiaminocyclohexaneplatinum 15 mg EPY0000259 Diclazuril for system suitability 20 mg EPY0000264 Diclazuril for veterinary use - Reference Spectrum unit EPY0001635 Diclofenac for system suitability (1.002 mg) 1 mg Diclofenac impurity A 0.005 mg EPD1040000 1-(2,6-dichlorophenyl)-indolin-2-one EPD1039990 Diclofenac potassium 100 mg EPS0765000 Diclofenac sodium 100 mg EPD1050000 Dicloxacillin sodium 250 mg EPD1060000 Dicycloverine hydrochloride 100 mg EPY0000439 Didanosine 10 mg EPY0000440 Didanosine for system suitability 10 mg Didanosine impurity A 10 mg EPY0000441 1,7-dihydro-6H-purin-6-one (hypoxanthine) Didanosine impurity G 10 mg 9-(2,3-dideoxy-β-D-glycero-pentofuranosyl)-9H-purin-6-amine EPY0000442 (2',3'-dideoxyadenosine) EPD1200000 150 mg EPD1410000 Diethyl phthalate 1 mL EPD1300000 Diethylcarbamazine citrate 250 mg EPY0000217 Diethylene glycol (monoethyl ether) - Reference Spectrum unit

30 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPD1500000 100 mg EPD1600000 Diethylstilbestrol dimethyl ether 10 mg EPD1700000 Diethylstilbestrol monomethyl ether 10 mg EPY0001423 Difloxacin hydrochloride 60 mg Difloxacin impurity G 15 mg EPY0001429 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid EPD1750000 Diflunisal 30 mg EPD1800000 200 mg EPY0000640 Digoxigenin 10 mg EPD1900000 Digoxin 30 mg EPY0000554 Digoxin for peak identification 10 mg EPY0000232 Dihydralazine for system suitability 10 mg EPD1940001 Dihydralazine sulphate (hydrated) - Reference Spectrum unit EPY0000216 hydrogen tartrate - Reference Spectrum unit EPD1945000 Dihydroergocristine mesilate 250 mg EPY0000831 Dihydroergotamine for peak identification 10 mg EPD1950000 Dihydroergotamine mesilate 100 mg EPD1952000 Dihydroergotamine tartrate 150 mg EPD1954000 Dihydrostreptomycin sulfate (for LC assay) 25 mg EPY0000544 Dihydrotachysterol 30 mg EPY0000482 Dihydrotachysterol for system suitability 5 mg EPY0001141 Diltiazem for system suitability 10 mg EPD1980000 Diltiazem hydrochloride 300 mg Diltiazem impurity F 10 mg (2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5- EPY0001439 benzothiazepin-4(5H)-one EPD2000000 Dimenhydrinate 100 mg EPY0001103 Dimenhydrinate for peak identification 1 mg EPD2050000 Dimethyl sulfoxide 1 mL EPD2200000 Dimeticone 200 mg EPD2205000 Dimetindene maleate 50 mg EPD2255000 Dinoprost trometamol 60 mg EPD2250000 Dinoprostone 100 mg Dinoprostone impurity C 10 mg (E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- EPD2250015 5-oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2;(5E)-PGE2) EPY0000094 Diosmin 70 mg EPY0000095 Diosmin for system suitability 5 mg EPD2600000 Diphenhydramine hydrochloride 100 mg Diphenhydramine impurity A 10 mg EPY0000135 2-(diphenylmethoxy)-N-methylethanamine EPY0001430 for system suitability 10 mg EPY0001415 Diphenoxylate hydrochloride 15 mg EPD2630000 Diphenoxylate hydrochloride - Reference Spectrum unit EPY0000258 Diphtheria toxin BRP 1 mL EPD2700000 Diphtheria vaccine (absorbed) BRP 32 mg EPY0000394 Dipivefrine for system suitability 10 mg EPY0000376 Dipivefrine hydrochloride 100 mg EPD2750100 Dipotassium clorazepate - Reference Spectrum unit EPD2800000 Diprophylline 100 mg EPD2850000 Dipyridamole 50 mg EPY0000802 Dipyridamole for peak identification 2 mg EPD2880000 Dirithromycin 100 mg

Edition 2014 Visit us at www.lgcstandards.com 31

European Pharmacopoeia

Code Product Unit EPD2900000 Disodium edetate 100 mg EPD2920000 Disopyramide 100 mg EPD2922000 Disopyramide phosphate 100 mg EPD2950000 Disulfiram 100 mg EPD2953000 Dithranol 55 mg Dithranol impurity C 15 mg EPD2953025 Dithranol-dimer 4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione Dithranol impurity D 20 mg EPD2953050 1-hydroxyanthracen-9(10H)-one EPM0950000 DL-Methionine 50 mg EPD2954000 Dobutamine hydrochloride 100 mg EPY0001239 Dobutamine impurity mixture 0.1 mg EPY0001155 Docetaxel for system suitability 10 mg Docetaxel impurity E 15 mg 5ß,20-epoxy-4-(acetyloxy)-1,7ß,10ß,13-tetrahydroxy-9-oxotax-11-en-2-yl benzoate (10- EPY0001452 desacetyl-baccatin III) EPY0001133 Docetaxel trihydrate 160 mg EPD2954600 Docosahexaenoic acid ethyl 150 mg EPY0001567 Docusate sodium 10 mg EPD2954500 Docusate sodium - Reference Spectrum unit EPY0000365 Dodecyl gallate 30 mg EPD2955000 150 mg EPD2957000 Domperidone maleate 150 mg EPD2960000 Dopamine hydrochloride 50 mg EPY0000612 Dopexamine dihydrochloride 10 mg Dopexamine impurity B 10 mg EPY0000613 2-methoxy-4-[2-[[6-[(2-phenylethyl)hexyl]amino]ethyl] Dopexamine impurity F 10 mg EPY0000614 4-Chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol EPY0000750 Dorzolamide for system suitability 5 mg EPY0000726 Dorzolamide hydrochloride 50 mg Dorzolamide impurity A 5 mg (4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b] EPY0000727 thiopyran-2-sulphonamide 7,7-dioxide EPD2962000 Dosulepin hydrochloride 100 mg Dosulepin impurity A 30 mg (E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)- EPD2962005 N,N'-dimethylpropan-1-amine S-oxide EPD2963000 Doxapram hydrochloride 50 mg Doxapram impurity B 10 mg EPY0000208 (4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one Doxazosin impurity D 10 mg EPY0000551 6,7-dimethoxyquinazoline-2,4(1H,3H)-dione Doxazosin impurity F 15 mg EPY0000552 2-chloro-6,7-dimethoxyquinazolin-4-amine EPY0000553 Doxazosin mesilate 60 mg EPY0000851 Doxepin for system suitability 1 mg EPY0000838 Doxepin hydrochloride 5 mg EPD2975000 Doxorubicin hydrochloride 150 mg EPD3000000 Doxycycline hyclate 50 mg EPY0001492 Doxylamine for system suitability 100 mg EPY0001562 Doxylamine hydrogen succinate 60 mg EPY0000163 Doxylamine hydrogen succinate - Reference Spectrum unit EPD3100000 Droperidol 150 mg EPY0001105 60 mg

32 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Drospirenone impurity E 0.06 mg 3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa EPY0001115 [6,7:15,16]pregn-4-ene-21,17-carbolactone (17-epidrospirenone) EPY0001454 Duloxetine for system suitability 40 mg EPY0001453 Duloxetine hydrochloride 120 mg Duloxetine impurity A 10 mg EPY0001455 (3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine EPY0001598 Dutasteride 150 mg EPY0001603 Dutasteride for system suitability 10 mg EPY0001004 50 mg Dydrogesterone impurity A 6 mg EPY0001005 9β,10-pregna-4,6,8(14)-triene-3,20-dione Dydrogesterone impurity B 5 mg EPY0001006 pregna-4,6-diene-3,20-dione EPE0400000 4-Epianhydrotetracycline hydrochloride 20 mg EPE0440000 4-Epidemeclocycline hydrochloride 20 mg EPE0530000 4-Epioxytetracycline 40 mg EPE0600000 4-Epitetracycline hydrochloride 30 mg EPY0000249 Ebastine - Reference Spectrum unit Ebastine impurity C 10 mg EPY0000247 4-(diphenylmethoxy)piperidine Ebastine impurity D 10 mg EPY0000248 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one EPY0001236 Econazole 10 mg EPY0000254 Econazole for system suitability 20 mg EPE0050000 Econazole nitrate 100 mg EPE0085000 Eicosapentaenoic acid ethyl ester 200 mg EPY0000537 Emedastine difumarate 10 mg Emedastine impurity E 10 mg EPY0000512 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole EPE0100000 Emetine hydrochloride 100 mg EPE0110000 Enalapril for system suitability 20 mg EPY0001211 Enalapril impurity mixture 0.06 mg EPE0109000 Enalapril maleate 50 mg EPY0000615 Enalaprilat dihydrate 100 mg EPY0000629 Enalaprilat for system suitability 10 mg Enalaprilat impurity G 0.005 mg (2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo EPY0000678 [1,2-a]pyrazin-2(1H)-4-phenylbutanoic acid EPE0150000 Endotoxin standard BRP 10 mg EPY0000136 Enilconazole 60 mg Enilconazole impurity E 20 mg EPY0000137 (1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol EPE0180000 Enoxaparin sodium 200 mg EPE0180500 100 mg EPY0001259 Enrofloxacin 5 mg EPY0001160 Enrofloxacin for system suitability 10 mg EPY0001249 Entacapone 160 mg Entacapone impurity A 10 mg EPY0001250 Z isomer of entacapone EPE0200000 Enterokinase BRP 200 mg EPE0305000 Ephedrine hydrochloride (racemic) Drug Precursor 50 mg EPE0300000 Ephedrine hydrochloride Drug Precursor 150 mg EPY0001139 Epinastine hydrochloride 20 mg EPY0001128 Epinastine hydrochloride for system suitability 10 mg

Edition 2014 Visit us at www.lgcstandards.com 33

European Pharmacopoeia

Code Product Unit EPE0550000 Epirubicin hydrochloride 100 mg EPE0850010 Eq influenza Subtype 1 Strain A/eq/Newmarket/77 Horse Antiserum BRP 3x1 mg EPE0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse Antiserum BRP 3x1 mg EPE0850021 Eq influenza Subtype 2 American-like/Newmarket Horse Antiserum BRP 3x1 mg EPY0000712 Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP 3x1 mg EPY0000052 15 mg EPY0001325 Equisetum palustre 200 mg EPE0900000 Ergocalciferol 500 mg EPE1000000 Ergometrine maleate Drug Precursor 50 mg EPE1100000 Ergosterol 20 mg EPE1200000 Ergotamine tartrate Drug Precursor 100 mg EPY0000051 Erysipelas ELISA coating antigen BRP 0.4 mg EPY0000177 Erythritol 1000 mg EPE1305000 Erythromycin A 250 mg EPE1310000 Erythromycin B 50 mg EPE1320000 Erythromycin C 50 mg EPE1400000 Erythromycin estolate 100 mg EPE1500000 Erythromycin ethylsuccinate 10 mg EPE1300000 Erythromycin for microbiological assay 250 mg EPE1500800 Erythromycin stearate 50 mg EPE1515000 Erythropoietin BRP 37.5 mg EPY0001611 Esculetin 25 mg EPY0001612 Esculin 25 mg EPY0000324 Esketamine hydrochloride - Reference Spectrum unit Esketamine impurity D 10 mg EPY0000338 (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-) EPY0001660 Esomeprazole dihydrate 15 mg EPY0001028 Esomeprazole magnesium trihydrate 5 mg EPY0000749 Essential oil 1000 mg EPE1600000 benzoate 250 mg EPY0000852 for system suitability 10 mg EPY0000045 Estradiol butyrate 10 mg EPY0000314 Estradiol for peak identification 10mg EPE1620000 Estradiol hemihydrate 100 mg EPY0000046 50 mg EPE1680000 50 mg Estriol impurity A 20 mg EPE1680005 9,11-didehydroestriol EPE1700000 15 mg EPE1800000 Etacrynic acid 100 mg EPY0001263 Etacrynic acid for system suitability 10 mg EPE1830000 Etamsylate 30 mg EPE1840000 Ethacridine lactate monohydrate 50 mg EPY0000803 Ethambutol for system suitability 10 mg EPE1850000 Ethambutol hydrochloride 250 mg EPA1202800 Ethanol (anhydrous) - Reference Spectrum unit EPE1860100 Ethanol 96% - Reference Spectrum unit EPE1900000 200 mg EPY0001124 Ethinylestradiol for system suitability (1.0124 mg) 1 mg EPE2000000 Ethionamide 100 mg EPE2150000 Ethosuximide 30 mg

34 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Ethosuximide impurity A 30 mg EPE2250000 (2RS)-2-ethyl-2-methylbutanedioic acid EPE2195000 Ethyl acetate - Reference Spectrum unit EPY0000617 Ethyl indole-3-carboxylate 10 mg EPE2425000 Ethyl parahydroxybenzoate 150 mg EPY0001633 Ethylcellulose 100 mg EPE2195900 Ethylcellulose - Reference Spectrum unit EPE2300000 hydrochloride - Reference Spectrum unit EPE2400000 Ethylnicotinamide 150 mg EPY0000572 Etidronate disodium 10 mg EPE2450000 Etifenin 25 mg EPE2451000 Etilefrine hydrochloride 75 mg Etilefrine impurity A 20 mg EPE2451010 2-ethylamino-1-(3-hydroxyphenyl)ethanone EPE2470000 Etodolac 60 mg EPY0000768 Etodolac for peak identification 10 mg Etodolac impurity H 10 mg EPE2470050 2-(7-ethylindol-3-yl)ethanol EPE2499900 Etofenamate 40 mg EPE2499901 Etofenamate for peak identification 20 mg Etofenamate impurity G 25 mg EPE2499914 2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate EPE2500000 Etofylline 100 mg EPE2503000 50 mg Etomidate impurity B 25 mg EPE2503004 methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate EPE2600000 Etoposide 150 mg EPY0001365 Etoposide for system suitability 10 mg EPY0001605 Eucommia bark HRS 2100 mg EPE5000000 500 µL EPF0005000 Famotidine 100 mg EPY0000382 Famotidine for system suitability 10 mg Famotidine impurity D 10 mg EPY0000409 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide EPY0000556 Febantel 110 mg EPY0000660 Febantel for system suitability 10 mg EPY0000731 Felbinac 10 mg Felbinac impurity A 20 mg EPY0000732 4-acetyl biphenyl EPF0030000 Felodipine 120 mg EPY0000415 Felypressin 0.994 mg EPF0040000 Fenbendazole 150 mg Fenbendazole impurity A 20 mg EPF0040010 methyl(1H-benzimidazol-2-yl)carbamate Fenbendazole impurity B 25 mg EPF0040020 methyl[5(6)-chlorobenzimidazol-2-yl]carbamate EPF0041000 Fenbufen 100 mg EPF0048000 Fenofibrate 100 mg Fenofibrate impurity A 20 mg EPF0048005 (4-chlorophenyl)(4-hydroxyphenyl)methanone Fenofibrate impurity B 10 mg EPF0048010 2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid) Fenofibrate impurity G 25 mg 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl] EPF0048035 oxy]-2-methylpropanoate EPY0000756 Fenoterol for peak identification 1.2 mg

Edition 2014 Visit us at www.lgcstandards.com 35

European Pharmacopoeia

Code Product Unit EPF0050000 Fenoterol hydrobromide 100 mg EPF0054990 - Reference Spectrum unit EPF0055000 Fentanyl citrate - Reference Spectrum unit EPY0001509 Fentanyl for system suitability 25 mg Fenticonazole impurity D 0.01 mg (RS)-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3- EPF0060040 [4-(phenyl suphanyl)benzyl]imidazolium nitrate EPF0060000 Fenticonazole nitrate 50 mg EPF0100000 Ferrous gluconate 100 mg EPY0001013 Ferulic acid 20 mg EPY0000789 Fexofenadine hydrochloride 60 mg Fexofenadine impurity A 5 mg 2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] EPY0000751 butanoyl]phenyl]-2-methylpropanoic acid Fexofenadine impurity B 0.01 mg 2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl]-2- EPY0000752 methylpropanoic acid Fexofenadine impurity C 5 mg EPY0000753 (1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)phenyl]butan-1-ol EPY0001173 Filgrastim 0.2ml EPY0000090 Finasteride 60 mg EPY0001604 Finasteride for peak identification 15 mg EPY0000091 Finasteride for system suitability 120 mg EPY0000736 Flavoxate hydrochloride 10 mg Flavoxate impurity A 10 mg EPY0000737 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid Flavoxate impurity B 10 mg EPY0000738 ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate EPF0120000 Flecainide acetate 10 mg EPY0001274 Flecainide for system suitability 10 mg Flecainide impurity A 50 mg 3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a- EPF0120005 hexahydroimidazo[1,5-a]pyridine Flecainide impurity B 25 mg EPF0120010 (RS)-(piperidin-2-yl)methanamine EPY0001606 Fleeceflower root HRS 300 mg EPY0000138 Flubendazole 25 mg EPY0000139 Flubendazole for system suitability 20 mg Flucloxacillin impurity C 5 mg EPY0000889 6-aminopenicillanic acid Flucloxacillin impurity D 5 mg EPY0000890 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid Flucloxacillin impurity E 5 mg EPY0000891 6-aminopenicillanic acid flucloxacillin amide EPY0000892 Flucloxacillin magnesium octahydrate 5 mg EPF0150000 Flucloxacillin sodium 250 mg EPY0000557 Fluconazole 50 mg EPY0000558 Fluconazole for peak identification 10 mg Fluconazole impurity B 10 mg EPY0000573 2-[2-fluro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol Fluconazole impurity C 5 mg EPY0000574 1,1´-(1,3-phenylene)di-1H-1,2,4-triazole EPF0175000 Flucytosine 100 mg EPY0001262 Flucytosine for system suitability 10 mg EPY0001536 Fludarabine for system suitability 15 mg EPY0000419 Fludarabine phosphate 120 mg EPF0180000 acetate 100 mg

36 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPF0188000 - Reference Spectrum unit Flumazenil impurity B 5 mg ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo EPY0000335 [1,5-a][1,4]benzodiazepine-3-carboxylate EPF0189000 Flumequine 60 mg Flumequine impurity B 0.1 mg ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] EPF0189020 quinolizine-2-carboxylate EPF0188500 pivalate 100 mg EPF0189900 Flunarizine dihydrochloride 100 mg EPY0000265 Flunarizine dihydrochloride - Reference Spectrum unit EPY0000266 Flunarizine dihydrochloride for system suitability 20 mg EPF0190000 100 mg EPY0000169 Flunitrazepam - Reference Spectrum unit Flunixin impurity B 10 mg EPY0000444 2-methyl-3-(trifluoromethyl)aniline Flunixin impurity C 50 mg EPY0000445 ethyl 2-chloropyridine-3-carboxylate EPY0000443 Flunixin meglumine 10 mg EPF0200000 acetonide 100 mg EPF0230000 pivalate 100 mg EPY0000796 Fluorescein 120 mg Fluorescein impurity C 0.01 mg EPY0000804 2-(2,4-dihydroxybenzoyl)benzoic acid EPF0245000 Fluoresceine sodium - Reference Spectrum unit EPF0250000 Fluorouracil 40 mg Fluorouracil impurity A 10 mg EPY0000762 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) Fluorouracil impurity B 15 mg EPY0000763 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil) Fluorouracil impurity C 10 mg EPY0000764 pyrimidine-2,4(1H,3H)-dione (uracil) Fluorouracil impurity F 10 mg EPY0000765 2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil) EPY0000791 Fluorouracil impurity mixture 0.0002 mg EPF0253000 hydrochloride 250 mg Fluoxetine impurity B 10 mg EPF0253020 methyl(3-phenylpropyl)amine Controlled Substance Fluoxetine impurity C 5 mg EPF0253030 (RS)-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl]amine EPY0000064 Flupentixol dihydrochloride 100 mg Flupentixol impurity D 15 mg 2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl] EPY0000067 piperazin-1-yl]ethoxy]ethanol Flupentixol impurity F 25 mg 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl)prop-2-enyl]- EPY0000078 piperazin-1-yl]ethanol EPF0260000 Fluphenazine decanoate 60 mg EPF0280000 Fluphenazine dihydrochloride 50 mg EPY0000009 Fluphenazine enantate 100 mg EPY0000708 Fluphenazine impurity mixture 0.07 mg EPY0000298 Fluphenazine octanoate 20 mg EPY0000299 Fluphenazine sulphoxide 10 mg EPY0000211 monohydrochloride - Reference Spectrum unit EPF0285200 Flurbiprofen 50 mg Flurbiprofen impurity A 25 mg EPF0285202 (2RS)-2-(biphenyl-4-yl)propanoic acid

Edition 2014 Visit us at www.lgcstandards.com 37

European Pharmacopoeia

Code Product Unit EPY0000236 Fluspirilene 20 mg Fluspirilene impurity C 10 mg 8-[4,4-bis((4-fluorophenyl)butyl]-3-(hydroxymethyl)-1- EPY0000375 phenyl-1,3,8-triazaspiro[4.5]decan-4-one EPF0285600 50 mg EPY0001591 Flutamide for system suitability 10 mg Flutamide impurity C 20 mg EPF0285603 N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide impurity D 20 mg S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17a-propionyloxy-androsta-1,4- EPY0000221 diene-17β-carbothioate (S-methyl derivative) EPY0000284 100 mg EPF0290000 Flutrimazole 100 mg Flutrimazole impurity B 60 mg EPF0290010 (RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol EPY0001082 Fluvastatin for system suitability 0.5 mg EPY0001090 Fluvastatin sodium 110 mg EPY0000853 Fluvoxamine for system suitability 1.004 mg Fluvoxamine impurity D 10 mg EPY0000916 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one EPY0000854 Fluvoxamine maleate 5 mg Foeniculin for peak identification 100 mg EPY0000386 Anise oil EPF0300000 Folic acid 2x300mg Folic acid impurity A 15 mg (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid EPY0001242 (N-(4-aminobenzoyl)-l-) Folic acid impurity D 70 mg EPY0001243 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid) EPY0001629 Follitropin 0.2 mL EPY0000339 Formoterol for impurity I identification 10 mg EPF0372000 Formoterol fumarate dihydrate 10 mg EPY0000340 Formoterol fumarate for system suitability 10 mg Formylfolic acid 30 mg EPF0380000 10-Formylfolic acid Foscarnet impurity B 10 mg EPF0389004 disodium(ethoxyoxydophosphanyl)formate Foscarnet impurity D 50 mg EPY0001222 Ethyl (diethoxyphosphinyl)formate EPY0001213 Foscarnet impurity mixture 0.012 mg EPF0389000 Foscarnet sodium hexahydrate 50 mg EPY0000782 Fosfomycin calcium 10 mg EPF0399950 Fosfomycin sodium - Reference Spectrum unit EPF0400000 Fosfomycin trometamol 1500 mg Fosinopril impurity A 5 mg (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl] EPY0001228 acetyl]pyrrolidine-2-carboxylic acid Fosinopril impurity B 5 mg (2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4- EPY0001229 phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Fosinopril impurity C 10 mg mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4- phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and (2S,4S)-4-cyclohexyl-1-[[(R)- [(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2- EPY0001230 carboxylic acid Fosinopril impurity D 10 mg (2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl- 1-(1-oxopropoxy)propoxy](4-phenylbutyl) EPY0001231 phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

38 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Fosinopril impurity I 5 mg [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl) EPY0001232 phosphoryl]acetic acid Fosinopril impurity K 5 mg (2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl) EPY0001233 pyrrolidine-2-carboxylic acid EPY0001212 Fosinopril impurity mixture 0.02 mg EPY0001227 Fosinopril sodium 60 mg EPF0450000 Framycetin sulphate 2x25 mg EPF0550000 100 mg EPY0001399 120 mg EPY0001413 Fulvestrant for system sitability 40 mg EPF0600000 Fumaric acid 120 mg EPF0700000 100 mg EPY0001493 Furosemide for peak identification 10 mg Furosemide impurity A 5 mg EPF0702000 2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid EPY0001411 Fusidic acid 10 mg EPY0001394 Fusidic acid for peak identification 5 mg EPY0001384 Fusidic acid impurity mixture 0.0475 mg EPY0001280 Gabapentin 300 mg Gabapentin impurity A 20 mg EPY0001281 2-azaspiro[4.5]decan-3-one Gabapentin impurity B 20 mg EPY0001348 (1-cyanocyclohexyl)acetic acid Gabapentin impurity D 10 mg EPY0001349 [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid EPG0049000 Galactitol 50 mg EPG0050000 60 mg EPY0001279 Galantamine hydrobromide 10 mg EPY0001190 Galantamine natural for system suitability 10 mg EPY0001201 Galantamine racemic mixture 10 mg EPY0001191 Galantamine synthetic for system suitability 5 mg EPG0150000 Gammacyclodextrin 60 mg EPY0001129 Ganciclovir 220 mg EPY0001144 Ganciclovir impurity mixture 0.005 mg EPY0000675 Gemcitabine hydrochloride 50mg Gemcitabine impurity A 20 mg EPY0000676 4-aminopyrimidin-2(1H)-one (Cytosine) EPY0000513 Gemfibrozil 5 mg EPY0000514 Gemfibrozil for system suitability 0.196 mg EPY0001363 Gentamicin for peak identification 10 mg EPG0200000 Gentamicin sulphate 2x25 mg EPY0001112 100 mg EPY0001110 Gestodene for system suitability 10 mg Gestodene impurity I 0.01 mg EPY0001116 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20-yn-3-one EPY0001012 Ginkgo dry extract for peak identification 150 mg EPY0001010 Ginkgolic Acid 20 mg EPY0001029 dry extract 500 mg EPY0001347 Ginsenoside Rb1 30 mg EPG0300000 Gitoxin 30 mg EPG0325000 Glibenclamide 100 mg EPY0001511 Glibenclamide for peak identification 30 mg

Edition 2014 Visit us at www.lgcstandards.com 39

European Pharmacopoeia

Code Product Unit Glibenclamide impurity A 10 mg EPG0325010 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide Glibenclamide impurity B 20 mg EPY0000242 methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl] sulphonyl]carbamate EPG0326000 Gliclazide 20 mg Gliclazide impurity B 25 mg EPG0326004 2-nitroso-octahydrocyclopenta[c]pyrrole Gliclazide impurity F 50 mg EPG0326012 1-(hexahydrocyclopenta[c]pyrrol-2-(1H)-yl-3-[(2-methylphenyl)sulphonyl]urea EPY0000515 Glimepiride 60 mg EPY0000516 Glimepiride for system suitability 0.012 mg EPG0340000 Glipizide 50 mg Glipizide impurity A 10 mg EPG0342000 4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide Glipizide impurity C 10 mg EPY0000523 ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate Glipizide impurity D 10 mg EPY0000643 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide EPY0001140 Glipizide impurity mixture 0.002 mg EPY0001381 Glucosamine for system suitability 40 mg EPY0001406. Glucosamine hydrochloride 10 mg EPY0001407 Glucosamine sulfate sodium chloride 15 mg EPG0350500 Glucose 100 mg EPG0355000 Glutamic acid 50 mg EPY0000517 Glutathione 10 mg EPG0360000 50 mg EPG0400000 Glycerol (85 per cent) - Reference Spectrum unit EPY0001391 Glycerol formal 2x20 mg EPY0000794 Glycerol monocaprylate 400 mg EPY0000795 Glycerol monocaprylocaprate 500 mg EPG0400006 Glycerol monolinoleate 2000 mg EPG0400007 Glycerol mono-oleate 2500 mg EPG0400008 Glycerol monostearate 40-55 2000 mg EPG0400101 Glyceryl trinitrate - Reference Spectrum unit EPG0400100 Glyceryl trinitrate solution 0.5 mL EPG0450000 Glycine 50 mg EPY0001308 Glycopyrronium bromide 10 mg EPY0001309 Glycopyrronium for peak identification 10 mg Glycopyrronium impurity N 10 mg EPY0001358 (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium EPG0460000 Glycyrrhizate (monoammonium) 300 mg EPG0525000 Gonadorelin 5 mg EPY0000125 Goserelin 2 mg EPY0001473 Goserelin for NMR identification 14 mg EPY0000194 Goserelin validation mixture 1 mg EPY0000126 Gosereline - Reference Spectrum unit EPG0550000 Gramicidin 250 mg EPY0000396 Granisetron hydrochloride 120 mg Granisetron impurity A 1 mg 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1] EPY0000477 non-3-yl]-2H-indazole-3-carboxamide Granisetron impurity B 1 mg EPY0000478 N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide Granisetron impurity E 2x15 mg EPY0000395 (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine

40 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPG0600000 Griseofulvin 50 mg EPY0000619 Guaiacol 1500 mg EPG0700000 Guaifenesin 100 mg EPH1429700 4-Hydroxyphenoxymethylpenicillin potassium 20 mg EPY0000117 Halofantrine hydrochloride 125 mg Halofantrine impurity C 10 mg EPY0000118 [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol EPH0100000 60 mg EPH0100100 Haloperidol decanoate 60 mg EPY0001518 Haloperidol for peak identification 25 mg EPY0001517 Haloperidol for system suitability 25 mg EPH0150000 - Reference Spectrum unit EPY0000673 Harpagoside 1.03 mg EPY0001287 Heparin calcium for NMR identification 30 mg EPY0001282 Heparin for Physio-Chemical Analysis 300 mg EPH0185000 Heparin Low-Molecular-Mass for assay BRP 5x1 mg EPH0190000 Heparin Low-Molecular-Mass for calibration CRS 25 mg EPH0200000 Heparin sodium BRP 2 mL EPY0001283 Heparin sodium for NMR identification 30 mg EPH0205010 Hepatitis A vaccine (inactivated,absorbed) Type B BRP 3x0.5 mL EPY0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) 3x0.8 mL EPY0001624 Hepatitis A virus Coating Reagent for ELISA - BRR 1 mL EPY0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) 2x0.5 mL EPH0210010 Hepatitis B vaccine (rDNA) BRP method B 2x1 mL EPH0220000 Heptadecanol 2x600 mg EPY0000063 Heptaminol hydrochloride 150 mg Heptaminol impurity A 20 mg EPY0000057 (2RS)-6-methylhept-5-en-2-amine EPY0001203 Hesperidin 20 mg EPH0330000 Hexamidine diisetionate 20 mg EPH0325000 Hexetidine 100mg EPH0420000 Hexylresorcinol 100 mg EPH0500000 Hide Powder 500 mg EPH0600000 dihydrochloride 250 mg EPH0750000 Histidine 100 mg EPH0755000 Histidine hydrochloride monohydrate 100 mg EPH0800000 Homatropine hydrobromide 100 mg EPH0830000 Homatropine methylbromide 25 mg EPY0001383 Homatropine methylbromide for system suitability 5 mg EPY0001290 20 mg EPH0900000 Human albumin for electrophoresis BRP 1 mL EPY0000219 Human anti-D immunoglobulin BPR unit EPH0920000 Human coagulation factor VIII concentrate BRP 5x37 mg EPH0920500 Human coagulation factor IX concentrate BRP 5x30 mg EPY0000667 Human coagulation factor VII concentrate BRP 2x26 mg EPY0000191 Human glucagon 2x2.94mg EPH0950000 Human hepatisis A immunoglobulin BRP 3x10 mg EPY0001414 Human Hepatitis B immunoglobulin 100 mg EPY0000488 Human immunoglobulin (molecular size) BRP 3x700 mg EPY0001504 Human immunoglobulin BRP (ACA and Molecular size) 6000 mg EPY0001512 Human Immunoglobulin BRP (Fc Function and Molecular size) 9000 mg EPH1000000 Human immunoglobulin for electrophoresis BRP 96 mg

Edition 2014 Visit us at www.lgcstandards.com 41

European Pharmacopoeia

Code Product Unit EPH1005000 Human Plasma Pools for NAT Validation 3502 mg EPH1100000 Human rabies immunoglobulin BRP 3x170 mg EPH1110000 Human tetanus immunoglobulin BRP 87 mg EPY0000502 Human vaccinia immunoglobulin 3x1 mL EPH1115000 Hyaluronidase BRP 50 mg EPH1120000 Hydralazine hydrochloride 20 mg EPY0001151 hyrochloride 20 mg EPH1200000 Hydrochlorothiazide 160 mg EPY0001494 Hydrochlorothiazide for peak identification 10 mg EPY0000710 for peak identification Controlled Substance 10 mg EPY0000646 Hydrocodone hydrogen tartrate 2.5-hydrate Controlled Substance 10 mg EPH1300000 100 mg EPH1400000 125 mg EPY0001482 Hydrocortisone acetate for peak identification 15 mg EPY0001092 Hydrocortisone for peak identification 5 mg EPH1425000 Hydrocortisone hydrogen succinate 100 mg EPH1426000 Hydrogenated wool fat 250 mg EPY0000446 hydrochloride 10 mg EPB0650000 Hydrous benzoyl peroxide - Reference Spectrum unit EPH1428000 Hydroxocobalamin 10 mg EPY0000119 Hydroxycarbamide 175 mg EPH1429400 Hydroxyethyl salicylate 125 mg EPY0001322 Hydroxyethyl starch (high Mw) 800 mg EPY0001277 Hydroxyethyl starch (medium MW) 1200 mg EPY0000186 Hydroxypropylbetadex 200 mg EPH1435000 Hydroxyzine hydrochloride 600 mg EPY0000011 Hymecromone 100 mg Hymecromone impurity A 25 mg EPY0000012 Resorcinol Hymecromone impurity B 25 mg EPY0000013 7-hydroxy-2-methyl-4H-1-benzopyran-4-one EPY0000483 Hyoscine 10 mg EPH1450000 Hyoscine butylbromide 20 mg Hyoscine butylbromide impurity E 10 mg (1R,2R,4S,5S,7S)-9-butyl-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-3-oxa-9-azoni EPY0000447 atricyclo[3.3.1.02,4]nonane EPH1500000 Hyoscine hydrobromide 50 mg Hyoscine hydrobromide impurity B 10 mg (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl(2S)- EPY0000448 3-hydroxy-2-phenylpropanoate Hyoscine impurity A 10 mg (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2- EPY0000484 phenylpropanoate (norhyoscine) Hyoscyamine impurity E 10 mg EPY0000449 (1R,3s,5S)-8-azabicyclo[3.2.1] oct-3-yl(2S)-3-hydroxy-2-phenylpropanoate EPH1600000 Hyoscyamine sulfate 100 mg EPY0000915 Hypromellose phthalate 10 mg EPI0020000 Ibuprofen 250 mg EPY0000881 Ibuprofen for peak identification 0.09 mg Ibuprofen impurity B 1.15 mL EPB1220000 (2RS)-2-(4-Butylphenyl) (0,06% solution in Acetonitrile) Ibuprofen impurity F 5 mg EPY0000140 3-[4-(2-methylpropyl)phenyl]propanoic acid EPI0050000 Idoxuridine 50 mg EPI0060000 Ifosfamide 50 mg

42 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPI0060100 Ifosfamide - Reference Spectrum unit Ifosfamide impurity A 2x100 mg EPI0060002 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate Ifosfamide impurity B 40 mg EPI0060004 bis[3-[(2-chloroethyl)amino]propyl]dihydrogen diphosphate Ifosfamide impurity E 2x10 mg EPI0060010 3-chloro-N-(2-chloroethyl)propan-1-amine Ifosfamide impurity F 10 mg EPI0060012 (RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide EPI0086000 Imidazole 100 mg EPI0090000 100 mg EPY0000893 for system suitability 10 mg EPI0100000 Imipramine hydrochloride 50 mg EPY0001153 Immunoglobulin for anti-A, anti-B antibodies limit test 45 mg EPY0001152 Immunoglobulin panel for anti-A, anti-B antibodies test 96 mg EPY0000540 Immunoglobulin panel for anti-D antibodies test BRP unit EPY0001205 Imperatorin 20 mg EPI0150000 Indapamide 150 mg Indapamide impurity B 5 mg EPI0150020 4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulphamoylbenzamide EPY0000788 Indinavir 100 mg EPY0000746 Indinavir for system suitability 20 mg EPY0000880 Indinavir sulfate - Reference Spectrum unit EPI0200000 Indometacin 50 mg EPY0001640 Indometacine impurity mixture 0.002 mg EPI0305000 Insulin (bovine) 7.99 mg EPI0310000 Insulin (human) 8 mg EPI0320000 Insulin (porcine) 8.61mg EPY0000349 Insulin aspart 8 mg EPY0001542 Insulin glargine 15 mg EPY0001544 Insulin glargine for peak identification 3.2 mg EPY0000348 Insulin lispro 5.75 mg EPI0320301 Interferon alfa-2b 200 µL EPY0001101 Interferon beta-1a 0.5 mL EPI0320330 Interferon gamma 1b 2x0.5 mL EPY0001664 Interferon gamma-1b for system suitability 0.6 mg EPI0320331 Interferon gamma-1b validation solution 0.2 mL EPI0328000 Iobenguane sulfate 25 mg EPY0000839 Iobenguane sulphate - Reference Spectrum unit EPY0001294 60 mg Iodixanol impurity C 10 mg 5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2- EPY0001292 hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Iodixanol impurity E 10 mg 5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6- triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- EPY0001291 triiodobenzene-1,3-dicarboxamide Iodixanol impurity H 10 mg 5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6- triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]carbamoyl]-5-[(2,3- dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3- EPY0001293 dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide EPI0320800 150 mg EPY0000672 Iohexol for peak identification 10 mg Iohexol impurity A 50 mg EPI0320810 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3- dicarboxamide

Edition 2014 Visit us at www.lgcstandards.com 43

European Pharmacopoeia

Code Product Unit Iohexol impurity J 125 mg EPI0320820 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3-dicarboxamide EPI0329000 50 mg Iopamidol impurity A 10 mg EPI0329010 N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethy]-5-amino-2,4,6-tri-iodoisophthalamide Iopamidol impurity H 10 mg 4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5- EPY0000406 (2-hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide EPI0330000 100 mg EPY0001297 10 mg EPY0001020 100 mg EPY0001021 Iopromide for system suitability 1 5 mg EPY0001022 Iopromide for system suitability 2 5 mg Iopromide impurity A 0.125 mg EPY0001077 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3- dicarboxamide EPY0000555 100 mg EPY0000658 Iotrolan for system suitability 5 mg EPY0000141 125 mg Ioxaglic acid impurity A 20 mg EPY0000142 3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid EPI0360000 Ipratropium bromide 120 mg Ipratropium bromide impurity B 10 mg (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8- EPI0361000 azoniabicyclo[3.2.1]octane Ipratropium impurity A 10 mg EPY0000276 (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane EPY0001166 Irbesartan 60 mg Irbesartan impurity A 10 mg EPY0001156 1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide EPY0001616 Irisflorentin 15 mg EPI0375000 Isoconazole 200 mg EPI0380000 Isoconazole nitrate 200 mg EPI0400000 Isoemetine hydrobromide 25 mg EPY0000858 1.5 mL EPY0000037 Isoflurane - Reference Spectrum unit EPI0460000 Isoleucine 50 mg EPI0465000 Isomalt 3000 mg EPY0000070 Isomaltooligosaccharide 0.9 mg EPI0500000 Isoniazid 100 mg EPI0599990 Isoprenaline hydrochloride 50 mg EPY0001577 Isoprenaline impurity A 1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone 15 mg EPI0600000 Isoprenaline sulfate 500 mg EPI0725000 Isopropyl hexadecanoate 100 mg EPI0750000 Isopropyl tetradecanoate 2 mL EPY0001568 Isoquercitroside 15 mg EPI0775000 Isosorbide dinitrate 350 mg EPI0775010 Isosorbide mononitrate 150 mg EPI0775020 Isosorbide-2-nitrate 50 mg EPI0800000 Isotretinoin 60 mg EPY0001218 Isotretinoin for peak identification 10 mg EPI0900000 Isoxsuprine hydrochloride 50 mg EPY0000366 Isradipine 125 mg Isradipine impurity D 5 mg EPY0000367 methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethylpyridine-3,5-dicarboxylate EPI7000000 Itraconazole 20 mg

44 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0001100 Itraconazole for system suitability 25 mg EPI8000010 150 mg EPY0001592 Ivy leaf dry extract HRS 70 mg EPY0000575 Ivy leaf standardised tincture 2 mL EPK0100000 Kanamycin B sulfate 20 mg EPK0200000 Kanamycin monosulfate 150 mg EPY0000450 Ketamine hydrochloride Controlled Substance 10 mg Ketamine impurity A 50 mg EPK0551000 1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol EPY0000246 hydrochloride - Reference Spectrum unit Ketobemidone impurity B 5 mg EPY0000244 B 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone Ketobemidone impurity C 5 mg EPY0000245 1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one EPK0600000 150 mg EPK2000000 Ketoprofen 50 mg Ketoprofen impurity A 10 mg EPK2000010 1-(3-benzoylphenyl)ethanone Ketoprofen impurity C 5 mg EPK2000015 3-[(1RS)-1-carboxyethyl]benzoic acid EPY0000486 Ketorolac trometamol 10 mg EPY0000626 Ketorolac trometamol for peak identification 5 mg EPY0001617 Ketotifen for peak identification 15 mg EPY0001619 Ketotifen hydrogen fumarate 10 mg EPY0000164 Ketotifen hydrogen fumarate - Reference Spectrum unit Ketotifen impurity G 0.0225 mg EPY0000161 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)thiophen-9,10-dione EPY0001200 Kudzuvine root dry extract 200 mg EPL0050000 Labetalol hydrochloride 120 mg Labetalol impurity A 10 mg EPY0001548 2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic acid EPL0129000 Lactitol monohydrate 60 mg EPY0000257 Lactobionic acid 100 mg EPL0100000 Lactose 100 mg EPA1206000 Lactose (anhydrous) 100 mg EPL0130000 Lactulose 3000 mg EPY0001510 Lactulose for peak identification 2600 mg EPY0000188 Lactulose for system suitability 12 mg EPY0000425 Lamivudine 150 mg EPY0000518 Lamivudine for system suitability 1 10 mg EPY0000426 Lamivudine for system suitability 2 10.3 mg EPY0001030 Lamotrigine 10 mg EPY0001031 Lamotrigine for peak identification 20 mg EPY0001085 Lamotrigine for system suitability 10 mg Lamotrigine impurity E 15 mg EPY0001032 2,3-dichlorobenzoic acid EPY0000773 Lansoprazole 60 mg EPY0000774 Lansoprazole for peak identification 1.01 mg EPA1269000 L-Arabinitol 10 mg EPY0001474 Lauric acid 1500 mg EPY0000654 Leflunomide 100 mg EPY0000674 Leflunomide for peak identification 1 mg Leflunomide impurity A 25 mg EPY0000487 4-(trifluoromethyl)aniline

Edition 2014 Visit us at www.lgcstandards.com 45

European Pharmacopoeia

Code Product Unit EPY0000685 70 mg EPL0375000 Leucine 50 mg EPL0376000 1 mg EPL0376001 Leuprorelin - Reference Spectrum unit EPY0000048 Levamisole - Reference Spectrum unit EPL0380000 Levamisole hydrochloride 50 mg EPY0000047 Levamisole hydrochloride for system suitability 60 mg EPY0001253 Levetiracetam 110 mg Levetiracetam impurity A 10 mg EPY0001254 (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid Levetiracetam impurity B 15 mg EPY0001255 (2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide Levetiracetam impurity C 15 mg EPY0001256 pyridin-2-ol Levetiracetam impurity D 15 mg EPY0001257 (2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) EPY0001636 Levocabastine for system suitability 1 (5.028 mg) 5 mg EPY0001637 Levocabastine for system suitability 2 (5.005 mg) 5 mg EPL0390000 Levocabastine hydrochloride 125 mg Levocabastine impurity D 20 mg 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]- EPL0390008 4-phenylpiperidine-4-carboxylic acid EPL0399900 Levocarnitine 125 mg Levocarnitine impurity A 50 mg EPL0399905 (E)-or(Z)-4-(trimethylammonio)but-2-enoate EPL0400000 Levodopa 100 mg EPL0420000 Levodropropizine 60 mg Levodropropizine impurity A 25 mg EPL0420002 (2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol(dextrodropropizine) Levodropropizine impurity B 50 mg EPY0001033 1-phenylpiperazine Levodropropizine impurity C 300 mg EPY0001048 2,3-epoxypropan-1-ol EPL0500000 Levomepromazine hydrochloride 100 mg EPL0505000 Levomepromazine maleate 50 mg EPL0551000 30 mg EPY0001431 Levonorgestrel for system suitability 10 mg EPY0001618 Levonorgestrel for system suitability 2 10 mg Levonorgestrel impurity B 10 mg EPY0001379 13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one EPY0001382 for peak identification 10 mg EPL0570000 Levothyroxine sodium 100 mg EPH0837000 L-Homocycsteine thiolactone hydrochloride - Reference Spectrum unit EPL0595000 Lidocaine 50 mg EPL0600000 Lidocaine hydrochloride 100 mg EPY0001393 Lincomycin chlorhydrate for system suitability 10 mg EPL0650000 Lincomycin hydrochloride 250 mg EPY0000860 for peak identification 0.0046 mg EPL0700000 Liothyronine sodium 50 mg EPL0702000 Lisinopril dihydrate 50 mg EPY0001235 Lisinopril for system suitability 2 mg Lisinopril impurity F 0.01 mg (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrolidine- EPY0001234 2-carboxylic acid (cyclohexyl analogue) EPL0720000 Lithium clavulanate 125 mg

46 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPL0720800 Lithocholic acid 60 mg EPY0000112 hydrochloride 50 mg EPL0745000 Lomustine 50 mg EPY0001438 for system suitability 600 mg EPL0750000 hydrochloride 50 mg EPY0000322 Loperamide hydrochloride for system suitability 15 mg EPY0000341 Loperamide oxide monohydrate 20 mg EPY0001498 Lopinavir 200 mg EPY0001506 Lopinavir for peak identification 10 mg EPY0001505 Lopinavir for system suitability 10 mg EPY0000688 Loratadine 60 mg EPY0000603 Loratadine for system suitability 20 mg Loratadine impurity F 10 mg ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta EPY0000604 [1,2-b]pyridin-11-yl]piperidine-1-carboxylate Loratadine impurity H 50 mg EPY0000605 ethyl 4-oxopiperidine-1-carboxylate EPL0750500 Lorazepam 100 mg EPY0000576 Lorazepam for system suitability Controlled Substance 0.8 mg Lorazepam impurity D 10 mg (5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H- EPY0000718 1,4-benzodiazepine-2,3-dione EPY0001076 Losartan for system suitability 0.0015 mg Losartan impurity D 6 mg EPY0001072 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde EPY0001062 Losartan potassium 50 mg EPL0790000 Lovastatin 60 mg EPY0001136 Lovastatine for peak identification 20 mg EPY0001284 Lufenuron 140 mg EPY0001261 Lufenuron for peak identification 0.4028 mg Lufenuron impurity G 15 mg 2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl] EPY0001265 amino]phenyl phenyl carbonate EPL0800000 50 mg EPY0001034 Lynestrenol for peak identification 20 mg EPY0000397 Lysine acetate 60 mg EPL0900000 Lysine hydrochloride 50 mg EPY0001376 2-Methylpyrazine 100 mg EPY0001369 Macrogol 30 dipolyhydroxystearate 100 mg EPY0000745 Macrogol 40 sorbitol heptaoleate 20 mg EPY0001157 Macrogol polyvinyl alcohol grafted polymer 400 mg EPM0088000 Magnesium aspartate dihydrate 60 mg EPY0001289 20 mg EPM0120000 Malathion 250 mg Malathion impurity A 10 mg diethyl(2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] EPM0120005 butane dioate Malathion impurity B 10 mg EPM0120010 diethyl(2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate EPM0100000 Maleic acid 100 mg EPY0000143 Malic acid - Reference Spectrum unit EPM0160000 Maltitol 1200 mg EPM0200000 Mannitol 1200 mg EPM0206000 Maprotiline hydrochloride 100 mg

Edition 2014 Visit us at www.lgcstandards.com 47

European Pharmacopoeia

Code Product Unit Maprotiline impurity D 25 mg EPM0206040 3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine EPY0000819 Marbofloxacin 10 mg EPY0000820 Marbofloxacin for peak identification 20 mg EPM0210000 Measles vaccine (live) BRP 5 uc EPM0215000 Mebendazole 20 mg EPY0000144 Mebendazole for system suitability 20 mg EPY0001086 Mebrofenin 120 mg EPM0220000 Meclozine dihydrochloride 150 mg Meclozine impurity B 15 mg EPY0001310 4-chlorobenzhydrol Meclozine impurity H 15 mg EPY0001311 1-(4-chlorobenzhydryl)piperazine EPM0240000 Medronic acid 20 mg Medronic acid impurity A 60 µl Tris(1-methylethoxy)phosphane

EPY0001107 Medronic acid impurity B 40 µl EPY0001106 Tetrakis(1-methylethyl)methhylenediphosphonate EPM0250000 acetate 100 mg EPY0001484 Medroxyprogesterone acetate for peak identification 25 mg EPY0000598 Medroxyprogesterone acetate for system suitability 10 mg EPM0252600 50 mg Mefenamic acid impurity A 100 mg EPY0001081 2,3-dimethylaniline EPM0253000 Mefloquine hydrochloride 100 mg EPY0001514 acetate 120 mg EPY0001507 for peak identification 25 mg EPY0001524 Megestrol acetate for system suitability 50 mg EPY0001594 Megestrol acetate impurity K 0.01 mg EPY0001209 Meglumine 10 mg EPY0001080 Meloxicam 50 mg Meloxicam impurity A 5 mg EPY0001035 ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide Meloxicam impurity B 5 mg EPY0001036 5-methylthiazol-2-amine Meloxicam impurity C 5 mg N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- EPY0001037 benzothiazine-3-carboxamide 1,1-dioxide Meloxicam impurity D 5 mg N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- EPY0001039 benzothiazine-3-carboxamide 1,1-dioxide EPY0001513 Melphalan - Reference Spectrum unit EPY0001457 Melphalan for system suitability 10 mg EPY0001158 Melphalan hydrochloride 100 mg EPM0300000 Menadione 100 mg EPM0350000 150 mg EPM0370000 Mepivacaine hydrochloride 100 mg Mepivacaine impurity B 60 mg EPM0370020 (RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide EPM0400000 100 mg Mepyramine impurity A 10 mg EPY0000679 N-(4-methoxybenzyl)pyridin-2-amine Mepyramine impurity C 10 mg EPY0000680 pyridin-2-amine EPM0500000 Mepyramine maleate 1000 mg

48 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0001252 Meropenem trihydrate 110 mg EPY0000297 Mesalazine 125 mg EPY0001574 Mesalazine for system suitability 10 mg Mesalazine impurity A 15 mg EPY0001563 4-Aminophenol Mesalazine impurity C 15 mg EPY0001569 2-Aminophenol EPY0001040 Mesityl oxide 100 mg EPY0000337 Mesna - Reference Spectrum unit Mesna impurity C 10 mg EPY0000316 2-(Acetylsulphanyl)ethanesulphonic acid Mesna impurity D 10 mg EPY0000317 2,2'-(disulphanediyl)bis(ethanesulphonic acid) EPY0000227 Meso-rich exametazime 0.5 mg EPY0000097 120 mg Mesterolone impurity A 30 mg EPY0000096 17β-hydroxy-1alpha-methylandrost-4-en-3-one EPM0600000 100 mg EPY0000301 Metacresol - Reference Spectrum unit EPM0600500 Metacycline hydrochloride 50 mg Metamizole impurity A 15 mg EPM0600905 4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one EPM0600900 Metamizole sodium 10 mg Metamizole impurity E 0.01 mg EPY0001481 4-N-Demethylanalgin EPM0605000 Metformin hydrochloride 50 mg EPY0001590 Metformin impurity A 25 mg Metformin impurity F 72 mg EPY0001600 Dimethylamine hydrochloride EPM0610030 Methacrylic acid - ethyl acrylate copolymer (1:1), dispersion 30% - Reference Spectrum*) unit EPY0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B 200 mg EPM0610000 Methacrylic acid-ethylacrylate copolymer (1:1) - Reference Spectrum unit EPY0000770 Methacrylic acid-ethylacrylate copolymer (1:1)- type A 200 mg EPM0620000 Methacrylic acid-methylmethacrylate copolymer (1:1) - Reference Spectrum unit EPM0630000 Methacrylic acid-methylmethacrylate copolymer (1:2) - Reference Spectrum unit EPM0800000 hydrochloride - Reference Spectrum unit EPY0000428 Methanol - Reference Spectrum unit EPY0000754 Methenamine 10 mg EPM0960000 Methionine 50 mg EPM1000000 Methotrexate 100 mg EPY0000602 Methotrexate for peak identification 20 mg EPY0001668 Methotrexate for system suitability 100 mg Methotrexate impurity C 10 mg (2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6- yl)methyl]methylamino]benzoyl]amino]pentanedioic acid EPY0000663 (N-methylfolic acid, methopteridine) Methotrexate impurity D 10 mg EPM1000008 4-[[(2-amino-4hydroxypteridin-6-yl)methyl]methyl-amino]benzoic acid Methotrexate impurity E 10 mg 4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid EPY0000664 (4-amino-N10-methylpteroic acid, APA) EPM1556000 Methyl 12-hydroxystearate 100 mg EPM1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate 0.5 mL EPY0001488 Methyl methacrylate 50 mg EPY0000398 Methyl nicotinate 25 mg EPM1650000 Methyl parahydroxybenzoate 150 mg

Edition 2014 Visit us at www.lgcstandards.com 49

European Pharmacopoeia

Code Product Unit EPM1770180 Methyl ricinoleate 125 mg EPM1770200 Methyl stearate 100 mg EPM1300000 Methylatropine bromide 100 mg EPM1450000 Methylcarbidopa 1 mg EPM1500000 Methyldopa 50 mg EPY0001083 Methyldopa for system suitability 0.024 mg EPM1550000 Methylene chloride 2 mL EPY0000777 Methylergometrine for system suitability 0.53 mg EPY0000776 Methylergometrine maleate 10 mg EPM1625000 Methylnitrosoindoline 110 mg EPY0001017 Methylphenidate hydrochloride 40 mg Methylphenidate impurity C 10 mg EPY0001490 (2RS)-2-phenyl-2-[(2R)-piperidin-2-yl]ethanamide EPY0000910 Methylphenidate impurity mixture 0.04 mg EPM1700000 Methylphenobarbital 500 mg EPM1750000 150 mg EPM1755000 Methylprednisolone acetate 100 mg EPY0001602 Methylprednisolone for system suitability 10 mg EPM1755200 Methylprednisolone hydrogen succinate 125 mg EPM1755220 Methylprednisolone hydrogen succinate for performance test 50 mg EPY0000418 Methylrosanilinium chloride 40 mg EPY0000407 Methylrosanilinium chloride for system suitability 10 mg EPM1800000 100 mg EPY0000861 Methyltestosterone for system suitability 10 mg EPM1800900 Methylthioninium chloride 50 mg Methylthioninium impurity A 20 mg EPM1800902 3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium EPM1808000 Metixene hydrochloride 75 mg EPM1824990 Metoclopramid 100 mg EPM1825000 hydrochloride 50 mg Metoclopramide impurity A 25 mg EPM1824995 4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide Metoclopramide impurity E 40 mg EPM1825010 N,N-diethylethane-1,2-diamine EPY0000701 Metolazone 80 mg EPY0000702 Metolazone for system suitability 10 mg Metoprolol impurity A 5 mg EPY0000145 (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol EPY0000171 Metoprolol succinate - Reference Spectrum unit EPM1830000 Metoprolol tartrate 60 mg EPM1845000 Metrifonate 100 mg EPM1850000 Metronidazole 50 mg EPM1851000 Metronidazole benzoate 50 mg EPY0000069 Metronidazole benzoate - Reference Spectrum unit Metronidazole impurity A 10 mg EPY0000087 2-methyl-4-nitroimidazole EPM1860000 Mexiletine hydrochloride 100 mg Mexiletine impurity C 2 mg EPY0000202 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine Mexiletine impurity D 2 mg EPY0000203 (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine EPM1875000 hydrochloride 100 mg EPY0000862 Mianserin hydrochloride for system suitability 1.01 mg

50 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Mianserin impurity B 10 mg (14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f] EPY0001041 pyrazino[1,2-a]azepine-8-sulfonic acid EPM1880000 70 mg EPM1900000 Miconazole nitrate 150 mg EPM2200000 Midazolam 50 mg EPY0000599 Midazolam for system suitability Controlled Substance 1 mg Midazolam impurity C 0.08 mg acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo EPY0000562 [1,5-a][1,4]benzodiazepine-3-carboxylique EPY0000539 Milk thistle standardised dry extract 120 mg EPM2280000 Minocycline hydrochloride 125 mg EPM2300000 Minoxidil 50 mg EPY0001432 Minoxidil for system suitability 10 mg EPY0000705 Mirtazapine 10 mg EPY0000721 Mirtazapine for system suitability 10 mg EPY0000490 Misoprostol 60 mg EPY0001162 Misoprostol for system suitability 5 mg EPY0000378 Mitomycin 120 mg EPM2305000 Mitoxantrone hydrochloride 50 mg Mitoxantrone impurity A 5 mg EPM2305005 1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione EPY0000635 Modafinil 110 mg EPY0000636 Modafinil for system suitability 0.1 mg EPY0000251 Molgramostim 0.3 mL EPY0000821 Molsidomine 5 mg Molsidomine impurity B 10 mg EPY0000822 N-Nitrosomorpholine Molsidomine impurity D 10 mg EPY0000823 morpholine-4-carbaldehyde EPM2900000 furoate 100 mg EPY0001436 Montelukast dicyclohexylamine 150 mg EPY0001435 Montelukast for peak identification 20 mg EPY0001433 Montelukast racemate 10 mg EPY0001434 Montelukast sodium 20 mg EPY0000028 Morantel hydrogen tartrate 50 mg EPY0000830 Morphine for system suitability Controlled Substance 15 mg EPY0000451 Morphine hydrochloride (trihydrate) Controlled Substance 25 mg EPY0000452 Morphine sulphate Controlled Substance 40 mg EPY0000772 Moxidectin 70 mg EPY0000747 Moxidectin for system suitability 10 mg EPY0000717 Moxifloxacin for peak identification 10 mg EPY0000703 Moxifloxacin hydrochloride 110mg EPY0000226 Moxonidine 50 mg Moxonidine impurity A 10 mg EPY0000222 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine EPM3600000 Mumps vaccine (live) BRP 5x33 mg EPM3805000 Mupirocin - Reference Spectrum unit EPM3805500 Mupirocin calcium - Reference Spectrum unit EPM3806000 Mupirocin lithium 100 mg EPY0000489 Mycophenolate mofetil 30 mg EPY0000519 Mycophenolate mofetil for peak identification 10 mg EPY0000690 Mycoplasma hyorhinis BRP 1 mL EPY0000485 Myo-inositol 1020 mg

Edition 2014 Visit us at www.lgcstandards.com 51

European Pharmacopoeia

Code Product Unit EPE2202000 1-N-Ethylgaramin sulfate 50 mg EPY0001314 1-nonadecanol 425 mg EPY0000234 N,N-Dimethylacetamide - Reference Spectrum unit EPN0020000 Nabumetone 60 mg Nabumetone impurity D 10 mg EPN0020020 (E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one Nabumetone impurity F 10 mg EPN0020030 6,6'-dimethoxy-2,2'-binaphthalenyl EPC0200010 N-acetyl-cys1-calcitonin 20 mg EPA0208000 N-Acetyltryptophan 125 mg EPA0202000 N-Acetyltyrosine 200 mg EPY0000146 Nadolol 100 mg EPY0001215 Nadolol impurity mixture 0.01 mg EPN0025000 Nadroparin calcium 250 mg EPY0000077 Naftidrofuryl - Reference Spectrum unit Naftidrofuryl impurity A 10 mg EPY0000120 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid Naftidrofuryl impurity B 25 mg EPY0000121 ethyl 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoate Naftidrofuryl impurity F 10 mg 2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- EPY0000331 (tetrahydrofuran-2-yl)propanoate EPN0050000 Nalidixic acid 100 mg EPY0000695 for peak identification 5.075 mg EPN0075000 Naloxone hydrochloride dihydrate 100 mg EPY0001571 Naloxone impurity D 25 mg EPY0000400 hydrochloride 50 mg Naltrexone impurity C 15 mg EPY0000410 N-(3-butenyl)- EPY0000542 decanoate 5 mg EPY0000547 for peak identification 10 mg EPY0000548 Nandrolone decanoate for system suitability 10 mg EPN0080000 Naphazoline hydrochloride 50 mg Naphazoline impurity A 15 mg EPN0200000 N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide (Naphthylacetylethylenediamine) EPN0100000 Naphazoline nitrate 10 mg EPN0250000 Naproxen 100 mg EPY0000399 Naproxen (racemic) 10 mg Naproxen impurity L 10 mg EPY0000631 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin) EPY0001378 Naringin 20 mg EPY0001437 Nateglinide 200 mg Nateglinide impurity A 10 mg EPY0001440 trans-4-(1-methylethyl)cyclohexanecarboxylic acid Nateglinide impurity B 15 mg N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine EPY0001441 (L- isomer) Nateglinide impurity C 10 mg EPY0001442 N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer) EPD0350000 N-Demethylerythromycin A 10 mg EPN0300000 Neamine 0.5 mg EPN0399000 Neohesperidin dihydrochalcone 125 mg Neohesperidin dihydrochalcone impurity B 10 mg 7-[[2-O-(6-deoxy-α-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2- EPN0399004 (3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one (neodiosmin) EPN0400000 Neomycin sulfate 50 mg

52 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPN0401000 Neomycin sulphate for microbiological assay 25 mg EPN0500000 Neostigmine bromide 50 mg EPY0001639 Neostigmine impurity A 0.0025 mg EPN0550000 Neostigmine metilsulfate 50 mg EPN0559000 Netilmicin sulphate 2x25 mg EPY0000520 Nevirapine (anhydrous) 30 mg EPY0000521 Nevirapine for peak identification 0.058 mg EPY0001499 Nevirapine hemihydrate 15 mg EPY0000388 Newcastle Disease Vaccine (inacativated) BRP 4 uc EPY0001373 Nicergoline 50 mg EPY0001362 Nicergoline for peak identification 1 mg EPY0001352 Nicergoline for system suitability 10 mg Nicergoline impurity D 20 mg EPY0001356 5-bromopyridine-3-carboxylic acid EPN0560000 Niclosamide (anhydrous) 50 mg EPN0600000 50 mg EPN0590000 - Reference Spectrum unit EPN0590200 Nicotine ditartrate 120 mg EPY0001425 Nicotine ditartrate dihydrate 15 mg EPY0001023 Nicotine for system suitability 1 mg EPN0700000 Nicotinic acid 100 mg EPY0001268 Nicotinic acid impurity mixture 0.12 mg EPN0750000 50 mg Nifedipine impurity A 25 mg EPN0750010 Dimethyl 2,6-dimethyl-4-(2-nitrophenyl) pyridine-3,5-dicarboxylate Nifedipine impurity B 25 mg EPN0750015 Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl) pyridine-3,5-dicarboxylate EPY0000824 10 mg Niflumic acid impurity A 10 mg EPY0000825 2-chloropyridine-3-carboxylic acid Niflumic acid impurity B 10 mg EPY0000826 2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide Niflumic acid impurity E 15 mg EPY0000827 6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid EPY0000836 Nifuroxazide 10 mg EPN0800000 Nikethamide 1 mL EPY0000829 110 mg Nilutamide impurity B 5 mg EPY0000894 4-nitro-3-(trifluoromethyl)aniline EPN0845000 Nimesulide 100 mg EPY0001237 Nimesulide for peak identification 10 mg Nimesulide impurity D 0.004 mg EPN0845008 4-nitro-2-phenoxyaniline EPN0850000 Nimodipine 50 mg Nimodipine impurity A 1 mL 2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) EPN0850010 pyridine-3,5-dicarboxylate EPN0900000 Nitrazepam 100 mg EPN0905000 60 mg EPY0001456 Nitrendipine for peak identification 10 mg Nitrendipine impurity A 30 mg ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate; EPN0905005 (nitrophenylpyridine analogue) EPN0930000 - Reference Spectrum unit EPN0950000 Nitrofural 100 mg

Edition 2014 Visit us at www.lgcstandards.com 53

European Pharmacopoeia

Code Product Unit EPY0001377 Nitrofural for peak identification 0.11 mg Nitrofural impurity B 30 mg EPY0001570 (5-nitrofuran-2-yl)methylene diacetate EPN1000000 Nitrosotriaminopyrimidine 50 mg EPN1090000 Nizatidine 250 mg EPY0001278 Nizatidine for system suitability 10 mg Nizatidine impurity F 10 mg (EZ)N1,N1-[thiazole-2,4-diylbis(methylenesulphanediylethylene)] EPN1090060 bis(N’-methyl-2-nitroethene-1,1-diamine) EPY0000190 N-Methylpyrrolidone - Reference Spectrum unit EPN1080000 acetate 100 mg impurity A 50 mg EPN1080005 6-alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate EPY0000670 2x10 mg EPY0000755 Nonoxinol 9 10 mg Noradrenaline impurity D 15 mg 4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol EPY0000681 (Noradrenaline methyl ether) Noradrenaline impurity E 10 mg EPY0000682 2-chloro-1-(3,4-dihydroxyphenyl)ethanone Noradrenaline impurity F 10 mg EPY0000686 N-benzyl-1-phenylmethanamine EPN1100000 Noradrenaline tartrate 200 mg EPN1130000 Norcyclobenzaprine 25 mg Nordazepam 50 mg EPN1140000 Dipotassium clorazepate impurity B EPN1200000 50 mg EPN1225000 100 mg EPY0001532 Norethisterone acetate for system suitability 2.585 mg EPY0000522 Norethistherone for system suitability 10 mg EPN1230000 Norfloxacin 50 mg EPY0001301 Norfloxacin for peak identification 10 mg EPY0001015 Norfloxacin for system suitability 8 mg Norfloxacin impurity A 20 mg EPN1230010 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid EPY0001609 Norflurane - reference spectrum unit EPY0000724 10 mg EPY0000725 Norgestimate for system suitability 5 mg EPN1250000 30 mg EPN1279000 Norpseudoephedrine hydrochloride Controlled Substance 50 mg EPY0001296 Nortriptyline for system suitability 20 mg EPN1280000 Nortriptyline hydrochloride 10 mg EPN1300000 Noscapine 100 mg EPN1400000 Nystatin 100 mg EPO0100900 Octoxinol 10 300 mg EPY0000368 Octyl gallate 30 mg EPO0101000 Octyldodecanol 400 mg EPO0120000 50 mg Ofloxacin impurity A 20 mg (RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido EPO0120010 [1,2,3-de][1,4]benzoxazine-6-carboxylic acid (FPA) Ofloxacin impurity E 20 mg (RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] EPO0120050 [1,4]benzoxazine-6-carboxylic acid EPY0001370 Olanzapine 200 mg EPY0001380 Olanzapine for system sitability 10 mg

54 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Olanzapine impurity A 5 mg EPY0001392 5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile EPY0001204 20 mg EPY0001479 Oleic acid 2000 mg EPY0000805 20 mg EPY0001405 Olmesartan medoxomil 100 mg EPY0001424 Olmesartan medoxomil for system suitability 10 mg EPO0146000 Olsalazine sodium 70 mg EPO0146010 Olsalazine sodium for performance test 60 mg EPO0150000 Omeprazole 50 mg EPY0001042 Omeprazole for peak identification 10 mg Omeprazole impurity D 10 mg EPO0151000 Omeprazole sulphone EPY0001043 Omeprazole magnesium 10 mg EPY0000197 Ondansetron for LC system suitability 10 mg EPY0000196 Ondansetron for TLC system suitability 30 mg EPY0000218 Ondansetron hydrochloride dihydrate 200 mg Ondansetron impurity A 10 mg (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9- EPY0001345 tetrahydro-4H-carbazol-4-one Ondansetron impurity D 15 mg EPY0000195 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one Ondansetron impurity E 10 mg EPY0001326 Imidazole EPY0001320 Ondansetron impurity F 10 mg Ondansetron impurity G 10 mg (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro- EPY0001346 4H-carbazol-4-one (C-demethylondansetron) EPY0001125 Orbifloxacin 200 mg EPY0001147 Orbifloxacin impurity mixture 0.0008 mg EPY0000895 Orciprenaline for system suitability 5 mg EPO0180000 Orciprenaline sulfate 100 mg EPY0001501 Orientvine stem HRS 600 mg EPY0000101 Orphenadrine citrate 100 mg EPY0001181 Orphenadrine for peak identification 0.42 mg EPY0000100 Orphenadrine hydrochloride 100 mg Orphenadrine impurity E 60 mg (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine EPY0000102 (meta-methylbenzyl isomer) Oseltamivir impurity A 10 mg EPY0001338 (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid Oseltamivir impurity B 10 mg ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- EPY0001339 (1-ethylpropoxy)cyclohexanecarboxylate Oseltamivir impurity C 10 mg EPY0001340 (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid Oseltamivir impurity H 30 mg EPY0001341 tributylphosphane oxide EPY0001337 Oseltamivir phosphate impurity B free 300 mg EPY0001207 Osthole 20 mg EPO0200000 Ouabain 150 mg EPY0000560 Oxacillin for peak identification 10 mg EPY0000638 Oxacillin sodium monohydrate 110 mg EPY0000271 Oxaliplatin 250 mg Oxaliplatin impurity B 22 mg (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN']platinum EPY0000272 (diaquodiaminocyclohexaneplatinum)

Edition 2014 Visit us at www.lgcstandards.com 55

European Pharmacopoeia

Code Product Unit Oxaliplatin impurity C 25 mg (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)- EPY0000273 kO¹,kO²]dihydroxyplatinum Oxaliplatin impurity D 10 mg (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)- EPY0000274 kO¹,kO² ]platinum (S,S-enantiomer of oxaliplatin) EPO0225000 Oxazepam 50 mg EPY0000543 Oxazepam for peak identification 0.008 mg EPY0001576 Oxcarbazepine 120 mg EPY0001549 Oxcarbazepine impurity mixture 0.008 mg EPY0000350 Oxeladin hydrogen citrate 50 mg Oxeladin impurity C 10 mg EPY0000404 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate Oxeladin impurity D 20 mg EPY0000390 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate EPO0225800 Oxfendazole for veterinary use 50 mg Oxfendazole impurity B 10 mg EPY0000224 methyl[5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate EPY0000225 Oxfendazole with impurity D 10 mg EPO0260000 Oxibendazole 100 mg EPY0000709 Oxitropium bromide 50 mg Oxitropium bromide impurity B 15 mg (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9- 2,4 EPY0000715 azoniatricyclo[3.3.1.0 ]nonane (methylhyoscine) Oxitropium bromide impurity D 10 mg (1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3-oxa-9- 2,4 EPY0000713 azoniatricyclo[3.3.1.0 ]nonane (apo-N-ethylhyoscine) EPO0240000 Oxolinic acid 50 mg Oxolinic acid impurity A 20 mg EPO0240005 8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid Oxolinic acid impurity B 20 mg EPO0240010 ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7-carboxylate EPO0250000 Oxprenolol hydrochloride 50 mg EPO0270000 Oxybuprocaine hydrochloride 150 mg EPO0288000 Oxybutynin hydrochloride 150 mg Oxybutynin impurity A 20 mg EPO0288005 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3-enyl)-2-cyclohexyl-2-hydroxyacetate EPY0000492 hydrochloride 100 mg Oxycodone impurity D 50 mg 7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy-17- EPY0000453 methylmorphinan-6-one (14-hydroxycodeinone) EPO0290000 Oxymetazoline hydrochloride 80 mg Oxymetazoline impurity A 15 mg EPY0001044 N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetamide EPO0400000 Oxytetracycline 100 mg EPO0500000 Oxytetracycline hydrochloride 20 mg EPO0700000 Oxytocin 1 mg Oxytocin/Desmopressin validation mixture 20 mg EPO0770000 about 0.1 mg oxytocin + 0.1 mg desmopressin per vial (20 mg) EPY0000698 40 mg Paclitaxel impurity C 5 mg EPY0000699 N-debenzoyl-N-hexanoylpaclitaxel EPY0000700 Paclitaxel natural for peak identification 10 mg EPY0000719 Paclitaxel semi-synthetic for peak identification 10 mg EPY0000739 Paclitaxel semi-synthetic for system suitability 1 mg EPP0090000 Palmitic acid 100 mg EPY0000524 Pamidronate disodium pentahydrate 10 mg EPP0100000 Pancrease powder (amylse and lipase) BRP 2000 mg

56 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0001632 Pancreas powder (amylase) BRP 2000 mg EPY0001631 Pancreas powder (lipase) BRP 2000 mg EPP0200000 Pancreas powder (protease) BRP 2000 mg Pancuronium bromide 20 mg EPP0250000 Vecuronium impurity B EPY0000577 Pancuronium bromide for system suitability 20 mg EPY0001001 Pantoprazole for system suitability 0.5055 mg EPY0000835 Pantoprazole sodium sesquihydrate 20 mg EPP0270000 Papaverine hydrochloride 25 mg EPP0300000 50 mg EPY0000780 Paraffin (hard) 10 mg EPY0000058 Paraffin (liquid) - Reference Spectrum unit EPY0000913 Paraffin (White soft) 10 mg EPY0000912 Paraffin (Yellow soft) 10 mg EPP0305000 Parnaparin sodium 250 mg EPY0000630 Paroxetine for system suitability 5 mg EPY0000578 Paroxetine hydrochloride (anhydrous) 100 mg Paroxetine hydrochloride (anhydrous) impurity C 10 mg (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine EPY0000579 (N-benzylparoxetine) Paroxetine hydrochloride (anhydrous) impurity H 10 mg EPY0000581 [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol EPY0000281 Paroxetine hydrochloride hemihydrate 200 mg Paroxetine impurity A 15 mg EPY0000233 (3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine (desfluoroparoxetine) Paroxetine impurity D 5 mg (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ((+)-trans- EPY0000256 paroxetine) Paroxetine impurity E 5 mg EPY0000580 (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophenyl)piperidine (cis-paroxetine) Pefloxacin impurity B 10 mg 1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid EPP0309020 (chlorinated homologue of pefloxacin) Pefloxacin impurity C 0.01 mg 1-ethyl-6-fluoro-5-(4-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid EPP0309030 (isopefloxacin) EPP0309000 Pefloxacin mesilate dihydrate 200 mg EPY0001539 Pemetrexed disodium heptahydrate 200 mg EPY0001538 Pemetrexed for system suitability 20 mg EPY0001535 Pemetrexed impurity mixture 0.002 mg Penbutolol impurity A 20 mg EPP0307005 (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl)amino]propan-2-ol EPP0307000 Penbutolol sulfate 100 mg EPP0310000 Penicillamine 100 mg Penicillamine disulphide 100 mg EPP0320000 3,3-(disulphanediyl)bis[(2)-2-amino-3-methylbutanoic]acid EPP0405000 Pentamidine diisetionate 30 mg EPP0405500 - Reference Spectrum unit EPP0405510 Pentazocine hydrochloride - Reference Spectrum unit EPY0000417 Pentazocine lactate - Reference Spectrum unit EPY0001051 Pentetate sodium calcium 100 mg EPP0500000 500 mg EPP0510000 Pentoxifylline 100 mg EPY0000076 Pentoxyverine hydrogen citrate - Reference Spectrum unit Pentoxyverine impurity A 10 mg EPY0000098 1-phenylcyclopentanecarboxylic acid

Edition 2014 Visit us at www.lgcstandards.com 57

European Pharmacopoeia

Code Product Unit Pentoxyverine impurity B 10 mg EPY0000099 2-(diethylamino)ethyl-1-phenylcyclopentanecarboxylate (caramiphen) EPP0525000 Pepsin powder 2000 mg EPY0000010 Pergolide mesilate 150 mg EPY0000771 Perindopril for peak identification 5 mg EPY0000207 Perindopril for stereochemical purity 40 mg Perindopril impurity A 10 mg EPY0000237 (2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid EPY0000238 Perindopril tert-butylamine 40 mg EPP0550000 Perphenazine 100 mg EPY0001045 Perphenazine for system suitability 5 mg EPY0000021 Pertussis toxin BRP 2x0.05 mg EPP0600000 hydrochloride - Reference Spectrum unit Pethidine impurity A 20 mg EPP0600002 1-methyl-4-phenylpiperidine (MPP) EPP0800000 Phenazone 20 mg Phenazone impurity A 20 mg EPY0001138 5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one Pheniramine impurity A 20 mg EPY0001428 2-Benzylpyridine EPP0850000 Pheniramine maleate 250 mg EPP0900000 200 mg Phenobarbital impurity A 15 mg EPY0001350 (5RS)-5-ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one Phenobarbital impurity B 15 mg EPY0001351 (5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione EPP0950000 Phenoxyethanol 1 mL EPP1000000 Phenoxymethylpenicillin 250 mg EPP1100000 Phenoxymethylpenicillin potassium 250 mg EPY0001127 Phentolamine mesilate 10 mg EPP1109000 Phentolamine mesilate - Reference Spectrum unit EPY0001251 Phentolamine mesilate for system suitability 10 mg EPP1150000 Phenylalanine 60 mg EPP1200000 Phenylbutazone 100 mg Phenylbutazone impurity B 20 mg EPY0000147 (4-butyl-4-hydroxy-1,2-diphenyl-3,5)pyrazolidinedione EPP1240000 Phenylephrine 60 mg EPP1250000 Phenylephrine hydrochloride 50 mg EPY0000683 Phenylephrine hydrochloride for peak identification 2 mg EPY0000229 Phenylmercuric acetate - Reference Spectrum unit EPP1255100 Phenylmercuric borate - Reference Spectrum unit EPP1260000 Phenylpropanolamine hydrochloride (Norephedrin hydrochloride) DRUG PRECURSOR 50 mg EPP1290000 100 mg EPY0001167 Phenytoin for system suitability 20 mg EPP1300000 Phenytoin sodium 250 mg EPY0000493 Phloroglucinol (anhydrous) 210 mg EPY0000761 (Pholcodine-Monohydrat) 10 mg EPY0000798 Pholcodine for peak identification 10 mg Phthalic acid 20 mg EPY0000766 benzene-1,2-dicarboxylic acid EPP1500000 Phthalylsulfathiazole 100 mg EPP1600000 Physostigmine salicylate 100 mg EPP1609000 Phytomenadione 150 mg EPY0001104 Picosulfate for system suitability 0.5 mg

58 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Picotamide impurity A 25 mg EPP1645005 4-methoxybenzene-1,3-dicarboxylic acid EPP1645000 Picotamide monohydrate 125 mg EPY0001508 Picrotin 40 mg EPY0001528 Picrotoxinin 40 mg Pidolate impurity B 110 mg EPY0000124 (2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid EPY0000123 Pidolic acid 125 mg EPP1650000 Pilocarpine hydrochloride 50 mg EPP1700000 Pilocarpine nitrate 50 mg EPY0000106 Pilocarpine nitrate for system suitability 20 mg EPY0000525 Pimobendan 10 mg EPY0000401 Pimobendan for system suitability 0.1 mg EPP1750000 Pimozide 150 mg EPP1800000 Pindolol 100 mg EPY0001519 Pioglitazone for system suitability 15 mg EPY0001520 Pioglitazone hydrochloride 120 mg EPY0001476 Pipemidic acid trihydrate 15 mg EPY0000061 Pipemidic acid trihydrate - Reference Spectrum unit EPP1890000 Piperacillin 100 mg EPP1900000 Piperazine adipate 250 mg EPP2000000 Piperazine citrate 250 mg EPP2100000 Piperazine hydrate 250 mg EPY0001217 30 mg EPY0000288 Piracetam 150 mg EPY0000038 Pirenzepine dihydrochloride monohydrate 250 mg EPP2120000 Piretanide 100 mg EPY0001458 Piretanide for system suitability 10 mg EPP2130000 Piroxicam 50 mg EPY0001475 Piroxicam for system suitability 15 mg EPP2150000 Pivampicillin 2x50 mg EPP2152000 Pivmecillinam hydrochloride 100 mg Pivmecillinam impurity C 10 mg methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo-1H-azepin-1-yl) EPP2152015 methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate Plastic additive 01 2 mL EPP2155001 (2RS)-2-ethylhexyl)benzene-1,2-dicarboxylate Plastic additive 03 100 mg EPP2155003 N,N'-ethylenedialcanamide Plastic additive 04 500 mg EPE0800000 Epoxidised soya oil Plastic additive 05 500 mg EPP2155005 Epoxidised linseed oil Plastic additive 08 500 mg EPP2155008 Ethylene bis [3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate] Plastic additive 09 250 mg EPP2155009 pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate] Plastic additive 10 250 mg EPP2155010 4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)-trio[2,6-bis(1,1-dimethylethyl)phenol] Plastic additive 11 500 mg EPP2155011 Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate Plastic additive 12 250 mg EPP2155012 Tris(2,4-di-1,1-dimethylethylphenyl)phosphite R Plastic additive 13 250 mg EPP2155013 1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5-triazine-2,4,6-trione

Edition 2014 Visit us at www.lgcstandards.com 59

European Pharmacopoeia

Code Product Unit Plastic additive 14 250 mg EPP2155014 2,2'-Di(octadecycloxy)5,5'-spirobi(1,3,2,-dioxaphosphorinane) R Plastic additive 15 500 mg EPP2155015 Dioctadecyl disulphide Plastic additive 16 250 mg EPP2155016 Didodecyl 3,3'-thiodipropionate R Plastic additive 17 250 mg EPP2155017 Dioctadecyl 3,3'-thiodipropionate R EPP2155018 Plastic additive 18 100 mg Plastic additive 20 100 mg EPO0140000 R Plastic additive 21 100 mg EPE1260000 Erucamide R Plastic additive 22 100 mg Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1- EPP2155022 yl)ethanol Plastic additive 23 200 mg di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate containing about 27% of (tri(isooctyl)2,2',2''-[monooctylstannylidyne)tris(thio)]triacetate EPP2155023 Tin-content of 15.4% EPP2160000 Poliomyelitis vaccine (inactivated) BRP 5x0.5 mL EPP2161000 Poliomyelitis vaccine (oral) BRP 5x1 mL EPP2163920 Poloxamer 124 30 mg EPP2164009 Poloxamer 188 100 mg EPP2164020 Poloxamer 237 100 mg EPP2164021 Poloxamer 338 100 mg EPP2164030 Poloxamer 407 100 mg EPY0001557 Poly (vinyl acetate) 100 mg EPY0000792 Poly(vinyl acetate) dispersion 30% 1500 mg EPY0001550 Poly(vinyl alcohol) 100 mg EPP2600000 Poly(vinyl chloride) 100 mg EPP2170000 Polyacrylate - Reference Spectrum unit EPP2400000 Polymyxin B sulfate 25 mg EPY0000355 Polymyxin B sulfate for microbiological assay 25 mg EPY0000289 Polysorbate 20 - Reference Spectrum unit EPY0000290 Polysorbate 40 - Reference Spectrum unit EPY0000291 Polysorbate 60 - Reference Spectrum unit EPY0000007 Polysorbate 80 - Reference Spectrum unit EPP2649610 Potassium clavulanate - Reference Spectrum unit EPY0001168 Potassium clavulanate impurity G 5 mg EPY0000315 Potassium hydrogen aspartate hemihydrate 50 mg EPP2650000 Potassium sorbate 100 mg EPY0001275 Potassium sucrose octasulfate 100 mg EPP2660000 Povidone 50 mg EPY0000466 Povidone (iodinated) 10 mg EPY0001266 Pramipexole dihydrochloride monohydrate 5 mg EPY0001187 Pramipexole for system suitability 15 mg Pramipexole impurity D 5 mg EPY0001267 (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine EPY0000204 Pravastatin 1,1,3,3-tetramethylbutylamine 30 mg Pravastatin impurity A 0.1 mg (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)- 2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid EPY0000223 (6'-epipravastatin) EPY0000215 Pravastatin sodium - Reference Spectrum unit

60 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPP2669000 Prazepam 50 mg EPP2670000 Praziquantel 200 mg EPY0001533 Praziquantel for system suitability 10 mg Praziquantel impurity A 10 mg EPP2675000 (11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one EPP2680000 Prazosin hydrochloride 50 mg EPP2698000 100 mg EPY0001443 Prednicarbate for system suitability 10 mg EPY0001630 Prednicarbate for system suitability A 10 mg EPP2700000 150 mg EPP2800000 120 mg EPY0000582 Prednisolone acetate for peak identification 10 mg EPY0001359 Prednisolone for peak identification 10 mg EPY0001355 Prednisolone for system suitability 10 mg EPP2804000 Prednisolone hexanoate 10 mg EPP2805000 Prednisolone pivalate 120 mg EPP2810000 Prednisolone sodium phosphate 100 mg EPP2900000 100 mg EPP2920000 isobutyrate 200 mg EPY0000263 Prekallikrein activator in albumin BRP 3x1 mL EPP2939000 Prilocaine 150 mg EPP2939060 Prilocaine hydrochloride 100 mg Prilocaine impurity B 80 mg EPY0001408 2-methylbenzenamine hydrochloride Prilocaine impurity E 25 mg EPP2939025 (RS)-N-(methylphenyl)-2-(propylamino)propanamide EPP2940000 Primaquine diphosphate 500 mg EPP2950000 Primidone 150 mg EPY0000369 Primidone for peak identification 10 mg EPP3000000 Probenecid 100 mg EPP3050000 Procainamide hydrochloride 100 mg EPP3090000 Procaine benzylpenicillin 250 mg EPP3100000 Procaine hydrochloride 100 mg EPP3200000 Prochlorperazine maleate 100 mg EPP3300000 50 mg Progesterone impurity C 10 mg EPY0000148 (20R)-20-hydroxypregn-4-en-3-one EPY0000179 Proguanil hydrochloride - Reference Spectrum unit Proguanil impurity C 10 mg EPY0000181 1,5-bis(4-chlorophenyl)biguanide Proguanil impurity D 10 mg EPY0000182 1,5-bis(1-methylethyl)biguanide EPP3350000 60 mg EPP3390000 Promazine hydrochloride 100 mg EPY0000797 Promethazine for peak identification 5 mg EPP3400000 Promethazine hydrochloride 50 mg Promethazine impurity D 15 mg EPY0000769 (2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide EPP3490000 Propacetamol hydrochloride - Reference Spectrum unit EPY0000455 Propafenone hydrochloride 10 mg Propafenone impurity B 10 mg 2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy] EPY0000456 phenyl]-3-phenylprop-2-en-1-one EPY0000278 Propanol - Reference Spectrum unit

Edition 2014 Visit us at www.lgcstandards.com 61

European Pharmacopoeia

Code Product Unit EPY0000016 370 mg EPY0000017 Propofol for peak identification 0.1 mL Propofol impurity J 20 mg EPY0000018 2,6-bis (1-methylethyl)-1,4-benzoquinone EPP3500000 hydrochloride 30 mg EPP3600000 Propranolol hydrochloride for performance test 20 mg EPP3640000 Propyl gallate 50 mg EPP3650000 Propyl parahydroxybenzoate 150 mg EPY0001547 Propylene glycol 150 mg EPY0000318 Propylene glycol dilaurate 100 mg EPY0000319 Propylene glycol monolaurate 100 mg EPP3700000 100 mg EPP3750000 Propyphenazone 200 mg EPP3760000 Protirelin 2x5.03 mg EPP3800000 Proxyphylline 100 mg EPP3850000 Pseudoephedrine hydrochloride Drug Precursor 50 mg EPY0000387 Pseudoisoeugenyl 2-methylbutyrate for peak identification 100 mg EPY0001537 Purified quillaia saponins 30 mg EPP3900000 Purpureaglycoside A 25 mg EPP4000000 Purpureaglycoside B 25 mg EPY0000402 Pyrantel embonate 10 mg Pyrantel impurity A 20 mg EPY0000403 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine EPP4050000 Pyrazinamide 30 mg EPP4099900 Pyridostigmine bromide 30 mg Pyridostigmine impurity A 20 mg EPP4099910 pyridin-3-yl-dimethylcarbamate Pyridostigmine impurity B 10 mg EPY0001486 3-hydroxy-1-methylpyridinium EPP4100000 Pyridoxine hydrochloride 100 mg Pyridoxine impurity A 5 mg EPY0001226 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol EPP4200000 Pyrimethamine 250 mg EPY0000659 Pyrrolidone 20 mg EPY0001009 dihydrate 25 mg EPY0001419 Quetiapine for system suitability (2.005 mg) 2 mg EPY0001657 Quetiapine fumarate 50 mg EPY0001564 Quillaia saponin assay 30 mg EPY0001502 Quinapril for peak identification 5.075 mg EPY0001503 Quinapril for system suitability 5.125 mg EPY0001491 Quinapril hydrochloride 30 mg EPQ0100000 Quinidine sulfate 300 mg EPQ0200000 Quinine sulfate 300 mg EPR0100000 Rabies vaccine (inactivated) for veterinary use BRP 3x86 mg EPY0000896 110 mg EPY0000902 Racecadotril for peak identification 5 mg Racecadotril impurity A 1.1 mL EPY0000897 Ethanethioic acid Racecadotril impurity G 10 mg EPY0000898 benzyl[[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate EPY0001374 Racemic methyldopa 5 mg EPY0001134 hydrochloride 110 mg EPY0001135 Raloxifene hydrochloride for peak identification 10 mg EPR0145000 Ramipril 20 mg

62 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Ramipril impurity A 10 mg (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino] propanoly]octahydrocyclopenta[b]pyrrole-2-carboxylic acid EPR0145005 (ramipril methylester) Ramipril impurity B 10 mg (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3-phenylpropyl] amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid EPR0145010 (ramipril isopropyl ester) Ramipril impurity C 10 mg (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino] EPR0145015 propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (hexahydroramipril) Ramipril impurity D 10 mg ethyl(2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1H-cyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate EPR0145020 (ramipril diketopiperazine) EPY0000411 Ranitidine for system suitability 20 mg EPR0150000 Ranitidine hydrochloride 100 mg Ranitidine impurity J 0.00025 mg 1,1'-N-[methylenebis(sulphanediylethylene)]bis EPY0000416 (N'-methyl-2-nitroethene-1,1-diamine) EPY0001565 Recombinant Major Allergen rBet v 1 0.01025 mg EPY0001566 Recombinant Major Allergen rPhl p 5a 0.00856 mg EPY0000457 Repaglinide 20 mg EPY0000458 Repaglinide for system suitability 6 mg Repaglinide impurity E 10 mg EPY0000459 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid EPR0200000 Reserpine 100 mg EPR0250000 Residual solvents solution class I 1500 mg EPY0000767 Resorcinol 20 mg EPY0001194 20 mg EPR0300000 Retinol acetate 1000 mg EPR0290000 Retinol ester 100 mg EPR0500500 Reviparin sodium 250 mg EPY0000377 Ribavirin 2x150mg EPY0000757 Riboflavin for peak identification 0.12 mg EPR0600000 Riboflavin (Vitamine B2) 130 mg EPR0630000 Riboflavine sodium phosphate 250 mg EPY0000662 Ribonucleic acid 100 mg EPY0000149 Rifabutin 150 mg Rifabutin impurity A 20 mg EPY0000184 1-(2-methylpropyl)piperidin-4-one EPR0700000 Rifampicin 100 mg EPR0800000 Rifampicin quinone 100 mg EPR0900000 Rifamycin B 50 mg EPR0950000 Rifamycin S 50 mg EPR1000000 Rifamycin sodium 300mg EPY0001074 Rifaximin 160 mg EPY0001075 Rifaximin for system suitability 10 mg EPY0000250 Rilmenidine dihydrogenophosphate - Reference Spectrum unit EPY0000187 Rilmenidine for system suitability 30 mg EPY0001558 Risedronate impurity A 15 mg Risedronate impurity E 15 mg EPY0001540 2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid) EPY0001541 Risedronate sodium 2.5-hydrate 15 mg EPR1000600 50 mg EPY0000370 Risperidone for system suitability 20 mg

Edition 2014 Visit us at www.lgcstandards.com 63

European Pharmacopoeia

Code Product Unit Risperidone impurity K 0.015 mg 3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4Hpyrido[1,2- EPY0001276 a]pyrimidin-4-one (desfluoro risperidone) EPY0000714 Ritonavir 80 mg EPY0000706 Ritonavir for peak identification 10 mg EPY0001485 Rivastigmine for system suitability 1.0114 mg EPY0001516 Rivastigmine hydrogen tartrate 350 mg Rivastigmine impurity D 10 mg EPY0001515 3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)-enantiomer) EPY0001302 Rizatriptan benzoate 200 mg EPY0001303 Rizatriptan for system suitability 15 mg RK 13 cells 2x1 mL cell lines (kidney,rabbit) titration of live measles, EPR1300000 mumps and rubella vaccines EPY0001580 Rocuronium bromide 10 mg EPY0000594 Rocuronium bromide - Reference Spectrum unit EPY0000527 Rocuronium for peak identification 10 mg EPY0000742 Ropivacaine hydrochloride monohydrate 10 mg Ropivacaine impurity G 5 mg EPY0000743 (+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)-ropivacaine) EPY0000786 Rosmarinic acid 50 mg EPR1500000 Roxithromycin 125 mg EPY0000220 Roxithromycin for system suitability 5 mg EPT1610000 RRR-alpha-Tocopheryl hydrogen succinate 150 mg EPR2000000 Rubella vaccine (live) BRP 5x18 mg EPY0000494 Ruscogenins 10 mg EPY0000105 Rutoside trihydrate 100 mg EPY0000385 1,4-Sorbitan 50 mg EPS0360090 (RS)-Selegiline hydrochloride 25 mg EPS0040000 Saccharin 30 mg EPS0050000 Saccharin Sodium 50 mg EPS0100000 Salbutamol 50 mg Salbutamol impurity B 10 mg EPY0000030 (1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol Salbutamol impurity D 10 mg 5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2- EPY0000071 hydroxybenzaldehyde Salbutamol impurity F 10 mg 1,1'[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis EPY0000031 [2-[(1,1-dimethylethyl)amino]ethanol] Salbutamol impurity G 5 mg 2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-hydroxymethyl) EPY0000034 phenyl]ethanone Salbutamol impurity I 0.006 mg EPY0000032 (1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4-benzyloxyphenyl] ethanol Salbutamol impurity J 0.00045mg EPY0001186 2-[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone (salbutamone) EPS0150000 Salbutamol sulfate 50 mg EPY0001288 Salbutamol sulfate for system suitability 10 mg EPY0000669 Salicin 50 mg EPS0200000 Salicylic acid 100 mg Salicylic acid impurity B 10 mg EPY0000405 4-hydroxyisophthalic acid EPY0000422 Salmeterol xinafoate 50 mg EPY0001625 Salmeterol xinafoate for peak identification 15 mg EPY0000423 Salmeterol xinafoate for system suitability 25 mg

64 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0001559 Salvianolic acid B 15 mg EPY0001052 Santonin 20 mg EPY0001056 Saquinavir for system suitability 0.3033 mg EPY0001049 Saquinavir mesilate 70 mg EPY0001483 Saw palmetto extract 8 g EPB0680000 S-Benzylmercaptoacetyltriglycin 10 mg EPY0000814 Selamectin 100 mg EPY0000815 Selamectin for system suitability 5 mg EPS0360000 Selegiline hydrochloride 2x50 mg EPS0400000 Senna extract 50 mg EPS0450000 50 mg EPS0460000 Sertaconazole nitrate 125 mg EPY0000866 Sertraline for peak identification 5.4 mg EPY0000867 Sertraline for system suitability 6.18 mg EPY0000828 Sertraline hydrochloride 200 mg EPY0001285 Sertraline impurity E 15 mg EPY0000371 Sestamibi labelling kit 22mg EPY0001623 Set of Hepatitis A virus Detection Antibodies for ELISA - BRR 420 µL EPY0001046 1 mL EPY0001578 Sildenafil citrate 100 mg Sildenafil impurity A 10 mg 5-[2-ethoxy-5[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl- EPY0001579 3-(2-methylpropyl)-6,7-dihydro-1H-pyrazol[4,3-d]pyrimidin-7-one EPS0500000 Silicone elastomer 2000 mg EPS0600000 Silicone oil 1 mL EPS0650000 Simvastatin 100 mg EPY0001066 Simvastatin for peak identification 10 mg EPY0001208 Sinomenine 20 mg EPS0660000 Sisomicin sulfate 60 mg EPY0000014 Sodium alendronate 150 mg EPS0695000 Sodium amidotrizoate 125 mg EPY0000300 Sodium aminosalicylate dihydrate - Reference Spectrum unit EPY0000039 Sodium ascorbate 50 mg EPS0700000 Sodium calcium edetate 100 mg EPS0710000 Sodium cetostearyl sulfate 100 mg EPS0750000 Sodium cromoglicate 10 mg EPY0001300 Sodium cromoglicate for system suitability 20 mg EPS0760000 Sodium cyclamate 100 mg EPY0001410 Sodium fusidate 10 mg EPS0781000 Sodium hyaluronate - Reference Spectrum unit EPS0780000 Sodium hyaluronate BRP 300 mg EPY0001468 Sodium iodohippurate 15 mg EPY0000620 Sodium laurilsulfate 40 mg EPY0000808 Sodium phenylbutyrate 5 mg Sodium phenylbutyrate impurity C 10 mg EPY0000809 4-cyclohexylbutanoic acid EPS0785000 Sodium picosulfate 100 mg EPY0000210 Sodium polystyrene sulphonate - Reference Spectrum unit EPY0000268 Sodium propionate - Reference Spectrum unit EPS0800000 Sodium salicylate 100 mg EPS0808000 Sodium stearyl fumarate 50 mg EPS0808060 Sodium stearyl maleate 10 mg

Edition 2014 Visit us at www.lgcstandards.com 65

European Pharmacopoeia

Code Product Unit EPS0900000 Sodium taurocholate BRP 10000 mg EPS0930000 Sodium 150 mg EPS0945000 Somatostatin 2.45 mg EPS0947000 Somatropin 55 mg EPY0000711 Somatropin/desamidosomatropin resolution mixture 33 mg EPS0950000 Sorbic acid 10 mg EPS1000000 Sorbitol 1200 mg EPY0000114 Sotalol hydrochloride 25 mg Sotalol impurity B 20 mg EPY0000115 N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide EPY0001011 Spanish sage oil for peak identification 250 mg EPY0000549 Spectinomycin for system suitability 20 mg EPY0000597 Spectinomycin hydrochloride 100 mg EPY0000655 Spectinomycin sulphate tetrahydrate 10 mg EPY0001126 Spike lavender oil 400 µl EPS1100000 Spiramycin 200 mg EPY0000332 Spirapril for system suitability 15 mg EPY0000381 Spirapril hydrochloride monohydrate 60 mg EPS1200000 160 mg EPY0001295 Spironolactone for system suitability 2.055 mg EPY0000185 Squalane 0.25 mL EPY0001050 St.John's wort standardised dry extract 500 mg EPY0001091 Standardised artichoke leaf dry extract 60 mg EPS1250000 50 mg Stanozolol impurity A 10 mg EPS1250010 (5α,17β)-17-hydroxy-17-methylandrostan-3-one EPY0001420 Stanozolol impurity B 10 mg EPS1300000 Starch BRP 50000 mg EPY0000408 Stavudine 100 mg EPY0000421 Stavudine for system suitability 10 mg 100 mg EPS1340000 Plastic additive 19 EPS1350000 Stearyl alcohol 250 mg EPY0000868 Streptokinase for system suitability 30 µl EPS1400000 Streptomycin sulphate 100 mg EPY0001324 Sucralfate 10 mg EPY0001344 Sucralose 550 mg Sucralose impurity B 0.5 mg 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl 6-chloro-6-deoxy-α-D-glucopyranoside (1‘,6,6‘- EPY0001342 trichloro-1‘,6,6‘-trideoxysucrose) EPS1600000 Sucrose 100 mg EPS1608100 - Reference Spectrum unit EPS1609000 Sufentanil citrate - Reference Spectrum unit EPY0000528 Sulbactam 150 mg EPY0000550 Sulbactam for peak identification 20 mg EPY0000529 Sulbactam sodium 10 mg EPS1700000 Sulfacetamide sodium 50 mg EPS1800000 Sulfadiazine 100 mg EPY0001480 Sulfadiazine for identification of impurity F 15 mg Sulfadiazine impurity A 20 mg EPY0001469 2,6-dimethylaniline EPS1900000 Sulfadimidine 100 mg EPY0001495 Sulfadimidine for peak identification 50 mg

66 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPS1950000 Sulfadoxine 50 mg EPS1975000 Sulfafurazole 100 mg EPS1975600 Sulfaguanidine 60 mg EPS2000000 Sulfamerazine 100 mg EPS2050000 Sulfamethizole 100 mg EPS2100000 Sulfamethoxazole 50 mg Sulfamethoxazole impurity A 5 mg EPY0000412 N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide Sulfamethoxazole impurity F 5 mg EPY0000413 4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide EPS2150000 Sulfamethoxypyridazine 50 mg EPS2151000 Sulfanilamide 100 mg EPS2159100 Sulfapyridine 20 mg EPS2155000 Sulfasalazine 2x250 mg Sulfasalazine derivative for resolution 20 mg EPS2155010 2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic acid EPS2158000 Sulfathiazole 100 mg EPS2159000 Sulfinpyrazone 30 mg EPY0001238 Sulfinpyrazone for system suitability 0.5 mg Sulfinpyrazone impurity A 20 mg EPS2159010 1,2-diphenyl-4-(2-phenylsulphonylethyl)pyrazolidine-3,5-dione Sulfinpyrazone impurity B 20 mg EPS2159015 1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione EPS2180000 Sulindac 50 mg EPS2190000 100 mg Sulpiride impurity A 20 mg EPS2191000 [(2RS)-1-ethylpyrrolidin-2-yl]methanamine Sulpiride impurity B 20 mg EPS2192000 methyl 2-methoxy-5-sulphamoylbenzoate EPY0000530 Sultamicillin 10 mg EPY0000532 Sultamicillin for peak identification 10 mg EPY0000531 Sultamicillin tosilate 200 mg EPY0000027 Sumatriptan for system suitability 2 mg EPY0000026 Sumatriptan impurity mixture 3 mg EPY0000022 Sumatriptan succinate 50 mg EPS2200000 Suxamethonium chloride 1000 mg EPS2400000 Suxibuzone 50 mg Suxibuzone impurity B 10 mg EPS2400004 (4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate Suxibuzone impurity C 10 mg EPS2400006 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione EPS5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines-vet.use) BRP 1 mg EPS5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines-vet.use) BRP 1 mg EPY0000644 (R)-Timolol 20 mg EPY0001497 3-Trimethylsilyl-1-propanesulfonic acid sodium salt 120 mg EPT1899000 3,4,6-Tri-O-acetyl-D-glucal - Reference Spectrum unit EPY0001417 Tadalafil 200 mg EPT0010000 Talampicillin hydrochloride 50 mg EPT0014000 citrate 80 mg EPT0015000 Tamoxifen citrate for performance test 10 mg EPY0000650 Tamsulosin hydrochloride 10 mg Tamsulosin impurity D 10 mg EPY0000651 2-methoxy-5[(2R)-2-[[2-(2-methyoxyphenoxy)ethyl]amino]propyl]benzenesulfonamide Tamsulosin impurity H 10 mg EPY0000652 (2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine

Edition 2014 Visit us at www.lgcstandards.com 67

European Pharmacopoeia

Code Product Unit EPY0000653 Tamsulosin racemate 15 mg EPY0001560 Tanshinone IIa 15 mg EPY0001102 Teicoplanin 52 mg EPY0001047 Teicoplanin for identification 40 mg EPY0000648 Telmisartan 30 mg EPY0000649 Telmisartan for peak identification 10 mg EPY0001003 Telmisartan for system suitability 0.26 mg EPT0040000 Temazepam 50 mg Temazepam impurity C 5 mg (3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate EPY0000344 Controlled Substance Temazepam impurity D 5 mg (3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one EPY0000345 Controlled Substance Temazepam impurity F 5 mg EPY0000346 (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione Temazepam impurity G 5 mg EPY0000347 (5RS)-7-chloro-1,4-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione EPT0040800 Tenoxicam 100 mg EPY0001114 Tenoxicam impurity mixture 0.0042 mg EPY0000666 Terazosin for system suitability 0.5 mg EPY0000621 Terazosin hydrochloride dihydrate 40 mg Terazosin impurity A 10 mg EPY0000622 2-chloro-6,7-dimethoxyquinazolin-4-amine Terazosin impurity E 10 mg EPY0000665 2,2`-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) Terazosin impurity L 10 mg EPY0000623 1-(furan-2-ylcarbonyl)piperazine Terazosin impurity N 10 mg EPY0000624 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine EPY0001143 Terbinafine for system suitability 10 mg EPY0000535 Terbinafine hydrochloride 10 mg Terbutaline impurity C 15 mg EPT0050015 1-(3,5-dihydroxyphenyl)-2-[(1,1- dimethylethyl)amino]-ethanone EPT0050000 Terbutaline sulfate 100 mg EPT0060000 Terconazole 250mg EPT0071000 Terfenadine 100 mg Terfenadine impurity A 20 mg 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] butan-1-one EPT0080000 (ketone) EPT0100000 30 mg EPT0210000 Testosterone caproate 50 mg EPT0240000 Testosterone decanoate 50 mg EPY0000696 Testosterone decanoate for system suitability 0.4 mg EPT0250000 Testosterone enantate 100 mg EPY0001312 Testosterone enantate for peak identification 10 mg EPY0001317 Testosterone enantate for system suitability 2 mg Testosterone enantate impurity H 10 mg EPY0001313 delta-5-testosterone-3,17-dienantate EPY0000342 Testosterone for impurity D identification 20 mg EPY0000343 Testosterone for system suitability 20 mg EPT0260000 Testosterone isocaproate 50 mg EPY0000716 Testosterone isocaproate for system suitability 5 mg EPT0300000 60 mg EPY0001409 Testosterone propionate for system suitability 5 mg EPT0400000 Tetanus vaccine (adsorbed) BRP 30 mg

68 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0001002 Tetracaine for system suitability 2 mg EPT0500000 Tetracaine hydrochloride 100 mg EPT0550000 Tetracosactide 2x0.366mg EPT0600000 Tetracycline hydrochloride 100 mg EPY0001165 Tetrandrine 20 mg EPY0001087 Tetra-O-acetyl-mannose triflate 60 mg EPY0000015 Tetrazepam - Reference Spectrum unit Tetrazepam impurity C 20 mg EPY0000008 7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one EPY0000460 Tetryzoline hydrochloride 10 mg EPY0000723 Controlled Substance 15 mg EPT0700000 Theobromine 25 mg EPT0800000 Theophylline 100 mg EPY0000294 Theophylline - Reference Spectrum unit Thiamazol impurity A 15 mg EPY0000372 2,2-dimethoxy-N-methylethanamine Thiamazol impurity C 20 mg EPY0000373 1-methyl-2-(methylsulphanyl)-1H-imidazole EPY0000336 125 mg EPY0000467 Thiamine hydrochloride 10 mg Thiamine impurity E 10 mg 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl) EPY0000059 4-methyl-4-thiazolidine-2-thione EPY0000060 Thiamine nitrate - Reference Spectrum unit EPT1100000 Thiamphenicol 125 mg EPY0000546 Thioctic acid 110 mg EPY0000545 Thioctic acid containing impurity B 30 mg EPY0000592 Thioctic acid for system suitability 10 mg EPY0000109 Thiomersal 30 mg EPT1200000 Thiopental 500 mg EPY0001478 Thiopental for system suitability 10 mg EPY0000704 Thioridazine 10 mg EPY0000541 Thioridazine for system suitability 0.21 mg EPT1300000 Thioridazine hydrochloride 100 mg EPT1305100 Thioxanthene 20 mg EPT1305000 Thioxanthone 10 mg EPT1340000 50 mg EPT1350000 50 mg EPT1410000 Tiabendazole 50 mg EPY0000379 Tiamulin - Reference Spectrum unit EPY0000414 Tiamulin for peak identification 10mg EPY0000333 Tiamulin hydrogen fumarate 500 mg EPY0000152 for system suitability 30 mg Tianeptine impurity A 20 mg EPY0000153 ethyl 7-bromoheptanoate EPY0000151 Tianeptine sodium - Reference Spectrum unit EPT1405000 Tiapride hydrochloride 60 mg EPT1405050 Tiapride N-oxide 20 mg EPT1410900 Tiaprofenic acid 50 mg Tiaprofenic acid impurity C 20 mg EPT1410910 (2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid EPY0000748 - Reference Spectrum unit EPY0000668 Tibolone for system suitability 10 mg

Edition 2014 Visit us at www.lgcstandards.com 69

European Pharmacopoeia

Code Product Unit Ticarcillin impurity A 50 mg (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]-amino]-4-thia-1- EPT1420010 azabicyclo[3.2.0]heptane-2-carboxylic acid (decarboxyticarcillin) EPY0000465 Ticarcillin monosodium 250 mg EPT1423000 Ticlopidine hydrochloride 50 mg Ticlopidine impurity F 10 mg EPT1423025 6-(2-chlorobenzyl)4,5,6,7-tetrahydrothieno [3,2-c]pyridine EPY0000325 hydrochloride hemihydrate - Reference Spectrum unit EPY0001270 Timolol for system suitability 5.045 mg EPT1450000 Timolol maleate 100 mg EPT1470000 Tinidazole 100 mg Tinidazole impurity A 15 mg EPY0000899 2-methyl-5-nitro-1H-imidazole Tinidazole impurity B 20 mg EPT1471000 1-(2-ethylsulphonylethyl)-2-methyl-4-nitroimidazole EPT1490000 Tinzaparin sodium 250 mg EPY0000292 Tioconazole - Reference Spectrum unit EPY0000282 Tioconazole for system suitability 50 mg EPY0001188 Tiotropium bromide monohydrate 10 mg EPY0001189 Tiotropium for system suitability 10 mg Tiotropium impurity F 15 mg EPY0001216 dithiophen-2-ylmethanone EPY0001179 Tiotropium impurity mixture 0.08 mg EPT1500000 Tobramycin 49 mg EPY0001210 Tobramycin for identification 250 mg EPT1700000 Tolbutamide 100 mg EPY0000154 100 mg EPT1707000 Tolnaftate 60 mg EPY0001123 Tolnaftate for system suitability 10 mg EPY0000461 Torasemide anhydrous 10 mg EPY0000462 Torasemide for system suitability 5 mg Torasemide impurity E 0.0006 mg EPY0001366 ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate EPY0000155 hydrochloride 75 mg Tramadol impurity A 25 mg EPY0000156 (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Tramadol impurity E 15 mg EPY0000157 (2RS)-2-[(dimethylamino)methyl]cyclohexanone EPY0000072 Tramazoline hydrochloride monohydrate 20 mg Tramazoline impurity A 15 mg EPY0000065 N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine Tramazoline impurity B 10 mg mixture of: 1-acetyl-2-[(5,6,7,8-tetrahydronaphthalen-1-yl)amino]-4,5-dihydro-1H-imidazole EPY0000066 and N-(4,5-dihydro-1H-imidazol-2-yl)-N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide EPY0000501 Trandolapril 10 mg Trandolapril impurity C 10 mg (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1- (ethoxycarbonyl)propyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid EPY0000495 (hexahydrotrandolapril) Trandolapril impurity D 10 mg ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]- EPY0000496 4-phenylbutanoate (trandolapril diketopiperazine) EPT1810000 Tranexamic acid 50 mg EPP1609010 trans-Epoxyphytomenadione 5 mg EPT1820000 Trapidil 50 mg Trapidil impurity A 20 mg EPT1820002 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol

70 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit Trapidil impurity B 20 mg EPT1820004 1,2,4-triazol-3-amine EPY0001172 Trehalose dihydrate 250 mg EPT1850000 Tretinoin 50 mg EPG0400010 Triacetin - Reference Spectrum unit EPT1899990 150 mg EPT1900000 150 mg EPY0001459 Triamcinolone acetonide for system suitability 10 mg EPT1950000 Triamcinolone hexacetonide 100 mg Triamcinolone impurity C 10 mg EPY0000050 9-fluoro-11ß-16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione EPY0000837 Triamterene 10 mg Triamterene impurity B 0.5 mg EPY0000870 2,7-diamino-6-phenylpteridin-4-ol EPT1975000 Triazolam 10 mg Tribenoside impurity A 70 mg EPY0000166 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-α-D-glucofuranose EPY0001628 Tribenoside impurity D 35 mg EPY0001055 Tributyl acetylcitrate 1 mL EPY0000799 Tributyl acetylcitrate for peak identification 25 mg EPT1977990 Tricaprin 150 mg EPT1977995 Tricaproin 40 mg EPT1978000 Tricaprylin 225 mg EPY0000111 Trichloroacetic acid - Reference Spectrum unit EPT1985000 Trichlorotrifluoroethane 2.5 mL EPT1986000 Triethyl citrate - Reference Spectrum unit EPT2000000 Trifluoperazine hydrochloride 100 mg EPT2005000 Triflusal 50 mg Triflusal impurity B 25 mg EPT2005010 2-hydroxy-4-(trifluoromethyl)benzoic acid EPY0000720 Triglycerol diisostearate 200 mg EPY0000108 Trihexyphenidyl hydrochloride 100 mg Trihexyphenidyl impurity A 20 mg EPY0000068 1-phenyl-3-(piperidin-1-yl)propan-1-one EPT2009000 Trilaurin 1250 mg EPY0001260 for system suitability 1.017 mg EPY0001319 Trimebutine maleate 10 mg EPY0000092 Trimetazidine dihydrochloride - Reference Spectrum unit EPY0000093 Trimetazidine for system suitability 50 mg EPT2100000 Trimethadione 250 mg EPT2200000 Trimethoprim 50 mg EPY0000684 Trimethoprim for system suitability 0.00075 mg Trimethoprim impurity B 15 mg EPT2200010 (2,4-diaminopyrimidin-5-yl)(3,4,5- trimethoxyphenyl)methanone EPT2450000 Trimethyltetradecylammonium bromide 200 mg EPY0000759 Trimipramine for peak identification 0.51 mg EPT2500000 Trimipramine maleate 100 mg EPT2500100 Trimyristin 500 mg EPY0000279 Tri-n-butyl phosphate 300 µL EPY0001113 Triolein 30 mg EPT2501200 Tristearin 100 mg EPT2545000 Trolamine 2250 mg Trolamine impurity A 250 mg EPY0001184 Ethanolamine

Edition 2014 Visit us at www.lgcstandards.com 71

European Pharmacopoeia

Code Product Unit Trolamine impurity B 1 mL EPY0001183 Diethanolamine EPT2550000 Trometamol 100 mg EPT2580000 Tropicamide 50 mg EPY0001316 Tropicamide for peak identification 10 mg Tropicamide impurity C 10 mg EPY0001247 (2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid) Tropicamide impurity D 10 mg EPY0001248 Phenylacetic acid DRUG PRECURSOR EPT2580300 Tropine 50 mg EPY0000616 hydrochloride 40 mg Tropisetron impurity B 10 mg EPY0000618 1H-indole-3-carboxylic acid EPY0000429 Trospium chloride 10 mg Trospium impurity A 20 mg EPY0000432 Hydroxydiphenylacetic acid (benzilic acid) Trospium impurity B 20 mg EPY0000431 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate Trospium impurity C 5 mg EPY0000430 (1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] EPY0000497 Troxerutin 30 mg EPT2600000 Trypsin BRP 100 mg EPT2610000 Tryptophan 100 mg EPT2880000 Tylosin 150 mg EPT2880100 Tylosin D 5 mg EPY0000498 Tylosin phosphate for peak identification 10 mg EPT2880200 Tylosin tartrate - Reference Spectrum unit EPT2900000 50 mg EPT3000000 Tyrothricin 20 mg EPU0020000 Ubidecarenone 50 mg EPU0020001 Ubidecarenone for system suitability 1 mg Ubidecarenone impurity D 5 mg 5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35- nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl] EPU0020008 benzene-1,4-dione EPU0100000 Uracil arabinoside 60 mg EPU0600000 Urea 100 mg EPU0800000 Ursodeoxycholic acid 100 mg EPY0001163 Ursodeoxycholic acid for system suitability 1.26 mg EPY0001523 25 mg EPY0001225 Valaciclovir for system suitability 10 mg EPY0000834 Valaciclovir hydrochloride (anhydrous) 100 mg Valaciclovir impurity D 10 mg EPY0001096 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate Valaciclovir impurity E 10 mg EPY0001097 2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate Valaciclovir impurity F para-toluenesulfonate 12 mg EPY0001098 2-hydroxyethyl L-valinate Valaciclovir impurity G 10 mg EPY0001099 N,N-dimethylpyridin-4-amine EPY0001662 Valaciclovir impurity P 5 mg EPY0001655 Valaciclovir impurity S 15 mg EPY0000583 standardised dry extract 400 mg EPV0030000 Valine 50 mg EPY0000585 Valnemulin for peak identification 20 mg EPY0000584 Valnemulin hydrochloride 10 mg

72 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia

Code Product Unit EPY0000533 Valnemulin hydrogen tartrate 120 mg Valnemulin impurity E 10 mg (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro- EPY0000586 3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate (pleuromulin) EPV0033000 Valproic acid 100 mg EPY0001422 Valproic acid for system suitability 10 mg EPY0001132 Valsartan 10 mg EPY0001131 Valsartan for peak identification 10 mg EPY0001145 Valsartan for system suitability 0.202 mg EPV0045000 Vancomycin hydrochloride 100 mg EPV0050000 100 mg EPY0001198 Varicella vaccine (live) 420 mg EPY0000561 Vecuronium bromide 10 mg EPY0000625 Vecuronium for peak identification 10 mg EPY0001093 Vedaprofen 5 mg EPY0001118 Vedaprofen impurity mixture 0.006 mg EPY0000588 Venlafaxine for system suitability 1 mg EPY0000587 Venlafaxine hydrochloride 50 mg EPV0100000 hydrochloride 100 mg Verapamil impurity I 5 mg (2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4)dimethoxyphenyl)- EPV0100018 ethyl](methyl)amino]ethyl]3-methylbutanenitrile Verapamil impurity M 10 mg 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)- EPV0100026 2-(1-methylethyl)pentanenitrile EPY0000661 Verbenalin 11 mg EPY0001400 Vigabatrin 10 mg Vigabatrin impurity A 25 mg EPY0001401 (5RS)-5-ethenylpyrrolidin-2-one Vigabatrin impurity B 20 mg EPY0001402 (2E)-2-(2-aminoethyl)but-2-enoic acid Vigabatrin impurity D 50 mg EPY0001404 4-aminobutanoic acid Vigabatrin impurity E 10 mg EPY0001403 2-[(2RS)-2-aminobut-3-enyl]propanedioic acid EPV0300000 Vinblastine sulphate 5 mg EPV0305000 Vinblastine sulfate - Reference Spectrum unit EPV0400000 Vincristine sulphate 4.98 mg EPV0405000 Vincristine sulfate - Reference Spectrum unit EPV0500000 Vindesine sulphate 5.11 mg EPV0500010 Vindesine sulfate - Reference Spectrum unit Vinorelbine impurity B 7 mg EPY0000464 4-O-deacetylvinorelbine EPY0000463 Vinorelbine tartrate 50 mg EPY0000589 Vinpocetine 10 mg Vinpocetine impurity A 10 mg (12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H- EPY0000590 indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (ethyl vincaminate) Vinpocetine impurity B 10 mg (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1- EPY0000591 ij][1,5]naphthyridine-12-carboxylate (apovincamine) Vinpocetine impurity C 10 mg ethyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1- EPY0000790 de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (methoxyvinpocetine) Vinpocetine impurity D 10 mg (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1- EPY0000760 de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (dihydrovinpocetine)

Edition 2014 Visit us at www.lgcstandards.com 73

European Pharmacopoeia

Code Product Unit EPY0000793 Vinyl acetate 200 mg EPY0001395 Voriconazole 120 mg Voriconazole impurity B 10 mg EPY0001396 (2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Voriconazole impurity D 10 mg (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol EPY0001398 (epi-voriconazole) Voriconazole impurity E 50 mg [(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid ((+-)- EPY0001397 camphorsulfonic acid) EPW0100000 Warfarin sodium 10 mg EPY0000778 Warfarin sodium clathrate 10 mg EPY0001599 15 mg EPX0075000 Xylazine hydrochloride 125 mg Xylazine impurity C 50 mg EPY0000158 2,6-dimethylphenyl Xylazine impurity E 15 mg EPY0000159 N-(2,6-dimethylphenyl)-S-methyldithiourea EPY0001224 Xylazine impurity mixture 0.02 mg EPX0080000 Xylitol 500 mg EPX0100000 Xylometazoline Hydrochloride 100 mg Xylometazoline impurity A 10 mg EPX0101000 N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl)acetamide EPX0200000 Xylose 100 mg EPY0000656 Yohimbine hydrochloride 20 mg EPZ1900000 Zidovudine 60 mg EPY0001641 Zidovudine for system suitability 10 mg Zidovudine impurity A 10 mg EPZ1902000 1-[(2R,5S)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methylpyrimidine-2,4(1H,3H)-dione Zidovudine impurity B 15 mg EPZ1904000 1-(3-chloro-2,3-dideoxy-ß-D-ribofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione Zidovudine impurity D 15 mg EPY0001654 Triphenylmethanol EPZ2000000 Zinc acexamate 50 mg Zinc acexamate impurity A 50 mg EPZ2000010 6-[[6-(acetylamino)hexanoyl]amino] hexanoic acid EPY0001272 Ziprasidone for system suitability 1 10 mg EPY0001241 Ziprasidone for system suitability 2 0.465 mg EPY0001286 Ziprasidone hydrochloride monohydrate 100 mg EPY0001626 Ziprasidone mesylate trihydrate 30 mg impurity A 10 mg N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol EPZ2500010 [1,2-a]pyridin-3-yl] acetamide EPZ2500000 Zolpidem tartrate 200 mg EPZ3000000 Controlled Substance 40 mg EPZ3001000 Zopiclone oxide 20 mg EPY0000062 Zuclopenthixol decanoate - Reference Spectrum unit EPY0000534 Zuclopenthixol for system suitability 0.1 mg Zuclopenthixol impurity B 10 mg 2-chloro-9H-thioxanthen-9-one EPY0000083

74 Visit us at www.lgcstandards.com Edition 2014

ATCC microbiology products

ATCC microbiology products As a scientist you know the importance of using the best materials to support your quality control programme. As Europe’s only officially authorized distributor of ATCC cultures, LGC Standards can supply all ATCC organisms specified in the pharmacopoeia. ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never subcultured or transferred in any way from ATCC’s strains and our European stock- holding means orders are usually filled within 3 - 5 working days. So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with authentic, high-quality ATCC materials – exclusively from LGC Standards.

European Pharmacopoeia, 8th Edition, general chapters

Code Product Unit 2.6.1 - Sterility ATCC-16404 Aspergillus niger amp. ATCC-6633 Bacillus subtilis amp. ATCC-10231 Candida albicans amp. ATCC-11437 Clostridium sporogenes amp. ATCC-19404 Clostridium sporogenes amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. 2.6.2 - Mycobacteria ATCC-25177 Mycobacterium tuberculosis amp. 2.6.7 - Mycoplasmas ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp. ATCC-19989 Mycoplasma fermentans Amp. ATCC-19610 Mycoplasma gallisepticum amp. ATCC-17981 Mycoplasma hyorhinis Switzer amp. ATCC-29052 Mycoplasma hyorhinis Amp. ATCC-23714 Mycoplasma orale amp. ATCC-15531 Mycoplasma pneumoniae amp. ATCC-25204 Mycoplasma synoviae amp. 2.6.12 - Microbiological examination of non-sterile products (total ...) ATCC-16404 Aspergillus brasiliensis (formerly Aspergillus niger) amp. ATCC-6633 Bacillus subtilis amp. ATCC-10231 Candida albicans amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. 2.6.13 - Microbiological examination of non-sterile products (tests for ...) ATCC-10231 Candida albicans amp. ATCC-11437 Clostridium sporogenes amp. ATCC-19404 Clostridium sporogenes amp. ATCC-8739 Escherichia coli amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-14028 Salmonella enterica subsp. enterica serovar Typhimurium Amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. 2.6.27 - Microbiological control of cellular products ATCC-16404 Aspergillus niger amp. ATCC-6633 Bacillus subtilis amp. ATCC-10231 Candida albicans amp.

Edition 2014 Visit us at www.lgcstandards.com 75

European Pharmacopoeia, 8th Edition, general chapters

Code Product Unit ATCC-19404 Clostridium sporogenes amp. ATCC-11437 Clostridium sporogenes amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. 2.7.2 - Microbiological assay of antibiotics ATCC-14884 Bacillus pumilus amp. ATCC-11774 Bacillus subtilis amp. ATCC-6633 Bacillus subtilis amp. ATCC-4617 Bordetella bronchiseptica amp. ATCC-10541 Enterococcus hirae (as Streptococcus faecalis) amp. ATCC-9637 Escherichia coli amp. ATCC-10536 Escherichia coli amp. ATCC-10031 Klebsiella pneumoniae ss. pneumoniae amp. ATCC-9341 Kocuria rhizophila amp. ATCC-10240 Micrococcus luteus amp. ATCC-607 Mycobacterium smegmatis amp. ATCC-9763 Saccharomyces cerevisiae amp. ATCC-9144 Staphylococcus aureus ss. aureus amp. ATCC-6538P Staphylococcus aureus subsp. aureus amp. ATCC-12228 Staphylococcus epidermidis amp. 5.1.1 - Methods of preparation of sterile products ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp. 5.1.2 - Biological indicators of sterilisation ATCC-27142** Bacillus pumilus amp. ATCC-7953** Bacillus stearothermophilus amp. ATCC-9372** Bacillus subtilis amp. 5.1.3 - Efficacy of antimicrobial preservation ATCC-16404 Aspergillus niger amp. ATCC-10231 Candida albicans amp. ATCC-8739 Escherichia coli amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. **=Alternative strain All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia.

76 Visit us at www.lgcstandards.com Edition 2014

With links to all webshop products

United States Pharmacopeia

@LGCStdsPharma www.lgcstandards.com From Atorvastatin to Zopiclone: Over 3,000 pharmaceutical impurities

LGC Standards offers over 3,000 reference standards for impurities to support the pharmaceutical industry.

Acknowledged by regulation authorities worldwide

Impurities linked to the European Pharmacopoeia (Ph. Eur.) wherever possible

Customised pharmaceutical impurities created on request

Detailed certificates of analysis provided

Additional documentation on request

Assistance in finding the right material to suit your analyses

Further information at

www.lgcstandards.com

LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043

© LGC Limited, 2013. All rights reserved. LGC Standards is part of the LGC Group. 3664/LB/0713

3677_pharma_A-Z_ad_v4.indd 1 1/14/2014 11:20:32 AM Intoduction

United States Pharmacopeia (USP) and National Formulary (NF) (from page 81)

Background USP reference standards are highly purified substances that are provided specifically for use in the official test methods of the United States Pharmacopeia and National Formulary. When used as a part of the relevant official monograph they provide the means to verify the compliance of a material with USP-NF standards for identity, concentration, quality and purity. Official USP and NF reference standards are made available as required for use in assays and tests appearing in the current edition of the USP-NF. They are collaboratively tested and approved for such use by the USP Reference Standards Committee and released only under the authority of the USP Board of Trustees.

Production and certification The development of USP reference standards is a multi-step process that makes much use of voluntary cooperation from the pharmaceutical industry, government agencies including the United States Food and Drug Administration (FDA), and both USP in-house scientific staff and the members of the Committee of Revision.

Proper use A full description of the background to, proper use of and lot control procedures for USP-NF reference standards is given in General Chapter <11> of the current USP-NF publication. Analysts are strongly advised to review this section on a regular basis. It must be noted that any other use of a USP reference standard in non-official procedures becomes the responsibility of the user.

Shelf life, expiry dates and size units USP reference standards are not labeled with an expiry date. The official lot number system provides greater flexibility than a simple expiry date system. USP reference standards stocks are regularly and rigorously checked. Under normal circumstances a new lot is made official and held for future use, before the old lot is sold out. The old lot remains official for a period of time so that in-house reference substances can be recertified against the out-going and incoming lots and also to prevent unnecessary waste. Please note, that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. Once opened, USP can no longer guarantee the stability of the material and any of the USP RS not used should be disposed of and not kept for future use.

Validation of secondary standards against USP reference substances All secondary in-house working standards have to be compared against the corresponding USP reference standard. Please make sure that the secondary material is used only for the same official purposes for which the primary pharmacopoeial material also was designed.

Email: [email protected] | Website: www.lgcstandards.com 79

3970_3Pharma_catalogue_internal_US_pharma_v1.indd 79 6/13/2014 12:14:25 PM Storage conditions The USP-NF states that “generally, reference standards should be stored in their original sealed containers away from heat and protected from light. Avoid humid storage areas in particular”. In addition, the USP-NF recommends in its General Notices, that “where no specific storage directions or limitations are provided in the individual monograph, it is to be understood that conditions of storage include protection from moisture, freezing and excessive heat”.

Controlled substances The USP list contains substances subject to Controlled Substance Regulations Schedules I, II, III, IV and V. Special ordering procedures apply, please contact LGC Standards for details and costs.

Restricted reference standards The United States Government restricts the export of chemicals appearing on the US Munition list, the Commerce Control list or in the Chemical Weapons Convention Annex on chemicals. Listed below are USP reference standards that are now currently restricted and may not be exported to any country outside the United States.

USP1106001 Chlorambucil USP1157002 Cyclophosphamide USP1376505 Mechlorethamine Hydrochloride USP1379300 Melphalan Hydrochloride USP1706009 Uracil

80 Email: [email protected] | Website: www.lgcstandards.com

3970_3Pharma_catalogue_internal_US_pharma_v1.indd 80 6/13/2014 12:14:25 PM United States Pharmacopeia and National Formulary

USP standards

Code Product Unit USP1035300 1,6-Anhydro-D-glucose 50 mg USP1025806 2-[3-Amino-5-(n-methylacetamido)-2,4,6-triiodobenzamido]-2-deoxy-d-glucose 25 mg USP1009479 2-Acetylpyridine 1 g USP1022808 2-Amino-5-chlorobenzophenone 25 mg USP1076261 3-Acetyl-11-Keto-Beta-Boswellic Acid 20 mg USP1026605 3-Amino-2,4,6-triiodobenzoic Acid 50 mg USP1036507 3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile (AS) 25 mg USP1019870 4-Aminobenzoylglutamic Acid 50 mg USP1021204 4-Aminophenol 100 mg USP1012178 5'-Adenylic Acid 500 mg USP1027007 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid 50 mg Abacavir Related Compound A 20 mg USP1000420 [4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol Abacavir Related Compound B 20 mg USP1000441 [4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol Abacavir Related Compound C 20 mg USP1000452 [(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol HCl Abacavir Related Compound D 20 mg N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chlorpyrimidin-4-yloxy)methyl] cyclopent-2- USP1000437 enyl}-9H-purine-2,6-diamine USP1000485 Abacavir Related Compounds Mixture 15 mg USP1000496 Abacavir Stereoisomers Mixture 15 mg USP1000408 Abacavir Sulfate 200 mg Abacavir Sulfate Racemic 20 mg USP1000419 4-[2-amino-6-(cyclopropylamino)9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1) USP1000500 Abacavir System Suitability Mixture 15 mg USP1000554 Acamprosate Calcium 200 mg USP1000565 Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid) 15 mg USP1000521 Acarbose 200 mg USP1000532 Acarbose System Suitability Mixture 2 mg USP1000601 Acebutolol HCl 125 mg Acebutolol Related Compound A 20 mg USP1000612 N-(3-acetyl-4-hydroxyphenyl)butanamide (AS) USP1001003 Acenocoumarol 200 mg USP1001502 Acepromazine Maleate 250 mg USP1002505 Acesulfame Potassium 200 mg USP1003009 Acetaminophen 400 mg Acetaminophen Related Compound A 15 mg USP1003010 4-(acetylamino)phenyl acetate Acetaminophen Related Compound B 50 mg USP1003027 N-(4-hydroxyphenyl)propanamide Acetaminophen Related Compound C 50 mg USP1003031 N-(2-hydroxyphenyl)acetamide Acetaminophen Related Compound D 50 mg USP1003042 N-phenylacetamide Acetaminophen Related Compound F 50 mg USP1003064 p-nitrophenol Acetaminophen Related Compound J 50 mg USP1003100 N-(4-chlorophenyl)acetamide USP1004001 Acetanilide Melting Point Standard (Approximately 114°C) 500 mg USP1005004 Acetazolamide 2 g USP1006007 Acetohexamide 250 mg USP1006506 Acetohydroxamic Acid 200 mg USP1006801 Acetone 3x1.5 mL

Edition 2014 Visit us at www.lgcstandards.com 81

United States Pharmacopeia and National Formulary

Code Product Unit USP1007000 Acetophenazine Maleate 200 mg USP1008501 Acetylcholine Chloride 200 mg USP1009005 Acetylcysteine 200 mg USP1009901 Acetyltributyl Citrate 500 mg USP1009923 Acetyltriethyl Citrate 500 mg USP1011007 Acitretin 200 mg Acitretin Related Compound A 20 mg USP1011018 (2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid Acitretin Related Compound B 20 mg USP1011029 ethyl(all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate USP1012032 Actein 20 mg USP1012065 Acyclovir 300 mg Acyclovir Related Compound A 50 mg USP1012076 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate Acyclovir Related Compound F 50 mg USP1012054 N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide Acyclovir Related Compound G 50 mg USP1012087 (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate) USP1011709 Adapalene 200 mg Adapalene Related Compound A 50 mg USP1011710 Methyl 6-bromo-2-naphthoate Adapalene Related Compound B 50 mg USP1011721 Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate Adapalene Related Compound C 25 mg USP1011732 2-(adamant-1-yl)methoxybenzene Adapalene Related Compound D 25 mg USP1011743 4,4'-dimethoxy-3,3'-di(adamant-1-yl)biphenyl Adapalene Related Compound E 25 mg USP1011754 2,2'binaphthyl-6,6'-dicarboxylic acid USP1012134 Ademetionine Disulfate Tosylate 500 mg USP1012101 Adenine 200 mg USP1012123 Adenosine 200 mg USP1012190 Adipic Acid 100 mg USP1012214 Agar 500 mg USP1012145 Agigenin 25 mg USP1012203 25 mg USP1012553 Albendazole 200 mg USP1012600 Albuterol 200 mg Albuterol Related Compound A 25 mg USP1012644 4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate Albuterol Related Compound B 10 mg USP1012655 2-(tert-butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone Albuterol Related Compound E 10 mg USP1012689 2,2'-oxybis(methylene)bis{4-[2-(tert-butylamino)-1-hydroxyethyl]phenol} diacetate USP1012633 Albuterol Sulfate 200 mg USP1012757 Dipropionate 300 mg Alclometasone Dipropionate Related Compound A 20 mg USP1012746 11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate USP1012768 Alcohol 5x1.2 mL USP1012699 Alcohol Determination-Acetonitrile 5x5 mL USP1012688 Alcohol Determination-Alcohol 5x5 mL USP1012780 Alendronate Sodium 200 mg USP1012906 Alfentanil HCl Controlled Substance CII 500 mg USP1012917 Alfuzosin HCl 150 mg USP1012928 Alfuzosin System Suitability Mixture 15 mg

82 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Alfuzosin System Suitability Mixture A 25 mg USP1012871 Alfuzosin HCl containing Impurity A, Impurity D, and Impurity E USP1012848 Alitame 250 mg USP1012859 Alitame - Alanine Amide Impurity (N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alanimamide) 25 mg USP1012939 Allantoin 200 mg USP1012950 Alliin 25 mg USP1013002 Allopurinol 250 mg Allopurinol Related Compound A 25 mg USP1013024 3-Amino-4-carboxamidopyrazole Hemisulfate Allopurinol Related Compound B 25 mg USP1013013 5-(formylamino)-1H-pyrazole-4-carboxamide Allopurinol Related Compound C 25 mg USP1013035 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide Allopurinol Related Compound D 35 mg USP1013046 ethyl 5-amino-1H-pyrazole-4-carboxylate Allopurinol Related Compound E 25 mg USP1013068 ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate Allopurinol Related Compound F 25 mg USP1013079 ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate USP1039152 Allyl Anthranilate 5 x 0.5 mL USP1084215 Allyl Butyrate 5 x 0.5 mL USP1133999 Allyl Cinnamate 5 x 0.5 mL USP1223209 Allyl Disulfide 5 x 0.5 mL USP1636800 Allyl Sulfide 5 x 0.5 mL USP1013206 Almond Oil 1 g USP1013512 Almotriptan Malate 200 mg Almotriptan Related Compound A 20 mg USP1013523 {3-[2-(Dimethylamino)ethyl]-5-[)pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol Almotriptan Related Compound B (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3- 15 mg USP1013545 yl}ethanamine hemifumarate) Almotriptan Related Compound C 15 mg USP1013556 (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine) Almotriptan Related Compound D (1-[({3-[2-(dimethylamino)ethyl]indol-5- 15 mg USP1013567 yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride) Almotriptan System Suitability 20 mg USP1013534 Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog USP1013727 Aloin 25 mg USP1154558 Alpha Cyclodextrin 500 mg USP1368201 Alpha Lipoic Acid 500 mg USP1667600 Alpha Tocopherol (Vitamin E Alcohol) 250 mg USP1667701 Alpha Tocopheryl Acetate (Vitamin E Acetate) 250 mg USP1667803 Alpha Tocopheryl Acid Succinate (Vitamin E Succinate) 250 mg USP1034501 alpha-Amylcinnamyl Acetate 500 mg USP1034512 alpha-Amylcinnamyl Alcohol 500 mg USP1013909 Alpha-Lactalbumin 400 mg USP1014005 Alphaprodine HCl CII 250 mg USP1015008 Alprazolam CIV 200 mg Alprazolam Related Compound A 30 mg USP1015019 2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine USP1016000 Alprostadil 25 mg USP1017105 Altretamine 500 mg USP1017364 Aluminum Sulfate (AS) 2 g USP1018505 Amantadine HCl 200 mg USP1019202 200 mg USP1019406 Amifostine 150 mg USP1019417 Amifostine Disulfide 100 mg

Edition 2014 Visit us at www.lgcstandards.com 83

United States Pharmacopeia and National Formulary

Code Product Unit Amifostine Thiol 50 mg USP1019428 2-[(3-aminopropyl)amino]ethanethiol, dihydrochloride USP1019508 Amikacin 300 mg USP1019494 Amikacin Sulfate 100 mg USP1019701 Amiloride HCl 500 mg Amiloride Related Compound A 30 mg USP1019712 Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate (AS) USP1025602 Amino Methacrylate Copolymer 1.5 g USP1019756 Aminobenzoate Potassium 200 mg USP1019767 Aminobenzoate Sodium 200 mg Aminobenzoic Acid 200 mg USP1019803 p-aminobenzoic acid USP1020008 Aminobutanol 500 mg USP1021000 Aminocaproic Acid 200 mg USP1025205 Aminoglutethimide 200 mg USP1025351 Aminohippuric Acid 200 mg USP1025908 Aminopentamide Sulfate 200 mg USP1026401 Aminosalicylic Acid 125 mg USP1027302 Amiodarone HCl 200 mg Amiodarone Related Compound D 20 mg USP1027346 (2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone Amiodarone Related Compound E 25 mg USP1027357 (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone Amiodarone Related Compound H 20 mg USP1027380 2-chloro-N,N-diethylethanamine HCl USP1028000 Amitraz 200 mg USP1029002 Amitriptyline HCl 200 mg Amitriptyline Related Compound A 25 mg USP1029013 Dibenzosuberone Amitriptyline Related Compound B 25 mg USP1029024 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol USP1029308 Amlexanox 200 mg USP1029501 Amlodipine Besylate 350 mg Amlodipine Related Compound A 15 mg 3-Ethyl,5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5- USP1029512 pyridinedicarboxylate]fumarate Amlodipine Related Compound B 25 mg (3-Ethyl-5-methyl-4-(2-chlorophenyl)-6-methyl-2-({2-[2- USP1029523 (methylcarbamoyl)benzamido]ethoxy}methyl)-1,4-dihydropyridine-3,5-dicarboxylate) USP1029909 Ammonio Methacrylate Copolymer Type A 500 mg USP1029910 Ammonio Methacrylate Copolymer Type B 500 mg USP1029942 Ammonium Carbonate (AS) 2 g USP1029953 Ammonium Chloride 200 mg USP1029929 Ammonium Glycyrrhizate 100 mg USP1029986 Ammonium Phosphate Dibasic (AS) 1 g USP1030001 Amobarbital CII 200 mg USP1031004 Amodiaquine HCl 500 mg USP1031401 200 mg USP1031503 Amoxicillin 200 mg Amoxicillin Related Compound A 15 mg USP1031514 (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Amoxicillin Related Compound B 15 mg USP1031525 L-amoxicillin Amoxicillin Related Compound C 15 mg (4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]- USP1031536 5,5-dimethylthiazolidine-4-carboxylic acid

84 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Amoxicillin Related Compound D 50 mg (4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5- USP1031547 dimethylthiazolidine-4-carboxylic acid, monosodium salt Amoxicillin Related Compound F 15 mg USP1031569 3-(4-Hydroxyphenyl)pyrazin-2-ol; phenylpyrazinediol Amoxicillin Related Compound G: (2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4- 15 mg hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1- USP1031570 azabicyclo[3.2.0]heptane-2-carboxylic acid; D-hydroxyphenylglycylamoxicillin USP1031591 Amoxicillin Related Compound I: (R)-2-Amino-2-(4-hydroxyphenyl)acetic acid 15 mg Amoxicillin Related Compound J: Mixture of amoxicillin and amoxicillin related compound J 15 mg USP1031605 (open ring dimer) USP1031558 Amoxicillin Related Compounds D and E Mixture 15 mg USP1032007 Amphotericin B 125 mg USP1033000 Ampicillin 200 mg USP1033203 Ampicillin Sodium 125 mg USP1033247 Ampicillin System Suitability Mixture 10 mg USP1033407 Ampicillin Trihydrate 200 mg USP1034002 Amprolium 200 mg USP1034308 Amrinone (Inamrinone) 500 mg Amrinone Related Compound A 100 mg USP1034320 5-carboxamide[3,4'-bipyridin]-6(1H)-one (Inamrinone Related Compound A) Amrinone Related Compound B 100 mg N-(1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-yl)-2-hydroxypropanamide USP1034341 (Inamrinone Related Compound B) Amrinone Related Compound C 50 mg USP1034363 1,6-dihydro-6-oxo-(3,4'-bipyridine)-5-carbonitrile (Inamrinone Related Compound C) USP1034738 Anagrelide HCl 100 mg Anagrelide Related Compound A 25 mg USP1034749 ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate Anagrelide Related Compound B 25 mg USP1034750 (2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid Anagrelide Related Compound C 25 mg USP1034771 Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate USP1034807 Anastrozole 200 mg Anastrozole Related Compound A 20 mg USP1034818 2,2'-(5-methyl-1,3-phenylene)bis(2-methylpropanenitrile) USP1034862 Andrographolide 50 mg USP1035005 (AS) 2 mL USP1356676 Anhydrous Lactose 100 mg USP1036948 o-Anisaldehyde 3 x 0.5 mL USP1036008 HCl CII 250 mg USP1037011 Anisole 3x1.2 mL USP1037022 Anisyl Butyrate 5 x 0.5 mL USP1037044 Anisyl Phenylacetate 5 x 0.5 mL USP1037033 Anisyl Propionate 5 x 0.5 mL USP1038003 Antazoline Phosphate 200 mg USP1039006 Anthralin 200 mg USP1039390 Antimony Trioxide 100 mg USP1040005 Antipyrine 200 mg Antipyrine Related Compound A 25 mg USP1040016 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one USP1040683 30 mg USP1040708 Apigenin-7-glucoside 30 mg Apocarotenal 3 x 50 mg USP1040854 Beta-Apo-8'-Carotenal USP1041008 Apomorphine HCl 250 mg

Edition 2014 Visit us at www.lgcstandards.com 85

United States Pharmacopeia and National Formulary

Code Product Unit USP1041609 Apraclonidine HCl 100 mg USP1041904 Aprepitant 50 mg Aprepitant Related Compound A 10 mg 3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4- USP1041915 fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one Aprepitant Related Compound B 10 mg 3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4- USP1041926 fluorophenyl)morpholino]methyl-1H-1,2,4-triazol-5(4H)-one USP1042408 Argatroban 350 mg Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L- 15 mg USP1042419 arginyl]-4-methylpiperidine-2-carboxylic acid) USP1042554 Arginine Ethyl Ester Dihydrochloride 250 mg USP1042601 Arginine HCl 125 mg USP1042634 Aripiprazole 200 mg Aripiprazole Related Compound B 25 mg USP1042645 7-(4-hydroxy-butoxy)3,4-dihydroquinolin-2(1H)-one Aripiprazole Related Compound C 25 mg USP1042656 1-(2,3-dichlorophenyl)piperazine HCl Aripiprazole Related Compound F 25 mg USP1042689 4-(2,3-dichlorophenyl-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide Aripiprazole Related Compound G 25 mg USP1042690 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one Aripiprazole Related Compound H 25 mg USP1042714 7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2-(1H)-one USP1042703 Arsanilic Acid 25 mg USP1042780 Artemether 100 mg Artemether Related Compound A 15 mg (3R,5aS,6R,8aS,9R,12R,12aR)-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H- USP1042791 pyrano[4,3-j]-1,2-benzodioxepin Artemether Related Compound B 15 mg (3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy- USP1042805 12H-pyrano[4,3-j]-1,2-benzodioxepin USP1042850 Artesunate 200 mg Artesunate Related Compound C 25 mg USP1042882 (Anhydrodihydroartemisinin) USP1042907 Articaine 40 mg USP1042918 Articaine HCl 125 mg Articaine Related Compound A 40 mg USP1042929 Methyl 4-methyl-3-[2-propylamino) acetamido)thiophene-2-carboxylate Articaine Related Compound B 25 mg USP1042930 4-methyl-3-{[2-(propylamino)propanoy]amino}thiophene-2-carboxylic acid Articaine Related Compound E 40 mg USP1042962 Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate USP1043003 Ascorbic Acid (Vitamin C) 1 g USP1043105 Ascorbyl Palmitate (AS) 2 g USP1043331 Asiaticoside 30 mg USP1043502 Asparagine Anhydrous 200 mg USP1043513 Asparagine Monohydrate 200 mg USP1043706 Aspartame 200 mg USP1043750 Aspartame Acesulfame 200 mg Aspartame Related Compound A 25 mg USP1043728 5-Benzyl-3,6-dioxo-2-piperazineacetic Acid USP1043819 Aspartic Acid 100 mg USP1044006 Aspirin 500 mg USP1044200 Astaxanthin (Synthetic) 3 x 30 mg USP1044210 Astaxanthin from Haematococcus pluvialis 5 x 100 mg USP1044301 Astemizole 200 mg

86 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1044403 Atenolol 200 mg Atenolol Related Compound B (2-{4-[2-hydroxy-3- 20 mg USP1044425 (isopropylamino)propoxy]phenyl}acetonitrile) Atenolol Related Compound C (2-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl} acetic 20 mg USP1044436 acid) Atenolol Related Compound D (N-Isopropyl-N,N-bis{3-[4-(2-amino-2-oxoethyl)phenoxy]-2- 20 mg USP1044447 hydroxyprop-1-yl}amine) USP1044451 Atenolol Related Compound E (2-{4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}acetamide) 20 mg USP1044469 Atomoxetine HCl 100 mg Atomoxetine Related Compound A 10 mg USP1044470 3-(Methylamino)-1-phenylpropan-1ol Atomoxetine Related Compound B 10 mg USP1044488 N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine HCl Atomoxetine Related Compound C 10 mg USP1044491 N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine HCl Atomoxetine S-Isomer 10 mg USP1044913 (S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine HCl USP1044516 Atorvastatin Calcium 100 mg Atorvastatin Related Compound A 20 mg Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1- USP1044527 yl]-3,5-dihydroxyheptanoic acid calcium salt Atorvastatin Related Compound B 20 mg 3S,5R isomer,or (3S,5R)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H- USP1044538 pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt Atorvastatin Related Compound C 20 mg Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H- USP1044549 pyrrol-1-yl]-3,5-dihydroxyheptcnoic acid calcium salt Atorvastatin Related Compound D 10 mg Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2-carboxylic acid USP1044550 phenylamide Atorvastatin Related Compound E 10 mg USP1044571 3S,5S enantiomer of Atorvastatin Calcium Atorvastatin Related Compound H 20 mg 5-(4-Fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2- USP1044582 isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide Atorvastatin Related Compound I 20 mg tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl)-1H- USP1044593 pyrrol-1-yl)]ethyl}-2,2-dimetyl-1,3-dioxan-4-yl)acetate USP1044651 Atovaquone 200 mg Atovaquone Related Compound A 25 mg USP1044662 cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone USP1044800 Atracurium Besylate 100 mg USP1045009 Atropine Sulfate 500 mg USP1045508 Aurothioglucose 100 mg USP1045337 Avobenzone 500 mg USP1045520 Azacitidine 150 mg Azacitidine Related Compound A 15 mg USP1045539 4-Amino-1,3,5-triazin-2(1H)-one Azacitidine Related Compound B 15 mg USP1045541 1-O-Acetyl-2,3,5-tri-O-benzoyl-Beta-D-ribofuranose Azacitidine Related Compound C 15 mg USP1045574 (1-beta-D-Ribofuranosyl-3-guanylurea picrate) Azaerythromycin A 100 mg USP1045600 9-Deoxo-9a-aza-9a-homoerythromycin A USP1045756 Azaperone 200 mg USP1045803 Azatadine Maleate 200 mg USP1046001 Azathioprine 200 mg USP1046158 Azelastine Hydrochloride 300 mg

Edition 2014 Visit us at www.lgcstandards.com 87

United States Pharmacopeia and National Formulary

Code Product Unit Azelastine Related Compound B 20 mg USP1046170 (N'-(1-methylazepan-4-yl)benzohydrazide hydrochloride) Azelastine Related Compound D 20 mg USP1046191 4-(4-chlorobenzyl)phthalazin-1(2H)-one Azelastine Related Compound E 20 mg USP1046202 (3-(4-chlorobenzylidene)isobenzofuran-1(3H)-one) USP1046056 Azithromycin 100 mg USP1046012 Azithromycin Identification Mixture 75 mg USP1046067 Azithromycin Identity 75 mg USP1046090 Azithromycin N-Oxide 15 mg Azithromycin Related Compound F 25 mg USP1046045 3'-N-demethyl-3'-N-formylazithromycin Azithromycin Related Compound H 15 mg USP1046023 3'-N-[[4-(acetylamino)phenyl]sulfonyl]-3'-N-demethylazithromycin USP1046147 Azo-Aminoglutethimide 100 mg USP1733122 Aztec Marigold Zeaxanthin Extract 4 x 50 mg USP1046205 Aztreonam 200 mg USP1046307 Aztreonam E-Isomer 15 mg USP1056504 1,4-Benzoquinone 200 mg USP1064003 1-Benzyl-3-methyl-5-aminopyrazole HCl 25 mg USP1081807 1-Butanol 3x1.2 mL USP1074700 2,5-Bis-(D-arabino-1,2,3,4-tetrahydroxybutyl)pyrazine 25 mg USP1081829 2-Butanol 3x1.2 mL USP1077708 8-Bromotheophylline 400 mg USP1047300 Bacampicillin HCl 200 mg USP1047503 Bacitracin (Susceptibility disk standard) 1 g USP1048007 Bacitracin Zinc 200 mg USP1048200 Baclofen 350 mg Baclofen Related Compound A 50 mg USP1048222 4-(4-Chlorophenyl)-2-pyrrolidinone USP1048233 Bacoside A3 15 mg USP1048255 Balsalazide Disodium 200 mg Balsalazide Related Compound A 100 mg USP1048266 (E)-5-[(p-carboxyphenyl)azo]-2-salicylic acid, disodium salt Balsalazide Related Compound B 25 mg USP1048277 (E)-5-((m-[(2-carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid USP1048506 Beclomethasone Dipropionate 200 mg USP1048550 Behenoyl Polyoxylglycerides 500 mg USP1048572 Bemotrizinol 200 mg USP1048583 Bemotrizinol Impurity Mixture 100 mg USP1048619 Benazepril HCl 125 mg Benazepril Related Compound A 25 mg (3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1- USP1048620 benazapine-1-acetic acid, monohydrochloride Benazepril Related Compound B 15 mg (Mixture of (1R,3S) and (1S, 3R) 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5- USP1048630 tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) Benazepril Related Compound C 50 mg (3S)-3-[[(1S)-1-(carboxy)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine]- USP1048641 1-acetic acid Benazepril Related Compound D 15 mg 3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)- USP1048652 benzazepine-1-acetic acid monohydrochloride Benazepril Related Compound E 25 mg USP1048663 3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride Benazepril Related Compound F 15 mg USP1048674 3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, tert-butyl ester

88 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Benazepril Related Compound G 15 mg 3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)- USP1048685 benzazepine-1-acetic acid, ethyl ester USP1049000 Bendroflumethiazide 200 mg USP1050009 Benoxinate HCl 200 mg USP1050905 Benzaldehyde 2x1 mL USP1050949 Benzaldehyde Propylene Glycol Acetal 5 x 0.5 mL USP1051001 Benzalkonium Chloride 5 mL USP1051500 Benzethonium Chloride 500 mg USP1051602 Benzhydrol 50 mg USP1054000 Benzocaine 500 mg USP1055002 Benzoic Acid 300 mg USP1056005 Benzonatate 1 g Benzothiadiazine Related Compound A 100 mg USP1057507 4-Amino-6-chloro-1,3-benzenedisulfonamide USP1059003 Benzphetamine HCl CIII 200 mg USP1061005 Benztropine Mesylate 200 mg USP1061901 Benzyl Alcohol 500 mg USP1062008 Benzyl Benzoate 5 g USP1062074 Benzyl Mercaptan 5 x 0.5 mL USP1062085 Benzyl Methyl Sulfide 5 x 0.5 mL USP1065006 Bephenium Hydroxynaphthoate 500 mg USP1065210 Berberine Chloride 50 mg USP1012495 Beta Alanine 100 mg USP1065480 Beta Carotene 3 x 250 mg USP1065491 Beta Carotene System Suitability 200 mg USP1154569 Beta Cyclodextrin 250 mg Beta Glucan 1 g Beta Glucan from Baker's Yeast USP1048288 Saccharomyces cerevisiae USP1115556 β-Chlorogenin 20 mg USP1065550 Betadex Sulfobutyl Ether Sodium 500 mg USP1065618 Betahistine HCl 200 mg USP1065695 Betaine 1 g USP1065709 Betaine HCl 200 mg USP1066009 Betamethasone 200 mg USP1067001 Betamethasone Acetate 500 mg USP1067307 200 mg USP1067704 Betamethasone Dipropionate 125 mg USP1068004 Betamethasone Sodium Phosphate 500 mg USP1069007 Betamethasone Valerate 200 mg Betamethasone Valerate Related Compound A 50 mg USP1069018 Betamethasone 21-valerate (AS) USP1612947 Beta-Sitosterol 100 mg USP1069903 Betaxolol HCl 200 mg USP1070006 Betazole HCl 200 mg USP1071009 Bethanechol Chloride 200 mg USP1071202 Bicalutamide 200 mg Bicalutamide Related Compound A 25 mg N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2- USP1071213 methyl-propanamide Bicalutamide Related Compound B 10 mg (RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfonyl)- USP1071224 2-hydroxy-2-methylpropanamide USP1071304 Bile Salts 10 g

Edition 2014 Visit us at www.lgcstandards.com 89

United States Pharmacopeia and National Formulary

Code Product Unit USP1071381 20 mg USP1071508 Biotin 200 mg USP1072001 Biperiden 200 mg USP1073004 Biperiden HCl 200 mg USP1075203 Bis(2-ethylhexyl)maleate 2 g USP1074007 Bisacodyl 125 mg Bisacodyl Related Compound A 20 mg USP1074030 4,4'-(Pyridin-2-ylmethylene)diphenol Bisacodyl Related Compound B 20 mg USP1074042 2,4'-(Pyridin-2-ylmethylene)diphenol Bisacodyl Related Compound C 20 mg USP1074051 4-[(4-Hydroxyphenyl)(pyridin)-2-yl)methyl]phenyl acetate Bisacodyl Related Compound E 20 mg USP1074073 2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate USP1075305 Bisdesmethoxycurcumin 30 mg USP1075531 Bismuth Citrate 100 mg USP1075600 Bismuth Subcarbonate (AS) 1 g USP1075622 Bismuth Subgallate (AS) 2 g USP1075644 Bismuth Subnitrate (AS) 1.5 g USP1075553 Bismuth Subsalicylate 100 mg USP1075677 Bisoctrizole 200 mg Bisoctrizole Related Compound A 25 mg USP1075688 2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol USP1075699 Bisoctrizole Resolution Mixture 50 mg USP1075757 Bisoprolol Fumarate 200 mg USP1076308 Bleomycin Sulfate 15 mg USP1076341 Boric Acid (AS) 1 g USP1076115 Bosentan 200 mg Bosentan Related Compound A 15 mg USP1076126 (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide) Bosentan Related Compound B 15 mg USP1076137 4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide Bosentan Related Compound C 15 mg 1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4- USP1076148 yl}oxy)ethane Bosentan Related Compound D 15 mg USP1076159 (4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine) Bosentan Related Compound E 15 mg USP1076160 4-(tert-butyl)benzenesulfonamide USP1076250 Boswellia Serrata Extract 1 g USP1535824 Bovine Acellular Dermal Matrix Reference Photomicrographs (CD) Each USP1076352 Bretylium Tosylate 200 mg USP1076363 Brinzolamide 200 mg Brinzolamide Related Compound A 50 mg (S)-(-)-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6- USP1076374 sulfonamide-1,1-dioxide Brinzolamide Related Compound B 50 mg (R)-4-amino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide-1,1- USP1076385 dioxide ethanedioate USP1076465 Bromazepam (AS) CIV 100 mg USP1076501 Bromocriptine Mesylate 150 mg USP1077005 Bromodiphenhydramine HCl 200 mg USP1077887 Bromperidol Decanoate 15 mg USP1078008 Brompheniramine Maleate 125 mg USP1078201 Budesonide 200 mg USP1078303 Bumetanide 125 mg

90 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Bumetanide Related Compound A 10 mg USP1078325 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid Bumetanide Related Compound B 25 mg USP1078336 3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid USP1078507 Bupivacaine HCl 300 mg Bupivacaine Related Compound A 50 mg USP1078518 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide (AS) Bupivacaine Related Compound B 50 mg USP1078529 (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (AS) USP1078700 Buprenorphine HCl CIII 50 mg Buprenorphine Related Compound A 25 mg 21-[3-(1-propenyl)]7-alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14- USP1078711 tetrahydrooripavine Controlled Substance CII USP1078733 HCl 200 mg Bupropion HCl Related Compound A 15 mg USP1078744 2-(tert-butylamino)-4'-chloropropiophenone hydrochloride Bupropion HCl Related Compound B 10 mg USP1078755 2-(tert-butylamino)-3'-bromopropiophenone hydrochloride Bupropion HCl Related Compound C 40 mg USP1078766 1-(3-chlorophenyl)-2-hydroxy-1-propanone Bupropion HCl Related Compound F 30 mg USP1078799 1-(3-chlorophenyl)-1-hydroxy-2-propanone USP1078802 Buspirone HCl 200 mg USP1079000 Butabarbital Controlled Substance CIII 200 mg USP1080000 Butacaine Sulfate 600 mg USP1081002 Butalbital CIII 200 mg USP1081501 Butamben 200 mg USP1082956 Butane-1,3-diol 1 mL USP1082300 Butoconazole Nitrate 200 mg USP1082504 Tartrate Controlled Substance CIV 350 mg USP1082901 Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate 25 mg USP1082606 Butyl Acetate 3x1.2 mL USP1082628 Butyl Heptanoate 5 x 0.5 mL USP1083529 Butyl Palmitate 500 mg USP1082639 Butyl Stearate 500 mg USP1082708 Butylated Hydroxytoluene 500 mg USP1084000 Butylparaben 200 mg USP1084259 Butyraldehyde 3 x 1.2 mL USP1096790 (+)- 25 mg USP1157501 2-Cyclopropylmethylamino-5-chlorobenzophenone 50 mg USP1112299 3-Chlorobenzoic Acid 25 mg USP1162126 5'-Cytidylic Acid 500 mg USP1084306 Cabergoline 125 mg USP1084995 Caffeic Acid 15 mg USP1085003 Caffeine 200 mg USP1086006 Caffeine Melting Point Standard (Approximately 236°C) 1 g USP1086039 Caftaric Acid 20 mg USP1086108 Calcifediol 75 mg USP1086200 Calcitonin Salmon 20 mg Calcitonin Salmon Related Compound A 20 mg USP1086210 N-acetyl-Cys(1)-calcitonin salmon Calcitonin Salmon Related Compound B 0.34 mg USP1086221 calcitonin salmon-glycine USP1086301 Calcitriol 10 mg USP1086312 Calcitriol Solution 5 mL

Edition 2014 Visit us at www.lgcstandards.com 91

United States Pharmacopeia and National Formulary

Code Product Unit USP1086334 Calcium Acetate (AS) 1 g USP1086356 Calcium Ascorbate 200 mg USP1086378 Calcium Benzoate 200 mg USP1086403 Calcium Carbonate (AS) 1 g USP1086436 Calcium Chloride (AS) 1 g USP1086447 Calcium Cyclamate 200 mg USP1379081 Calcium D,L-5-Methyltetrahydrofolate 300 mg USP1086800 Calcium Gluceptate 200 mg USP1086822 Calcium Gluconate Anhydrous 200 mg USP1086833 Calcium Gluconate Monohydrate 200 mg USP1086855 Calcium Hydroxide (AS) 1 g USP1086888 Calcium Lactate 1 g USP1086902 Calcium Lactobionate 200 mg USP1086935 Calcium Levulinate (AS) 1 g USP1086957 Calcium Lignosulfonate (40-65) 2 g USP1087009 Calcium Pantothenate (Vitamin B5) 200 mg USP1087202 Calcium Saccharate 200 mg USP1087359 Calcium Stearate (AS) 2 g USP1087406 Calcium Sulfate (AS) 1 g USP1086866 Calcium(-)-Hydroxycitrate 150 mg USP1087508 Camphor 1 g USP1087701 Candelilla Wax 250 mg USP1087803 Candesartan Cilexetil 100 mg USP1088001 Candicidin 200 mg USP1090150 Canola Oil 1 g USP1090706 Capecitabine 200 mg Capecitabine Related Compound A 10 mg USP1090717 5'-deoxy-5-fluorocytidine Capecitabine Related Compound B 20 mg USP1090728 5'-deoxy-5-fluorouridine Capecitabine Related Compound C 10 mg USP1090739 2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl) cytidine USP1091006 Capreomycin Sulfate 250 mg USP1091040 Caprylic Acid 300 mg USP1091505 Caprylocaproyl Polyoxylglycerides 200 mg USP1091108 Capsaicin 100 mg USP1091200 Captopril 200 mg USP1091221 Captopril Disulfide 100 mg USP1092009 Carbachol 200 mg USP1093001 Carbamazepine (CRM) 100 mg Carbamazepine Related Compound A 30 mg USP1093012 10,11-dihydrocarbamazepine Carbamazepine Related Compound B 50 mg USP1093023 Iminostilbene USP1093205 Carbarsone 200 mg USP1093500 Carbenicillin Indanyl Sodium 300 mg USP1094004 Carbenicillin Monosodium Monohydrate 200 mg USP1095506 Carbidopa 400 mg Carbidopa Related Compound A 25 mg USP1095517 3-O-Methylcarbidopa USP1096000 Carbinoxamine Maleate 200 mg USP1096407 Carboplatin 100mg USP1096509 Carboprost Tromethamine 25 mg

92 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1096531 Carboxymethylcellulose Calcium (AS) 1.5 g USP1096553 Carboxymethylcellulose Sodium 1.5 g USP1096600 Carisoprodol Controlled Substance CIV 1 g Carisoprodol Related Compound A 10 mg USP1096597 2-hydroxymethyl-2-methylpentyl carbamate USP1096611 Carmellose 500 mg USP1096724 Carmustine 75 mg Carmustine Related Compound A 10 mg USP1096735 1,3-bis(2-chloroethyl)urea USP1096699 Carprofen 200 mg Carprofen Related Compound A 50 mg USP1096702 Carbazole USP1096757 Carteolol HCl 200 mg USP1096622 Carvedilol 200 mg Carvedilol Related Compound A 15 mg 1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2- USP1096633 methoxyphenoxy)ethylamino)propan-2-ol Carvedilol Related Compound B 15 mg USP1096644 3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol) Carvedilol Related Compound C 20 mg USP1096655 1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol Carvedilol Related Compound D 15 mg USP1096666 4-(Oxiran-2-ylmethoxy)-9H-carbazole Carvedilol Related Compound E 15 mg USP1096677 2-(2-methoxyphenoxy)ethylamine Carvedilol System Suitability Mixture 25 mg USP1096688 carvedilol spiked with carvedilol related compound F USP1096779 Casticin 25 mg Cathinone HCl 50 mg USP1096804 alpha-Aminopropiophenone HCl Controlled Substance CI USP1096906 Cefaclor 400 mg USP1096917 Cefaclor, Delta-3-Isomer 15 mg USP1097104 Cefadroxil 200 mg Cefadroxil Related Compound B 25 mg USP1097126 (6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cefadroxil Related Compound D 25 mg (6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1- USP1097148 azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cefadroxil Related Compound I 25 mg (6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1- USP1097192 azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid USP1096994 Cefadroxil System Suitability Mixture 25 mg USP1097308 Cefamandole Lithium 200 mg USP1097400 Cefamandole Nafate 250 mg USP1097603 Cefazolin 200 mg USP1097614 Cefdinir 200 mg Cefdinir Related Compound A 10 mg 2(R)-2-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7- USP1097625 oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid Cefdinir Related Compound B 10 mg (6R,7R)-7-[2-(2-amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]-oct-2- USP1097589 ene-2-carboxylic acid USP1097590 Cefditoren Pivoxil 350 mg USP1097636 Cefepime HCl 500 mg Cefepime Related Compound D 20 mg USP1097680 (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid Cefepime Related Compound E 20 mg 1-{[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en -3-yl]methyl}-1- USP1097691 methylpyrrolidin-1-ium chloride

Edition 2014 Visit us at www.lgcstandards.com 93

United States Pharmacopeia and National Formulary

Code Product Unit USP1097658 Cefixime 500 mg USP1097771 Cefmenoxime HCl 350 mg USP1097782 Cefmetazole 200 mg USP1097750 Cefonicid Sodium 1 g USP1097705 Cefoperazone Dihydrate 200 mg USP1097807 Ceforanide 200 mg USP1097909 Cefotaxime Sodium 350mg USP1097975 Cefotetan 500 mg USP1098005 Cefotiam HCl 350 mg USP1098107 Cefoxitin 500 mg USP1098118 Cefpiramide 300 mg USP1098027 Cefpodoxime Proxetil 350 mg USP1098062 Cefprozil 200 mg USP1098049 Cefprozil (E)-Isomer 50 mg USP1098050 Cefprozil (Z)-Isomer 200 mg Cefprozil L-Epimer 30 mg (6R,7R)-7-[(S)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1- USP1097997 azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cefprozil Related Compound D 30 mg (6R,7R)-7-amino-8-oxo-3-[)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic USP1097986 acid Cefprozil Related Compound H 30 mg (6R,7R)-7{(R)-2-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2-(4- hydroxyphenyl)acetamido}-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- USP1098016 carboxylic acid Cefprozil Related Compound K 30 mg 3-(5-ethyl-7-oxo-2,4,5,7-tetrahydro1H-furo[3,4-d][1,3]thiazin-2-yl(-6-(4- USP1098038 hydroxyphenyl)piperazine-2,5-dione USP1098130 Ceftazidime Pentahydrate 300 mg USP1098129 Ceftazidime, Delta-3-Isomer 10 mg USP1098082 Ceftiofur Sodium 100 mg USP1098173 Ceftizoxime 350 mg USP1098184 Ceftriaxone Sodium 350 mg USP1098195 Ceftriaxone Sodium E-Isomer 25 mg USP1098220 Cefuroxime Axetil 350 mg USP1098231 Cefuroxime Axetil Delta-3-Isomers 10 mg USP1098209 Cefuroxime Sodium 200 mg USP1098504 Celecoxib 200 mg Celecoxib Relaed Compound A 10 mg USP1098515 4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Celecoxib Relaed Compound B 10 mg USP1098526 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide USP1098322 Cellaburate (Cellulose Acetate Butyrate) 350 mg USP1098355 Cellacefate (Cellulose Acetate Phthalate) 125 mg USP1098300 Cellulose Acetate 125 mg USP1098708 Cephaeline HBr 200 mg USP1099008 Cephalexin 400 mg USP1102000 Cephalothin Sodium 200 mg USP1102408 Cephapirin Benzathine 100 mg USP1102500 Cephapirin Sodium 500 mg USP1102805 Cephradine 200 mg USP1102929 Cetirizine Hydrochloride 250 mg Cetirizine Related Compound A 20 mg USP1102930 (RS)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester USP1102974 Cetrimonium Bromide 1 g

94 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1103003 Cetyl Alcohol 100 mg USP1103105 Cetyl Palmitate 50 mg USP1104006 Cetylpyridinium Chloride 500 mg USP1105315 Chicoric Acid 100 mg USP1105508 Chitosan 500 mg USP1107004 Chloramphenicol 200 mg USP1107300 Chloramphenicol Palmitate 200 mg USP1107401 Chloramphenicol Palmitate Nonpolymorph A 200 mg USP1107503 Chloramphenicol Palmitate Polymorph A 100 mg USP1109000 Chlordiazepoxide CIV 200 mg USP1110009 Chlordiazepoxide HCl CIV 200 mg Chlordiazepoxide Related Compound A 25 mg USP1110020 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide USP1111001 Chlorhexidine 200 mg USP1111103 Chlorhexidine Acetate 200 mg USP1112503 200 mg USP1115545 Chlorogenic Acid 50 mg USP1115705 Chloromethyl Isopropyl Carbonate 100 mg USP1117008 Chloroprocaine HCl 200 mg USP1118000 Chloroquine Phosphate 500 mg Chloroquine Related Compound A 25 mg USP1118328 4,7-dichloroquinoline Chloroquine Related Compound D 15 mg USP1118350 7-Chloro-4-{[4-(ethylamino)-1-methylbutyl] amino} quinoline Chloroquine Related Compound E 15 mg USP1118361 N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate Chloroquine Related Compound G 15 mg USP1118394 4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate USP1118317 Chloroquine Sulfate 500 mg USP1121005 Chlorothiazide 200 mg USP1122700 Chloroxylenol 125 mg Chloroxylenol Related Compound A 25 mg USP1122722 2-chloro-3,5-dimethylphenol USP1123000 Chlorpheniramine Maleate 125 mg Chlorpheniramine Related Compound B 25 mg USP1123135 di(pyridin-2-yl)amine Chlorpheniramine Related Compound C 10 mg USP1123146 3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine maleate USP1124003 Chlorphenoxamine HCl 200 mg USP1125006 Chlorpromazine HCl 200 mg USP1126009 Chlorpropamide 200 mg USP1129007 Chlortetracycline HCl 200 mg USP1130006 Chlorthalidone 200 mg Chlorthalidone Related Compound A 10 mg USP1119309 4'-Chloro-3'-sulfamoyl-2-benzophenone Carboxylic Acid USP1130505 Chlorzoxazone 350 mg Chlorzoxazone Related Compound A 50 mg USP1130527 2-Amino-4-chlorophenol USP1131009 Cholecalciferol (Vitamin D3) 5x30 mg USP1131960 Cholesterol 125 mg USP1132001 Cholesteryl Caprylate 200 mg USP1133004 Cholestyramine Resin 500 mg USP1133503 Cholic Acid (AS) 2 g USP1133536 Choline Bitartrate 200 mg USP1133547 Choline Chloride 200 mg

Edition 2014 Visit us at www.lgcstandards.com 95

United States Pharmacopeia and National Formulary

Code Product Unit USP1133570 Chondroitin Sulfate Sodium 300 mg USP1133638 Chromium Picolinate 100 mg USP1134007 Chymotrypsin 300 mg USP1134018 Ciclopirox 50 mg USP1134030 Ciclopirox Olamine 125 mg Ciclopirox Related Compound A 25 mg USP1134029 3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxayzolyl acetic acid Ciclopirox Related Compound B 25 mg USP1134040 6-Cyclohexyl-4-methyl-2-pyrone Ciclopirox Related Compound C 10 mg USP1134084 6-Cyclohexyl-4-metylpyridin-2(1H)-one USP1134051 Cilistatin Ammonium Salt 100 mg USP1134153 Cilostazol 200 mg Cilostazol Related Compound A 50 mg USP1134164 6-hydroxy-3,4-dihydro-1H-quinolin-2-one Cilostazol Related Compound B 50 mg USP1134175 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one Cilostazol Related Compound C 50 mg 1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4- USP1134186 dihydroquinolin-2(1H)-one USP1134062 Cimetidine 200 mg USP1134073 Cimetidine HCl 200 mg USP1133933 Cinnamic Acid 100 mg USP1134109 Cinoxacin 200 mg USP1134313 Ciprofloxacin 200 mg Ciprofloxacin Ethylenediamine Analog 25 mg 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[(2-aminoethyl)-amino]-3-quinoline-carboxylic USP1134324 acid hydrochloride USP1134459 Ciprofloxacin Formamide 125 mg USP1134335 Ciprofloxacin HCl 400 mg Ciprofloxacin Related Compound A 25 mg 7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid USP1134346 hydrochloride salt (AS) USP1134120 Cisapride 200 mg USP1134118 Cisatracurium Besylate 350 mg USP1134131 Cisatracurium Besylate System Suitability Mixture 20 mg USP1134357 Cisplatin 100 mg USP1134233 Citalopram HBr 200 mg Citalopram Related Compound A 25 mg USP1134244 1-(3-(dimethyl)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide Citalopram Related Compound B 25 mg 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5- USP1134255 carbonitrile oxylate Citalopram Related Compound C 25 mg USP1134266 3-[3-(dimethylamino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate Citalopram Related Compound D 15 mg 1-(4'-fluorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzofuran-5-carbonitrile USP1134277 hydrochloride Citalopram Related Compound E 25 mg 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N- USP1134288 oxide hydrochloride Citalopram Related Compound F 200 mg USP1134299 dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride Citalopram Related Compound G 25 mg USP1134197 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane hydrobromide Citalopram Related Compound H 25 mg USP1134222 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide USP1134368 Citric Acid 200 mg

96 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1134200 Cladribine 200 mg Cladribine Related Compound A 20 mg USP1134211 2-methoxy-2'-deoxyadenosine USP1134379 Clarithromycin 100 mg USP1134390 Clarithromycin Identity 10 mg Clarithromycin Impurity D 10 mg USP1134619 N-desmethyl clarithromycin Clarithromycin Impurity H 10 mg USP1134620 N-formyl clarithromycin Clarithromycin Impurity Q 10 mg USP1134631 N-oxide clarithromycin Clarithromycin Impurity R 10 mg USP1134642 N-desmethyl erythromycin A Clarithromycin Related Compound A 50 mg USP1134380 6,11-di-O-methylerythromycin A USP1134404 Clavam-2-carboxylate Potassium 3.4 µg USP1134426 Clavulanate Lithium 200 mg USP1134506 Clemastine Fumarate 250 mg USP1134674 Clenbuterol HCl 100 mg Clenbuterol Related Compound B 10 mg USP1134696 1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone HCl USP1135000 Clidinium Bromide 500mg Clidinium Bromide Related Compound A 250 mg USP1135021 3-Hydroxy-1-methylquinuclidinium Bromide USP1135600 Climbazole 400 mg USP1136002 Clindamycin HCl 200 mg USP1137005 Clindamycin Palmitate HCl 500 mg USP1138008 Clindamycin Phosphate 250 mg USP1138201 Clioquinol 500 mg USP1138405 Clobetasol Propionate 200 mg Clobetasol Propionate Related Compound A 50 mg 9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxo-androsta-1,4-diene-17(R)-spiro-2'- USP1138427 [4'-chloro-5'-ethylfuran-3'(2'H)-one] USP1138507 Pivalate 200 mg USP1138904 Clofazimine 200 mg USP1139000 Clofibrate 1 g USP1140000 Clomiphene Citrate 500 mg Clomiphene Related Compound A 100 mg USP1140101 (E,Z)-2-[4-(1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride USP1140247 Clomipramine HCl 200 mg USP1140305 Clonazepam CIV 200 mg Clonazepam Related Compound A 25 mg USP1140327 3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril Clonazepam Related Compound B 25 mg USP1140338 2-Amino-2'-chloro-5-nitrobenzophenone Clonazepam Related Compound C 25 mg USP1140349 2-Bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide USP1140393 Clonidine 200 mg USP1140407 Clonidine HCl 200 mg Clonidine Related Compound A 25 mg USP1140418 Acetylclonidine Clonidine Related Compound B 25 mg 2-[(E)-2,6-Dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}- USP1140429 ethyl)-imidazolidine USP1140430 Clopidogrel Bisulfate 125 mg

Edition 2014 Visit us at www.lgcstandards.com 97

United States Pharmacopeia and National Formulary

Code Product Unit Clopidogrel Related Compound A 20 mg (S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5-(4H)- USP1140586 acetic acid, hydrochloride Clopidogrel Related Compound B 20 mg USP1140597 (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothienol[2,3-c]pyridine-6(7H)-acetate, hydrochloride Clopidogrel Related Compound C 20 mg methyl(-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)- USP1140600 acetate,hydrogen sulfate USP1140666 Cloprostenol Sodium 400 mg USP1140509 Clorazepate Dipotassium Controlled Substance CIV 125 mg USP1140702 Clorsulon 200 mg USP1141002 Clotrimazole 200 mg Clotrimazole Related Compound A 25 mg USP1141024 (o-chlorophenyl)diphenylmethanol USP1141909 Cloxacillin Benzathine 200 mg USP1142005 Cloxacillin Sodium 200 mg USP1142107 Clozapine 100 mg USP1142108 Clozapine Resolution Mixture 30 mg USP1143008 Cocaine HCl CII 250 mg USP1145207 Cod Liver Oil 1 g USP1143802 Codeine N-Oxide CI 50 mg USP1144000 Codeine Phosphate Controlled Substance CII 100 mg USP1145003 Codeine Sulfate Controlled Substance CII 250 mg USP1145025 Codeine System Suitability Mixture CI 25 mg USP1146006 Colchicine 350 mg USP1146505 Colestipol HCl 200 mg USP1147009 Colistimethate Sodium 200 mg USP1148001 Colistin Sulfate 200 mg USP1623386 Compressible Sugar 200 mg USP1148500 Copovidone 100 mg USP1148806 Corn Oil (AS) 1 g USP1149004 Corticotropin 5 vials USP1150003 150 mg USP1150207 Cottonseed Oil (AS) 1 g USP1150353 Creatinine 100 mg USP1150502 Cromolyn Sodium 500 mg Cromolyn Sodium Related Compound A 25 mg USP1150513 1,3-Bis-(2-acetyl-3-hydroxyphenoxy)-2-propanol (AS) USP1150706 Crospovidone 100 mg USP1151006 Crotamiton 200 mg Cryopreserved Human Fibroblast-Derived Dermal Substitute Reference Photomicrographs unit USP1535868 (CD) USP1535835 Cultured Rat Pheochromocytoma Reference Photomicrographs (CD) unit USP1151709 Cumene 3x1.2 mL USP1151855 30 mg USP1151866 Curcuminoids 300 mg USP1151924 Cyanidin Chloride 25 mg USP1151935 Cyanidin-3-O-glucoside Chloride 15 mg USP1152009 Cyanocobalamin (Vitamin B12) 1.5 g USP1152600 Cyclamic Acid 100 mg USP1152701 Cyclandelate 200 mg USP1154004 Cyclizine HCl 200 mg Cyclizine Related Compound A 50 mg USP1154015 1-methylpiperazine

98 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1154503 Cyclobenzaprine HCl 200 mg Cyclobenzaprine Related Compound A 10 mg USP1154514 5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]-cyclohepten-5-ol Cyclobenzaprine Related Compound B 10 mg USP1154525 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride USP1154649 Cyclohexanecarboxylic Acid 500 mg USP1154605 Cyclohexylmethanol 2x1 mL USP1154707 Cyclomethicone 4 200 mg USP1154809 Cyclomethicone 5 200 mg USP1154900 Cyclomethicone 6 200 mg USP1156000 Cyclopentolate HCl 300 mg Cyclophosphamide Related Compound A 25 mg USP1157013 bis(2-chloroethyl)amine HCl Cyclophosphamide Related Compound B 25 mg USP1157024 3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane Cyclophosphamide Related Compound C 25 mg USP1157035 (3-aminopropyl dihydrogen phosphate Cyclophosphamide Related Compound D 25 mg USP1157046 3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride USP1158005 Cycloserine 250 mg USP1158504 Cyclosporine 50 mg USP1158650 Cyclosporine Resolution Mixture 25 mg USP1159008 (AS) 200 mg USP1161000 Cyproheptadine HCl 500 mg Cyproheptadine Related Compound A 40 mg USP1161010 5H-dibenzo[a,d]cycloheptene (AS) Cyproheptadine Related Compound C 25 mg USP1161032 (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) USP1161203 Cyromazine 200 mg USP1161586 Cystine 200 mg USP1162002 Cytarabine 250 mg USP1162148 Cytosine 100 mg USP1201002 17α-Dihydroequilin 50 mg USP1187954 2,4-Dichlorophenol 100 mg USP1223005 2,4-Disulfamyl-5-trifluoromethylaniline 50 mg USP1171251 2-Deoxy-D-Glucose (AS) 100 mg USP1162308 Dacarbazine 125 mg Dacarbazine Related Compound A 50 mg USP1162320 5-aminoimidazole-4-carboxamide HCl Dacarbazine Related Compound B 50 mg USP1162330 2-azahypoxanthine USP1162400 Dactinomycin 50 mg USP1162421 25 mg USP1162432 30 mg USP1162501 200 mg USP1163140 Dantrolene 200 mg Dantrolene Related Compound A 50 mg USP1163162 5-(4-nitrophenyl)-2-furaldehyde azine Dantrolene Related Compound B 50 mg USP1163173 5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl)semicarbazone Dantrolene Related Compound C 50 mg USP1163184 (5-(4-nitrophenyl)-2-furancarboxyaldehyde USP1163151 Dantrolene Sodium 100 mg USP1164008 Dapsone 200 mg USP1164700 Daunorubicin HCl 200 mg

Edition 2014 Visit us at www.lgcstandards.com 99

United States Pharmacopeia and National Formulary

Code Product Unit Deacetylnorgestimate 25 mg USP1471958 (E)- and (Z)-17-deacetyl norgestimate mixture USP1165408 Decoquinate 200 mg USP1617474 Defatted Powdered Soy 2.5 g USP1166003 Deferoxamine Mesylate 300 mg USP1166116 (100 mg) 100 mg USP1012772 Dehydrated Alcohol 5x1.2 mL USP1166309 Dehydroacetic Acid 200 mg USP1166400 Dehydrocarteolol HCl 100 mg USP1166502 Dehydrocholic Acid 200 mg USP1131803 Delta-4,6-cholestadienol 30 mg USP1651621 Delta-9- Controlled Substance 1 mL USP1169001 Demecarium Bromide 250 mg USP1170000 Demeclocycline HCl 200 mg USP1171003 Denatonium Benzoate 200 mg USP1171397 Depramine (3-(5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride) 20 mg USP1171455 Dermatan Sulfate 25 mg USP1171706 Desacetyl Diltiazem HCl 50 mg Desbenzyl Donepezil Hydrochloride (5,6-Dimethoxy-2-(piperidin-4-ylmethyl)indan-1-one 20 mg USP1171819 hydrochloride) USP1171900 Desflurane 0.5 mL Desflurane Related Compound A 0.1 mL USP1171910 bis-(1,2,2,2-tetrafluoroethyl) ether USP1172006 Desipramine HCl 125 mg USP1173009 Deslanoside 100 mg USP1173100 Desmethoxycurcumin 30 mg USP1173235 Desogestrel 50 mg Desogestrel Related Compound A 15 mg 13-ethyl-11-methylene-18,19-dinor-5alpha, 17alpha-pregn-3-en-20-yl-17-ol, USP1173246 desogestrel delta-3 isomer Desogestrel Related Compound B 15 mg USP1173257 3-Hydroxy-desogestrel Desogestrel Related Compound C 25 mg USP1173268 3-Keto-desogestrel USP1046078 Desosaminylazithromycin 15 mg USP1173508 200 mg USP1174001 Desoxycorticosterone Acetate 200 mg USP1175004 Desoxycorticosterone Pivalate 125 mg USP1176007 Dexamethasone 125 mg USP1176506 Dexamethasone Acetate 200 mg USP1177000 Dexamethasone Phosphate 200 mg USP1177032 Dexamethasone Sodium Phosphate 350 mg USP1178002 Dexbrompheniramine Maleate 200 mg USP1179005 Dexchlorpheniramine Maleate 300 mg USP1179333 Dexmedetomidine Hydrochloride 200 mg USP1179504 Dexpanthenol 500 mg USP1179628 Dextran 1 50 mg USP1179865 Dextran 10 Calibration 100 mg USP1179898 Dextran 250 Calibration 100 mg USP1179854 Dextran 4 Calibration 100 mg USP1179708 Dextran 40 50 mg USP1179876 Dextran 40 Calibration 100 mg USP1179720 Dextran 40 System Suitability 200 mg USP1179741 Dextran 70 50 mg

100 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1179887 Dextran 70 Calibration 100 mg USP1179763 Dextran 70 System Suitability 200 mg USP1179650 Dextran T-10 200 mg USP1179800 Dextran Vo Marker 100 mg Dextroamphetamine Related Compound A 25 mg USP1180015 1-Phenyl-2-propanol Dextroamphetamine Related Compound B 25 mg USP1180026 Phenyl acetone Controlled Substance CII USP1180004 Dextroamphetamine Sulfate Controlled Substance CII 500 mg USP1180503 Dextromethorphan 2 g USP1181007 Dextromethorphan HBr (CRM) 500 mg USP1181302 Dextrose 500 mg USP1294319 D- 50 mg USP1181506 Diacetylated Monoglycerides 200 mg USP1182000 Diacetylfluorescein 200 mg USP1183002 Diacetylmorphine HCl ( HCl) (AS) CI 25 mg USP1184005 Diatrizoic Acid 100 mg Diatrizoic Acid Related Compound A 50 mg USP1184027 5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid USP1185008 Diazepam CIV 100 mg Diazepam Related Compound A 25 mg USP1185020 2-Methyl-amino-5-chlorobenzophenone Diazepam Related Compound B 25 mg USP1023403 3-Amino-6-chloro-1-methyl-4-phenylcarbostyril USP1186000 Diazoxide 200 mg USP1551128 Dibasic Potassium Phosphate (AS) 5 g USP1187003 Dibucaine HCl 500 mg USP1187080 Dibutyl Phthalate 200 mg USP1187091 Dibutyl Sebacate 1 mL USP1187207 Dichloralphenazone CIV 200 mg USP1188006 Dichlorphenamide 200 mg Dichlorvos 150 mg USP1188301 2,2-dichlorovinyl dimethyl phosphate (AS) USP1188560 Diclazuril 200 mg USP1188571 Diclazuril System Suitability Mixture 50 mg USP1188709 Diclofenac Potassium 200 mg Diclofenac Related Compound A 25 mg USP1188811 N-(2,6-dichlorophenyl)indolin-2-one USP1188800 Diclofenac Sodium 200 mg USP1189009 Dicloxacillin Sodium 500 mg USP1190008 Dicumarol 200 mg USP1190904 Dicyclohexyl 2x2 mL USP1191000 Dicyclomine HCl 125 mg USP1191204 Didanosine 200 mg Didanosine Related Compound A 25 mg USP1191226 Hypoxanthine Didanosine Related Compound B 25 mg USP1191237 2',3'-dideoxyadenosine USP1191215 Didanosine System Suitability Mixture 10 mg USP1192003 Dienestrol 125 mg USP1192808 Diethanolamine 3 mL USP1193505 Diethyl Phthalate 200 mg USP1194803 Diethyl Sebacate 1 mL USP1193006 Diethylcarbamazine Citrate 200 mg

Edition 2014 Visit us at www.lgcstandards.com 101

United States Pharmacopeia and National Formulary

Code Product Unit USP1193265 Diethylene Glycol 0.5 mL USP1193301 Diethylene Glycol Monoethyl Ether 0.5 mL USP1194009 Diethylpropion HCl Controlled Substance CIV 200 mg USP1195001 Diethylstilbestrol 200 mg USP1197007 Diethyltoluamide 3 g USP1197302 Diacetate 200 mg USP1197506 Diflunisal 200 mg USP1198000 Digitalis 3 g USP1199002 Digitoxin 200 mg USP1200000 Digoxin 250 mg USP1200600 25 mg USP1200804 Dihydrocodeine Bitartrate Controlled Substance CII 200 mg USP1202005 Dihydroergotamine Mesylate 500 mg USP1203008 Dihydrostreptomycin Sulfate 200 mg USP1204000 Dihydrotachysterol 4x30 mg USP1204102 Dihydroxyacetone 250 mg USP1204805 Diloxanide Furoate 200 mg USP1205003 Diltiazem HCl 200 mg Diltiazem Related Compound A (AS) 25 mg USP1205014 trans-diltiazem hydrochloride USP1353000 Diluted Isosorbide Dinitrate 500 mg USP1353102 Diluted Isosorbide Mononitrate 750 mg Diluted Isosorbide Mononitrate Related Compound A 100 mg USP1353113 1,4:3,6-dianhydro-D-glucitol 2-nitrate USP1466506 Diluted Nitroglycerin 5 ampules USP1206006 Dimenhydrinate 200 mg Dimenhydrinate Related Compound E 15 mg USP1206017 8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione USP1208001 Dimethisoquin HCl 2 g USP1211006 Dimethyl Sulfoxide 3 g USP1213001 Dinoprost Tromethamine 50 mg USP1213103 Dinoprostone 50 mg USP1213318 Diosmin 300 mg USP1213329 Diosmin for System Suitability 15 mg USP1214004 Dioxybenzone 150 mg USP1217909 Diphenhydramine Citrate 200 mg USP1218005 Diphenhydramine HCl 200 mg Diphenhydramine Related Compound A 15 mg USP1218016 2-(Diphenylmethoxy)-N-methylethanamine HCl USP1219008 Diphenoxylate HCl CII 200 mg USP1220302 Dipivefrin HCl 200 mg USP1220506 Dipyridamole 200 mg USP1220700 Dirithromycin 200 mg USP1222400 Disodium 5'-Uridylate 500 mg USP1221000 Disodium Guanylate 350 mg USP1222002 Disodium Inosinate 500 mg USP1222501 Disopyramide Phosphate 200 mg USP1224008 Disulfiram 200 mg USP1224201 Divalproex Sodium 200 mg USP1224507 Dobutamine HCl 400 mg USP1224551 Docetaxel 200 mg USP1224562 Docetaxel Identification 50 mg USP1224573 Docetaxel System Suitability Mixture 15 mg

102 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1224620 Docosahexaenoic Acid Ethyl Ester 500 mg USP1224664 Docosyl Ferulate 50 mg USP1224700 Docusate Calcium 500 mg USP1224904 Docusate Potassium 100 mg USP1224802 Docusate Sodium 500 mg Docusate Sodium Related Compound B 40 mg USP1224824 Disodium mono (2-ethylhexyl) sulfosuccinate USP1224937 Dofetilide 200 mg Dofetilide Related Compound A 25 mg N-[4-(2-(2-[4-(methanesulfonamido)phenoxy]ethyl)amino)phenyl] USP1224948 methanesulfonamide USP1224959 Dolasetron Mesylate 200 mg Dolasetron Mesylate Related Compound A 25 mg USP1224960 Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one HCl USP1224981 Donepezil HCl 200 mg Donepezil Related Compound A 25 mg USP1224992 (E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one USP1224970 Donepezil-N-Oxide 20 mg USP1225204 Dopamine HCl 200 mg USP1225281 Dorzolamide HCl 200 mg Dorzolamide Hydrochloride Related Compound A 20 mg (4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno USP1225292 [2,3-b]thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride Dorzolamide Related Compound B 15 mg (4R,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2.3b]thiopyran-2-sulfonamide 7,7- USP1225317 dioxide HCl Dorzolamide Related Compound D 15 mg (4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide USP1225306 HCl USP1225000 Doxapram HCl 200 mg USP1225419 Doxazosin Mesylate 200 mg Doxazosin Related Compound A 20 mg USP1225420 N-(1,4-benzodioxane-2-carbonyl)piperazine hydrochloride Doxazosin Related Compound B 20 mg USP1225441 6,7-dimethoxyquinazoline-2,4-dione Doxazosin Related Compound C 20 mg USP1225452 2-chloro-4-amino-6,7-dimethoxyquinazoline Doxazosin Related Compound D 20 mg USP1225463 1,4-benzodioxane-2-carboxylic acid Doxazosin Related Compound E 20 mg USP1225474 2,4-dichloro-6,7-dimethoxyquinazoline Doxazosin Related Compound F 15 mg USP1225485 N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine USP1225500 Doxepin HCl 500 mg Doxepin Related Compound A 50 mg USP1225511 dibenzo[b,e]oxepin-11(6H)-one Doxepin Related Compound B 50 mg USP1225522 (11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol Doxepin Related Compound C 25 mg USP1225533 (E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine HCl USP1225703 Doxorubicin HCl 50 mg USP1226003 Doxycycline Hyclate 200 mg Doxycycline Related Compound A 10 mg USP1226014 6-epidoxycycline USP1227006 Doxylamine Succinate 300 mg USP1017502 Dried Aluminum Hydroxide Gel 200 mg Drometrizole 25 mg USP1228009 2-(2H-Benzotriazol-2-yl)-p-cresol

Edition 2014 Visit us at www.lgcstandards.com 103

United States Pharmacopeia and National Formulary

Code Product Unit Drometrizole Trisiloxane 200 mg USP1228010 2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-p-cresol Drometrizole Trisiloxane Related Compound A 25 mg USP1228029 2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol Drometrizole Trisiloxane Related Compound B 25 mg USP1228031 2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol Drometrizole Trisiloxane Related Compound C 150 mg USP1228042 2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol Drometrizole Trisiloxane Related Compound D 25 mg USP1228053 2-(2H-Benzothiazol-2-yl)-6-isobutyl-p-cresol Drometrizole Trisiloxane Related Compound E 150 mg 2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1- USP1228064 [bis(trimethylsiloxy)methylsilyl]-p-cresol USP1229001 Droperidol 250 mg USP1229409 Drospirenone 200 mg Drospirenone Related Compound A 15 mg 17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21- USP1229410 carboxylic acid, gamma-lactone USP1229817 Duloxetine HCl 100 mg Duloxetine Related Compound A 10 mg USP1229828 5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone Duloxetine Related Compound F 10 mg USP1229872 (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine HCl Duloxetine Related Compound H 10 mg USP1229883 (S)-4-(Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino)-4-oxobutanoic acid USP1707817 D-Valacyclovir (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester) 25 mg D-Valganciclovir 10 mg 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester USP1708015 monohydrochloride USP1230000 Dyclonine HCl 200 mg USP1231003 Dydrogesterone 200 mg USP1231502 Dyphylline 200 mg USP1236700 (-)-Epigallocatechin-3-O-gallate 20 mg USP1265526 2-Ethylhexan-1-ol 1.5 mL USP1171207 23-EPI-26-Deoxyactein 20 mg USP1236506 4-Epianhydrotetracycline HCl 50 mg USP1231207 Ebastine 200 mg Ebastine Related Compound B 100 mg USP1231229 1-[4-(Dimethylethyl)phenyl]ethanone Ebastine Related Compound C 15 mg USP1231230 4-(diphenylmethoxy)piperidine hydrochloride Ebastine Related Compound D 15 mg USP1231246 1-[4-(1,1-Dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one Ebastine Related Compound E 25 mg USP1231251 1-[4-(1,1-Dimethylpropyl)phenyl]-4-[4-(diphenylmethoxy)piperidin-1-yl]-butan-1-one fumarate Ebastine Related Compound F 15 mg USP1231262 1-[4-(1,1-dimethylethyl)phenyl]-4-[cis-4-(diphenylmethoxy)-1-oxidopiperidin-1-yl]butan-1-one Ebastine Related Compound G 15 mg 1-[4-(1,1-dimethylethyl)phenyl]-4-[trans-4-(diphenylmethoxy)-1-oxidopiperidin-1-yl]butan-1- USP1231273 one Ecamsule Related Compound A 50 mg USP1231615 1,4-Phenylenedimethanol Ecamsule Related Compound B 50 mg USP1231626 4-(hydroxymethyl)benzoic acid Ecamsule Related Compound C 50 mg USP1231637 terephthalic acid Ecamsule Related Compound D 50 mg USP1231648 ((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid

104 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Ecamsule Related Compound E 25 mg sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2- USP1231659 oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate Ecamsule Related Compound F 25 mg 4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2- USP1231660 ylidene)methyl)benzoic acid Ecamsule Related Compound G 25 mg 4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2- USP1231681 ylidene)methyl)benzaldehydre, sodium salt USP1231580 Ecamsule Solution 0.5 mL USP1231604 Ecamsule Triethanolamine 200 mg USP1231750 Echinacoside 15 mg USP1231808 Econazole Nitrate 100 mg USP1232006 Edetate Calcium Disodium 200 mg USP1233009 Edetate Disodium 200 mg USP1233508 Edetic Acid 200 mg USP1234001 Edrophonium Chloride 200 mg USP1234103 200 mg Efavirenz Racemic 20 mg (+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)- USP1234114 2H-3,1-benzoxazin-2-one Efavirenz Related Compound A 20 mg USP1234125 (S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol) Efavirenz Related Compound B 10 mg USP1234147 (S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one Efavirenz Related Compound C 20 mg USP1234136 6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline USP1234249 Eflornithine Hydrochloride 150 mg USP1234307 Eicosapentaenoic Acid Ethyl Ester 500 mg USP1234668 Eleutheroside B (Syringin) 15 mg USP1234680 Eleutheroside E (Syringaresinol diglucoside) 15 mg USP1234806 Emedastine Difumarate 100 mg USP1235004 Emetine HCl 300 mg USP1235106 Emtricitabine 200 mg USP1235128 Emtricitabine System Suitability Mixture A 15 mg USP1235139 Emtricitabine System Suitability Mixture B 15 mg USP1235300 Enalapril Maleate 200 mg USP1235274 Enalaprilat 300 mg USP1235503 Endotoxin unit USP1235809 1 mL USP1235820 Enoxaparin Sodium 300 mg USP1235831 Enoxaparin Sodium for Bioassays unit USP1235853 Enoxaparin Sodium Molecular Weight Calibrant A 8 mg USP1235864 Enoxaparin Sodium Molecular Weight Calibrant B 6 mg USP1235900 Enrofloxacin 200 mg USP1235911 Enrofloxacin Related Compound Mixture 50 mg Ensulizole 200 mg USP1530809 2-Phenylbenzimidazole-5-sulfonic acid USP1235933 Entacapone 150 mg Entacapone Related Compound A 25 mg USP1235944 (Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide USP1236007 Ephedrine Sulfate Drug Precursor 200 mg USP1236801 Epilactose 200 mg USP1237000 Epinephrine Bitartrate 200 mg USP1237382 Epirubicin HCl 200 mg USP1237509 Epitetracycline HCl (AS) 200 mg

Edition 2014 Visit us at www.lgcstandards.com 105

United States Pharmacopeia and National Formulary

Code Product Unit Epoprostenol Related Compound A 15 mg 7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydrocyoct-1-enyl]cyclopentyl}-6-oxoheptanoic USP1237611 acid Epoprostenol Related Compound B 15 mg USP1237622 Sodium 5-(diphenylphosphinoyl)pentanoate USP1237600 Epoprostenol Sodium 100 mg USP1237752 Eprinomectin 300 mg Eprosartan Mesylate 50 mg (E)-2-Butyl-1-(pcarboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, USP1238217 monomethanesulfonate Eprosartan Related Compoud C 25 mg USP1238240 2-(thiophen-2-ylmethyl)malonic acid Eprosartan Related Compound A 20 mg USP1238228 (E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid HCl Eprosartan Related Compound B 15 mg USP1238239 3-(thiophen-2-yl)propanoic acid Eprosartan Related Compound D 15 mg USP1238251 4-(bromomethyl)benzoic acid Eprosartan Related Compound E 15 mg USP1238262 4-(hydroxymethyl)benzoic acid USP1238002 Equilin 25 mg USP1239005 Ergocalciferol (Vitamin D2) 5x30 mg USP1239504 Mesylates 300 mg USP1240004 Ergonovine Maleate Drug Precursor 100 mg USP1241007 Ergosterol 50 mg USP1241506 Ergotamine Tartrate Drug Precursor 150 mg USP1241550 Ergotaminine Drug Precursor 100 mg USP1241823 Erythorbic Acid 50 mg USP1241903 Erythritol 200 mg USP1242000 Erythromycin 250 mg USP1242010 Erythromycin B 100 mg USP1242021 Erythromycin C 50 mg USP1243002 Erythromycin Estolate 200 mg USP1245008 Erythromycin Ethylsuccinate 200 mg USP1246000 Erythromycin Gluceptate 200 mg USP1247003 Erythromycin Lactobionate 200 mg Erythromycin Related Compound N 50 mg USP1242032 N-Demethylerythromycin A USP1248006 Erythromycin Stearate 200 mg USP1249202 Escin 350 mg USP1249406 Escitalopram Oxalate 200 mg Escitalopram Related Compound A 10 mg USP1249417 (-)4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)]-3-(hydroxymethyl)benzonitrile USP1249701 Esmolol HCl 100 mg USP1249789 Esomeprazole Magnesium 10 mg USP1249905 Estazolam CIV 100 mg Estazolam Related Compound A 10 mg USP1249916 5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone USP1250008 Estradiol 500 mg USP1251000 Estradiol Benzoate (AS) 250 mg USP1252003 200 mg Estradiol Related Compound B 10 mg USP1250020 1,3,5(10),6-estratetraen-3,17beta-diol Estradiol Related Compound C 15 mg USP1250041 1,3,5(10)estratrien-3,17beta-diol-6-one USP1254009 Estradiol Valerate 100 mg

106 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1254508 Estriol 100 mg USP1255001 Estrone 200 mg USP1255500 500 mg USP1255850 Eszopiclone CIV 100 mg Eszopiclone Related Compound A 10 mg 6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine- USP1255861 1-carboxylate 4-oxide) USP1256004 Ethacrynic Acid 200 mg USP1257007 Ethambutol HCl 200 mg Ethambutol Related Compound A 15 mg USP1257018 (2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol Ethambutol Related Compound B 15 mg USP1257029 ((2R,2'R)-2,2'-[ethane-1,2-diylbis(azanediyl]dibutan-1-ol)HCl USP1258305 Ethchlorvynol Controlled Substance CIV 0.7 mL USP1260001 Ethinyl Estradiol 150 mg Ethinyl Estradiol Related Compound A 20 mg USP1260012 6-Keto-ethinyl estradiol Ethinyl Estradiol Related Compound B 10 mg USP1260023 19-Nor-17alpha-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol USP1261004 Ethionamide 200 mg USP1262801 Ethopabate 125 mg Ethopabate Related Compound A 25 mg USP1262823 Methyl-4-acetamido-2-hydroxybenzoate USP1264002 Ethosuximide 500 mg USP1264501 Ethotoin 200 mg USP1265005 Ethoxzolamide 200 mg USP1265402 Ethyl Acetate 3x1.2 mL USP1265424 Ethyl Acrylate and Methyl Metacrylate Copolymer Dispersion 1.5 g USP1265606 Ethyl Formate 3x1.2 mL USP1265752 Ethyl Laurate 500 mg USP1265800 Ethyl Lauroyl Arginate 200 mg USP1266008 Ethyl Maltol 1 g USP1267500 Ethyl Vanillin 200 mg USP1265457 Ethylbenzene 3x0.5 mL USP1265504 Ethylcellulose 1 g USP1265515 Ethylene Glycol 0.5 mL USP1265592 Ethylene Glycol and Vinyl Alcohol Graft Copolymer 1 g USP1265537 Ethylhexyl Triazone 200 mg Ethylhexyl Triazone Related Compound A 20 mg USP1265548 2-ethylhexyl 4-aminobenzoate Ethylhexyl Triazone Related Compound B 20 mg USP1265559 4-(4,6-bis(4-((2-ethylhexyloxy)carbonyl)phenylamino)-1,3,5-triazin-2-ylamino)benzoic acid Ethylhexyl Triazone Related Compound C 20 mg bis(2-ethylhexyl)4,4'-(6-(4-(ethyoxycarbonyl)phenylamino)-1,3,5-triazine-2,4- USP1265560 diyl)bis(azanediyl)dibenzoate USP1266507 Ethylnorepinephrine HCl 200 mg USP1267000 Ethylparaben 200 mg USP1268003 Ethynodiol Diacetate 200 mg USP1268502 Etidronate Disodium 200 mg Etidronate Disodium Related Compound A 300 mg USP1268513 Sodium phosphite dibasic pentahydrate USP1268604 Etidronic Acid Monohydrate 1 g USP1268706 Etodolac 400 mg Etodolac Related Compound A 25 mg USP1268728 (+/-)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid USP1268750 Etomidate 200 mg

Edition 2014 Visit us at www.lgcstandards.com 107

United States Pharmacopeia and National Formulary

Code Product Unit USP1268783 50 mg Etonogestrel Related Compound A 10 mg USP1268794 (13Beta-Ethyl-11-methylenegon-4-ene-3,17-dione) USP1268808 Etoposide 300 mg USP1268852 Etoposide Resolution Mixture 30 mg USP1268863 Etoricoxib 200 mg Etoricoxib Related Compound A 50 mg USP1268874 4-methylsulfonyl acetophenone Etoricoxib Related Compound B 50 mg USP1268885 4-(methylsulfonyl)-phenyl acetic acid Etoricoxib Related Compound C 50 mg USP1268896 2-chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate USP1268900 200 mg USP1268965 Eugenol 500 mg USP1269050 150 mg Exemestane Related Compound A 15 mg USP1269061 6-Methyleneandrosta-4-ene-3,17-dione Exemestane Related Compound B 15 mg USP1269072 6-hydroxymethylandrostra-1,4-diene-3,17-dione Exemestane Related Compound C 15 mg USP1269083 androsta-1,4-diene-3,17-dione Controlled Substance CIII USP1269094 Exemestane System Suitability Mixture 25 mg USP1090014 Exo-tetrahydrocannabinol Controlled Substance 1 mL USP1286300 10-Formylfolic Acid 25 mg USP1269152 Famciclovir 200 mg Famciclovir Related Compound A 20 mg USP1269174 2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride Famciclovir Related Compound B 20 mg USP1269185 4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate Famciclovir Related Compound C 20 mg USP1269196 4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate Famciclovir Related Compound E 25 mg USP1269130 2-aminopurine Famciclovir Related Compound F 25 mg USP1269141 2-Amino-6-chloropurine Famciclovir System Suitability Mixture 20 mg USP1269163 Mixture of Famciclovir, Propionylfamciclovir and 6-Chlorofamciclovir USP1269119 FAME Standard Mixture 100 mg USP1269200 Famotidine 125 mg Famotidine Related Compound B 25 mg 3,5-bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphany]ethyl]-4H-1,2,4,6- USP1269221 thiatriazine1,1-dioxide (AS) Famotidine Related Compound C 25 mg USP1269232 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide HCl Famotidine Related Compound D 25 mg USP1269243 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide Famotidine Related Compound E 25 mg USP1269254 2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine Famotidine Related Compound F 25 mg USP1269265 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid Famotidine Sulfoxide 25 mg USP1269298 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylsulfinyl]-N'-sulfamoylpropanimidamide USP1269312 Felbamate 250 mg Felbamate Related Compound A 25 mg USP1269323 3-Hydroxy-2-phenylpropyl carbamate Felbamate Related Compound B 25 mg USP1269334 Phenethyl carbamate USP1269389 Felodipine 300 mg

108 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Felodipine Related Compound A 15 mg USP1269390 ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate USP1269403 Fenbendazole 100 mg Fenbendazole Related Compound A 30 mg USP1269414 Methyl(1H-benzimidazole-2-yl)carbamate Fenbendazole Related Compound B 30 mg USP1269425 Methyl[5(6)-chlorobenzimidazole-2-yl]carbamate USP1269447 Fenofibrate 200 mg Fenofibrate Related Compound A 25 mg USP1269607 (4-chlorophenyl)(4-hydroxyphenyl) methanone Fenofibrate Related Compound B 25 mg USP1269618 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid Fenofibrate Related Compound C 25 mg 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2- USP1269629 methylpropanoate USP1269458 Fenoldopam Mesylate 200 mg Fenoldopam Related Compound A 20 mg USP1269469 N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol HCl Fenoldopam Related Compound B 20 mg USP1269470 1H-3-Benzazapine-7,8-diol, 2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate USP1269505 Fenoprofen Calcium 500 mg USP1269550 Fenoprofen Sodium 500 mg USP1269902 Fentanyl Controlled Substance CII 100 mg USP1270005 Fentanyl Citrate Controlled Substance CII 100 mg Fentanyl Related Compound A 100 mg USP1269913 (2-bromoethyl)benzene Fentanyl Related Compound B 10 mg USP1269924 4-Anilinopiperidine Fentanyl Related Compound D 10 mg USP1269946 N-Phenyl-1-(phenylmethyl)-4-piperidinamine Fentanyl Related Compound E 10 mg USP1269957 N-Phenyl-1-(2-phenylethyl)-4-piperidinamine CII Fentanyl Related Compound G 10 mg USP1269979 Acetyl fentanyl USP1270355 Ferrous Sulfate 1.5 g Ferulic Acid 25 mg USP1270311 trans-4-hydroxy-3-methoxycinnamic acid USP1270377 Fexofenadine HCl 200 mg Fexofenadine Related Compound A 25 mg 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl USP1270388 benzeneacetic acid Fexofenadine Related Compound B 25 mg 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl USP1270399 benzeneacetic acid hydrochloride Fexofenadine Related Compound C 15 mg USP1270446 (+)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene (AS) USP1270435 Filgrastim 0.98 mg USP1270402 Finasteride 200 mg USP1270424 Fish Oil 1 g USP1270708 Flavoxate HCl 200 mg Flavoxate Related Compound A 25 mg USP1270719 3-methylflavone-8-carboxylic acid Flavoxate Related Compound B 20 mg USP1270720 3-Methylflavone-8-carboxylic acid methyl ester Flavoxate Related Compound C 20 mg USP1270731 3-Methylflavone-8-carboxylic acid ethyl ester USP1270800 Flecainide Acetate 200 mg Flecainide Related Compound A 75 mg USP1270821 3-[2,5-bis(2,2,2-trifluoroethoxy) phenyl]-1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine HCl

Edition 2014 Visit us at www.lgcstandards.com 109

United States Pharmacopeia and National Formulary

Code Product Unit USP1271008 Floxuridine 250 mg USP1271700 Fluconazole 200 mg Fluconazole Related Compound A 10 mg USP1271711 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol Fluconazole Related Compound B 10 mg USP1271722 2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol Fluconazole Related Compound C 10 mg USP1271733 1,1'-(1,3-phenylene)di(1H-1,2,4-triazole) USP1272000 Flucytosine 200 mg USP1272204 Fludarabine Phosphate 300 mg USP1272907 Fludeoxyglucose 100 mg Fludeoxyglucose Related Compound A 15 mg USP1272918 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8.]hexacosane Fludeoxyglucose Related Compound B 10 mg USP1272929 2-chloro-2-deoxy-D-glucose USP1273003 Fludrocortisone Acetate 200 mg USP1273808 Flumazenil 200 mg Flumazenil Related Compound A 20 mg 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] USP1273819 [1,4]benzodiazepine-3-carboxylic acid Flumazenil Related Compound B 20 mg Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] USP1273820 [1,4]benzodiazepine-3-carboxylate Flumazenil Related Compound C 500 mg USP1273841 N,N-Dimethylformamide diethyl acetal USP1274006 Flumethasone Pivalate 200 mg USP1274505 200 mg USP1274607 Flunixin Meglumine 300 mg Flunixin Related Compound A 15 mg USP1274629 (2-Chloronicotinic acid) Flunixin Related Compound B 25 mg USP1274630 (2-Methyl-3-(trifluoromethyl)aniline) Flunixin Related Compound C 50 mg USP1274631 (Ethyl 2-chloronicotinate) USP1275009 100 mg USP1276001 100 mg USP1277004 Fluorescein 200 mg USP1277252 Fluoride Dentifrice: Sodium Fluoride/Silica 4.6 oz USP1277274 Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder 4 oz USP1277423 Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica 5.25 oz USP1277300 Fluoride Dentifrice: Sodium Monofluorophosphate - Calcium Carbonate 4.6 oz USP1277354 Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate 4.6 oz USP1277401 Fluoride Dentifrice: Sodium Monofluorophosphate (1000 ppm)/Silica 5.25 oz USP1277456 Fluoride Dentifrice: Stannous Fluoride-Silica 4 oz USP1278007 200 mg USP1278109 200 mg USP1278302 Fluoroquinolonic Acid 150 mg USP1279000 Fluorouracil 250 mg Fluorouracil Related Compound A 25 mg USP1279019 (Pyrimidine-2,4,6(1H,3H,5H)-trione) Fluorouracil Related Compound B 25 mg USP1279021 (Dihydropyrimidine-2,4,5(3H)-trione) Fluorouracil Related Compound E 25 mg USP1279054 5-Chloropyrimidine-2,4(1H,3H)-dione Fluorouracil Related Compound F 25 mg USP1279065 (2-Ethoxy-5-fluoropyrimidin-4(1H)-one) USP1279804 Fluoxetine HCl 200 mg

110 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Fluoxetine Related Compound A 15 mg USP1279815 N-methyl-3-phenyl-3-[(alpha,alpha,alpha-(trifluoro-m-tolyl)oxy]propylamine HCl Fluoxetine Related Compound B 5 mL USP1279826 N-methyl-3-phenylpropylamine Controlled Substance Fluoxetine Related Compound C 15 mg USP1279837 N-Methyl-N-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl] succinamic acid USP1280009 Controlled Substance CIII 200 mg USP1280803 Fluphenazine Decanoate Dihydrochloride 500 mg USP1281001 Fluphenazine Enanthate Dihydrochloride 125 mg USP1282004 Fluphenazine HCl 125 mg USP1284000 Flurandrenolide 100 mg USP1285002 Flurazepam HCL Controlled Substance CIV 200 mg Flurazepam Related Compound C 50 mg USP1285308 5-chloro-2-(2-diethylaminoethyl(amino)-2'-fluorobenzophenone HCl Flurazepam Related Compound F 50 mg USP1285603 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one) USP1285750 Flurbiprofen 200 mg Flurbiprofen Related Compound A 100 mg USP1285760 2-(4-Biphenylyl)propionic Acid USP1285807 Flurbiprofen Sodium 200 mg USP1285851 Flutamide 200 mg Flutamide Related Compound A 20 mg USP1285997 (4-nitro-3-(trifluoromethyl)aniline) Flutamide Related Compound B 20 mg USP1285986 N-[4-nitro-3-(trifluoromethyl)phenyl]acetamide USP1285873 Fluticasone Propionate 100 mg USP1285910 Fluticasone Propionate Nasal Spray Resolution Mixture 25 mg USP1285840 Fluticasone Propionate Related Compounds Mixture 25 mg USP1285884 Fluticasone Propionate Resolution Mixture 25 mg Fluticasone Propionate System Suitability Mixture 25 mg USP1285895 Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D Fluvastatin Related Compound B 15 mg [R*,S*-E](+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic USP1285964 acid 1,1-dimethylethyl ester USP1285931 Fluvastatin Sodium 350 mg USP1285909 Fluvoxamine Maleate 200 mg USP1286005 Folic Acid (Vitamin M or Vitamin Bc) 500 mg Folic Acid Related Compound A 50 mg USP1286027 Calcium Formyltetrahydrofolate USP1283200 Formic Acid 3x1.2 mL USP1286060 50 mg USP1286107 Formoterol Fumarate 100 mg USP1286129 Formoterol Fumarate Resolution Mixture 20 mg USP1286118 Formoterol Fumarate System Suitability Mixture 20 mg Forskolin 40 mg USP1283244 7Beta-acetoxy-8,13-epoxy-1alpha,6Beta,9alpha-trihydroxy-labd-14-en-11-one Foscarnet Related Compound B 10 mg USP1283313 Disodium (Ethoxyoxidophosphanyl) formate Foscarnet Related Compound D 0.27 mL USP1283324 O,O-diethyl ethoxycarbonylphosphonate USP1283302 Foscarnet Sodium 50 mg USP1286322 Fosfomycin Tromethamine 800 mg Fosinopril Related Compound A 25 mg USP1283415 (4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]-acetyl-L-proline Fosinopril Related Compound B 15 mg ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl- USP1283426 D-proline propionate (ester), hemibarium salt, sesquihydrate)

Edition 2014 Visit us at www.lgcstandards.com 111

United States Pharmacopeia and National Formulary

Code Product Unit Fosinopril Related Compound C 15 mg (4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L- USP1283437 proline propionate (ester),sodium salt Fosinopril Related Compound D 15 mg (4R)-4-cyclohexyl-1-[(R)-[(S]-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L- USP1283448 proline propionate (ester), sodium salt Fosinopril Related Compound E 15 mg (4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl]phospinyl]acetyl-L- USP1283459 proline propionate (ester), sodium salt Fosinopril Related Compound F 15 mg (4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phospinyl]acetyl-L-proline USP1283460 propionate (ester),sodium salt Fosinopril Related Compound G 15 mg USP1283470 (4-phenylbutyl)phosphinyl acetic acid, disodium salt Fosinopril Related Compound H 25 mg USP1283481 4-phenylbutyl phosphonic acid USP1283404 Fosinopril Sodium 200 mg USP1286366 Fosphenytoin Sodium 250 mg USP1286504 Fructose 125 mg USP1286650 Fulvestrant 150 mg USP1286661 Fulvestrant System Suitability Mixture 15 mg USP1286708 Fumaric Acid 200 mg USP1286800 Furazolidone 200 mg USP1287008 Furosemide 200 mg Furosemide Related Compound A 50 mg USP1287020 2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid Furosemide Related Compound B 100 mg USP1287030 4-Chloro-5-sulfamoylanthranilic Acid USP1287303 Gabapentin 250 mg Gabapentin Related Compound A 50 mg USP1287325 2-Azaspiro[4.5]decan-3-one Gabapentin Related Compound B 30 mg USP1287347 (1-cyanocyclohexyl)acetic acid Gabapentin Related Compound D 10 mg USP1287358 (1-(3-oxo-2-aza-spiro[4,5]dec-2-ylmethyl)-cyclohexyl)acetic acid Gabapentin Related Compound E 25 mg USP1287369 carboxymethyl-cyclohexanecarboxylic Acid USP1287507 500 mg Gadodiamide Related Compound A 50 mg USP1287518 sodium diethylenetriamine pentaacetic acid monomethylamide Gadodiamide Related Compound B 50 mg USP1287529 gadolinium disodium diethylenetriamine pentaacetic Acid USP1287609 Gadopentetate Monomeglumine 500 mg USP1287631 500 mg Gadoteridol Related Compound A 50 mg USP1287642 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclodedodecane-1,4,7-triaacetic Acid Gadoteridol Related Compound B 50 mg USP1287653 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt Gadoteridol Related Compound C 50 mg USP1287664 1,4,7,10-Tetraaza-11-oxo-bicylco[8.2.2]tetradecan-4,7-diacetic Acid USP1287675 200 mg Gadoversetamide Related Compound A 200 mg Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato USP1287686 (4-)]gadolinium USP1287711 Galactitol 500 mg USP1287722 Galactosamine HCl 50 mg USP1287700 Galactose 200 mg USP1287755 Galantamine HBr 200 mg USP1287766 Galantamine HBr Racemic 15 mg

112 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1287777 Galantamine HBr Related Compounds Mixture 25 mg USP1288000 Gallamine Triethiodide 200 mg USP1154591 Gamma Cyclodextrin 200 mg USP1020023 Gamma-Aminobutyric Acid 50 mg USP1294848 gamma-Glutamyl-(S)-allyl-L-cysteine 25 mg USP1288306 Ganciclovir 200 mg Ganciclovir Mono-N-methyl Valinate 10 mg USP1288339 2-(RS)-[(guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride Ganciclovir Related Compound A 15 mg USP1288317 (RS)-2-Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydropurin-6-one USP1288408 Gatifloxacin 300 mg USP1288463 Gemcitabine Hydrochloride 200 mg USP1288500 Gemfibrozil 200 mg Gemfibrozil Related Compound A 20 mg USP1288510 2,2-dimethyl-5-[2,5-dimethyl-4-propene-1-yl)phenoxy] USP1288816 15 mg USP1288805 30 mg USP1289003 Gentamicin Sulfate 200 mg USP1290002 Gentian Violet 650 mg USP1291005 Gibberellic Acid 200 mg Constituent Mixture 0.2 mg USP1291446 6- and 6- USP1291559 Ginkgo Terpene Lactones 50 mg USP1291548 Ginkgolic Acids 10 mg USP1292008 Gitoxin 50 mg USP1005706 Glacial Acetic Acid (AS) 3 x 1.5 mL USP1292303 Glimepiride 200 mg Glimepiride Related Compound A 20 mg USP1292314 Glimepiride cis-isomer Glimepiride Related Compound B 20 mg USP1292325 Glimepiride Sulfonamide Glimepiride Related Compound C 20 mg USP1292336 Glimepiride urethane Glimepiride Related Compound D 20 mg USP1292347 Glimepiride-3-isomer USP1292507 Glipizide 125 mg Glipizide Related Compound A 25 mg USP1292609 N-{2-[(4-aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide Glipizide Related Compound B 15 mg USP1292610 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide Glipizide Related Compound C 15 mg USP1292631 1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]urea USP1294207 Glucosamine HCl 200 mg USP1294976 Glutamic Acid 200 mg USP1294808 100 mg USP1294820 Glutathione 300 mg USP1295505 Glyburide 200 mg Glyburide Related Compound A 25 mg USP1295516 5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide Glyburide Related Compound B 25 mg USP1295527 methyl-[[4-[2-[5(-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate (AS) USP1295607 Glycerin 2 mL USP1295709 Glyceryl Behenate 200 mg USP1295724 Glyceryl Distearate 500 mg USP1295731 Glyceryl Monolinoleate 500 mg USP1295753 Glyceryl Monooleate 40% 500 mg

Edition 2014 Visit us at www.lgcstandards.com 113

United States Pharmacopeia and National Formulary

Code Product Unit USP1295742 Glyceryl Monooleate 90% 250 mg USP1295800 Glycine 200 mg USP1295844 15 mg USP1295855 15 mg USP1296009 Glycopyrrolate 200 mg Glycopyrrolate Erythro Isomer 25 mg USP1296010 (RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide Glycopyrrolate Related Compound A 50 mg USP1296029 5-Nitrobenzene-1,3-dicarboxylic acid Glycopyrrolate Related Compound B 75 mg USP1296031 1-Metyhlpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Glycopyrrolate Related Compound C 25 mg USP1296042 2-Cyclopentyl-2-hydroxy-2-phenylacetic acid Glycopyrrolate Related Compound I (15 mg) 15 mg (RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1- USP1296086 ium bromide Glycopyrrolate Related Compound L 50 mg USP1296100 Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate USP1295888 Glycyrrhizic Acid 25 mg USP1296756 Gonadorelin Acetate 50 mg Gonadorelin Acetate Related Compound A 10 mg USP1296767 Gonadorelin free acid trifluoroacetate salt USP1296803 Gonadorelin Hydrochloride 6.53 mg USP1297205 Goserelin Acetate 100 mg Goserelin Related Compound A 2 mg USP1297216 4-D-Serine Goserelin USP1297250 Goserelin System Suitability Mixture 1 mg USP1535846 Graftskin Reference Photomicrographs (CD) unit USP1298004 Gramicidin 200 mg USP1298106 Granisetron HCl 150 mg Granisetron Related Compound A 15 mg USP1298117 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide Granisetron Related Compound B 15 mg USP1298128 N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide Granisetron Related Compound C 15 mg USP1298139 N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide HCl Granisetron Related Compound D 15 mg USP1298140 1-methyl-1H-indazole-3-carboxylic acid Granisetron Related Compound E 15 mg USP1298150 (1R,3r,5S)-9-azabicyclo[3.3.1]nonan-3-amine acetate USP1298208 Grape Seeds Oligomeric Proanthocyanidins 500 mg USP1299007 Griseofulvin 200 mg USP1299200 Griseofulvin Permeability Diameter 2 g USP1300004 Guaiacol 1 g USP1301007 Guaifenesin 200 mg USP1301404 Guanabenz Acetate 200 mg USP1301608 Guanadrel Sulfate 200 mg USP1301801 Guanethidine Monosulfate 200 mg USP1302101 Guanfacine HCl 125 mg USP1302156 Guanine 100 mg USP1302214 Z 25 mg USP1302247 Gymnemagenin 15 mg USP1331008 12-Hydroxystearic Acid 200 mg USP1305507 2E,4E-Hexadienoic Acid Isobutylamide 25 mg USP1327408 6-Hydroxynicotinic Acid 50 mg USP1302305 Halazepam (AS) CIV 200 mg

114 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1302509 200 mg USP1302906 Halobetasol Propionate 200 mg USP1303002 Haloperidol 200 mg USP1303057 Haloperidol Decanoate 200 mg Haloperidol Related Compound A 10 mg USP1303013 4,4'-Bis[4-(p-chlorophenyl)-4-hydroxy-piperidino]-butyrophenone Haloperidol Related Compound B 10 mg USP1303024 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one USP1303501 Halothane 1 mL USP1303750 Hemoglobin Protease Substrate 100 g USP1304005 Heparin Sodium 10x1 mL USP1304016 Heparin Sodium for Assays 9.5 mg USP1304038 Heparin Sodium Identification 50 mg USP1304107 Heparin Sodium Molecular Weight Calibrant 10.3 mg USP1304049 Heparin Sodium System Suitability 50 mg USP1304050 Heparin Sodium with Oversulfated Chondroitin Sulfate 8.8 mg Heptamethyl Trisiloxane 150 mg USP1228075 1,1,1,3,5,5,5-Heptamethyltrisiloxane USP1304209 Heptane 3x1.2 mL USP1305008 Hexachlorophene 500 mg USP1305303 Hexacosanol 100 mg USP1307003 Hexobarbital Controlled Substance CIII 500 mg USP1308006 Hexylcaine HCl 1 g USP1308200 Hexylene Glycol 125 mg USP1308307 Hexylresorcinol 200 mg USP1342150 High Molecular Weight Insulin Human 8.4 mg USP1546707 High-Density Polyethylene 3 strips USP1309009 Histamine Dihydrochloride 250 mg USP1310008 Homatropine HBr 200 mg USP1311000 Homatropine Methylbromide 250 mg USP1311306 Homopolymer Polypropylene 3 strips USP1311408 Homosalate 500 mg USP1297001 Human Chorionic - 5,760 USP units per package vial USP1535857 Human Fibroblast-Derived Skin Substitute Reference Photomicrographs (CD) unit USP1313006 Hydralazine HCl 200 mg USP1313210 Hydrastine 10 mg USP1314009 Hydrochlorothiazide 200 mg USP1314960 Hydrocodone (Base) 125 mg USP1315001 Hydrocodone Bitartrate Controlled Substance CII 100 mg Hydrocodone Bitartrate Related Compound A 70 mg USP1315012 -6-one, 4-hydroxy-3-methoxy-17-methyl Controlled Substance CII USP1316004 Hydrocortisone 200 mg USP1317007 Hydrocortisone Acetate 200 mg USP1317302 200 mg USP1318000 200 mg USP1319002 Hydrocortisone Hemisuccinate 200 mg USP1320001 Triethylamine 200 mg USP1321004 200 mg USP1322007 Hydroflumethiazide 200 mg USP1323000 Hydromorphone HCl CII 50 mg USP1323019 Hydromorphone N-Oxide HCl CII 15 mg Hydromorphone Related Compound A CII 10 mg USP1323021 7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one hydrochloride

Edition 2014 Visit us at www.lgcstandards.com 115

United States Pharmacopeia and National Formulary

Code Product Unit USP1324002 Hydroquinone 500 mg USP1325005 Hydroxyamphetamine HBr 200 mg USP1327000 Hydroxychloroquine Sulfate 200 mg USP1329006 Hydroxyprogesterone Caproate 200 mg USP1329709 Hydroxypropyl Betadex 200 mg USP1329800 Hydroxypropyl Cellulose 500 mg USP1332000 Hydroxyurea 200 mg USP1333003 Hydroxyzine HCl 500 mg USP1334006 Hydroxyzine Pamoate 500 mg Hydroxyzine Related Compound A 25 mg USP1333058 p-Chlorobenzhydrylpiperazine Hyoscyamine Related Compound A 10 mg USP1335010 Norhyoscyamine Sulfate USP1335009 Hyoscyamine Sulfate 125 mg USP1335202 50 mg USP1330005 Hypromellose (Hydroxypropyl Methylcellulose) 250 mg USP1335279 Hypromellose Acetate Succinate 100 mg USP1335304 Hypromellose Phthalate 100 mg Ibandronate Related Compound A 25 mg USP1335428 3-[Methyl(pentyl)amino]propanoic acid HCl USP1335417 Ibandronate Sodium 200 mg USP1335508 Ibuprofen 750 mg Ibuprofen Related Compound C 3x0.2 mL USP1335541 4-isobutylacetophenone USP1335610 Ibutilide Fumarate 100 mg Ibutilide Related Compound B 20 mg USP1335632 (N-Ethyl-N-heptyl-4-hydroxy-4-[4-(methylsulfonamido)phenyl]butanamide) USP1335701 Idarubicin HCl 50 mg USP1336001 Idoxuridine 250 mg USP1336205 Ifosfamide 500 mg USP1336500 Imidazole 200 mg USP1336806 Imidurea 200 mg USP1337004 Iminodibenzyl 25 mg USP1337809 Imipenem Monohydrate 100 mg USP1338007 Imipramine HCl 200 mg USP1338481 Imipramine Pamoate 300 mg USP1338313 Imiquimod 200 mg Imiquimod Related Compound A 25 mg USP1338324 1-Isobutyl-1H-imidazo[4,5-c]quinoline Imiquimod Related Compound B 25 mg USP1338335 1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide Imiquimod Related Compound C 25 mg USP1338346 4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinolone) Imiquimod Related Compound D 25 mg USP1338357 1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine Imiquimod Related Compound E 25 mg USP1338368 N4-Isobutylquinoline-3,4-diamine USP1338801 Indapamide 250 mg Indapamide Related Compound A 50 mg USP1338812 4-Chloro-N-(2-methyl-indol-1-yl)-3-sulfamoylbenzamide (AS) USP1339000 Indigotindisulfonate Sodium 500 mg USP1339178 Indinavir 100 mg USP1339189 Indinavir System Suitability 100 mg USP1340009 Indocyanine Green 250 mg USP1341001 Indomethacin 200 mg

116 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1340960 Inositol 500 mg USP1342208 Insulin (Beef) 100 mg USP1342300 Insulin (Pork) 2x6.25mg USP1342037 Insulin Aspart 7.45 mg USP1342106 Insulin Human 100 mg USP1342321 Insulin Lispro 5.76 mg USP1343007 Iodipamide 200 mg USP1343517 Iodixanol 200 mg Iodixanol Related Compound D 50 mg 5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N'-bis(2,3-dihydroxypropyl) USP1343550 2,4,6-triiodo-1,3-benzenedicarboxamide USP1344509 Iodoquinol 100 mg USP1344600 Iohexol 200 mg Iohexol Related Compound A 100 mg USP1344622 5-(acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide Iohexol Related Compound B 50 mg USP1344644 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide Iohexol Related Compound C 50 mg USP1344666 N,N'-bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide USP1344702 Iopamidol 200 mg Iopamidol Related Compound A 50 mg USP1344724 N,N'Bis-(1,3-dihydroxy-2-propyl)5-amino-2,4,6-triiodoiso-phthalamide Iopamidol Related Compound B 50 mg USP1344735 5-Glycolamido-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide Iopamidol Related Compound C 40 mg USP1344746 4-chloro-N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide USP1344804 Iopromide 400 mg Iopromide Related Compound A 50 mg USP1344826 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide Iopromide Related Compound B 50 mg 5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3- USP1344837 benzenedicarboxamide USP1345002 Iothalamic Acid 200 mg USP1345104 200 mg Ioversol Related Compound A 50 mg USP1345115 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide Ioversol Related Compound B 50 mg N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbonyl)methoxy]- USP1345126 2,4,6-triiodoisophthalamide USP1345159 Ioxaglic Acid 100 mg USP1345206 400 mg Ioxilan Related Compound A 100 mg USP1345228 5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic Acid USP1347008 200 mg USP1347507 Ipratropium Bromide 100 mg Ipratropium Bromide Related Compound A 10 mg USP1347518 endo-3-Hydroxy-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide Ipratropium Bromide Related Compound B 10 mg (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8- USP1347529 azoniabicyclo[3.2.1]octane, bromide Ipratropium Bromide Related Compound C 15 mg USP1347530 (2-RS)-3-hydroxy-2-phenylpropanoic acid USP1347700 Irbesartan 200 mg Irbesartan Related Compound A 25 mg 1-pentanoylamino-cyclopentanecarboxylic acid[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]- USP1347711 amide USP1347609 Irinotecan Hydrochloride 100 mg

Edition 2014 Visit us at www.lgcstandards.com 117

United States Pharmacopeia and National Formulary

Code Product Unit Irinotecan Related Compound A 10 mg USP1347610 (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Irinotecan Related Compound B 10 mg (S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)- USP1347631 dione Irinotecan Related Compound C 10 mg 11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H- USP1347642 pyrano[3',4':6,7]indolizino[1,2-b]quinoline-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride Irinotecan Related Compound D 15 mg (R)-9-[(1,4'Bipiperidine)-1'carboxyl]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo- USP1347653 1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin hydrochloride, trihydrate Irinotecan Related Compound E 15 mg USP1347664 (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione USP1347755 Isoamyl Methoxycinnamate 750 mg USP1347802 Isobutyl acetate 3x1.2 mL USP1347880 Isobutyraldehyde 3 x 1.2 mL USP1348000 Isocarboxazid 200 mg USP1348500 Isoetharine HCl 250 mg USP1348907 Acetate 200 mg USP1349003 Isoflurane 1 mL Isoflurane Related Compound A 0.1 mL USP1349014 1-chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether Isoflurane Related Compound B 0.1 mL USP1349025 2,2,2-Trifluoroethyldifluoromethyl ether USP1349604 Isomalathion 50 mg USP1349626 Isomalt 200 mg USP1349637 Isomaltulose 5 g USP1349659 Isometheptene Mucate 200 mg USP1349706 Isoniazid 200 mg USP1350002 Isopropamide Iodide 200 mg USP1350104 Isopropyl Acetate 3x1.2 mL USP1350400 Isopropyl Myristate 500 mg USP1350603 Isopropyl Palmitate 500 mg USP1351005 Isoproterenol HCl 125 mg USP1351107 Isopteropodine 20 mg USP1351800 Isorhamnetin 15 mg USP1352008 Isosorbide (75% solution) 1 g USP1353500 Isotretinoin 200 mg USP1354003 Isoxsuprine HCl 200 mg USP1354207 Isradipine 200 mg Isradipine Related Compound A 15 mg USP1354218 Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinecarboxylate USP1354251 Itraconazole 100 mg USP1354262 Itraconazole System Suitability Mixture 25 mg USP1354309 Ivermectin 200 mg USP1354900 15 mg USP1355006 Kanamycin Sulfate 200 mg USP1355753 Kawain 200 mg KDN 100 mg USP1354852 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid USP1356009 Ketamine HCl Controlled Substance CIII 250 mg Ketamine Related Compound A 50 mg USP1356020 1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol USP1356508 Ketoconazole 200 mg USP1356632 Ketoprofen 200 mg

118 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Ketoprofen Related Compound A 25 mg USP1356643 alpha-Methyl-3-(4-methylbenzoyl) benzeneacetic Acid (AS) Ketoprofen Related Compound C 20 mg USP1356552 2-(3-carboxyphenyl)propionic acid Ketoprofen Related Compound D 20 mg USP1356563 3-acetylbenzophenone Ketorolac Related Compound A 20 mg 5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrroliine-1- USP1356315 carboxamide Ketorolac Related Compound B 20 mg USP1356326 5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol Ketorolac Related Compound C 20 mg USP1356337 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-one Ketorolac Related Compound D 20 mg USP1356348 5-benzoyl-2,3-dihydro-1H-pyrrolizine USP1356665 Ketorolac Tromethamine 200 mg USP1356599 Krill Oil 2 g USP1356698 Lactase 200 mg USP1356734 Lactic Acid 3 x 1.5 mL USP1356687 Lactitol 500 mg USP1356825 Lactobionic Acid 200 mg USP1356701 Lactose Monohydrate 500 mg USP1356803 Lactulose 750 mg USP1012509 L-Alanine 200 mg USP1012531 L-Alanyl-L-Alanine 200 mg USP1356836 Lamivudine 200 mg USP1356847 Lamivudine Resolution Mixture A 10 mg USP1356858 Lamivudine Resolution Mixture B 10 mg USP1356869 Lamivudine Resolution Mixture C 0.8 mg USP1356756 Lamotrigine 100 mg Lamotrigine Related Compound B 20 mg USP1356778 2,3-dichlorobenzoic acid Lamotrigine Related Compound C 10 mg USP1356789 3-amino-6-(2,3-dichlorophenyl)1,2,4-triazin-5(4H)-one Lamotrigine Related Compound D 10 mg USP1356790 N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide USP1356880 Lanolin 20 g USP1356905 Lanolin 5 g USP1356916 Lansoprazole 150 mg Lansoprazole Related Compound A 25 mg USP1356927 2-[[[3-methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole Lansoprazole Related Compound B 25 mg USP1356931 2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole USP1042102 L-Arabinitol 500 mg USP1042500 L-Arginine 200 mg USP1357475 Latanoprost 50 mg Latanoprost Related Compound A 50 mg Isopropy l(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)- USP1357486 3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate Latanoprost Related Compound B 25 mg (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]- USP1357497 5-heptenoate) Latanoprost Related Compound D 25 mg (Isopropyl (Z)-7-{(1R,2R,3R,5S)-2-[(R)-5-phenyl-3-(triethylsilyloxy)pentyl]-3,5- USP1357522 bis(triethylsilyloxy)cyclopentyl}hept-5-enoate) Latanoprost Related Compound E 25 mg (Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5- USP1357533 heptenoic acid

Edition 2014 Visit us at www.lgcstandards.com 119

United States Pharmacopeia and National Formulary

Code Product Unit USP1356949 Lauric Acid 500 mg Lauroyl Arginine 100 mg USP1356945 (S)-2-dodecanamido-5-guanidinopentanoic acid HCl USP1356950 Lauroyl Polyoxylglycerides 500 mg USP1161509 L-Cysteine HCl 200 mg USP1356960 Leflunomide 200 mg Leflunomide Related Compound A 100 mg USP1357045 4-trifluoromethyl)aniline Leflunomide Related Compound B 10 mg USP1357056 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide Leflunomide Related Compound C 10 mg USP1357067 N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide USP1356971 Letrozole 200 mg Letrozole Related Compound A 25 mg USP1356982 4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile USP1358004 Leucovorin Calcium 500 mg USP1358503 Leuprolide Acetate 200 mg USP1358784 Levalbuterol HCl 200 mg Levalbuterol Related Compound A 30 mg USP1358795 4-(2-tert-butylamino-ethyl)-2-hydroxymethyl-phenol Levalbuterol Related Compound B 20 mg USP1358809 alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol Levalbuterol Related Compound C 30 mg USP1358810 alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol Levalbuterol Related Compound D 30 mg 5-[2-{(1,1-dimethylethyl)amino}-1-hydroxyethyl]-2-hydroxy-benzaldehyde benzenesulfonic USP1358820 acid salt Levalbuterol Related Compound E 30 mg USP1358831 alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol Levalbuterol Related Compound F 30 mg USP1358842 alpha-[{(1,1-Dimethylethyl)amino}methyl}-4-(phenylmethoxy)-1,3-benzenedimethanol Levalbuterol Related Compound G 20 mg USP1358853 alpha[{(1,1-Dimethylethyl)amino}methyl]-4,5-dihydroxy-1,3-benzenedimethanol Levalbuterol Related Compound H 5 mg USP1358864 4-[2-(tert-butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol USP1359302 Levamisole HCl 125 mg USP1359404 Levetiracetam 200 mg USP1359415 Levetiracetam Racemic Mixture 15 mg Levetiracetam Related Compound A 20 mg USP1359426 (S)-N(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide Levetiracetam Related Compound B 20 mg USP1359437 (S)-2-aminobutanamide HCl USP1359506 Levmetamfetamine Controlled Substance CII 75 mg USP1359801 Levobunolol HCl 200 mg USP1359856 Levocabastine HCl 50 mg Levocabastine Related Compound A 50 mg 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid USP1359867 hydrochloride USP1359903 Levocarnitine 400 mg Levocarnitine Related Compound A 100 mg USP1359925 2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-,chloride USP1361009 Levodopa 200 mg Levodopa Related Compound A 50 mg USP1361010 3-(3,4,6-Trihydroxyphenyl)-alanine Levodopa Related Compound B 50 mg USP1420006 3-Methoxytyrosine USP1362103 200 mg

120 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Levofloxacin Related Compound A 25 mg (S)-9-fluoro-2,3-dihydro-3-methyl-10-(piperazin-1-yl)-7-oxo-7H-pyrido[1,2,3- USP1362114 de][1,4]benzoxazine-6-carboxylic acid Levofloxacin Related Compound B: (S)-9,10,difluro-3-methyl-7-oxo-2,3-dihydro-7H- 35 mg USP1362125 pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid Levofloxacin Related Compound C 25 mg (S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3- USP1362136 de]-1,4-benzoxazine-6-carboxylate USP1179344 Levomedetomidine 25 mg USP1362307 Levomenol 100 mg USP1362500 Levonordefrin 200 mg USP1362602 Levonorgestrel 125 mg USP1363004 Levopropoxyphene Napsylate 300 mg USP1364007 Tartrate Controlled Substance CII 500 mg USP1365000 Levothyroxine 500 mg Levothyroxine for Peak Identification 15 mg levothyroxine sodium spiked with liothyronine, triiodothyroacetic acid, tetraiodothyroacetic USP1365021 acid USP1365065 Levothyroxine Sodium 50 mg USP1286606 L-Fucose 200 mg USP1294987 L-Glutamic Acid HCl 100 mg USP1308505 L-Histidine 200mg USP1366002 Lidocaine 250 mg USP1367005 Lincomycin HCl 200 mg USP1367504 200 mg USP1367561 Linezolid 200 mg USP1367570 ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) 20 mg USP1367581 ((S)-N-{[3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide) 20 mg USP1367592 ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) 20 mg USP1367708 Linoleoyl Polyoxylglycerides 100 mg USP1368008 Liothyronine 250 mg USP1368609 Lisinopril 300 mg Lisinopril Related Compound A 15 mg ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl}-4- USP1368610 phenylbutanoic acid USP1349502 L-Isoleucine 200 mg USP1369000 Lithium Carbonate 300 mg USP1357001 L-Leucine 200 mg USP1371501 L-Lysine Acetate 200 mg USP1372005 L-Lysine HCl 200 mg USP1411504 L-Methionine 200 mg USP1369419 Lomustine 200 mg Lomustine Related Compound B 25 mg USP1369431 1-(2-Chloroethyl)-3-cyclohexylurea Lomustine Related Compound C 25 mg USP1369442 1,3-Dicyclohexylurea Lomustine Related Compound D 25 mg USP1369453 (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) USP1370000 Loperamide HCl 200 mg USP1370101 Lopinavir 350 mg USP1370156 Lopinavir System Suitability Mixture 10 mg USP1370203 Loracarbef 200 mg USP1370225 Loracarbef L-Isomer 25 mg USP1370270 Loratadine 200 mg Loratadine Related Compound A 15 mg USP1370280 8-chloro-6,11-dihydro-11(4-piperidinylidene)-5H-benzo[5,6]cyclohepta [1,2-b]pyridine

Edition 2014 Visit us at www.lgcstandards.com 121

United States Pharmacopeia and National Formulary

Code Product Unit Loratadine Related Compound B 15 mg 8-chloro-6,11-dihydro-11-(N-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta USP1370291 [1,2-b]pyridine Loratadine Related Compound C 15 mg USP1370269 8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one USP1370305 Lorazepam CIV 200 mg Lorazepam Related Compound A 25 mg 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepine-2-one USP1370327 Controlled Substance Lorazepam Related Compound B 25 mg USP1370338 2-Amino-2',5-dichlorobenzophenone Lorazepam Related Compound C 25 mg USP1370349 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde Lorazepam Related Compound D 25 mg USP1370350 6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid Lorazepam Related Compound E 25 mg USP1370360 6-Chloro-4-(o-chlorophenyl)-2-quinazoline Methanol USP1370462 Losartan Potassium 150 mg Losartan Related Compound A 20 mg USP1370473 (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde) USP1370600 Lovastatin 125 mg Lovastatin Related Compound A 20 mg USP1370611 Dihydro-lovastatin USP1304118 Low Molecular Weight Heparin for Bioassays 5 mg USP1448854 Low Molecular Weight Heparin Molecular Weight Calibrant 10.6 mg Loxapine Related Compound A 20 mg USP1370713 3-Chloro-11-(4-methylpiperazine-1-yl)dibenzo[b,f][1,4]oxazepine USP1370702 Loxapine Succinate 125 mg USP1530503 L-Phenylalanine 200 mg USP1568506 L-Proline 200 mg USP1612506 L-Serine 200 mg USP1652704 L-Theanine 200 mg USP1667202 L-Threonine 200 mg USP1700501 L-Tryptophan 200 mg USP1705006 L-Tyrosine 500 mg USP1370746 Lumefantrine 100 mg Lumefantrine Related Compound A 25 mg USP1370757 (RS,Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol USP1370804 Lutein 3 x 50 mg USP1708503 L-Valine 200 mg USP1370860 Lycopene 500 mg USP1370906 Lynestrenol 20 mg Lypressin 2.2 mg USP1711133 8-L-lysine vasopressin USP1371002 Lysergic Acid Diethylamide Tartrate (AS) (LSD) CI 10 mg USP1372050 Lysophosphatidylcholine 250 mg USP1372061 Lysophosphatidylcholine 40 mg USP1437053 2-Methyl-1-propanol 3x1.2 mL USP1391000 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt 75 mg USP1424153 3-Methyl-1-butanol 3x1.2 mL USP1425000 4-Methyl-2,5-dimethoxyamphetamine HCl (STP) (AS) CI 25 mg USP1373008 Mafenide Acetate 200 mg Mafenide Related Compound A 50 mg USP1286209 4-Formylbenzenesulfonamide USP1374000 Magaldrate 200 mg USP1374226 Magnesium Carbonate (AS) 2 g

122 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1374248 Magnesium Chloride (AS) 1 g USP1374260 Magnesium Hydroxide (AS) 1 g USP1374292 Magnesium Phosphate (AS) 2 g USP1374306 Magnesium Salicylate 200 mg USP1374340 Magnesium Stearate (AS) 5 g USP1374361 Magnesium Sulfate (AS) 1 g USP1374408 Malathion 500 mg USP1374500 Maleic Acid 300 mg USP1374601 Malic Acid 500 mg USP1374907 Maltitol 200 mg USP1375003 Maltol (FCC) 4 g USP1375025 Maltose Monohydrate 500 mg USP1025307 m-Aminoglutethimide 100 mg USP1026004 m-Aminophenol 300 mg USP1375058 Mandelic Acid (AS) 500 mg Related Comound A 15 mg USP1375070 Manganese (II) dipyridoxyl monophosphate sodium salt Mangafodipir Related Comound B 15 mg USP1375080 Manganese (II) dipyridoxyl diphosphate mono-overalkylated sodium salt Mangafodipir Related Comound C 15 mg USP1375091 Manganese (III) dipyridoxyl diphosphate sodium salt USP1375069 Mangafodipir Trisodium 200 mg USP1375127 Manganese Chloride (AS) 1 g USP1375149 Manganese Sulfate (AS) 1 g USP1375105 Mannitol 200 mg USP1375160 Mannosamine HCl 300 mg USP1375182 Mannose 300 mg USP1375207 Maprotiline HCl 200 mg Maprotiline Related Compound D 15 mg USP1375241 (3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine, hydrochloride) USP1539803 Maritime Pine Extract 2 g USP1375309 Mazindol CIV 350 mg USP1375502 Mebendazole 200 mg USP1375513 Mebendazole Polymorph C 200 mg Mebendazole Related Compound A 15 mg USP1374995 (2-amino-5-benzoylbenzimidazole) Mebendazole Related Compound B 15 mg USP1375535 (5-benzoyl-1H-benzo[d]imidazole-2(3H)-one) Mebendazole Related Compound C 15 mg USP1375546 (2-Amino-5-benzoyl-1-methylbenzimidazole) Mebendazole Related Compound D 15 mg USP1375524 Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate USP1375557 Mebendazole Related Compound E (Ethyl(5-benzoyl-1H-benzimidazol-2-yl)carbamate) 15 mg USP1375706 Mebrofenin 100 mg USP1376006 Mecamylamine HCl 200 mg Mecamylamine Related Compound A 10 mg USP1376017 N,1,7,7-tetramethyl bicyclo[2.2.1]heptan-2-amine hydrochloride USP1377009 Meclizine HCl 500 mg Meclizine Related Compound A 15 mg USP1377010 4-chlorobenzhydrol Meclizine Related Compound B 15 mg 1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride USP1377029 monohydrate USP1377508 Meclocycline Sulfosalicylate 300 mg USP1377803 Meclofenamate Sodium 500 mg

Edition 2014 Visit us at www.lgcstandards.com 123

United States Pharmacopeia and National Formulary

Code Product Unit USP1378001 Medroxyprogesterone Acetate 200 mg Medroxyprogesterone Acetate Related Compound A 25 mg USP1378012 4,5-beta-Dihydromedroxyprogesterone acetate USP1379004 500 mg USP1379605 Mefenamic Acid 200 mg USP1379059 Mefloquine Hydrochloride 100 mg Mefloquine Related Compound A 20 mg USP1379060 threo-mefloquine USP1379106 Megestrol Acetate 250 mg USP1379140 Meglumine (AS) 500 mg Melamine 250 mg USP1379183 2,4,6-Triamino-1,3,5-triazine USP1380105 Melatonin (AS) 150 mg Melatonin Related Compound A 15 mg USP1380116 2-(5-methoxy-1-H-indol-3-yl)ethanamine USP1379254 Acetate 125 mg Related Compound A 25 mg USP1379265 17-hydroxy-16-methylenepregna-4-ene-3,20-dione 17-acetate Melengestrol Acetate Related Compound B 25 mg USP1379276 6,16-dimethylene-17-hydroxypregna-4-ene-3,20-dione 17-acetate USP1379401 Meloxicam 400 mg Meloxicam Related Compound A 25 mg USP1379412 ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide Meloxicam Related Compound B 25 mg USP1379423 2-Amino-5-methylthiazole Meloxicam Related Compound C 30 mg USP1379434 Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide Meloxicam Related Compound D 30 mg 4-Methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2yl)-2H-1,2-benzothiazine-3-carboxamide-1,1- USP1379445 dioxide USP1380502 Memantine Hydrochloride 150 mg Memantine Related Compound A 50 mg USP1380513 (1,3-Dimethyladamantane) Memantine Related Compound B 15 mg USP1380524 3,5-Dimethyladamantane-1-ol Memantine Related Compound C 50 mg USP1380535 1-Chloro-3,5-dimethyladamantane Memantine Related Compound D 50 mg USP1380546 1-Bromo-3,5-dimethyladamantane Memantine Related Compound E 15 mg USP1380557 N-3,5-Dimethyladamantan-1-yl formamide USP1381006 Menadione (Vitamin K3) 200 mg USP1381200 Menhaden Oil 2 mL USP1381709 Menthol 250 mg USP1381742 Menthyl Anthranilate 500 mg USP1382009 Mepenzolate Bromide 200 mg USP1383001 Meperidine HCl Controlled Substance CII 200 mg USP1385007 Mephenytoin 250 mg USP1386000 Mephobarbital CIV 250 mg USP1387002 Mepivacaine HCl 200 mg USP1388005 200 mg USP1389008 Meprobamate CIV 200 mg USP1390007 Meprylcaine HCl 200 mg USP1392002 Mercaptopurine 500 mg USP1392454 Meropenem 300 mg USP1392705 Mesalamine 200 mg

124 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1392807 Mesna 200 mg Mesna Related Compound A 50 mg USP1392818 2-(Acetylsulfanyl)ethanesulfonic acid Mesna Related Compound B 50 mg USP1392829 (2,2-(Disulfanediyl)bis(ethanesulfonic acid)) USP1393005 Mesoridazine Besylate 250 mg USP1733119 Meso-Zeaxanthin 5x30mg USP1394008 Mestranol 200 mg USP1395204 Metacresol 1 mL USP1395500 Metaproterenol Sulfate 200 mg USP1396003 Metaraminol Bitartrate 200 mg USP1396149 Metaxalone 200 mg Metaxalone Related Compound A 10 mg USP1396150 4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one USP1396309 Metformin HCl 200 mg Metformin Related Compound A 30 mg USP1396310 1-Cyanoguanidine Metformin Related Compound B 25 mg USP1396331 1-Methylbiguanide hydrochloride Metformin Related Compound C 25 mg USP1396342 N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine USP1396364 Methacholine Chloride (AS) 500 mg USP1396400 Methacrylic Acid Copolymer Type A 200 mg USP1396502 Methacrylic Acid Copolymer Type B 200 mg USP1396604 Methacrylic Acid Copolymer Type C 200 mg USP1397006 Methacycline HCl 200 mg USP1398009 Methadone HCl CII 200 mg USP1399001 Methamphetamine HCl CII 125 mg USP1401001 Methantheline Bromide 200 mg USP1402004 Methapyrilene Fumarate 200 mg USP1405002 Metharbital CIII 200 mg USP1406005 Methazolamide 500 mg USP1408000 Methdilazine HCl 200 mg USP1409003 Methenamine 500 mg USP1409502 Methenamine Hippurate 200 mg USP1409604 Methenamine Mandelate 200 mg USP1410002 Methicillin Sodium (AS) 500 mg USP1411005 Methimazole 200 mg USP1412008 Methocarbamol 200 mg USP1413000 Methohexital Controlled Substance CIV 500 mg USP1414003 Methotrexate 500 mg Methotrexate Related Compound B 75 mg USP1414025 (S)-2-{4-[2,4-diaminopteridin-6yl)methylamino]benzoamido}pentanedioic acid Methotrexate Related Compound C 50 mg (S)-2-(4{[(2-amino-4-oxo-1,4-dihydropteridin-6- USP1414036 yl)methyl](methyl)amino}benzamido)pentanedioic acid Methotrexate Related Compound E 50 mg USP1414058 4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride USP1413999 Methotrexate System Suitability Mixture 5 mg USP1415006 Methotrimeprazine 200 mg USP1416009 Methoxamine HCl 200 mg USP1417001 Methoxsalen 200 mg USP1418004 0.5 mL USP1418650 Methoxymethylguanine 20 mg USP1421009 Methscopolamine Bromide 200 mg

Edition 2014 Visit us at www.lgcstandards.com 125

United States Pharmacopeia and National Formulary

Code Product Unit USP1422001 Methsuximide 500 mg USP1424007 Methyclothiazide 200 mg Methyclothiazide Related Compound A 50 mg USP1424018 4-amino-6-chloro-N-3-methyl-m-benzenedisulfonamide USP1424051 Methyl Acetate 3x1.2 mL USP1424109 Methyl Alcohol 3x1.5 mL USP1424222 Methyl Benzylidene Camphor 200 mg USP1424233 Methyl Caprate 300 mg USP1424244 Methyl Caproate 300 mg USP1424255 Methyl Caprylate 300 mg USP1430101 Methyl Ethyl Ketone 3x1.2 mL USP1430203 Methyl Isobutyl Ketone 3x1.2 mL USP1430305 Methyl Laurate 500 mg USP1430327 Methyl Linoleate 5x50 mg USP1430349 Methyl Linolenate 5x50 mg USP1431501 Methyl Myristate 300 mg USP1431556 Methyl Oleate 500 mg USP1431603 Methyl Palmitate 300 mg USP1431625 Methyl Palmitoleate 300 mg USP1437450 (AS) 2 mL USP1437508 Methyl Stearate 300 mg USP1438205 Methyl Tricosanoate 200 mg USP1424211 Methylbenzethonium Chloride 200 mg USP1424209 Methylbenzhydrol 50 mg USP1424506 Methylcellulose (AS) 1 g USP1426002 Methyldopa 500 mg USP1427005 Methyldopate HCl 200 mg USP1428008 Methylene Blue 500 mg USP1429000 Methylenedioxy-3,4-amphetamine HCl (MDA) (AS) CI 25 mg USP1430000 Methylergonovine Maleate 50 mg USP1432005 Methylparaben 125 mg USP1433008 Methylphenidate HCl CII 125 mg USP1434011 Methylphenidate HCl Erythro Isomer Solution Controlled Substance CII 0.5 mL Methylphenidate Related Compound A 50 mg USP1434022 alpha-Phenyl-2-piperidineacetic Acid HCl USP1435003 Methylprednisolone 200 mg USP1436006 Methylprednisolone Acetate 200 mg USP1437009 Methylprednisolone Hemisuccinate 200 mg USP1437202 Methylpyrrolidone 2 g USP1437600 Methylsulfonylmethane 200 mg USP1438001 Methyltestosterone Controlled Substance CIII 200 mg USP1440003 Methysergide Maleate 350 mg USP1440808 Metoclopramide HCl 500 mg Metoclopramide Related Compound A 15 mg USP1440819 4-acetamido-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide Metoclopramide Related Compound B 15 mg USP1440820 methyl 4-acetamido-5-chloro-2-methoxybenzoate Metoclopramide Related Compound D 15 mg USP1440841 methyl 4-acetamido-2-methoxybenzoate USP1441200 Metolazone 200 mg Metomidate HCl methyl 50 mg USP1268772 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride USP1441287 Metoprolol Fumarate 200 mg

126 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Metoprolol Related Compound A 20 mg USP1441232 (+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol Metoprolol Related Compound B 100 mg USP1441243 (+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propane Metoprolol Related Compound C 15 mg USP1441254 (+/-)4-[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde Metoprolol Related Compound D 50 mg (+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl] USP1441265 (1-methylethyl)amine hydrochloride USP1441298 Metoprolol Succinate 200 mg USP1441301 Metoprolol Tartrate 200 mg USP1441505 500 mg USP1442009 Metronidazole 100 mg USP1442100 Metronidazole Benzoate 100 mg USP1443001 200 mg USP1443205 Metyrosine 200 mg USP1443250 Mexiletine HCl 200 mg USP1443307 Mezlocillin Sodium 350 mg USP1443362 CIII 200 mg USP1443409 Miconazole 200 mg USP1443500 Miconazole Nitrate 200 mg USP1098388 Microcystalline Cellulose (AS) 1 g USP1443599 Midazolam CIV 300 mg USP1443602 Midazolam HCl (AS) Controlled Substance CI 200 mg USP1443704 Midodrine HCl 200 mg Midodrine Related Compound A 40 mg USP1443715 2-amino-1-(2,5-dimethoxyphenyl)ethanol USP1443759 200 mg USP1443806 Milbemycin Oxime 200 mg USP1443908 Milrinone 500 mg Milrinone Related Compound A 50 mg USP1443919 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carboxamide USP1443952 Mineral Oil 1.5 mL USP1444004 Minocycline HCl 350 mg USP1444208 Minoxidil 125 mg USP1444279 Mirtazapine 350 mg Mirtazapine Related Compound A 15 mg USP1444285 1,2,3,4,10,14b-hexahydropyrazino[2,1-a}pyrido[2,3-c][2]benzazepine Mirtazapine Related Compound B 25 mg 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide USP1444235 monohydrate Mirtazapine Related Compound C 50 mg USP1444241 2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one Mirtazapine Related Compound D 50 mg USP1444252 2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one USP1444296 Mirtazapine Resolution Mixture 25 mg USP1444300 Misoprostol 100 mg USP1444707 Mitomycin 50 mg USP1445007 500 mg USP1445200 Mitoxantrone HCl 400 mg USP1445211 Mitoxantrone System Suitability Mixture 0.3 mg USP1445404 Modafinil CIV 200 mg Modafinil Related Compound A 20 mg USP1445346 2-[(diphenylmethyl)sulfinyl]acetic acid Modafinil Related Compound B 20 mg USP1445357 2-[diphenylmethyl)sulfonyl]acetamide

Edition 2014 Visit us at www.lgcstandards.com 127

United States Pharmacopeia and National Formulary

Code Product Unit Modafinil Related Compound C 20 mg USP1445368 2-[(diphenylmethyl)sulfenyl]acetamide Modafinil Related Compound D 20 mg USP1445379 Bis(diphenylmethyl)ether Modafinil Related Compound E 20 mg USP1445380 Bis(diphenylmethyl)disulfide USP1445426 Moexipril Hydrochloride 100 mg Moexipril Related Compound A 20 mg ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3- USP1445608 isoquinolinecarboxylic acid) Moexipril Related Compound B 20 mg (S)-ethyl-2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H-pyrazino[1,2- USP1445619 b]isoquinolin-2(6H,11H,11aH)-yl}-4-phenylbutanoate Moexipril Related Compound C 20 mg (S)-tert-butyl-2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7- USP1445620 dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate Moexipril Related Compound D 20 mg (S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy- USP1445631 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride Moexipril Related Compound E 20 mg USP1445642 (S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride Moexipril Related Compound F 20 mg USP1445653 ((S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoic acid) Moexipril Related Compound G 20 mg (S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}- USP1445664 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride USP1445448 Mogroside V 100 mg USP1445459 Molindone HCl 500 mg USP1445470 Mometasone Furoate 200 mg USP1445481 Monensin Sodium 200 mg USP1445492 Monk Fruit Extract 500 mg USP1551139 Monobasic Potassium Phosphate (AS) 5 g USP1445506 Monobenzone 200 mg USP1445925 Monoethanolamine 1 mL USP1446000 Monoglycerides 125 mg USP1446600 Monosodium Glutamate (AS) 1 g USP1446804 Monostearyl Maleate 100 mg USP1446815 Montelukast Dicyclohexylamine 150 mg USP1446837 Montelukast for Peak Identification 20 mg USP1446848 Montelukast Racemate 20 mg USP1446859 Montelukast Sodium 50 mg USP1446906 Morantel Tartrate 100 mg Moxifloxacin Related Compound B 25 mg (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b] USP1448628 pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) USP1446950 Moricizine HCl 250 mg USP1447002 Morphine Monohydrate (AS) CII 50 mg USP1448005 Morphine Sulfate Controlled Substance CII 500 mg Morphine Sulfate Related Compound A 20 mg USP1448016 Morphine N-Oxide Controlled Substance CI Morphine Sulfate Related Compound B 20 mg USP1448027 Pseudomorphine Controlled Substance CII USP1448559 Moxidectin 200 mg USP1448560 Moxidectin System Suitability Mixture 50 mg USP1448606 Moxifloxacin HCl 200 mg Moxifloxacin Related Compound A 25 mg 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4- USP1448617 dihydroquinoline-3-carboxylic acid

128 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Moxifloxacin Related Compound C 25 mg 1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4- USP1448639 b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate Moxifloxacin Related Compound E 25 mg 1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4- USP1448655 b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride USP1448901 Mupirocin 50 mg USP1448912 Mupirocin Calcium 200 mg USP1448923 Mupirocin Lithium 100 mg USP1448956 Mycophenolate Mofetil 200 mg Mycophenolate Mofetil Related Compound A 15 mg 2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4- USP1448967 methyl-4-hexenoate Mycophenolate Mofetil Related Compound B 15 mg [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H- USP1448978 isobenzofuranyl-1-one] USP1448990 Myristic Acid 200 mg USP1449008 Myristyl Alcohol 1 g (Z)-N'-Methylmeloxicam 30 mg ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H- benzo[e][1,2]thiazine-3- USP1379456 carboxamide 1,1-dioxide) USP1685500 2-[N-(2,2,2-Trifluoro-ethyl)amino-5]-chlorobenzophenone 25 mg USP1449518 Nabumetone 200 mg Nabumetone Related Compound A 15 mg USP1449530 1-(6-methoxy-2-naphthyl)-but-1-en-3-one USP1010022 N-Acetylglucosamine 200 mg USP1010106 N-Acetyl-L-Tyrosine 100 mg USP1612619 N-Acetylneuraminic Acid 200 mg USP1449700 Nadolol 200 mg USP1450007 Nafcillin Sodium 200 mg USP1450404 Naftifine HCl 200 mg USP1451000 Nalidixic Acid 200 mg USP1452002 HCl Controlled Substance CIII 250 mg USP1453005 Naloxone 125 mg USP1453504 Naltrexone 200 mg Naltrexone Related Compound A 30 mg USP1453526 N-(3-butenyl)-noroxymorphone HCl Controlled Substance CII USP1454008 Nandrolone Controlled Substance CIII 50 mg USP1455000 Nandrolone Decanoate Controlled Substance CIII 250 mg USP1456003 Nandrolone Phenpropionate Controlled Substance CIII 250 mg USP1457006 Naphazoline HCl 200 mg USP1457083 Naphthalene 200 mg USP1457301 Naproxen 200 mg USP1457403 Naproxen Sodium 200 mg USP1457458 Narasin 125 mg USP1457469 Naratriptan HCl 125 mg USP1457491 Naratriptan Resolution Mixture 20 mg USP1457505 Natamycin 200 mg USP1457607 Nateglinide 200 mg Nateglinide Related Compound A 10 mg USP1457618 trans-4-isopropylcyclohexanecarboxylic acid Nateglinide Related Compound B 10 mg USP1457629 N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine Nateglinide Related Compound C 5 mg USP1457630 N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine USP1302258 Native Gymnema Extract 1 g

Edition 2014 Visit us at www.lgcstandards.com 129

United States Pharmacopeia and National Formulary

Code Product Unit USP1064122 N-Benzyl-N-methyl-ethanolamine (2-[benzyl(methyl)amino]ethanol) 3 x 0.2 mL USP1046089 N-Demethylazithromycin 15 mg USP1457844 Near IR System Suitability unit USP1457902 Nefazodone HCl 200 mg Nefazodone Related Compound A 25 mg USP1457913 1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride Nefazodone Related Compound B 25 mg 2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H- USP1457924 1,2,4-triazol-3-one hydrochloride USP1457968 Nelfinavir Mesylate 200 mg Nelfinavir Related Compound A 15 mg (3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4- USP1457979 (phenylsulfinyl)butyl]decahydroisoquinoline-2-carboxymide USP1458053 Neohesperidine Dihydrochalcone 100 mg USP1458009 Neomycin Sulfate 200 mg USP1459001 Neostigmine Bromide 200 mg USP1460000 Neostigmine Methylsulfate 200 mg USP1460204 Neotame 200 mg Neotame Related Compound A 15 mg USP1460215 N-[N-(3-3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine USP1266802 N-Ethylpiperazine 0.5 mL USP1460500 Netilmicin Sulfate 500 mg USP1460703 Nevirapine Anhydrous 100 mg USP1460714 Nevirapine Hemihydrate 100 mg Nevirapine Related Compound A 15 mg USP1460725 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one Nevirapine Related Compound B 15 mg USP1460736 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one Nevirapine Related Compound C 15 mg USP1460747 (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one) USP1294284 N-Glycolylneuraminic Acid 200 mg USP1461003 200 mg USP1462006 Niacinamide (Vitamin B3) 500 mg USP1463224 Hydrochloride 200 mg USP1463304 Nicotine Bitartrate Dihydrate 500 mg USP1463508 Nifedipine 125 mg USP1463600 Nifedipine Nitrophenylpyridine Analog 25 mg USP1463701 Nifedipine Nitrosophenylpyridine Analog 25 mg Niltazoxanide Related Compound A 25 mg USP1463971 2-Amino-5-nitrothiazole USP1463858 Nimodipine 125 mg Nimodipine Related Compound A 50 mg USP1463870 2-methoxyethyl-1-methylethyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate Nimodipine Related Compound B 50 mg bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate USP1463869 (AS) USP1463960 Nitazoxanide 200 mg USP1463950 Nitrilotriacetic Acid 50 mg USP1464001 Nitrofurantoin 500 mg Nitrofurantoin Related Compound A 20 mg USP1021703 N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine USP1465004 Nitrofurazone 200 mg Nitrofurazone Related Compound A 500 mg USP1466007 5-Nitro-2-furfuraldazine USP1465503 Nitrofurfural Diacetate 100 mg USP1467804 Nizatidine 200 mg

130 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1468002 Nonoxynol 10 200 mg USP1467950 Nonoxynol 9 0.5 mL Nordazepam CIV 50 mg USP1468400 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one USP1468501 Norepinephrine Bitartrate 125 mg USP1469005 Norethindrone 200 mg USP1470004 Norethindrone Acetate 100 mg USP1471506 Norfloxacin 200 mg USP1471914 Norgestimate 200 mg Norgestimate Related Compound A 25 mg USP1471925 Levonorgestrel Acetate USP1472000 Norgestrel 125 mg USP1473002 Noroxymorphone HCl Controlled Substance CII 50 mg USP1473206 Norphenylephrine Hydrochloride 25 mg USP1474005 Nortriptyline HCl 200 mg USP1474504 Noscapine 100 mg USP1475008 Novobiocin 200 mg USP1476000 Nylidrin HCl 200 mg USP1477003 Nystatin 200 mg USP1430509 3-O-Methylmethyldopa 50 mg USP1477900 Octinoxate (Octyl Methoxycinnamate) 500 mg USP1477943 Octisalate (Octyl Salicylate) 400 mg USP1477411 Octocrylene 500 mg USP1477502 Octoxynol 9 200 mg USP1477604 Acetate 80 mg USP1477615 Octreotide Non-Cyclic System Suitability Marker 20 mg USP1477808 Octyldodecanol 200 mg USP1478108 Ofloxacin 200 mg Ofloxacin Related Compound A 25 mg 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4- USP1478119 benzoxazine-6-carboxylic acid USP1285862 o-Flutamide 50 mg USP1344305 o-Iodohippuric Acid 100 mg USP1478301 Olanzapine 200 mg Olanzapine Related Compound A 20 mg USP1478312 5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile Olanzapine Related Compound B 15 mg USP1478323 2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one Olanzapine Related Compound C 5 mg USP1478334 2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide USP1478130 Oleic Acid 1 g USP1478152 Oleoyl Polyoxylglycerides 100 mg USP1478200 Oley Oleate 0.5 mL USP1478254 (AS) 1 g USP1478367 Olmesartan Medoxomil 100 mg Olmesartan Medoxomil Related Compound A 20 mg 1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol- USP1478378 6(4H)-one USP1478403 Olopatadine HCl 150 mg Olopatadine Related Compound B 35 mg (Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine USP1478425 oxide Olopatadine Related Compound C 35 mg USP1478436 (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid USP1478505 Omeprazole 200 mg

Edition 2014 Visit us at www.lgcstandards.com 131

United States Pharmacopeia and National Formulary

Code Product Unit USP1478549 Omeprazole Magnesium 10 mg Omeprazole Related Compound A 15 mg Omeprazole Sulfone or 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]- USP1478516 1H-benzimidazole Omeprazole Related Compound E 15 mg (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine USP1478527 1-oxide) USP1478491 Omeprazole Related Compound F and G Mixture 25 mg Omeprazole Related Compound I 15 mg 4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1- USP1478561 oxide USP1478571 Ondansetron 300 mg USP1478582 Ondansetron HCl 300 mg Ondansetron Related Compound A 50 mg USP1478593 3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride Ondansetron Related Compound C 30 mg USP1478618 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one Ondansetron Related Compound D 30 mg USP1478629 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one USP1478630 Ondansetron Resolution Mixture 50 mg USP1046409 Open Ring Aztreonam 10 mg USP1478673 Orbifloxacin 350 mg USP1478800 200 mg Orlistat Related Compound A 25 mg USP1478811 (3S,4S)3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone Orlistat Related Compound B 15 mg USP1478822 diisopropyl bicarbamate Orlistat Related Compound C 25 mg USP1478833 Orlistat Related Compound D 10 mg USP1478844 N-formyl-L-leucine (3S,4R,6S)-tetrahydro-3-hexyl-2-oxo-6-undecyl-2H-pyran-4-yl ester Orlistat Related Compound E 10 mg USP1478855 N-formyl-S-isoleucin-(S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester USP1478742 Hydrochloride 200 mg USP1479009 Orphenadrine Citrate 200 mg Orphenadrine Related Compound A 50 mg USP1479010 (RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate (AS) Orphenadrine Related Compound B 20 mg USP1479020 N-ethyl-N,N-dimethyl[2-[2-methylbenzhydryloxy)ethyl]ammonium chloride Orphenadrine Related Compound C 20 mg USP1479031 N-methyl-[2-(2-methylbenhydryloxy)ethyl]amine hydrochloride USP1479304 Oseltamivir Phosphate 200 mg Oseltamivir Related Compound A 10 mg USP1479315 (3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(penta-3-yloxy)cyclohexanecarboxylate USP1672010 o-Toluenesulfonamide 200 mg USP1133580 Oversulfated Chondroitin Sulfate 10 mg USP1481000 Oxacillin Sodium 200 mg USP1481204 Oxaliplatin 125 mg Oxaliplatin Related Compound A 100 mg USP1481215 Oxalic acid dihydrate Oxaliplatin Related Compound B 15 mg USP1481226 [SP-4-2-(1R-trans-)]-(1,2-cyclohexanediamine-N,N')dinitratoplatinum (II) Oxaliplatin Related Compound C 20 mg USP1481237 [1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalato(2-)-O,O']platinum (IV) Oxaliplatin Related Compound D 10 mg USP1481248 cis[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum Oxaliplatin Related Compound F 25 mg USP1481260 [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N-N')diiodidoplatinum(II)

132 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Oxaliplatin System Suitability 25 mg USP1481306 [SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N')dichloridoplatinum (II) USP1482003 Controlled Substance CIII 50 mg Oxandrolone Related Compound A 20 mg 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one USP1482014 Controlled Substance CIII Oxandrolone Related Compound B 20 mg USP1482025 17 beta-hydroxy-17-alpha-methyl-4-oxa-5 alpha-androsta-3-one CIII Oxandrolone Related Compound C 20 mg 17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one USP1482036 Controlled Substance CIII USP1482207 Oxaprozin 200 mg USP1483006 Oxazepam CIV 200 mg Oxazepam Related Compound A 15 mg USP1483017 7-chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione Oxazepam Related Compound B 15 mg USP1483028 7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate Oxazepam Related Compound C 15 mg USP1483039 6-chloro-4-phenylquinazoline-2-carbaldehyde USP1483152 Oxcarbazepine 100 mg Oxcarbazepine Related Compound A 10 mg USP1483163 N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide Oxcarbazepine Related Compound B 10 mg USP1483174 N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide Oxcarbazepine Related Compound C 10 mg USP1483185 Acridin-9(10H)-one Oxcarbazepine Related Compound D 10 mg 10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine- USP1483196 5-carboxamide Oxcarbazepine Related Compound E 10 mg USP1483200 10(11H)-Oxo-5H-dibenz[b,f]azepine USP1483301 Oxfendazole 200 mg USP1483505 Oxprenolol HCl 200 mg USP1484009 Oxtriphylline 500 mg USP1485001 Oxybenzone 150 mg USP1485103 Oxybutynin Chloride 200 mg Oxybutynin Related Compound A 100 mg USP1485114 Phenylcyclohexylglycolic Acid Oxybutynin Related Compound B 20 mg USP1485125 Cyclohexyl mandelic acid methyl ester Oxybutynin Related Compound C 20 mg USP1485136 4-(Ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride USP1485191 Oxycodone Controlled Substance CII 200 mg USP1485205 Oxycodone Hydrochloride CII 1 g Oxycodone Related Compound A 10 mg USP1485216 14-hydroxycodeinone CII Oxycodone Related Compound B 15 mg USP1485227 Oxycodone N-oxide Controlled Substance CII Oxycodone Related Compound C 15 mg USP1485238 Controlled Substance CII USP1486004 Oxymetazoline HCl 200 mg USP1487007 Controlled Substance CIII 200 mg USP1488000 CII 500 mg USP1490103 Oxyquinoline Sulfate 200 mg USP1491004 Oxytetracycline 200 mg USP1491015 Oxytetracycline HCl 200 mg USP1491300 Oxytocin 5 vials USP1491296 Oxytocin Identification 15 mg

Edition 2014 Visit us at www.lgcstandards.com 133

United States Pharmacopeia and National Formulary

Code Product Unit USP1570483 1,3-Propanediol 1 mL USP1504955 1-Pentanol 3x1.2 mL USP1570406 1-Propanol 3x1.2 mL USP1570428 2-Propanol 3x1.2 mL USP1570439 2-Propanol System Suitability 3 x 1 mL USP1533308 5-Phenylhydantoin 100 mg USP1491332 Paclitaxel 200mg USP1491365 Paclitaxel Impurity Mixture 10 mg Paclitaxel Related Compound A 20 mg USP1491343 Cephalomannine Paclitaxel Related Compound B 20 mg USP1491354 10-Deacetyl-7-epipaclitaxel USP1491503 Padimate O 300 mg USP1491809 Paliperidone 200 mg Paliperidone Related Compound A 20 mg USP1491818 3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one Paliperidone Related Compound B 20 mg USP1491820 6-fluoro-3-(piperidin-4-yl)benzoisoxazole HCl Paliperidone Related Compound C 20 mg USP1491831 3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4Hpyrido[1,2-alpha]pyrimidin-4-one Paliperidone Related Compound D (20 mg) 20 mg (3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9- USP1491842 tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one N-oxide) USP1492040 Palm Oil (AS) 1 g USP1492007 Palmitic Acid 500 mg USP1492801 Pamidronate Disodium 100 mg USP1493000 Pamoic Acid 250 mg USP1494057 Pancreatin Amylase and Protease 2 g USP1494079 Pancreatin Lipase 2 g USP1494217 Pancuronium Bromide 200 mg Pancuronium Bromide Related Compound A 15 mg 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1- USP1494228 methylpiperidinium) dibromide Pancuronium Bromide Related Compound B 15 mg 1,1'-(17beta-Acetoxy-3alpha-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1- USP1494239 methylpiperidinium) dibromide Pancuronium Bromide Related Compound C 15 mg 1,1'-(3alpha-acetoxy-17beta-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1- USP1494240 methylpiperidinium) dibromide USP1494501 Panthenol, Racemic 200 mg USP1494807 Pantolactone 500 mg Pantoprazole Related Compound A 25 mg USP1494909 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole Pantoprazole Related Compound B 25 mg USP1494910 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]1-H-benzimidazole Pantoprazole Related Compound C 20 mg USP1494920 5-(difluoromethoxy)-1H-benzimidazole-2-thiol Pantoprazole Related Compound E 20 mg 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H,1'H-5,5'- USP1494942 bibenzimidazolyl USP1494931 Pantoprazole Related Compounds D and F Mixture 20 mg USP1494895 Pantoprazole Sodium 250 mg USP1495005 Papain 1 g USP1496008 Papaverine HCl 200 mg USP1496802 Parachlorophenol 500 mg USP1496904 Paraffin 1 g USP1497000 Paramethadione 500 mg

134 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1498706 Parbendazole 200 mg USP1499006 Pargyline HCl 200 mg USP1499403 Paricalcitol 10 mg USP1499414 Paricalcitol Solution 3 mL USP1500003 Paromomycin Sulfate 125 mg USP1500218 Paroxetine HCl 350 mg Paroxetine Related Compound B 15 mg USP1500230 trans-4-phenyl-3-([(3,4-methylenedioxy)phenoxymethyl]piperidine HCl Paroxetine Related Compound C 15 mg USP1500240 (+)-trans-Paroxetine HCl Paroxetine Related Compound D 10 mg USP1500251 cis-Paroxetine HCl (AS) Paroxetine Related Compound E Mixture 25 mg USP1500262 1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix Paroxetine Related Compound F 10 mg USP1500273 trans(-)-1-methyl-3-[(1,3-benzodioxol-5-yloxy)Methyl]-4-(4-fluorophenyl)piperidine Paroxetine Related Compound G 10 mg USP1500284 (+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine HCl USP1500353 Paroxetine System Suitability Mixture A 50 mg USP1500400 Parthenolide 25 mg USP1396659 Partially-Neutralized Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) 1 g USP1500502 Particle Count Set unit USP1075509 p-Bis(di-n-propyl)carbamylbenzenesulfonamide 50 mg USP1111908 p-Chloroaniline 200 mg USP1500557 Peanut Oil (AS) 1 g USP1500808 Penbutolol Sulfate 200 mg USP1502701 Pencillin G Sodium 150 mg USP1501006 Penicillamine 200 mg USP1501108 Penicillamine Disulfide 200 mg USP1502009 G Benzathine 200 mg USP1502508 Penicillin G Potassium 200 mg USP1502552 Penicillin G Procaine 200 mg USP1504489 Penicillin V 200 mg USP1504503 Penicillin V Potassium 200 mg USP1504900 Pentamidine Isethionate 200 mg USP1504933 Pentane 3x1.2 mL USP1505007 Pentazocine CIV 500 mg USP1505506 Pentetic Acid 100 mg USP1507002 Pentobarbital CII 200 mg USP1508901 Pentoxifylline 200 mg USP1510051 Pepsin for Assay 5 x 1 g USP1510801 0.5 mL USP1510845 Pergolide Mesylate 200 mg USP1510867 Pergolide Sulfoxide 50 mg USP1510889 Perindopril Erbumine 100 mg Perindopril Related Compound A 20 mg USP1510890 (2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid Perindopril Related Compound B 10 mg (2S,3aS,7aS)-1-{(S)-2-[(S)-1-carboxybutylamino]propanoyl}octahydro-1H-indole-2-carboxylic USP1510903 acid Perindopril Related Compound D 25 mg (S)-2-{(3S,5aS,9aS,10aR)-3-metyhl-1,4-dioxodecahydropyrazino[1,2-a]indol-2-(1H)- USP1510925 yl}pentanoic acid Perindopril Related Compound E 10 mg (2S,3aS,7aS)-1-{(S)-2-[(S)-1-isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H- USP1510936 indole-2-carboxylic acid, tert-butylamine

Edition 2014 Visit us at www.lgcstandards.com 135

United States Pharmacopeia and National Formulary

Code Product Unit Perindopril Related Compound F 10 mg (S)-ethyl 2-{(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)- USP1510947 yl}pentanoate Perindopril Related Compound K 10 mg USP1510999 (3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-a]indole-1,4-dione USP1511000 Perphenazine 200 mg Perphenazine Related Compound B 15 mg USP1511021 2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol USP1511203 Perphenazine Sulfoxide 100 mg USP1513005 Phenacetin 500 mg USP1514008 Phenacetin Melting Point Standard (Approximately 135°C) 500 mg USP1515000 Phenazopyridine HCl 200 mg USP1516003 HCl (AS) CII 25 mg USP1516502 Phendimetrazine Tartrate Controlled Substance CIII 350 mg USP1517006 Phenelzine Sulfate 200 mg USP1520000 Phenformin HCl 200 mg USP1522006 Phenindione 250 mg USP1522301 Pheniramine Maleate 150 mg USP1523009 Phenmetrazine HCl CII 200 mg USP1524001 Phenobarbital CIV 200 mg USP1524806 Phenol 500 mg USP1524908 Phenolphthalein 250 mg USP1525004 Phenolsulfonphthalein 100 mg USP1525707 Phenothiazine 500 mg USP1526007 Phenoxybenzamine HCl 250 mg Phenoxyethanol 500 mg USP1526200 2-Phenoxyethanol USP1528002 Phensuximide 500 mg USP1528501 Phentermine HCl CIV 200 mg USP1529005 Phentolamine HCl 300 mg USP1530004 Phentolamine Mesylate 200 mg USP1534209 Phenyl Salicylate Melting Point Standard (Approximately 41°C) 500 mg USP1531007 Phenylbutazone 250 mg Phenylbutyrate Related Compound A 25 mg USP1614523 4-oxo-4-phenylbutanoic acid Phenylbutyrate Related Compound B 100 mg USP1614556 3,4-dihydronaphthalen-1(2H)-one Phenylbutyrate Related Compound C 25 mg USP1614534 4-cyclohexylbutanoic acid (COLD SHIPMENT REQUIRED) USP1533002 Phenylephrine HCl 200 mg USP1533250 Phenylethyl Alcohol 1 mL USP1533851 Phenylpropanediol 100 mg USP1533909 Phenylpropanolamine Bitartrate Drug Precursor 100 mg USP1534005 Phenylpropanolamine HCl Drug Precursor 250 mg USP1534402 Phenyltoloxamine Citrate 100 mg Phenyltoloxamine Related Compound A 50 mg USP1534413 2-(2-benzylphenoxy)ethylmethylamine hydrochloride USP1535008 Phenytoin (CRM) 200 mg Phenytoin Related Compound A 50 mg USP1535019 2,2-Diphenylglycine Phenytoin Related Compound B 50 mg USP1535020 alpha-((aminocarbonyl)amino)-alpha-phenyl benzeneacetic acid USP1535507 Phenytoin Sodium 200 mg USP1535700 Phosphated Riboflavin 100 mg USP1535722 Phosphatidic Acid (Soy) Monosodium 50 mg

136 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1535733 Phosphatidylcholine 350 mg USP1535755 Phosphatidylcholine (Soy) 50 mg USP1535744 Phosphatidylethanolamine 100 mg USP1535766 Phosphatidylethanolamine (Soy) 50 mg USP1535788 Phosphatidylinositol (Soy) Sodium 10 mg USP1535802 (AS) 3x1.5 mL USP1536509 Phyllanthin 15 mg USP1537003 Physostigmine Salicylate 200 mg USP1538006 Phytonadione (Vitamin K1) 500 mg USP1538505 Pilocarpine 300 mg USP1538902 Pilocarpine HCl 200 mg USP1539009 Pilocarpine Nitrate 200 mg USP1539508 Pimozide 200 mg USP1539701 Pindolol 200 mg USP1539905 Pioglitazone HCl 50 mg USP1541000 Piperacetazine 250 mg USP1541500 Piperacillin 350 mg Piperacillin Related Compound E 25 mg USP1541529 1-ethylpiperazine-2,3-dione USP1541601 Piperazine 200 mg USP1541703 Piperazine Adipate 200 mg USP1541805 Piperazine Citrate 200 mg USP1541907 Piperazine Dihydrochloride 200 mg USP1542003 Piperazine Phosphate 200 mg USP1543006 Piperidolate HCl 200 mg USP1543200 Piperine 20 mg USP1544304 Pirbuterol Acetate (AS) 200 mg USP1544406 Piroctone Olamine 200 mg Piroctone Related Compound A 15 mg (2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl] USP1544417 acetic acid)2-aminoethanol salt Piroctone Related Compound B 25 mg USP1544428 4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one USP1544508 Piroxicam 125 mg USP1545409 Polacrilex Resin 100 mg USP1545500 Polacrilin Potassium 200 mg USP1546106 Poloxalene 500 mg USP1546150 Poloxamer Liquid 1 mL USP1546161 Poloxamer Solid 1 g USP1372333 Polyallylamine Hydrochloride (2-propen-1-amine hydrochloride, homopolymer) 200 mg USP1546285 Polydextrose 200 mg USP1546300 Polydimethylsiloxane 500 mg USP1546489 Polyethylene Glycol 1000 1 g USP1546627 Polyethylene Glycol 10000 1 g USP1546649 Polyethylene Glycol 12000 1 g USP1546503 Polyethylene Glycol 1500 1 g USP1546401 Polyethylene Glycol 200 1 g USP1546650 Polyethylene Glycol 20000 1 g USP1546423 Polyethylene Glycol 300 1 g USP1546525 Polyethylene Glycol 3000 1 g USP1546547 Polyethylene Glycol 3350 1 g USP1546660 Polyethylene Glycol 35000 1 g USP1546445 Polyethylene Glycol 400 1 g

Edition 2014 Visit us at www.lgcstandards.com 137

United States Pharmacopeia and National Formulary

Code Product Unit USP1546569 Polyethylene Glycol 4000 1 g USP1546467 Polyethylene Glycol 600 1 g USP1546580 Polyethylene Glycol 6000 1 g USP1546605 Polyethylene Glycol 8000 1 g USP1546853 Polyethylene Oxide 100 mg USP1546900 Polyethylene Terephthalate (PET) 3 strips USP1546922 Polyethylene Terephthalate G (PETG) 3 strips USP1546809 Polyethylene, Low Density 3 strips Polyglyceryl 3 Diisostearate 1 mL USP1546944 1,2,3-Propanetriol, homopolymer, diisoactadecanoate USP1546933 Polyglyceryl 3 Dioleate 1 g USP1546955 Polyglyceryl 6 Dioleate 1 g USP1546966 Polyisobutylene 1 g USP1547007 Polymyxin B Sulfate 200 mg USP1547302 Polyoxyl 10 Oleyl Ether 1 mL USP1372606 Polyoxyl 10 Stearyl Ether 1 g USP1547550 Polyoxyl 100 Stearate 200 mg USP1547255 Polyoxyl 15 Hydroxystearate 500 mg USP1547346 Polyoxyl 2 Stearyl Ether (AS) 1 g USP1547801 Polyoxyl 20 Cetostearyl Ether 100 mg USP1547368 Polyoxyl 20 Stearyl Ether 1 g USP1372468 Polyoxyl 23 Lauryl Ether 0.5 g USP1547391 Polyoxyl 32 Stearate 200 mg USP1547200 Polyoxyl 35 Castor Oil 1 g USP1372424 Polyoxyl 4 Lauryl Ether 1 mL USP1547903 Polyoxyl 40 Stearate 200 mg USP1547404 Polyoxyl 50 Stearate 200 mg USP1547379 Polyoxyl 6 Stearate 200 mg USP1547459 Polyoxyl 75 Stearate 200 mg USP1547380 Polyoxyl 8 Stearate 200 mg USP1372402 Polyoxyl Lauryl Ether 500 mg USP1372504 Polyoxyl Oleate 500 mg USP1547925 Polysorbate 20 2 g USP1547936 Polysorbate 40 2 g USP1547947 Polysorbate 60 2 g USP1547969 Polysorbate 80 (AS) 2 g USP1548032 Polyvinyl Acetate 1 g USP1548043 Polyvinyl Acetate Dispersion 1 g USP1548065 Polyvinyl Alcohol 100 mg USP1071439 Positive Bioreaction 3 strips USP1549807 Potassium Acetate (AS) 500 mg USP1548101 Potassium Benzoate 1 g USP1548134 Potassium Bicarbonate (AS) 1 g USP1549840 Potassium Bitartrate (AS) 3 g USP1548167 Potassium Carbonate (AS) 1 g USP1548190 Potassium Chloride (AS) 1 g USP1548225 Potassium Citrate (AS) 1 g USP1550001 Potassium Gluconate 200 mg USP1551004 Potassium Guaiacolsulfonate 500 mg USP1548280 (AS) 1 g USP1548349 Potassium Nitrate (AS) 5 g USP1551140 Potassium Sodium Tartrate (AS) 2 g

138 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1548407 Potassium Sorbate 1 g USP1551150 Potassium Sucrose Octasulfate 300 mg USP1551300 Potassium Trichloroammineplatinate 20 mg USP1551503 Povidone 100 mg USP1291683 Powdered American Ginseng Extract 1.5 g USP1034873 Powdered Andrographis Extract 500 mg USP1043309 Powdered Ashwagandha Extract 1 g USP1291708 Powdered Asian Ginseng Extract 1.5 g USP1048244 Powdered Bacopa Extract 500 mg USP1071268 Powdered Bilberry Extract 500 mg USP1076206 Powdered Black Cohosh Extract 1.5 g USP1509019 Powdered Extract 1 g USP1096848 Powdered Cat's Claw Extract 1 g USP1098402 Powdered Cellulose (AS) 1 g USP1297770 Powdered Centella Asiatica Extract 1 g USP1105009 Powdered Chaste Tree Extract 1.5 g USP1105417 Powdered Chinese Salvia Extract 1 g USP1298401 Powdered Decaffeinated Green Tea Extract 300 mg USP1231706 Powdered Echinacea Angustifolia Extract 1 g USP1231717 Powdered Echinacea Pallida Extract 1 g USP1231728 Powdered Echinacea Purpurea Extract 1 g USP1234704 Powdered Eleuthero Extract 1.5 g USP1283255 Powdered Forskohlii Extract 500 mg USP1288340 Powdered Garcinia Hydroxycitrate Extract 500 mg USP1291504 Powdered Ginger 500 mg USP1309911 Powdered Holy Extract 1 g USP1355709 Powdered Extract 1 g USP1374383 Powdered Malabar-Nut-Tree Leaf Extract 1 g USP1443850 Powdered Milk Thistle Extract 250 mg USP1536510 Powdered Phyllanthus Amarus Extract 1 g USP1599500 Powdered Red Clover Extract 500 mg USP1605668 Powdered Extract 1 g USP1605680 Powdered Rosemary Hydrophilic Extract 1 g USP1607506 Powdered St. John's Wort Extract 600 mg USP1707931 Powdered Valerian Extract 1 g USP1553000 Pralidoxime Chloride 200 mg USP1553859 Pramipexole Dihydrochloride Monohydrate 200 mg Pramipexole Related Compound A 15 mg USP1553768 (S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine Pramipexole Related Compound D 25 mg USP1553815 (R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole USP1554002 Pramoxine HCl 500 mg USP1554192 Pravastatin 1,1,3,3-Tetramethylbutylamine 200 mg Pravastatin Related Compound A 10 mg Sodium(3R,5R)-3,5-dihydroxy-7-[(1S,2S,3S,8S,8aR)-3-hydroxy-2methyl-8-[[(2S)-2- USP1554217 methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]heptanoate Pravastatin Related Compound B 20 mg sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2- USP1554228 methylbutanoyl]oxy]1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate USP1554206 Pravastatin Sodium 50 mg USP1554501 Prazepam CIV 500 mg USP1554603 Praziquantel 200 mg Praziquantel Related Compound A 20 mg USP1554658 2-benzoyl-1,2,3,6,7,11b-hexahydro-4 H-pyrazino[2,1-a]isoquinolin-4-one

Edition 2014 Visit us at www.lgcstandards.com 139

United States Pharmacopeia and National Formulary

Code Product Unit Praziquantel Related Compound B 50 mg USP1554669 2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]isoquinolin-4-one Praziquantel Related Compound C 50 mg USP1554670 2-(N-formylhexahydrohippuroyl-1,2,3,4-tetrahydroisoquinolin-1-one USP1554705 Prazosin HCl 350 mg USP1554909 Prednicarbate 200 mg Prednicarbate Related Compound A 20 mg USP1554910 1,2-dihydroprednicarbate Prednicarbate Related Compound B 20 mg USP1554920 prednisolone-17-ethylcarbonate Prednicarbate Related Compound C 20 mg USP1554931 prednisolone-21-propionate USP1555005 Prednisolone 200 mg USP1556008 Prednisolone Acetate 200 mg USP1556507 Prednisolone Hemisuccinate 125 mg USP1557000 Prednisolone Sodium Phosphate 500 mg USP1558003 200 mg USP1559006 Prednisone 250 mg Prednisone Tablets 30 tablets USP1559505 Dissolution calibrator tablets,Disintegrating USP1560990 Prilocaine 200 mg USP1561008 Prilocaine HCl 200 mg Prilocaine Related Compound A 100 mg USP1561019 o-toluidine hydrochloride Prilocaine Related Compound B 50 mg USP1561020 (RS)-N-(4-methylphenyl)-2-(propylamino)propanamide USP1561507 Primaquine Phosphate 200 mg Primaquine Related Compound A 15 mg USP1561518 8-[(4-Aminopentyl)amino]-6-methoxyquinoline USP1562000 Primidone 200 mg Primidone Related Compound A 20 mg USP1562011 2-ethyl-2-phenylmalonamide Primidone Related Compound C 20 mg USP1562033 2-phenylbutyramide USP1563003 Probenecid 200 mg USP1563309 Probucol 200 mg Probucol Related Compound A 25 mg USP1563320 2,2',6,6'-tetra-tert-butyldiphenoquinone Probucol Related Compound B 25 mg USP1563331 4,4'-dithio-bis(2,6-di-tert-butylphenol) Probucol Related Compound C 25 mg USP1563342 4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol USP1563502 Procainamide HCl 200 mg USP1564006 Procaine HCl 200 mg USP1565009 Procarbazine HCl 200 mg USP1566001 Prochlorperazine Maleate 200 mg Prochlorperazine Related Compound A 10 mg USP1566045 (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride) USP1567004 Procyclidine HCl 200 mg USP1568007 Progesterone 200 mg USP1568040 Proguanil HCl 200 mg Proguanil Related Compound A 25 mg USP1568028 1-cyano-3-isopropylguanidine Proguanil Related Compound C 25 mg USP1568051 1,5-bis(4-chlorophenyl)biguanide hydrochloride Proguanil Related Compound D 25 mg USP1568062 1,5-bis(1-methylethyl)biguanide hydrochloride

140 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Proguanil Related Compound E 25 mg USP1568073 1-(4-chlorophenyl)-3-cyanoguanidine Proguanil Related Compound F 25 mg USP1568084 1-(3,4-dichlorophenyl)-5-isopropylbiguanide hydrochloride Proguanil Related Compound G 25 mg USP1568095 1-(3-chlorophenyl)-5-isopropylbiguanide hydrochloride USP1569000 Promazine HCI 200 mg USP1570009 Promethazine HCl 500 mg USP1570304 Propafenone HCl 200 mg Propafenone Related Compound B 50 mg USP1570326 (2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one Propanolamine 100 mg USP1570450 3-aminopropan-1-ol USP1570508 Propantheline Bromide 200 mg Propantheline Bromide Related Compound A 50 mg USP1329505 9-Hydroxypropantheline Bromide USP1571001 Proparacaine HCl 200 mg USP1572208 Propionic Acid (AS) 3x1.5 mL USP1572503 Propofol 200 mg Propofol Related Compound A 10 mg USP1572536 3,3',5,5'-Tetraisopropyldiphenol Propofol Related Compound B 25 mg USP1572547 2,6-diisopropylbenzoquinone Propofol Related Compound C 25 mg USP1572558 2,6-diisopropylphenyl isopropylether Propofol Resolution Mixture 100 mg USP1572525 Propofol;2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol USP1573007 Propoxycaine HCl 200 mg USP1574000 Propoxyphene HCl Controlled Substance CII 1 g USP1575002 Propoxyphene Napsylate Controlled Substance CII 1 g Propoxyphene Related Compound A 50 mg USP1575206 alpha-d-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol HCl Propoxyphene Related Compound B 50 mg USP1008002 alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane USP1576005 Propranolol HCl 200 mg USP1576402 Propyl Acetate 3x1.2 mL USP1576800 Propyl Gallate 200 mg USP1576504 Propylene Carbonate 200 mg USP1576708 Propylene Glycol 1 mL USP1576683 Propylene Glycol Dicaprylate/Dicaprate 1 mL USP1576763 Propylene Glycol Dilaurate 500 mg USP1576661 Propylene Glycol Monocaprylate Type I 1 g USP1576672 Propylene Glycol Monocaprylate Type II 1 g USP1576785 Propylene Glycol Monolaurate Type I 500 mg USP1576796 Propylene Glycol Monolaurate Type II 500 mg USP1576945 Propylene Oxide 5x0.1mL USP1577008 Propylparaben 200 mg USP1578000 Propylthiouracil 200 mg USP1578500 A1 25 mg Prostaglandin B1 25 mg USP1578554 (13E,15S,)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic Acid USP1578805 Protein A 2 x 250 µL Protocatechuic Acid 25 mg USP1579310 3,4-dihydroxybenzoic acid USP1580002 Protriptyline HCl 200 mg USP1581005 Pseudoephedrine HCl Drug Precursor 125 mg

Edition 2014 Visit us at www.lgcstandards.com 141

United States Pharmacopeia and National Formulary

Code Product Unit USP1581504 Pseudoephedrine Sulfate Drug Precursor 200 mg USP1672020 p-Toluenesulfonamide 200 mg Purified Grape Seeds 500 mg USP1298219 Oligomeric Proanthocyanidins USP1302203 Purified Guggul Extract 500 mg USP1583805 Pygeum Extract 150 mg USP1584003 Pyrantel Pamoate 500 mg Pyrantel Related Compound A 25 mg USP1584014 1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine Pamoate USP1584105 Pyrantel Tartrate 200 mg USP1585006 Pyrazinamide 200 mg USP1585505 Pyrethrum Extract 100 mg USP1586009 Pyridostigmine Bromide 200 mg USP1587001 Pyridoxine HCl (Vitamin B6) 200 mg USP1588004 Pyrilamine Maleate 200 mg USP1589007 Pyrimethamine 200 mg USP1589109 Pyruvic Acid 500 mg USP1592001 Pyrvinium Pamoate 500 mg USP1592205 Quazepam Controlled Substance CIV 200 mg Quazepam Related Compount A 30 mg 7-Chloro-1-(2,2,2-trifluoroethyl)-5-(2-fluorophenyl)-1,3-dihydro- USP1592227 2H-1,4-benzodiazepine-2-one USP1592409 Quercetin 500 mg USP1593004 Quinacrine HCl 200 mg USP1593401 Quinapril HCl 400 mg Quinapril Related Compound A 50 mg Ethyl[3S-[2(R*),3a,11a beta]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo- USP1593412 alpha-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate Quinapril Related Compound B 50 mg 3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]- USP1593423 1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]]- USP1594007 Quinethazone 1.5 g USP1594506 Quinic Acid 200 mg USP1595000 Quinidine Gluconate 200 mg USP1595509 Quinidine Sulfate 500 mg USP1596807 Quinine HCl Dihydrate 1 g USP1597005 Quinine Sulfate 500 mg USP1597504 Quininone 50 mg Rabeprazole Related Compound A 25 mg USP1598020 2-(1H-Benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate, sodium salt Rabeprazole Related Compound B 15 mg 2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1- USP1598031 oxide Rabeprazole Related Compound C 25 mg USP1598042 1H-Benzimidazole-2-thiol Rabeprazole Related Compound D 25 mg USP1598053 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfonyl]benzimidazole Rabeprazole Related Compound E 25 mg USP1598064 2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole Rabeprazole related compound F 15 mg USP1598075 (2-{[(4-Chloro-3-methyl-2-pyridyl)methyl]sulfinyl}benzimidazole) USP1598019 Rabeprazole Sodium 200 mg USP1643292 Racemethionine 200 mg USP1643281 Racemic Tamsulosin HCl 50 mg Racemic Tiagabine Hydrochloride Mixture 25 mg USP1667235 (S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl], HCl

142 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1598100 Ractopamine HCl 200 mg USP1012595 rAlbumin Human (Recombinant Human Albumin) 4.92 mg USP1598201 Raloxifene HCl 200 mg Raloxifene Related Compound C 20 mg 2-(2-({4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}- USP1598234 ethyl)piperidine 1-oxide USP1598303 Ramipril 125 mg Ramipril Related Compound A 30 mg (2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]- USP1598314 octahydrocyclopenta[b]pyrrole-2-carboxylic acid Ramipril Related Compound B 20 mg USP1598323 Ramipril Isopropylester Ramipril Related Compound C 20 mg USP1598338 Hexahydroramipil HCl Ramipril Related Compound D 20 mg USP1598347 Ramipril Diketopiperazine USP1598405 Ranitidine HCl 200 mg Ranitidine Related Compound A 50 mg USP1598507 5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine hemifumarate Ranitidine Related Compound B 50 mg USP1598609 N,N'-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine Ranitidine Related Compound C 50 mg N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1- USP1598700 ethenediamine USP1598450 Ranitidine Resolution Mixture 20 mg Raspberry Alcohol 50 mg USP1598802 4-(3-Hydroxybutyl)phenol Raspberry Ketone 100 mg USP1598813 4-(4-hydroxyphenyl)-2-butanone USP1599000 Rauwolfia Serpentina 15 g R-Citalopram Oxalate 10 mg USP1134142 R-1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate USP1600121 Rebaudioside A 500 mg USP1600132 Rebaudioside B 100 mg USP1600154 Rebaudioside D 100 mg USP1600813 Repaglinide 200 mg Repaglinide Related Compound A 10mg USP1600824 (S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate Salt Repaglinide Related Compound B 50 mg USP1600835 3-Ethoxy-4-ethoxycarbonyl-phenylacetic Acid Repaglinide Related Compound C 25 mg USP1600846 (S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl]benzoic Acid USP1601000 Reserpine 200 mg USP1601226 Residual Solvent Class 1 - 1,1,1-Trichloroethane 3x1.2 mL USP1601204 Residual Solvent Class 1 - 1,1-Dichloroethene 3x1.2 mL USP1601180 Residual Solvent Class 1 - 1,2-Dichloroethane 3x1.2 mL USP1601146 Residual Solvent Class 1 - Benzene 3x1.2 mL USP1601168 Residual Solvent Class 1 - Carbon Tetrachloride 3x1.2 mL USP1601420 Residual Solvent Class 2 - 1,2-Dichloroethene 3x1.2 mL USP1601463 Residual Solvent Class 2 - 1,2-Dimethoxyethane 3x1.2 mL USP1601521 Residual Solvent Class 2 - 1,4-Dioxane 3x1.2 mL USP1601543 Residual Solvent Class 2 - 2-Ethoxyethanol 3x1.2 mL USP1601645 Residual Solvent Class 2 - 2-Methoxyethanol 3x1.2 mL USP1601340 Residual Solvent Class 2 - Acetonitrile 3x1.2 mL USP1601361 Residual Solvent Class 2 - Chlorobenzene 3x1.2 mL USP1601383 Residual Solvent Class 2 - 3x1.2 mL USP1601394 Residual Solvent Class 2 - Cumene 3x1.2ml

Edition 2014 Visit us at www.lgcstandards.com 143

United States Pharmacopeia and National Formulary

Code Product Unit USP1601408 Residual Solvent Class 2 - Cyclohexane 3x1.2 mL USP1601565 Residual Solvent Class 2 - Ethylene Glycol 3x1.2 mL USP1601587 Residual Solvent Class 2 - Formamide 3x1.2 mL USP1601601 Residual Solvent Class 2 - Hexane 3x1.2 mL USP1601623 Residual Solvent Class 2 - Methanol 3x1.2 mL USP1601667 Residual Solvent Class 2 - Methylbutylketone 3x1.2 mL USP1601689 Residual Solvent Classe 2 - Methylcyclohexane 3x1.2 mL USP1601441 Residual Solvent Class 2 - Methylene Chloride 3x1.2 mL USP1601281 Residual Solvent Class 2 - Mixture A 3x1.2 mL USP1601292 Residual Solvent Class 2 - Mixture B 3x1.2 mL USP1601306 Residual Solvent Class 2 - Mixture C 3x1.2 mL USP1601485 Residual Solvent Class 2 - N,N-Dimethylacetamide 3x1.2 mL USP1601500 Residual Solvent Class 2 - N,N-Dimethylformamide 3x1.2 mL USP1601725 Residual Solvent Class 2 - Nitromethane 3x1.2 mL USP1601703 Residual Solvent Classe 2 - N-Methylpyrrolidone 3x1.2 mL USP1601747 Residual Solvent Class 2 - Pyridine 3x1.2 mL USP1601769 Residual Solvent Class 2 - Sulfolane 3x1.2 mL USP1601770 Residual Solvent Class 2 - Tetrahydrofuran 3x1.2 mL USP1601780 Residual Solvent Class 2 - Tetralin 3x1.2 mL USP1601805 Residual Solvent Class 2 - 3x1.2 mL USP1601827 Residual Solvent Class 2 - 3x1.2 mL USP1601849 Residual Solvent Class 2 - Xylenes 3x1.2 mL USP1601102 Residual Solvent Mixture - Class 1 3x1.2 mL USP1602003 Resorcinol 200 mg USP1716002 Retinyl Acetate (Vitamin A) unit USP1602502 Retinyl Palmitate 200 mg USP1294036 rGlucagon 2x2.94 mg USP1311714 rHuman Interleukin 4 (recombinant interleukin 4, human) 51 µg USP1602706 Ribavirin 200 mg Ribavirin Related Compound A 15 mg USP1602717 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid Ribavirin Related Compound D 15 mg USP1602740 1H-1,2,4-triazole-3-carboxamide USP1603006 Riboflavin (Vitamin B2) 500 mg USP1603108 Ribose 300 mg USP1603800 Rifabutin 50 mg USP1604009 Rifampin 300 mg USP1604202 Rifampin Quinone 25 mg USP1604337 200 mg Riluzole Related Compound A 25 mg USP1604348 4-trifluoromethoxyaniline USP1604508 Rimantadine HCl 300 mg USP1604600 100 mg Risedronate Related Compound A 20 mg USP1604621 [1-hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid) Risedronate Related Compound B 20 mg [3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6- USP1604632 diyl]bis[phosphonic acid]disodium tetrahydrate salt Risedronate Related Compound C 20 mg USP1604643 [2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid) USP1604610 Risedronate Sodium 350 mg USP1604654 Risperidone 100 mg USP1604676 Risperidone Related Compounds Mixture 25 mg USP1604665 Risperidone System Suitability Mixture 10 mg

144 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1604701 Ritodrine HCl 200 mg USP1604803 Ritonavir 200 mg USP1604814 Ritonavir Related Compounds Mixture 50 mg USP1604836 Rivastigmine 0.1 mL Rivastigmine Related Compound A 15 mg USP1604869 (+)-Di-p-toluoyl-D-(+)-tartaric acid Rivastigmine Related Compound B 15 mg USP1604870 (R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate Rivastigmine Related Compound C 15 mg USP1604811 (S)-3-[1-(Dimethylamino)ethyl]phenol Rivastigmine Related Compound D 50 mg USP1604825 3-Acetylphenyl ethyl(methyl)carbamate USP1604858 Rivastigmine Tartrate 200 mg Rivastigmine Tartrate R-Isomer 20 mg USP1604847 (R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate USP1604880 Rizatriptan Benzoate 200 mg USP1604891 Rizatriptan Benzoate System Suitability Mixture 15 mg R-Methotrexate 5 mg USP1413988 (R)-2-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioic acid USP1604905 Rocuronium Bromide 250 mg Rocuronium Peak Identification Mixture 25 mg USP1604916 rocuronium bromide spiked with rocuronium related compounds A,B,C,D,E,F,G and H R-Ofloxacin ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H- 25 mg USP1478083 pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) USP1605205 Ropinirole HCl 200 mg Ropinirole Related Compound A 50 mg USP1605216 4-(2-hydroxyethyl)indolin-2-one Ropinirole Related Compound B 50 mg USP1605227 4-[2-(Dipropylamino)ethyl]indoline-2,3-dione HCl USP1605497 Ropivacaine 200 mg USP1605500 Ropivacaine HCl 200 mg Ropivacaine Related Compound A 25 mg USP1605512 2,6-dimethylaniline hydrochloride Ropivacaine Related Compound B 50 mg (R)-(+)-1-Propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)-amide hydrochloride USP1605523 monohydrate USP1605817 Rosiglitazone Maleate 200 mg Rosiglitazone Related Compound A 25 mg (5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4- USP1605828 dione USP1605952 Rosmarinic Acid 25 mg USP1606208 Roxarsone 200 mg USP1578816 rProtein A 2 x 250 µL USP1578827 rProtein A, C-Cys 2 x 250 µL USP1606274 Rubusoside 100 mg USP1606401 Rufinamide 200 mg Rufinamide Related Compound A 25 mg USP1606412 1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide Rufinamide Related Compound B 25 mg USP1606423 Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate USP1606503 Rutin 100 mg USP1616008 1,4-Sorbitan 300 mg USP1607007 Saccharin 200 mg USP1607029 Saccharin Calcium 100 mg USP1607040 Saccharin Sodium 100 mg USP1012112 S-Adenosyl-L-Homocysteine 50 mg USP1607200 Safflower Oil 1 g

Edition 2014 Visit us at www.lgcstandards.com 145

United States Pharmacopeia and National Formulary

Code Product Unit USP1608000 Salicylamide 200 mg USP1609002 Salicylic Acid 125 mg Salicylic Acid Related Compound A 100 mg USP1609013 4-hydroxybenzoic acid Salicylic Acid Related Compound B 100 mg USP1609024 4-hydroxyisophthalic acid Salicylic Acid Tablets 30 tablets USP1609501 Dissolution Calibrator, Non-disintegrating USP1013057 S-Allyl-L-Cysteine 25 mg Salmeterol Related Compound A 10 mg USP1609614 4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol Salmeterol Related Compound B 10 mg USP1609625 4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}2-(hydroxymethyl)phenol Salmeterol Related Compound H (15 mg) 15 mg (1-hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2- USP1609680 naphthoic acid) USP1609589 Salmeterol Resolution Check 15 mg USP1609590 Salmeterol System Suitability 15 mg USP1609603 Salmeterol Xinafoate 150 mg USP1609807 Salsalate 150 mg USP1609818 Salvianolic Acid B 25 mg USP1609829 Saquinavir Mesylate 200 mg Saquinavir Related Compound A 25 mg N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D- USP1609831 asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide USP1535813 Scaffold Human Dermis Reference Photomicrographs (CD) Each USP1610001 Scopolamine HBr 250 mg USP1610090 Scopoletin 20 mg USP1611004 Secobarbital CII 200 mg USP1611900 Selegiline HCl 200 mg Selegiline Related Compound D 15 mg USP1611944 (R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride USP1611955 Selenomethionine 100 mg USP1612018 Sennoside A 20 mg USP1612029 Sennoside B 20 mg USP1612007 Sennosides 500 mg USP1612539 Sertraline HCl 100 mg Sertraline HCl Racemic Mixture 25 mg 1:1 mixture of (1S,4S) and (1R, 4R)-4-(3,4-dichlorophenyl)- USP1612517 N-methyl-1,2,3,4-tetrahydro-1-naphthylamine HCl Sertraline HCl Related Compound A 25 mg 1:1 mixture of (1R, 4S) and (1S, 4R)-4-(3,4-dichlorophenyl)- USP1612528 N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride USP1612404 Sesame Oil (AS) 2x1 mL USP1612415 Sesame Oil Related Compound A 3x6 mg USP1612426 Sesame Oil Related Compound B 3x6 mg USP1612540 Sevoflurane 1 mL Sevoflurane Related Compound A 0.2 mL USP1612550 1,1,3,3,3-Pentafluoroisopropenyl fluoromethyl ether Sevoflurane Related Compound B 0.2 mL USP1612572 1,1,1,3,3,3-hexafluoro-2-methoxypropane Sevoflurane Related Compound C 0.2 mL USP1612594 1,1,1,3,3,3-hexafluoro-2-propanol USP1612845 Sibutramine HCl CIV 125 mg Sibutramine Related Compound A 20 mg USP1612856 N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine HCl

146 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Sibutramine Related Compound B 20 mg USP1612867 N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine HCl Sibutramine Related Compound C 20 mg USP1612878 N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine HCl Sibutramine Related Compound D 20 mg USP1612889 N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride USP1612561 Sildenafil Citrate 100 mg Sildenafil Related Compound A (5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1- 10 mg USP1612685 methyl-3-(2-methylpropyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one USP1098399 Silicified Microcystalline Cellulose 1 g USP1612608 Silver Sulfadiazine 200 mg USP1612630 Silybin 50 mg USP1612641 Silydianin 20 mg USP1612652 Simethicone 50 g USP1612700 Simvastatin 200 mg USP1612801 Sisomicin Sulfate 500 mg USP1613407 Sodium Acetate (AS) 1 g USP1613509 Sodium Ascorbate 200 mg USP1613564 Sodium Benzoate 1 g USP1613655 Sodium Bicarbonate (AS) 3 g USP1613597 Sodium Bromide 1 g USP1613600 Sodium Butyrate 25 mg USP1613757 Sodium Carbonate Anhydrous (AS) 1 g USP1613804 Sodium Chloride 1 g USP1613859 Sodium Citrate (AS) 1 g USP1613860 Sodium Cyclamate 200 mg USP1614002 Sodium Fluoride 1 g USP1614239 Sodium Iron EDTA 200 mg USP1614308 Sodium Lactate 200 mg USP1614363 Sodium Lauryl Sulfate (AS) 1 g USP1614396 Sodium Metabisulfite 1 g USP1614421 Sodium Molybdate Dihydrate 200 mg USP1614454 Sodium Nitrite (AS) 1 g USP1614501 Sodium Nitroprusside 500 mg USP1614512 Sodium Phenylbutyrate 200 mg USP1614578 Sodium Picosulfate 50 mg Sodium Picosulfate Related Compound A 20 mg USP1614589 4-[(pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate USP1614603 Sodium Propionate 200 mg USP1614636 Sodium Salicylate 500 mg USP1614669 Sodium Starch Glycolate Type A 400 mg USP1614670 Sodium Starch Glycolate Type B 400 mg USP1614705 Sodium Stearyl Fumarate 200 mg USP1614807 Sodium Sulfate Anhydrous (AS) 1 g USP1614909 Sodium Tartrate Dihydrate 4x500 mg USP1615107 Sodium Thiosulfate (AS) 1 g USP1615708 Somatropin unit USP1615956 Sorbic Acid 1 g USP1617000 Sorbitol 125 mg USP1617408 Sotalol HCl 300 mg Sotalol Related Compound A 50 mg USP1617419 N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride Sotalol Related Compound B 50 mg USP1617420 N(4-Formylphenyl)methanesulfonamide

Edition 2014 Visit us at www.lgcstandards.com 147

United States Pharmacopeia and National Formulary

Code Product Unit Sotalol Related Compound C 50 mg USP1617430 N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide monohydrochloride) USP1617500 Oil 1 g USP1618003 Spectinomycin HCl 200 mg USP1619006 Spironolactone 125 mg Spironolactone Related Compound A 100 mg USP1619017 Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21,17-carbolactone) (AS) USP1619505 Squalane 500 mg USP1620005 Stanozolol Controlled Substance CIII 200 mg USP1620209 Stavudine 250 mg USP1620220 Stavudine System Suitability Mixture 10 mg USP1621008 Stearic Acid 500 mg USP1621507 Stearoyl Polyoxyglycerides 100 mg USP1622000 Stearyl Alcohol 125 mg USP1622317 Steviol System Suitability 50 mg USP1622350 Steviolbioside 100 mg USP1622408 30 mg USP1623003 Streptomycin Sulfate 200 mg USP1623411 Succinic Acid 100 mg USP1623502 Succinylcholine Chloride 500 mg USP1623604 Succinylmonocholine Chloride 125 mg USP1623626 Sucralose 400 mg USP1623659 Sucromalt 200 mg USP1623637 Sucrose 100 mg USP1623615 Sucrose Octaacetate 500 mg USP1623648 Sufentanil Citrate Controlled Substance CII 25 mg USP1623670 Sulbactam 250 mg Sulbactam Related Compound D 15 mg Potassium (2S,5R,6R)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- USP1623772 carboxylate USP1623681 Sulconazole Nitrate 200 mg USP1623706 Sulfabenzamide 200 mg USP1623808 Sulfacetamide 300 mg USP1624006 Sulfacetamide Sodium 500 mg USP1624505 Sulfachlorpyridazine 200 mg USP1625009 Sulfadiazine 200 mg USP1626001 Sulfadimethoxine 200 mg USP1626500 Sulfadoxine 200 mg USP1628007 Sulfamerazine 500 mg USP1629000 Sulfamethazine 1 g USP1630009 Sulfamethizole 200 mg USP1631001 Sulfamethoxazole 200 mg USP1631500 Sulfamethoxazole N4-glucoside 25 mg USP1632004 Sulfanilamide 5 g USP1633007 Sulfanilamide Melting Point Standard (Approximately 165°C) 500 mg USP1633506 Sulfanilic Acid 200 mg USP1634000 Sulfapyridine 200 mg USP1635002 Sulfapyridine Melting Point Standard (Approximately 191°C) 1 g USP1635206 Sulfaquinoxaline 200 mg Sulfaquinoxaline Related Compound A 25 mg USP1635228 N1-N2-diquinoxalin-2-ylsulfanilamide USP1636005 Sulfasalazine 125 mg USP1636504 Sulfathiazole 350 mg

148 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1637008 Sulfinpyrazone 200 mg USP1638000 Sulfisoxazole 200 mg USP1639003 Sulfisoxazole Acetyl 200 mg USP1642008 Sulindac 200 mg Sulindac Related Compound A 20 mg USP1642019 trans-sulindac USP1642100 Sulisobenzone 500 mg USP1642154 Sumatriptan 50 mg USP1642201 Sumatriptan Succinate 200 mg Sumatriptan Succinate Related Compound A 15 mg [3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol-5- USP1642212 yl]-N-methylmethansulfonamide, succinate Salt Sumatriptan Succinate Related Compound C 50 mg [3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]- USP1642223 N-methylmethanesulfonamide succinate salt USP1642256 Sumatriptan Succinate Related Impurities 25 mg USP1642347 Sunflower Oil 1 g USP1642507 Suprofen 200 mg USP1666006 (E)-Thiothixene 100 mg USP1083008 2-tert-Butyl-4-hydroxyanisole 200 mg USP1083100 3-tert-Butyl-4-hydroxyanisole 200 mg USP1642700 Tacrine HCl 500 mg USP1642802 Tacrolimus 150 mg USP1642857 Tacrolimus System Suitability Mixture 10 mg USP1642879 Tadalafil 200 mg USP1642904 Tagatose 200 mg USP1643306 Tamoxifen Citrate 200 mg USP1643260 Tamsulosin HCl 200 mg USP1643328 Tannic Acid (AS) 2 g USP1643339 Tanshinone IIA 20 mg USP1643340 Tartaric Acid 1 g USP1643361 100 mg USP1643383 Tazobactam 200 mg Tazobactam Related Compound A 20 mg USP1643394 (2S,3S)2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid USP1643419 Telmisartan 200 mg Telmisartan Related Compound A 20 mg USP1643420 1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole Telmisartan Related Compound B 15 mg 4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl) USP1643437 methyl]biphenyl-2-carboxylic acid USP1643408 Temazepam CIV 200 mg Temazepam Related Compound A 15 mg USP1644319 5-chloro-2-methylaminobenzophenone Temazepam Related Compound F 15 mg USP1644364 7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione Temazepam Related Compound G 15 mg USP1646375 7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione USP1643543 Temozolomide 200 mg Temozolomide Related Compound A 15 mg USP1643554 4-diazo-4H-imidazole-5-carboxamide Temozolomide Related Compound B 15 mg USP1643565 3-methyl-1,1-dihenylurea Temozolomide Related Compound C 15 mg USP1643576 diphenylcarbamic chloride USP1643601 Tenofovir 15 mg

Edition 2014 Visit us at www.lgcstandards.com 149

United States Pharmacopeia and National Formulary

Code Product Unit USP1643656 Tenofovir Disoproxil Fumarate 200 mg Tenofovir Disoproxil Related Compound A 10 mg (S)-5-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5- USP1643612 phosphanonanedioic acid, bis(1-methylethyl)ester,5-oxide, (E)-2-butenedioate (1:1) Tenofovir Disoproxil Related Compound B 10 mg USP1643623 (E)-9-(Prop-1-enyl)9H-purin-6-amine Tenofovir Disoproxil Related Compound E 15 mg ({[(R)-1-(6-Amino-9H-purin-9-yl)propan-2-yloxy]methyl}(hydroxy)phosphoryloxy)methyl USP1643645 isopropyl carbonate Tenofovir Disoproxil Related Compound G 15 mg O-(Isopropoxycarbonyloxymethyl)-O-isopropyl-{(R)-[1-(6-amino-9H-purin-9-yl)propan-2- USP1643678 yloxy]}methylphosphonate) fumarate USP1643452 Terazosin HCl 200 mg Terazosin Related Compound A 50 mg USP1643463 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride Terazosin Related Compound B 50 mg USP1643474 1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine Terazosin Related Compound C 25 mg USP1643485 1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride USP1643496 Terbinafine HCl 200 mg Terbinafine Related Compound A 25 mg USP1424608 N-methyl-C-(naphthalen-1-yl)methanamine hydrochloride Terbinafine Related Compound B 25 mg (2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1- USP1643532 amine hydrochloride Terbinafine Related Compound C 25 mg (2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1- USP1353215 amine hydrochloride Terbinafine Related Compound D 25 mg (2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]-hept-2-en- USP1437701 4-yn-1-amine hydrochloride Terbutaline Related Compound A 50 mg USP1643510 tert-butylamino-3,5-dihydroxyacetophenone sulfate USP1643500 Terbutaline Sulfate 125 mg USP1643703 Terconazole 200 mg USP1643805 Terfenadine 200 mg Terfenadine Related Compound A 100 mg USP1643907 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butanone Terfenadine Related Compound B 50 mg USP1643929 Terfenadine-N-oxide USP1644003 Terpin Hydrate 750 mg USP1083303 tert-Butylmethyl ether 3x1.2 mL USP1645006 CIII 125 mg USP1646009 Testosterone Controlled Substance CIII 125 mg USP1647001 Controlled Substance CIII 200 mg USP1648004 Controlled Substance CIII 200 mg USP1649007 Testosterone Propionate Controlled Substance CIII 200 mg USP1650006 Tetracaine HCl 200 mg USP1651009 Tetracycline HCl 200 mg USP1652001 Tetrahydrozoline HCl 200 mg USP1652500 200 mg USP1653004 Theophylline (CRM) 200 mg USP1653117 Theophylline Melting Point Standard (Approximately 271°C) 500 mg USP1655000 Thiabendazole 100 mg USP1656002 Thiamine HCl (Vitamin B1 HCl) 500 mg USP1657005 Thiethylperazine Malate 200 mg USP1658008 Thiethylperazine Maleate 200 mg USP1659000 Thimerosal 500 mg

150 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1660000 Thioguanine 200 mg USP1661002 Thiopental Controlled Substance CIII 250 mg USP1662504 Thioridazine 200 mg USP1663008 Thioridazine HCl 200 mg Thioridazine Related Compound F 20 mg USP1663063 2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hydrochloride USP1663700 Thiostrepton 200 mg USP1664000 Thiotepa 500 mg USP1665003 Thiothixene 250 mg USP1667100 Thonzonium Bromide 200 mg USP1667213 Thymol 500 mg USP1667280 Tiagabine Hydrochloride 300 mg Tiagabine Related Compound A 15 mg USP1667224 (R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, HCl USP1667355 Tiamulin 100 mg USP1667290 Tiamulin Fumarate 250 mg Tiamulin Related Compound A 50 mg USP1667337 Tosyl pleuromutilin USP1667304 Ticarcillin Monosodium Monohydrate 350 mg USP1667144 Ticlopidine HCl 150 mg Ticlopidine Related Compound A 20 mg USP1667155 4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine Ticlopidine Related Compound B 20 mg USP1667166 5-(2-chlorobenzyl)4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine USP1667359 Tiletamine HCl 200 mg USP1667370 Tilmicosin 250 mg USP1667406 Timolol Maleate 200 mg USP1667520 Tinidazole 200 mg Tinidazole Related Compound A 100 mg USP1667530 2-methyl-5-nitroimidazole Tinidazole Related Compound B 20 mg USP1667541 (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole) USP1667439 Tioconazole 200 mg Tioconazole Related Compound A 25 mg USP1667450 1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole HCl Tioconazole Related Compound B 25 mg USP1667461 1-[2,4-Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole HCl Tioconazole Related Compound C 25 mg USP1667472 1-[2,4-Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole HCl USP1667585 Titanium Dioxide (AS) 1 g USP1667905 Tizanidine Hydrochloride 200 mg Tizanidine Related Compound A 50 mg USP1667916 4-amino-5-chloro-2,1,3-benzothiadiazole Tizanidine Related Compound B 50 mg USP1667924 N-acetyltizanidine Tizanidine Related Compound C 50 mg USP1667938 1-acetylimidazolidine-2-thione USP1667508 Tobramycin 350 mg USP1667552 Tocainide HCl 125 mg USP1668001 Tolazamide 200 mg USP1669004 Tolazoline HCl 300 mg USP1670003 Tolbutamide 200 mg USP1670207 Tolcapone 200 mg Tolcapone Related Compound A 25 mg USP1670218 4'-methyl-3,4-dihydroxybenzophenone

Edition 2014 Visit us at www.lgcstandards.com 151

United States Pharmacopeia and National Formulary

Code Product Unit Tolcapone Related Compound B 25 mg USP1670229 4-hydroxy-3-methoxy-4'-methyl-5-nitrobenzophenone USP1670502 Tolmetin Sodium 500 mg USP1671006 Tolnaftate 200 mg USP1672100 Tomato Extract Containing Lycopene 1 g USP1672206 150 mg Topiramate Related Compound A 25 mg USP1672210 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose USP1672257 Topotecan Hydrochloride 350 mg Topotecan Related Compound A 25 mg (S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H- USP1672268 pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Topotecan Related Compound C 25 mg USP1672280 (S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione USP1672304 Torsemide 200 mg Torsemide Related Compound A 75 mg USP1672315 4-[(3-methylphenyl)amino]-3-pyridinesulfonamide Torsemide Related Compound B 75 mg USP1672326 N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide Torsemide Related Compound C 30 mg USP1672337 N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide Torsemide Related Compound E 20 mg USP1672359 4-m-tolyl-2H-pyrido[4,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide USP1672600 Tramadol HCl 100 mg Tramadol Related Compound A 25 mg USP1672610 (+/-)-trans-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol hydrochloride Tramadol Related Compound B 25 mg USP1672621 2-(dimethylaminomethyl)-1-cyclohexanone hydrochloride USP1672687 Trandolapril 125 mg Trandolapril Related Compound A 25 mg (2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic USP1672698 acid 1-methyl ester Trandolapril Related Compound C 25 mg (2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-cyclohexylpropyl]-L-alanyl]hexahydro-2- USP1672701 indolinecarboxylic acid 1-ethyl ester HCl Trandolapril Related Compound D 25 mg (S)-ethyl 2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]- USP1672712 4-phenylbutanoate USP1672745 Tranexamic Acid 200 mg Tranexamic Acid Related Compound C 15 mg USP1672756 (RS)-4-(aminomethyl)cyclohex-1-enecarboxylic acid USP1672803 Transplatin 25 mg Tranylcypromine Related Compound A 40 mg USP1672916 (+/-)-cis-2-phenylcyclopropanamine HCl; cis-tranylcypromine HCl Tranylcypromine Related Compound B 40 mg USP1672927 trans-3-phenylallylamine hydrochloride; cinnamylamine hydrochloride USP1672905 Tranylcypromine Sulfate 125 mg USP1673001 Travoprost 3 mL Travoprost Related Compound A 1.5 mL (5Z,13E)-(9S,11R,15R)-9,11,15-trihydroxy-16-(m-trifluoromethylphenoxy)-17,18,19,20- USP1673012 tetranor-5,13-prostadienoic acid USP1673500 Trazodone HCl 200 mg Trazodone Related Compound C 20 mg 2-{3-[4-(4-chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one USP1673533 hydrochloride Trazodone Related Compound D 20 mg (2-{3-[4-(3-bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one USP1673544 hydrochloride) Trazodone Related Compound F 25 mg USP1673566 1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride

152 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1673715 Trehalose 400 mg USP1673828 Acetate Controlled Substance CIII 200 mg USP1673839 System Suitability Mixture Controlled Substance CIII 30 mg USP1674004 Tretinoin 5x30 mg USP1675007 Triacetin 1 g USP1676000 Triamcinolone 250 mg USP1677002 Triamcinolone Acetonide 500 mg USP1678005 350 mg USP1679008 Triamcinolone Hexacetonide 200 mg USP1680007 Triamterene 200 mg Triamterene Related Compound A 50 mg USP1680018 2,4,6-triamino-5-nitrosopyrimidine Triamterene Related Compound B 50 mg USP1680029 2,7-diamino-4-hydroxy-6-phenylpteridine Triamterene Related Compound C 50 mg USP1680030 2,4,diamino-7-hydroxy-6-phenylpteridine USP1680506 Triazolam CIV 200 mg USP1087031 Tribasic Calcium Phosphate (AS) 1 g USP1680608 Tributyl Citrate 500 mg USP1680685 Tributyl Phosphine Oxide 25 mg USP1680801 Trichlorfon 200 mg USP1681000 Trichlormethiazide 200 mg USP1681800 (200 mg) 200 mg Triclocarban Related Compound A 15 mg USP1681815 1,3-Bis(4-chlorophenyl)urea Triclocarban Related Compound C 15 mg USP1681845 1,3-Bis(3,4-dichlorophenyl)urea Triclocarban Related Compound D Mixture 15 mg Mixture of 3,5-Bis(4-chlorophenyl)-1-(3,4-dichlorophenyl)biuret and 1,5-Bis(4-chlorophenyl)- USP1681856 3-(3,4-dichlorophenyl)biuret USP1682206 200 mg USP1682217 Triclosan Related Compounds Mixture A 3x1.2 mL USP1683005 Tridihexethyl Chloride 200 mg USP1683504 Trientine HCl 200 mg USP1683606 Triethyl Citrate 500 mg Triethylamine 4 x 2 mL USP1683559 N,N-diethylethanamine USP1683708 Triethylene Glycol 0.5 mL USP1685000 Trifluoperazine HCl 200 mg USP1686003 Triflupromazine HCI 200 mg USP1686309 Trifluridine 100 mg Trifluridine Related Compound A 10 mg USP1686310 5-Carboxy-2'-deoxyuridine USP1687006 Trihexyphenidyl HCl 200 mg USP1689001 Trimeprazine Tartrate 200 mg USP1690000 Trimethadione 200 mg USP1692006 Trimethobenzamide HCl 200 mg USP1692505 Trimethoprim 300 mg Trimethoprim Related Compound A 25 mg USP1692516 4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol (AS) Trimethoprim Related Compound B 25 mg USP1692527 (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone (AS) USP1692709 Trimipramine Maleate 100 mg Trimipramine Related Compound A 25 mg USP1692710 Dehydro trimipramine

Edition 2014 Visit us at www.lgcstandards.com 153

United States Pharmacopeia and National Formulary

Code Product Unit USP1693009 Trioxsalen 200 mg USP1695004 Tripelennamine HCl 200 mg USP1695343 Triphenylmethanol 50 mg USP1696007 Triprolidine HCl 300 mg USP1696109 Triprolidine HCl Z-Isomer 50 mg USP1696200 Trisalicylic Acid 100 mg USP1696153 Tritricosanoin 50 mg USP1696958 Trolamine 3 mL USP1698002 Tromethamine 125 mg USP1699005 Tropicamide 200 mg USP1699300 Trospium Chloride 100 mg Trospium Chloride Related Compound A 20 mg USP1699311 Benzillic Acid Trospium Chloride Related Compound B 20 mg USP1699322 (1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl-hydroxydiphenylacetate Trospium Chloride Related Compound C 20 mg USP1699333 Azoniaspironortropanol chloride USP1700002 Trypsin Crystallized 300 mg Tryptophan Related Compound A 15 mg USP1700512 1,1'-ethylidene-bis-(L-tryptophan) Tryptophan Related Compound B 25 mg USP1700523 N-Acetyl-L-Tryptophan USP1702008 Tubocurarine Chloride 250 mg USP1703805 Tylosin 250 mg USP1703850 Tylosin Tartrate 100 mg USP1704003 Tyloxapol 600 mg USP1705301 Ubidecarenone 200 mg USP1705312 Ubidecarenone for System Suitability 25 mg Ubidecarenone Related Compound A 15 mg USP1705323 Coenzyme Q 9 USP1705505 Undecylenic Acid 200 mg USP1705753 Uracil 15 mg USP1705800 Uracil Arabinoside 50 mg USP1706698 Urea 200 mg USP1706701 Urea C 13 150 mg USP1707114 Uridine 15 mg USP1707806 Ursodiol 125 mg USP1707770 Ursolic Acid 25 mg USP1707839 Valacyclovir HCl 200 mg Valacyclovir Related Compound C 10 mg USP1707855 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate HCl Valacyclovir Related Compound D 15 mg USP1707861 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate Valacyclovir Related Compound E 25 mg 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy]carbonyl]-L- USP1707872 valinate Valacyclovir Related Compound F 25 mg USP1707883 2-hydroxyethyl valinate para-toluenesulfonate salt Valacyclovir Related Compound G 50 mg USP1707894 N,N-dimethylpyridin-4-amine USP1707908 15 mg USP1708004 Valganciclovir HCl 500 mg USP1708707 Valproic Acid 500 mg Valproic Acid Related Compound A 0.25 mL USP1708729 Diallylacetic Acid

154 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit Valproic Acid Related Compound B 25 mg USP1708718 (2RS)-2-(1-methylethyl) pentanoic acid (AS) USP1708730 Valrubicin 100 mg Valrubicin Resolution Mixture 25 mg USP1708751 Valrubicin spiked with seven related substance USP1708762 Valsartan 350 mg Valsartan Related Compound A 10 mg USP1708773 (R)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)-biphenyl-4-yl]-methyl)-valine Valsartan Related Compound B 10 mg USP1708784 (S)-N-butyryl-N-{[2'-(1-H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine Valsartan Related Compound C 10 mg USP1708795 (S)-N-valeryl-N-([2'-(1-H-tetrazole-5-yl)-biphenyl-4-yl]methyl)-valine benzyl ester USP1709018 Vancomycin B with Monodechlorovancomycin 300 mg USP1709007 Vancomycin HCl 4 vials USP1710006 Vanillin 200 mg USP1711009 Vanillin Melting Point Standard (Approximately 82°C) 1 g USP1711031 Vasicine 20 mg Vasopressin 1.70 mg USP1711100 8-L-arginine vasopressin USP1711155 Vecuronium Bromide 50 mg Vecuronium Bromide Related Compound A 25 mg USP1711166 3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan Vecuronium Bromide Related Compound B 15 mg Piperidinium,1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1- USP1711177 piperidinyl)androstan-16-yl]-1-methyl bromide Vecuronium Bromide Related Compound C 15 mg [Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1- USP1711188 piperidinyl)androstan-16-yl]-1-methyl bromide] Vecuronium Bromide Related Compound F 15 mg Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1- USP1711224 piperidinyl)androstan-16-yl]-1-methyl bromide USP1711268 Venlafaxine HCl 100 mg Venlafaxine Related Compound A 10 mg USP1711279 1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride USP1711202 Verapamil HCl 200 mg Verapamil Related Compound A 50 mg 3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)- USP1711304 benzeneacetonitrile monoHCl Verapamil Related Compound B 50 mg alpha-[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxy-alpha-(1- USP1711406 methylethyl)-benzeneacetonitrile monohydrochloride Verapamil Related Compound D 50 mg 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1- USP1711428 methylethyl)pentanenitrile]hydrochloride Verapamil Related Compound E 50 mg USP1711439 3,4-dimethoxybenzaldehyde Verapamil Related Compound F 150 mg USP1711440 3,4-Dimethoxybenzyl alcohol USP1711461 Verteporfin 200 mg Verteporfin Related Compound A 50 mg (+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H- USP1711472 benzo[b]prophine-9,13-dipropanoic Acid USP1711508 Vidarabine 200 mg USP1712001 Vigabatrin 100 mg Vigabatrin Related Compound A 50 mg USP1712012 5-vinylpyrrolidin-2-one Vigabatrin Related Compound B 30 mg USP1712023 (E)-2-(2-aminoethyl)bu-2-enoic acid HCl Vigabatrin Related Compound E 30 mg USP1712045 2-(2-aminobut-3-enyl)malonic acid

Edition 2014 Visit us at www.lgcstandards.com 155

United States Pharmacopeia and National Formulary

Code Product Unit USP1713004 Vinblastine Sulfate 50 mg USP1714007 Vincristine Sulfate 50 mg USP1714018 Vincristine Sulfate (Assay) (29.8 mg/vial) 30 mg Vinorelbine Related Compound A 25 mg USP1714528 4-O-Deacetylvinorelbine Tartrate USP1714506 Vinorelbine Tartrate 200 mg USP1714608 Vinpocetine 100 mg Vinpocetine Related Compound A 30 mg Ethyl(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H- USP1714619 indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate Vinpocetine Related Compound B 30 mg Methyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13bhexahydro-1H-indolo[3,2,1- USP1714620 de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate Vinpocetine Related Compound C 30 mg Ethyl(13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1- USP1714641 de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate Vinpocetine Related Compound D 30 mg Ethyl(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13boctahydro-1H-indolo[3,2,1- USP1714652 de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate USP1715000 Viomycin Sulfate 200 mg USP1717504 Vitamin D Assay System Suitability 1.5 g USP1717708 Vitexin 25 mg USP1718008 Voriconazole 100 mg Voriconazole Related Compound A 10 mg (2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2- USP1718019 ol Voriconazole Related Compound B 10 mg USP1718020 (2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Voriconazole Related Compound C 10 mg USP1718039 1(2,-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone Voriconazole Related Compound D 10 mg USP1718041 (2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-,1,2,4-triazol-1-yl)butan-2-ol Voriconazole Related Compound F 50 mg USP1718063 {(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1yl}methanesulphonic acid USP1719000 Warfarin 200 mg Warfarin Related Compound A 50 mg USP1719102 3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one USP1719500 Withanolide A 15 mg USP1719532 Withanoside IV 15 mg USP1720000 Xanthanoic Acid 100 mg USP1720203 Xanthone 100 mg USP1720407 Xylazine 200 mg USP1720429 Xylazine HCl 200 mg USP1720600 Xylitol 1 g USP1721002 Xylometazoline HCl 250 mg USP1722005 Xylose 1 g USP1724000 Yohimbine HCl 200 mg USP1724306 Zalcitabine 200 mg Zalcitabine Related Compound A 50 mg USP1724317 2',3'-Didehydro-2',3'-dideoxycytidine USP1724350 CIV 200 mg Zaleplon Related Compound A 15 mg (E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide USP1724361 Controlled Substance CIV Zaleplon Related Compund B 15 mg N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide USP1724372 Controlled Substance CIV USP1724088 Zanamivir 200 mg

156 Visit us at www.lgcstandards.com Edition 2014

United States Pharmacopeia and National Formulary

Code Product Unit USP1724077 Zanamivir Related Compounds Mixture 2.5 mg USP1724066 Zanamivir Resolution Mixture (Mixture of zanamivir and talo-zanamivir) 0.25 mg USP1724500 Zidovudine 400 mg Zidovudine Related Compound B 25 mg USP1724521 3'-chloro-3'-deoxythymidine Zidovudine Related Compound C 100 mg USP1724532 thymine Zidovudine Related Compound D 50 mg USP1724543 [1-(2-Deoxy-beta-D-ribofuranosyl)]thymine USP1724656 Zileuton 150 mg Zileuton Related Compound A 50 mg USP1724667 N-(1-Benzo[b]thien-2-ylethyl)urea Zileuton Related Compound B 50 mg USP1724678 2-(Benzo[b]thien-2-oyl)benzo[b]thiophene Zileuton Related Compound C 50 mg USP1724689 1-Benzo[b]thien-2-ylethanone USP1724747 Zinc Oxide (AS) 2 g USP1724769 Zinc Sulfate (AS) 1 g USP1724408 Ziprasidone HCl 200 mg Ziprasidone Related Compound A 10 mg USP1724419 3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride Ziprasidone Related Compound B 10 mg USP1724420 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione Ziprasidone Related Compound C 10 mg 5,5'-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6'-dichloro-3-hydroxy-3,3'- USP1724441 biindoline-2,2'-dione Ziprasidone Related Compound D 10 mg 3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6- USP1724452 chloroindolin-2-one USP1724805 Zolazepam HCl 500 mg USP1724827 Zoledronic Acid 150 mg Zoledronic Acid Related Compound A 30 mg USP1724838 2-(1H-Imidazol-1-yl)acetic acid USP1727009 Zolmitriptan 150 mg Zolmitriptan Related Compound A 20 mg USP1727020 (S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one Zolmitriptan Related Compound B 20 mg USP1727031 (S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol Zolmitriptan Related Compound D 20 mg USP1727053 (S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate Zolmitriptan R-Isomer 20 mg USP1727018 (R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one USP1724893 Zolpidem Controlled Substance CIV 10 mg USP1724951 Zolpidem Impurities Mixture CIV 15 mg Zolpidem Related Compound A 15 mg N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide USP1724918 Controlled Substance CIV USP1724907 Zolpidem Tartrate Controlled Substance CIV 200 mg USP1725003 Zonisamide 200 mg Zonisamide Related Compound A 20 mg USP1725014 1,2-benzisoxazole-3-methanesulfonic acid sodium salt Zonisamide Related Compound C 20 mg USP1725036 N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide Zopiclone R-Isomer CIV 10 mg (-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo{3,4-b]pyrazin-5-yl 4- methylpiperazine-1-carboxylate USP1729118

Edition 2014 Visit us at www.lgcstandards.com 157

ATCC microbiology products ATCC microbiology products As a scientist you know the importance of using the best materials to support your quality control programme. As Europe’s only officially authorized distributor of ATCC cultures, LGC Standards can supply all ATCC organisms specified in the pharmacopoeia. ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never subcultured or transferred in any way from ATCC’s strains and our European stock- holding means orders are usually filled within 3 - 5 working days. So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with authentic, high-quality ATCC materials – exclusively from LGC Standards.

US Pharmacopeia 37, monographs and general chapters

Code Product Unit Oil- and water-soluble vitamins with minerals tablets Monograph ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp. ATCC-8014 Lactobacillus plantarum 17-5 amp. ATCC-8042 Pediococcus acidilactici amp. Penicillamine Monograph ATCC-9341 Kocuria rhizophila amp. Penicillin G Procaine and novobiocin sodium intramammary infusion...... ATCC-12692 Staphylococcus aureus ss.aureus amp. Sargraostim Monograph ATCC-CRL-2003 TF-1 Cells amp. Tetracycline hydrochloride and novobiocin sodium tablets Monograph ATCC-10536 Escherichia coli amp. ATCC-29737 Staphylococcus aureus ss. aureus amp. Water-soluble vitamins capsules Monograph ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp. ATCC-8014 Lactobacillus plantarum 17-5 amp. ATCC-8042 Pediococcus acidilactici amp. <51> Antimicrobial effectiveness testing ATCC-16404 Aspergillus niger amp. ATCC-10231 Candida albicans amp. ATCC-8739 Escherichia coli amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. <55> Biological indicator for dry-heat sterilization, paper carrier ATCC-9372** Bacillus subtilis amp. <55> Biological indicator for ethylene oxide sterilization, paper carrier ATCC-9372** Bacillus subtilis amp. <55> Biological indicator for steam sterilization, paper carrier ATCC-7953** Bacillus stearothermophilus amp. ATCC-12980 Bacillus stearothermophilus amp. <55> Biological indicator for steam sterilization, self contained ATCC-7953** Bacillus stearothermophilus amp. ATCC-12980 Bacillus stearothermophilus amp. <61> Microbiological examination of nonsterile products: Microbial enumberation tests

158 Visit us at www.lgcstandards.com Edition 2014

US Pharmacopeia 37, monographs and general chapters

Code Product Unit ATCC-16404 Aspergillus niger amp. ATCC-6633 Bacillus subtilis amp. ATCC-10231 Candida albicans amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. <62> Microbiological examination of nonsterile products: Tests for specified microorganisms ATCC-10231 Candida albicans amp. ATCC-11437 Clostridium sporogenes amp. ATCC-19404 Clostridium sporogenes amp. ATCC-8739 Escherichia coli amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-14028 Salmonella enterica subsp. enterica serovar Typhimurium Amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. <63> Mycoplasma tests ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp. ATCC-19989 Mycoplasma fermentans; PG18 G Amp. ATCC-19610 Mycoplasma gallisepticum amp. ATCC-17981 Mycoplasma hyorhinis Switzer amp. ATCC-23714 Mycoplasma orale amp. ATCC-15531 Mycoplasma pneumoniae amp. ATCC-25204 Mycoplasma synoviae amp. ATCC-29747 Spiroplasma citri Each <71> Sterility tests ATCC-16404 Aspergillus niger amp. ATCC-6633 Bacillus subtilis amp. ATCC-8482 Bacteroides vulgatus amp. ATCC-10231 Candida albicans amp. ATCC-11437 Clostridium sporogenes amp. ATCC-19404 Clostridium sporogenes amp. ATCC-9341 Kocuria rhizophila amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. <81> Antibiotics microbial assays ATCC-6633 Bacillus subtilis amp. ATCC-4617 Bordetella bronchiseptica amp. ATCC-10541 Enterococcus hirae (as Streptococcus faecalis) amp. ATCC-10536 Escherichia coli amp. ATCC-10031 Klebsiella pneumoniae ss. pneumoniae amp. ATCC-9341 Kocuria rhizophila amp. ATCC-10240 Micrococcus luteus amp. ATCC-607 Mycobacterium smegmatis amp. ATCC-25619 Pseudomonas aeruginosa amp. ATCC-2601 Saccharomyces cerevisiae amp. ATCC-9763 Saccharomyces cerevisiae amp. ATCC-9144 Staphylococcus aureus ss. aureus amp. ATCC-29737 Staphylococcus aureus ss. aureus amp. ATCC-12228 Staphylococcus epidermidis amp. <87> Biological reactivity tests, in-vitro amp ATCC-CCL-1 L-929 mammalian fibroblasts NCTC Clone 929 amp.

Edition 2014 Visit us at www.lgcstandards.com 159

US Pharmacopeia 37, monographs and general chapters

Code Product Unit <90> Fetal bovine serum - Quality attributes and functionality tests ATCC-CCL-153 HFL1; Fetal Lung Fibroblast; Human (Homo sapiens) Amp. ATCC-CCL-64 Mv 1 Lu (NBL-7) Amp. ATCC-CCL-240 HL-60; Promyelocytic Leukemia; Human (Homo sapiens) Amp. ATCC-CCL-81 Vero cells amp. <91> Calcium pantothenate assay ATCC-8014 Lactobacillus plantarum 17-5 amp. <92> Growth factors and cytokines used in cell therapy manufacturing ATCC-CRL-2003 TF-1 Cells amp. <115> Dexpanthenol assay ATCC-8042 Pediococcus acidilactici amp. <171> Vitamin B12 activity assay ATCC-7830 Lactobacillus delbrueckii ss. lactis (as L.Leichmannii) amp. <441> Niacin or niacinamide assay ATCC-8014 Lactobacillus plantarum 17-5 amp. <1046> Analytical methodologies ATCC-VR-1448 Hybrid Moloney Amphotropic murine leukemia virus amp. ATCC-VR-1450 Hybrid Moloney Amphotropic murine leukemia virus amp. <1047> Gene therapy products ATCC-VR-1450 Hybrid Moloney Amphotropic murine leukemia virus amp. <1072> Disinfectants and antiseptics ATCC-16404 Aspergillus niger amp. ATCC-19659 Bacillus subtilis Amp. ATCC-2091 Candida albicans amp. ATCC-10231 Candida albicans amp. ATCC-11229 Escherichia coli Amp. ATCC-15442 Pseudomonas aeruginosa Amp. ATCC-11709 Penicillium chrysogenum; Wis. 49-133 Amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. <1211> Sterilzation and sterility assurance of compendial articles ATCC-27142** Bacillus pumilus amp. ATCC-7953** Bacillus stearothermophilus amp. ATCC-9372** Bacillus subtilis amp. ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp. ATCC-14756 Serratia marcescens amp. <2021> Microbial enumeration tests - Dietary supplements ATCC-16404 Aspergillus niger amp. ATCC-6633 Bacillus subtilis amp. ATCC-10231 Candida albicans amp. ATCC-8739 Escherichia coli amp. ATCC-13311 Salmonella choleraesuis ss. choleraesuis serotype typhimurium (as Salmonella typhimurium) amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. **=Alternative strain All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia.

160 Visit us at www.lgcstandards.com Edition 2014

With links to all webshop products

British Pharmacopoeia and others

@LGCStdsPharma www.lgcstandards.com NEW PRODUCT RANGE

Can’t find an official pharmacopoeial standard? Try our new range of pharmaceutical primary standards!

The FDA Guidance for Industry on “Analytical Procedures and Methods Validation” states: “When there is no official source, a reference standard should be of the highest possible purity and be fully characterised.” LGC Standards has launched a new range of pharmaceutical primary reference standards that fulfill FDA’s and other regulation bodies’ requirements. Please see our range of primary reference standards available from stock under www.lgcstandards.com. We also provide primary standards on a customised basis. The certificate of your primary standard from LGC includes:

Detailed identity information: Detailed purity/assay data: Nuclear magnetic resonance (NMR) Assay information by accredited technique, spectrum qNMR whenever possible Infrared spectrum (IR) Confirmation by orthogonal method, e.g. Mass spectrometry data (MS) mass balance

Further information at www.lgcstandards.com

LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043

© LGC Limited, 2013. All rights reserved. LGC Standards is part of the LGC Group. 3664/LB/0713

3677_pharma_primary_standards_ad_v7.indd 1 1/14/2014 11:20:06 AM Introduction

British Pharmacopoeia (BP) (from page 167)

Background British Pharmacopoeia chemical reference substances (BPCRS) available from BP are issued under the authority of the British Pharmacopoeia Commission and are solely for use in tests and assays of the British Pharmacopoeia or the British Pharmacopoeia (Veterinary). The list in this catalogue is current at the date of printing this catalogue, and includes all available BPCRS needed to follow the current official monographs. Most BP monographs for active substances conform with the monographs issued by the European Pharmacopoeia, and so require the use of European Pharmacopoeia chemical reference substances. Details of these are to be found under the ‘European Pharmacopoeia’ section of this catalogue.

Production and certification British Pharmacopoeia reference substances and preparations are selected and verified by the BP laboratories as being suitable for the use as prescribed in the relevant monographs of the British Pharmacopoeia.

Documentation BPCRS are of two types: normal CRS for identification purposes and assay standards. Assay standards are provided with a documented assay value, determined by the BP laboratories. The BP laboratories do not make available any other BPCRS certificates of analysis or other information, in connection with the prescribed use of the BPCRS.

Controlled substances Controlled drugs are subject to import and export control restrictions. Please contact LGC Standards for details.

Shelf life, expiry dates and size units British Pharmacopoeia chemical reference substances are subjected to regular inspection and repeat analysis by BP scientific staff. Each BPCRS is, on receipt by the customer, fit for the intended use. BP supplies only current lots. Formally, all BPCRS are supplied with three months shelf life. For this reason users are advised to order only as many units as required immediately. Please note, that new lots can have different unit sizes, especially with pharmacopoeial reference standards, and LGC Standards is not responsible for such cases. If the unit size of a new batch changes, LGC Standards will provide this information to customers in new lot lists. Once opened, BP can no longer guarantee the stability of the material and any of the CRS/BRP not used should be disposed of and not kept for future use.

Email: [email protected] | Website: www.lgcstandards.com 163

3970_4Pharma_catalogue_internal_UK_pharma_v1.indd 163 6/13/2014 12:23:37 PM French Pharmacopoeia (from page 183)

Background The list of reference substances and reference spectra available from the Pharmacopée Française (PF) are issued under the authority of the PF and are solely for use in tests and assays of the Pharmacopoeia Française and Pharmacopoeia Française (Vétérinaire). All PF CRS are available in restricted quantity and orders for multiple units will be reduced to a single unit.

Proper use Reference substances from the PF are designed for specific applications, which are identified by a code number included in each product description. The user is responsible for checking the suitability of the PF CRS for any non-monograph use.

Shelf life and expiry dates French Pharmacopoeia chemical reference substances are subject to regular inspection and repeated analysis by PF scientific staff. Each PF CRS is, on receipt by the customer, fit for the intended use. The shelf life and the expiry date are not given, and PF advises that unopened vials should not be stored for a long period of time.

International Pharmacopeia (IP) (from page 184)

Background The World Health Organization (WHO) as a specialised agency of the United Nations with a primary responsibility for international health matters and public health, is the issuing body of the substances described in the International Pharmacopoeia. Progress towards better health requires international cooperation in the establishment of international standards for biological substances and pharmaceuticals. The WHO has therefore authorised the establishment and maintenance of a number of reference collections. Two are of particular interest to analysts involved in pharmaceutical and clinical measurement sciences: the collections of international biological reference substances and international chemical reference substances.

International biological reference substances The range of biological reference substances was established to provide a means of ensuring international uniformity in the designation of the potency, activity or specificity of preparations that are used in the prevention, treatment or diagnosis of human or animal diseases, and for which chemical and physical assay terms are inappropriate. WHO biological reference substances are needed for certain antibiotic and hormone assays described in a number of pharmacopoeia. You can find the WHO antibiotic standards in the ‘Complementary products’ section of this catalogue. They can be ordered conveniently from LGC Standards.

164 Email: [email protected] | Website: www.lgcstandards.com

3970_4Pharma_catalogue_internal_UK_pharma_v1.indd 164 6/13/2014 12:23:37 PM International chemical reference substances (ICRS) International chemical reference substances are established upon the advice of the WHO expert committee on specifications for pharmaceutical preparations. They are intended for use in physical and chemical tests and assays described in the specifications for quality control published in the International Pharmacopoeia (IP), or as proposed in draft monographs. The list in this catalogue is based on the current WHO information.

Proper use Whilst the primary application of ICRS is in physical and chemical tests and assays as described in the International Pharmacopoeia, ICRS do have applications in other aspects of pharmaceutical analysis where a certificate of purity is required.

Documentation Directions for use and analytical data are provided in certificates distributed with the ICRS.The certificates show how the identity and purity of the material was confirmed, and in many cases demonstrate traceability to another primary reference material. This information fulfills most of the requirements of a certification report as defined by the ISO Guides on the preparation and use of certified reference materials.

Shelf life and expiry dates International Pharmacopoeia chemical reference substances are subject to regular inspection and repeated analysis by the WHO Collaborating Centre. Each ICRS is, on receipt by the customer, suitable for the intended use. Shelf life and expiry dates are not given, and IP advises that once opened, vials should not be stored for long periods of time. Only current lots are supplied by IP. For this reason users are advised to order only as required. Once opened IP can no longer guarantee the stability of the material and any of the ICRS not used should be disposed of.

Controlled substances For information on ordering please contact LGC Standards.

Email: [email protected] | Website: www.lgcstandards.com 165

3970_4Pharma_catalogue_internal_UK_pharma_v1.indd 165 6/13/2014 12:23:37 PM Notes

166 Email: [email protected] | Website: www.lgcstandards.com

3970_4Pharma_catalogue_internal_UK_pharma_v1.indd 166 6/13/2014 12:23:37 PM British Pharmacopoeia

British Pharmacopoeia standards

Code Product Unit BP 245 (1-Methyl-5-nitroimidazol-2-yl)methanol 25 mg BP 1059 (2-amino-5-nitrophenyl)(2-chlorophenyl)methanone 20 mg BP 602 (E)-4-Amino-2-ethylidenebutyric acid hydrochloride 25 mg BP 366 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-o-tolylsulphonylurea 30 mg BP 417 2-Amino-1-(4-nitrophenyl)propane-1,3-diol 50 mg BP 012 2-Amino-4,6-Dichlorophenol hydrochloride 50 mg BP 813 2-Amino-5-chloropyridine 25 mg BP 024 2-Azahypoxanthine 50 mg BP 839 3-amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one 25 mg BP 536 3-Amino-4-phenoxy-5-sulphamoylbenzoic acid 25 mg BP 014 3-Amino-4-propoxybenzoic acid 50 mg BP 374 3-Amino-6-chloro-1-methyl-4-phenylquinolin-2-ol 50 mg BP 601 3-Aminopent-4-ene-1,1-dicarboxylic acid 25 mg BP 681 4-Acetyl 2-fluorobiphenyl 25 mg BP 010 4-Amino-6-chlorobenzene-1-3-disulphonamide 50 mg BP 011 7-Aminodesacetoxycephalosporanic acid 20 mg BP 560 9-Allyl-2-chlorothioxanthen-9-ol 25 mg BP 001 Acepromazine maleate 50 mg BP 904 Acetazolamide Assay Standard 600 mg BP 907 Acetylcysteine Assay Standard 200 mg BP 438 Aciclovir Assay Standard 100 mg BP 003 Adrenaline (epinephrine) acid tartrate Assay Standard 100 mg BP 763 Albendazole Assay Standard 100 mg BP 436 Alexandrian senna fruit powder Assay Standard 1 g BP 006 Alfadolone acetate Assay Standard 100 mg BP 007 Assay Standard 100 mg BP 825 Alfuzosin hydrochloride Assay Standard 100 mg BP 847 Alfuzosin Impurity Standard 25 mg BP 415 Alimemazine tartrate Assay Standard 100 mg BP 870 Allopurinol 200 mg BP 831 Allopurinol Impurity A 20 mg BP 832 Allopurinol Impurity B 10 mg BP 843 Allopurinol Impurity C 10 mg BP 844 Allopurinol Impurity D 10 mg BP 845 Allopurinol Impurity E 20 mg BP 882 alpha-Tocopherol Assay Standard 200 mg BP 725 Alverine citrate Assay Standard 100 mg BP 724 Alverine citrate impurity standard solution 1 mL BP 530 Amantadine hydrochloride Assay Standard 200 mg BP 853 Amikacin sulfate Assay Standard 200 mg BP 008 Amiloride hydrochloride Assay Standard 100 mg BP 684 Aminoglutethimide Assay Standard 100 mg BP 881 Aminoglutethimide impurity A 20 mg BP 956 Aminoglutethimide impurity D 10 mg BP 532 Amiodarone hydrochloride Assay Standard 100 mg BP 015 Amitraz Assay Standard 200 mg BP 016 Amitriptyline hydrochloride Assay Standard 150 mg BP 748 Amoxicillin impurity standard 25 mg BP 019 Amoxicillin Trihydrate Assay Standard 500 mg

Edition 2014 Visit us at www.lgcstandards.com 167

British Pharmacopoeia

Code Product Unit BP 021 Ampicillin trihydrate 500 mg BP 785 Anhydrous Ampicillin Assay Standard 250 mg BP 546 Apramycin 250 mg BP 694 Arginine hydrochloride Assay Standard 100 mg BP 461 Ascorbic acid 100 mg BP 617 Aspirin Assay Standard 100 mg BP 492 Atenolol Assay Standard 100 mg BP 370 Atenolol impurity standard 50 mg BP 023 Atropine sulfate Assay Standard 200 mg BP 025 Azaperone Assay Standard 100 mg BP 534 Azapropazone Assay Standard 100 mg BP 515 Azapropazone impurity A 10 mg BP 516 Azapropazone impurity B 10 mg BP 517 Azapropazone impurity C 10 mg BP 527 Azapropazone impurity standard 50 mg BP 026 Azathioprine Assay Standard 100 mg BP 037 (1S,2R)-1-benzyl-3-dimethylamino-2-methyl-1-phenylpropyl acetate 25 mg BP 531 2-Butyl-3-(4-hydroxy-3,5-di-iodobenzoyl)benzofuran 25 mg BP 441 1,4-bis(4-Chlorobenzhydryl)piperazine 25 mg 17β,17'β-bis(3-[bis-(2-chloroethyl)carbamoyloxy] 25 mg BP 049 estra-1,3,5,(10)-trienyl)pyrophosphate BP 609 1-Benzyl-1-H-indazol-3-ol 50 mg BP 611 1-Benzyl-3-(3-diethylamino-propoxy)-1H-indazole 50 mg BP 046 2-(Biphenyl-4-yl)propionic acid 25 mg BP 613 2-Bromobenzyldimethylamine hydrochloride 0.1 mL BP 028 Baclofen Assay Standard 150 mg BP 535 Baclofen lactam 25 mg BP 030 Beclometasone dipropionate Assay Standard 100 mg BP 760 Beclometasone 17-propionate 25 mg BP 761 Beclometasone 21-propionate 25 mg BP 967 Bendroflumethiazide 100 mg BP 685 Benserazide hydrochloride Assay Standard 100mg BP 968 Benserazide Impurity A 20 mg BP 036 Benzatropine mesilate Assay Standard 100 mg BP 610 Benzydamine hydrochloride Assay Standard 100 mg BP 426 Benzyl benzoate Assay Standard 0.1 mL BP 824 Betahistine dihydrochloride Assay Standard 100 mg BP 043 Betamethasone 21-valerate 50 mg BP 575 Betamethasone Assay Standard 100 mg BP 041 Betamethasone sodium phosphate 100 mg BP 042 Betamethasone valerate Assay Standard 100 mg BP 686 Betaxolol hydrochloride Assay Standard 100 mg BP 755 Bezafibrate Assay Standard 100 mg BP 815 bis-(1,7-dihydro-6H-purine)-6,6-disulfide 25 mg BP 047 Bisacodyl Assay Standard 100 mg BP 971 Bleomycin sulfate 100 mg BP 612 Bretylium tosilate Assay Standard 200 mg BP 050 Bromocriptine Mesilate Assay Standard 100 mg BP 440 Buclizine hydrochloride impurity standard 50 mg BP 793 Budesonide Assay Standard 110 mg BP 894 Budesonide impurity Standard 10 mg BP 537 Bumetanide Assay Standard 100 mg

168 Visit us at www.lgcstandards.com Edition 2014

British Pharmacopoeia

Code Product Unit BP 479 Bupivacaine hydrochloride Assay Standard 100 mg BP 403 Busulfan Assay Standard 25 mg BP 955 1-(4-Chlorophenyl)-1-phenylethanol 25 mg BP 075 2-(4-Chloro-3-sulphamoylbenzoyl)benzoic acid 25 mg BP 477 2-Carbamoyl-1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride 25 mg BP 559 2-Chlorothioxanthone 25 mg BP 079 2-Chlorotritanol 25 mg BP 478 2-Cyano-1-methyl-3-[2-(5-methylimidazol-4-yl-methylsulphinyl)ethyl]guanidine 25 mg BP 071 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide 25 mg BP 074 4-Chloro-5-sulphamoylanthranilic acid 25 mg BP 446 5-(2-Chloroethyl)-4-methyl-3-[2-(4-methylthiazol-5-yl)ethyl]thiazolium chloride 25 mg BP 965 5-Chloro-1-methyl-4-nitroimidazole 100 mg BP 378 5-Chloro-2-methylaminobenzophenone 50 mg 6-(2-Chlorophenyl)-2,4-dihydro-2-[(dimethylamino)methylene] 25 mg BP 443 8-nitroimidazo[1,2-a][1,4]benzodiazepin-1-one BP 442 6-Chloro-1,4-dihydro-1-methyl-4-phenylquinazolin-4-ol 25 mg BP 376 6-Chloro-4-(2-chlorophenyl)quinazoline-2-carboxaldehyde 50 mg BP 470 7-Chloro-1-5-dihydro-5-phenyl-1,5-benzodiazepine-2,4(3H)-dione 25 mg BP 766 Caffeine Assay Standard 100 mg BP 355 Calcitonin (salmon) Assay Standard 1 mL BP 923 Calcium folinate 100 mg BP 059 Capreomycin sulfate 50 mg BP 538 Captopril Assay Standard 100 mg BP 500 Captopril disulphide 25 mg BP 974 Carbamazepine 200 mg BP 523 Carbaryl Assay Standard 100 mg BP 060 Carbidopa Assay Standard 100 mg BP 749 Carbimazole Assay Standard 100 mg BP 711 Carboplatin Assay Standard 100 mg BP 767 Carmellose sodium Assay Standard 100 mg BP 567 Carteolol hydrochloride Assay Standard 100 mg BP 792 Cefaclor Assay Standard 450 mg BP 784 Cefadroxil Assay Standard 100 mg BP 061 Cefalexin Assay Standard 150 mg BP 562 Cefalonium Assay Standard 100 mg BP 908 Cefalotin Sodium 100 mg BP 819 Cefazolin Sodium 150 mg BP 820 Cefoxitin Sodium Assay Standard 200 mg BP 063 Cefradine Assay Standard 300 mg BP 976 Ceftriaxone sodium Assay Standard 100 mg BP 977 Ceftriaxone sodium E-isomer 10 mg BP 502 Cefuroxime axetil Assay Standard 100 mg BP 925 Cefuroxime sodium Assay Standard 150 mg BP 757 Celiprolol hydrochloride Assay Standard 100 mg BP 837 Cetirizine hydrochloride 100 mg BP 1081 Cetirizine impurity standard 50 mg BP 926 Chenodeoxycholic acid 25 mg BP 064 Chlorambucil Assay Standard 100 mg BP 854 Chloramphenicol Assay Standard 500 mg BP 1061 Chloramphenicol sodium succinate 1500 mg BP 067 Chlorcyclizine hydrochloride 100 mg BP 068 Chlorhexidine acetate Assay Standard 100 mg

Edition 2014 Visit us at www.lgcstandards.com 169

British Pharmacopoeia

Code Product Unit BP 076 Chlorothiazide 100 mg BP 080 Chloroxylenol Assay Standard 500 mg BP 081 Chlorphenamine maleate Assay Standard 100 mg BP 856 Chlorpromazine hydrochloride 50 mg BP 467 Chlorpromazine sulphoxide 50 mg BP 491 Chlortalidone Assay Standard 100 mg BP 783 Chlortetracycline hydrochloride Assay Standard 100 mg BP 787 Cholecalciferol Assay Standard 500 mg BP 618 Cholic acid Assay Standard 100 mg BP 475 Cimetidine Assay Standard 100 mg BP 929 Ciprofloxacin Hydrochloride Assay Standard 100 mg BP 930 Ciprofloxacin impurity standard 10 mg BP 597 cis-Flupenthixol propionate dihydrochloride 100 mg BP 738 cis-Flupentixol 25 mg BP 809 Cisplatin Assay Standard 100 mg BP 833 Clarithromycin Assay Standard 100 mg BP 834 Clarithromycin impurity E 20 mg BP 525 Clemastine fumarate Assay Standard 200 mg BP 084 Clioquinol Assay Standard 200 mg BP 507 Clobazam Assay Standard Controlled Substance 100 mg BP 522 Clobetasol impurity A 25 mg BP 521 Clobetasol propionate Assay Standard 100 mg BP 482 Clobetasone butyrate Assay Standard 100 mg BP 406 Clocortolone hexanoate 100 mg BP 663 Clofazimine Assay Standard 100 mg BP 543 edisilate Assay Standard 100 mg BP 980 Clomipramine hydrochloride 100 mg BP 981 Clomipramine impurity C 10 mg BP 982 Clomipramine impurity D 10 mg BP 983 Clomipramine Impurity F 10 mg BP 484 Clonazepam Assay Standard 100 mg BP 085 Clonidine hydrochloride Assay Standard 100 mg BP 628 Cloprostenol sodium Assay Standard 50 mg BP 379 Clotrimazole Assay Standard 50 mg BP 088 Cloxacillin benzathine Assay Standard 250 mg BP 089 Cloxacillin sodium Assay Standard 125 mg BP 905 Clozapine Assay Standard 100 mg BP 715 Cocaine hydrochloride Assay Standard 100 mg BP 514 Codeine hydrochloride Assay Standard Controlled Substance 100 mg BP 090 Codeine Phosphate Assay Standard Controlled Substance 200 mg BP 091 Co-dergocrine mesilate Assay Standard 50 mg BP 614 Colestipol hydrochloride 50 mg BP 551 Colestyramine Assay Standard 500 mg BP 585 Cortisone acetate Assay Standard 100 mg BP 094 Crotamiton Assay Standard 100 mg BP 466 Cyanocobalamin Assay Standard 150 mg BP 096 Cyclizine hydrochloride Assay Standard 100 mg BP 886 Cyclobenzaprine hydrochloride 25 mg BP 098 Cyclopenthiazide 100 mg BP 380 Cyclopentolate hydrochloride Assay Standard 100 mg BP 688 Cyproterone acetate Assay Standard 100 mg BP 383 Cytarabine Assay Standard 100 mg

170 Visit us at www.lgcstandards.com Edition 2014

British Pharmacopoeia

Code Product Unit BP 721 1-(2,5-Dichlorophenyl)-5-isopropylbiguanide hydrochloride 25 mg BP 456 1,5-Dimethylhexyl(methyl)amine 50 mg BP 364 2,2-Dimethyl-5(2,4-xylyloxy)valeric acid 25 mg BP 122 2,3-Dihydro-6-phenylimidazo [2,1-b] thiazole 50 mg BP 361 2-Diethylaminoethyl-3-(1-naphthyl)-2-(1-naphthylmethyl)propionate oxalate 25 mg BP 608 3-(1,5-Dibenzyl-1H-indazole-3-yl)oxypropyl dimethylamine hydrochloride 25mg 3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylaminopropan-1-amine-S-oxide 25 mg BP 124 hydrochloride BP 607 3-Dimethylaminopropyl 2-benzylaminobenzoate hydrochloride 25 mg BP 195 4-Dimethylamino-3-methyl-1,2-diphenylbutan-2-ol hydrochloride 25 mg BP 100 Dacarbazine 25 mg BP 829 D-alpha-(4-hydroxyphenyl)glycine 50 mg BP 771 Dantrolene Assay Standard 100 mg BP 428 Dantron 50 mg BP 429 Dantron impurity standard 100 mg BP 102 Dapsone Assay Standard 100 mg BP 103 Debrisoquine sulfate 100 mg BP 104 Decoquinate 50 mg BP 791 Delta-3-Cefaclor 20 mg BP 572 Deltamedrane 25 mg BP 631 Deltamethrin Assay Standard 100 mg BP 632 Deltamethrin impurity standard 40 mg BP 789 Demeclocycline hydrochloride Assay Standard 100 mg BP 504 Desacetylmetipranolol 25 mg BP 987 Desferrioxamine mesilate 30 mg BP 931 Desipramine hydrochloride 100 mg BP 689 Desmethyl benzatropine hydrochloride 50 mg BP 568 Desogestrel Assay Standard 100 mg BP 816 Desogestrel impurity D 25 mg BP 817 Desogestrel impurity E 25 mg BP 578 Dexamethasone Assay Standard 100 mg BP 811 Dexamethasone impurity standard 25 mg BP 646 Dexamethasone phosphate Assay Standard 100 mg BP 108 Dexamethasone sodium phosphate 100 mg BP 465 Dextropropoxyphene HCl Assay Standard 100 mg BP 549 Diacetylfluorescein Assay Standard 200 mg BP 887 Diamorphine Hydrochloride Assay Standard 150 mg BP 111 Diazepam 100 mg BP 114 Dibenzo[b,e]thiepin-11(6H)-one 25 mg BP 858 Dibenzosuberone 100 mg BP 116 Dichlorophen Assay Standard 100 mg BP 420 Dichlorophen impurity standard Assay Standard 100 mg BP 598 Diclofenac diethylamine 100 mg BP 828 Diclofenac impurity A 25 mg BP 619 Diclofenac sodium Assay Standard 100 mg BP 810 Dicloxacillin sodium 250 mg BP 989 Dicycloverine hydrochloride 100 mg BP 118 Diethanolamine fusidate Assay Standard 100 mg BP 677 Diethylstilbestrol monophosphate 25 mg BP 119 Diethyl-4-decyloxy-3-ethoxyanilinomethylenemalonate 50 mg BP 737 Diethylcarbamazine citrate 100 mg BP 859 Diethylstilbestrol Assay Standard 100 mg

Edition 2014 Visit us at www.lgcstandards.com 171

British Pharmacopoeia

Code Product Unit BP 401 valerate Assay Standard 100mg BP 397 impurity standard 25 mg BP 855 Digitoxin Assay Standard 250 mg BP 431 Dihydrocodeine Tartrate Assay Standard Controlled Substance 100 mg BP 120 Dihydroergocristine mesilate 25 mg BP 726 Diltiazem HCl 100 mg BP 899 Diltiazem Impurity Standard 25 mg BP 511 Dimethyl{5-[2-(1-methylamino-2-nitrovinylamino) ethylsulphinylmethyl]furfuryl}amine 25 mg BP 865 Dimethyl-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate 25 mg BP 866 Dimethyl-2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate 25 mg BP 690 Dimpylate Assay Standard 100 mg BP 691 Dimpylate for chromatography 0.1 mL BP 902 Dinoprostone Assay Standard 100 mg BP 896 Diphenhydramine hydrochloride 100 mg BP 128 hydrochloride Assay Standard 100 mg BP 673 Dipivefrine hydrochloride Assay Standard 100 mg BP 659 Dipivefrine impurity standard 100 mg BP 589 Assay Standard 100 mg BP 131 Dipyridamole Assay Standard 100 mg BP 615 Disodium pamidronate Assay Standard 100 mg BP 132 Disulfiram Assay Standard 50 mg BP 385 Dithranol Assay Standard 100 mg BP 386 Dithranol dimer*) 50 mg BP 674 Dobutamine hydrochloride Assay Standard 100 mg BP 133 Docusate sodium Assay Standard 200 mg BP 669 Domperidone maleate Assay Standard 100 mg BP 468 Dopamine hydrochloride Assay Standard 100 mg BP 1069 Dorzolamide hydrochloride 100 mg BP 1070 Dorzolamide impurity B 25 mg Dorzolamide impurity D 25 mg BP 1071 (4S,6S)-4-amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide BP 134 Dosulepin hydrochloride Assay Standard 100 mg BP 135 Doxapram hydrochloride Assay Standard 100 mg BP 136 Doxepin hydrochloride Assay Standard 100 mg BP 823 Doxepin Impurity Standard 1 mg BP 990 Doxorubicin hydrochloride Assay Standard 100 mg BP 780 Doxycycline hyclate Assay Standard 100 mg BP 675 Droperidol Assay Standard 100 mg BP 138 Dydrogesterone 50 mg BP 871 6-Epidoxycycline hydrochloride 50 mg BP 139 Econazole nitrate Assay Standard 100 mg BP 743 Enalapril diketopiperazine 20 mg BP 741 Enalapril maleate 100 mg BP 742 Enalaprilat 20 mg BP 387 Ephedrine hydrochloride Assay Standard Drug Precursor 100 mg BP 992 Epirubicin hydrochloride 100 mg BP 788 Ergocalciferol Assay Standard 500 mg BP 405 Ergometrine maleate Assay Standard Drug Precursor 100 mg BP 141 Ergotamine tartrate Assay Standard Drug Precursor 50 mg BP 781 Erythromycin 50 mg BP 794 Erythromycin A Assay Standard 250 mg BP 795 Erythromycin B Assay Standard 50 mg

172 Visit us at www.lgcstandards.com Edition 2014

British Pharmacopoeia

Code Product Unit BP 796 Erythromycin C Assay Standard 50 mg BP 790 Erythromycin estolate 100 mg BP 798 Erythromycin ethyl succinate 50 mg BP 488 Erythromycin stearate Assay Standard 100 mg BP 396 Estradiol benzoate Assay Standard 50 mg BP 729 Estradiol hemihydrate Assay Standard 100 mg BP 142 25 mg BP 752 Estriol Assay Standard 100 mg BP 753 Estriol impurity standard 25 mg BP 860 Estrone 25 mg BP 616 Estropipate Assay Standard 100 mg BP 143 Etacrynic acid Assay Standard 100 mg BP 421 Ethinylestradiol Assay Standard 100 mg BP 145 Ethopabate Assay Standard 100 mg BP 146 Ethosuximide Assay Standard 200 mg BP 149 Ethyl meclofenamate 25 mg BP 541 Etodolac 1-methyl analogue 10 mg BP 542 Etodolac 8-methyl analogue 10 mg BP 533 Etodolac acid dimer 10 mg BP 529 Etodolac Assay Standard 150 mg BP 885 Etoposide Assay Standard 150 mg BP 163 4'-Fluoro-4-chlorobutyrophenone 0.5 mL BP 653 Famotidine Assay Standard 100 mg BP 655 Famotidine degradation impurity 1 25 mg BP 656 Famotidine degradation impurity 2 25 mg BP 654 Famotidine impurity C 25 mg BP 620 Felbinac Assay Standard 100 mg BP 777 Felodipine Assay Standard 100 mg BP 758 Felodipine impurity standard 20 mg BP 692 Fenbendazole 100 mg Fenbendazole impurity C 25 mg BP 693 {5-(phenylthio)-2-aminobenzimidazole} BP 354 Fenbufen Assay Standard 100 mg BP 661 Fenoterol degradation impurity A 25 mg BP 660 Fenoterol hydrobromide Assay Standard 100 mg BP 665 Fentanyl citrate Assay Standard 100 mg BP 666 Fentanyl impurity A 25 mg BP 156 Fenthion Assay Standard 0.25 mL BP 1095 Fexofenadine Hydrochloride 100 mg BP 740 Finasteride Assay Standard 100 mg BP 571 Flavoxate hydrochloride Assay Standard 100 mg BP 676 Flecainide acetate Assay Standard 100 mg BP 158 Flucloxacillin sodium Assay Standard 250 mg BP 159 Fludrocortisone acetate Assay Standard 50 mg BP 840 Flunitrazepam 25 mg BP 160 Fluocinolone acetonide Assay Standard 50 mg BP 489 Fluocinonide Assay Standard 100 mg BP 161 Fluocortolone hexanoate Assay Standard 50 mg BP 162 Fluocortolone pivalate Assay Standard 50 mg BP 573 Fluorometholone Assay Standard 100 mg BP 995 Fluorouracil 40 mg BP 797 Fluoxetine hydrochloride Assay Standard 250 mg

Edition 2014 Visit us at www.lgcstandards.com 173

British Pharmacopoeia

Code Product Unit BP 164 Fluoxymesterone 50 mg BP 554 Flupentixol decanoate dihydrochloride Assay Standard 100 mg BP 167 Fluphenazine hydrochloride Assay Standard 100 mg BP 574 Flurbiprofen sodium Assay Standard 100 mg BP 587 Fluticasone propionate Assay Standard 100 mg BP 588 Fluticasone S-methyl impurity 25 mg BP 600 Fluvoxamine maleate Assay Standard 100 mg BP 671 Fluvoxamine maleate impurity standard 100 mg BP 937 Folic acid Assay Standard 150 mg BP 639 Form-2',4'-xylidide 25 mg BP 997 Foscarnet Impurity B 10 mg BP 623 Foscarnet sodium Assay Standard 100 mg BP 678 sodium 50 mg BP 547 Furosemide Assay Standard 100 mg BP 643 Gallamine impurity standard 100 mg BP 363 Gemfibrozil Assay Standard 100 mg Gemfibrozil impurity A 10 mg BP 303 2,2-dimethyl-5-(4-propen-1-yl)-2,5-xylyloxy)valeric acid BP 365 Gemfibrozil methyl ester 0.1 mL BP 174 Gentamicin sulfate 25 mg BP 175 Glibenclamide Assay Standard 100 mg BP 368 Gliclazide Assay Standard 200 mg BP 580 Gliquidone Assay Standard 150 mg BP 581 Gliquidone sulphonamide 25 mg BP 652 Glyceryl trinitrate solution Assay Standard 50 mL BP 1110 Glycopyrronium bromide 100 mg BP 814 Goserelin Hexapeptide 10 mg BP 180 Griseofulvin Assay Standard 100 mg BP 181 Guanethidine monosulfate Assay Standard 100 mg BP 879 Guanine 25 mg BP 481 1-Hydroxy-9-anthrone 25 mg BP 526 2-(2-Hydroxyethyl)-1-methylpyrrolidine 100 mg BP 770 4'Hydroxyacetophenone 25 mg BP 196 5-[1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl]salicylic acid hydrochloride 50 mg BP 407 Haloperidol Assay Standard 150 mg BP 185 Homatropine hydrobromide Assay Standard 100 mg BP 186 Hydrochlorothiazide Assay Standard 200 mg BP 584 Hydrocortisone acetate Assay Standard 100 mg BP 576 Hydrocortisone Assay Standard 100mg BP 187 Hydrocortisone Hydrogen Succinate 100 mg BP 188 Hydrocortisone sodium phosphate 100mg BP 190 Hydroflumethiazide 100 mg BP 197 Hydroxycarbamide Assay Standard 200 mg BP 841 Hydroxyzine hydrochloride 100 mg BP 198 Hyoscine butylbromide Assay Standard 100 mg BP 199 Hyoscine Hydrobromide Assay Standard 200 mg BP 774 Hypromellose Assay Standard 100 mg BP 499 4'-(2-Isopropylaminoethyl)methanesulphonanilide hydrochloride 25 mg BP 557 4'-Isobutylacetophenone 100 mg BP 626 8s-Isopropyl-3β-hydroxytropanium bromide 25 mg BP 539 Ibuprofen Assay Standard 200 mg

174 Visit us at www.lgcstandards.com Edition 2014

British Pharmacopoeia

Code Product Unit Ibuprofen impurity B 1.15 mL BP 880 (2RS)-2-(4-butylphenyl)propanoic acid BP 202 Idoxuridine Assay Standard 100 mg BP 759 Ifosfamide Assay Standard 100 mg BP 664 Iminophenazine 25 mg BP 932 Imipramine hydrochloride 50 mg BP 999 Indapamide Assay Standard 150 mg BP 1000 Indapamide impurity B 10 mg BP 625 Ipratropium bromide Assay Standard 100 mg BP 550 Isoconazole nitrate Assay Standard 100 mg BP 1083 Isoniazid Assay Standard 100 mg BP 205 Isoprenaline hydrochloride Assay Standard 100 mg BP 778 Isopromethazine hydrochloride 25 mg BP 799 Isosorbide 2-nitrate 50 mg BP 206 Isosorbide dinitrate 300 mg BP 800 Isosorbide mononitrate Assay Standard 100 mg BP 621 Isradipine Assay Standard 100 mg BP 622 Isradipine impurity B 25 mg BP 624 Isradipine impurity D 25 mg BP 864 Ivermectin Assay Standard 250 mg BP 861 Kanamycin monosulfate 50 mg BP 736 Ketamine Hydrochloride Controlled Substance 100 mg BP 668 Ketoprofen Assay Standard 100 mg BP 667 Ketoprofen ethyl ester 100 mg BP 707 Lacidipine Assay Standard 100 mg BP 647 Lacidipine impurity Standard 25 mg BP 802 Lamivudine Assay Standard 200 mg BP 872 Lansoprazole Assay Standard 100 mg BP 873 Lansoprazole impurity standard 25 mg BP 212 Levamisole hydrochloride 100 mg BP 356 Levobunolol hydrochloride Assay Standard 100 mg BP 213 Levodopa Assay Standard 100 mg BP 772 Levomenthol Assay Standard 100 mg BP 723 Levomepromazine maleate Assay Standard 100 mg BP 634 Levomepromazine sulphoxide 25 mg BP 501 Levonorgestrel Assay Standard 100 mg BP 214 Lidocaine (Lignocaine) hydrochloride 50 mg BP 727 Lidocaine Assay Standard 100 mg BP 215 Lincomycin hydrochloride Assay Standard 250 mg BP 733 Linseed oil 0.5 mL BP 695 Lisinopril dihydrate Assay Standard 100 mg BP 696 Lisinopril diketopiperazine 25 mg BP 433 Lithium lactate Assay Standard 100 mg BP 927 Lithocholic acid 25 mg BP 697 Lofepramine hydrochloride Assay Standard 100 mg BP 635 Loperamide hydrochloride Assay Standard 100 mg BP 636 Loperamide N-oxide 25 mg BP 447 Loprazolam mesilate 50 mg BP 874 Loratadine Assay Standard 100 mg BP 875 Loratadine Impurity Standard 25 mg BP 434 Lorazepam Assay Standard 50 mg BP 528 Lormetazepam Assay Standard 100 mg

Edition 2014 Visit us at www.lgcstandards.com 175

British Pharmacopoeia

Code Product Unit BP 867 Losartan Potassium Assay Standard 150 mg BP 218 Lymecycline 100 mg BP 776 Lynestrenol 25 mg BP 232 1-(2-Methoxyphenyl)piperazine 25 mg BP 476 1-methyl-3-[2-(5-methylimidazol-4-yl-methylthio)ethyl]guanidine dihydrochloride 25 mg BP 605 1-Methyl-4-(2-benzoylhydrazino)azepan hydrochloride 25 mg BP 244 2-Methyl-5-Nitroimidazole 50 mg BP 457 2-Methyl-6-methylaminoheptan-2-ol 50 mg BP 239 3-Methyl-2,2-diphenyl-4-piperidinobutyronitrile 50 mg BP 569 3-Methylflavone-8-carboxylic acid 25 mg BP 570 3-Methylflavone-8-carboxylic acid ethyl ester 25 mg BP 444 4-methyl-5-(2-hydroxyethyl)thiazole 25 mg BP 445 4-Methyl-5-vinylthiazole edisilate 25 mg BP 1078 5-Methoxytryptamine 25 mg BP 1008 Mebendazole 10 mg BP 220 Meclozine hydrochloride 100 mg BP 221 Medroxyprogesterone acetate Assay Standard 100 mg BP 222 Megestrol 25 mg BP 223 Megestrol acetate Assay Standard 100 mg BP 1077 Melatonin Assay Standard 100 mg BP 629 Meloxicam Assay Standard 100 mg BP 630 Meloxicam impurity standard 100 mg BP 391 Melphalan Assay Standard 100 mg BP 699 Mepivacaine hydrochloride Assay Standard 100 mg BP 583 hydrochloride Assay Standard 100 mg BP 773 Mercaptopurine Assay Standard 100 mg BP 762 Mercaptopurine impurity standard 25 mg BP 1075 Mesalazine Assay Standard 125 mg BP 496 Mesoridazine besilate 50 mg BP 226 Metaraminol tartrate 100 mg BP 227 Metformin hydrochloride Assay Standard 100 mg BP 552 Methadone hydrochloride Assay Standard 100 mg BP 920 Methyl 3, 5-diamino-6-Chloropyrazine-2-Carboxylate 10 mg BP 644 Methyl 4-acetamido-2-hydroxybenzoate 25 mg Methyl N-4[2-(5-chloro- 25 mg BP 237 2-methoxybenzamido)ethyl]benzenesulphonyl carbamate BP 240 Methyldopa Assay Standard 100 mg BP 241 Methyldopate hydrochloride Assay Standard 100 mg BP 662 Methylphenobarbital Assay Standard 100 mg BP 249 Methylprednisolone acetate Assay Standard 200 mg BP 248 Methylprednisolone Assay Standard 100 mg BP 409 Methysergide maleate Assay Standard 50 mg BP 642 Metipranolol Assay Standard 100 mg BP 357 Metoclopramide hydrochloride Assay Standard 100 mg BP 540 Metoprolol tartrate Assay Standard 100 mg BP 603 Metronidazole Assay Standard 150 mg BP 735 Metronidazole benzoate 100 mg BP 251 Mexenone 100 mg BP 252 Mianserin hydrochloride Assay Standard 100 mg BP 884 Miconazole impurity A 25 mg BP 253 Miconazole nitrate Assay Standard 100 mg BP 722 Midazolam Assay Standard Controlled Substance 100 mg

176 Visit us at www.lgcstandards.com Edition 2014

British Pharmacopoeia

Code Product Unit BP 394 Minocycline hydrochloride Assay Standard 125 mg BP 637 Minoxidil Assay Standard 100 mg BP 842 Mirtazapine Assay Standard 100 mg BP 768 Mometasone furoate Assay Standard 100 mg BP 254 Monosulfiram 100 mg BP 648 Morphine sulphate Assay Standard Controlled Substance 100 mg BP 1109 Moxidectin 100 mg BP 804 Mupirocin lithium Assay Standard 100 mg BP 360 3-(1-Naphthyl)-2-tetrahydrofurfurylpropionic acid 25 mg BP 367 3-Nitroso-3-azabicyclo[3.3.O]octane 0.1 mL BP 640 N,N'-bis(2,4-Xylyl)formamidine 25 mg BP 384 N1,N2-Diquinoxalin-2-ylsulphanilamide 25 mg BP 358 Nabumetone Assay Standard 200 mg BP 851 Nabumetone impurity D 100 mg BP 362 Naftidrofuryl oxalate Assay Standard 100 mg BP 548 Naloxone hydrochloride Assay Standard 100 mg BP 257 Nandrolone Assay Standard Controlled Substance 100 mg BP 425 Nandrolone decanoate Controlled Substance 50 mg BP 259 Nandrolone laurate Controlled Substance 50 mg BP 260 Nandrolone Phenylpropionate Assay Standard Controlled Substance 100 mg BP 435 Naproxen Assay Standard 100 mg BP 889 N-Demethylerythromycin A 10 mg BP 730 N-Desalkylflurazepam 25 mg BP 437 N-Ethylglucamine hydrochloride 500 mg BP 460 Nicotinamide Assay Standard 100 mg BP 821 Nicotine Ditartrate unit BP 395 Nicotinyl alcohol tartrate 50 mg BP 462 Nifedipine Assay Standard 100 mg BP 651 Nimodipine Assay Standard 100 mg BP 262 Nitrazepam Assay Standard 100 mg BP 263 Nitrofurfural diacetate 50 mg BP 846 N-methyl-bis[beta-(2-pyridyl)ethyl]amine trihydrochloride 25 mg BP 641 N-Methyl-N'-(2,4-xylyl)formamidine 30 mg BP 512 Noradrenaline (norepinephrine) acid tartrate 100 mg BP 267 Norethisterone acetate Assay Standard 100 mg BP 266 Norethisterone Assay Standard 50 mg BP 670 Norfloxacin Assay Standard 100 mg BP 714 Norgestrel 100 mg BP 269 Nortriptyline hydrochloride Assay Standard 200 mg BP 756 N-p-chlorobenzoyltyramine 25 mg BP 765 Omeprazole Assay Standard 100 mg BP 805 Ondansetron for TLC system suitability 25 mg BP 808 Ondansetron hydrochloride dihydrate Assay Standard 100 mg BP 806 Ondansetron impurity standard 25 mg BP 272 Orciprenaline sulfate 100 mg BP 903 Oseltamivir Phosphate Assay Standard 100 mg BP 1021 Oxazepam Hydrochloride 50 mg BP 764 Oxibendazole 25 mg BP 700 Oxybuprocaine hydrochloride Assay Standard 100 mg BP 701 Oxybutynin hydrochloride Assay Standard 100 mg BP 273 Oxyclozanide 200 mg BP 782 Oxytetracycline Assay Standard 100 mg

Edition 2014 Visit us at www.lgcstandards.com 177

British Pharmacopoeia

Code Product Unit BP 275 Oxytetracycline hydrochloride 20 mg BP 035 1-Phenyl-3-pyrrolidinopropan-1-one hydrochloride 50 mg BP 769 Paeoniflorin Assay Standard 20 mg BP 276 Pancuronium bromide Assay Standard 25 mg BP 277 Papaverine hydrochloride Assay Standard 100 mg BP 371 Paracetamol Assay Standard 100 mg BP 1024 Paroxetine hydrochloride hemihydrate Assay Standard 200 mg BP 746 Paroxetine impurity standard 25 mg BP 278 Pentagastrin 0.1 mg BP 1073 Perindopril Erbumine Assay Standard 100 mg BP 1074 Perindopril impurity Standard 25 mg BP 422 Perphenazine Assay Standard 100 mg BP 683 Pethidine hydrochloride Assay Standard 100 mg BP 901 Phenobarbital Assay Standard 100 mg BP 282 Phenoxymethylpenicillin potassium Assay Standard 500 mg BP 520 Phentolamine mesilate 50 mg BP 1026 Phenylacetic acid DRUG PRECURSOR 25 mg BP 703 Phenylcyclohexylglycolic acid 25 mg BP 284 Phenylephrine Hydrochloride Assay Standard 100 mg BP 423 Phytomenadione Assay Standard 0.25 mL BP 503 Pilocarpine nitrate Assay Standard 200 mg BP 682 Pimozide Assay Standard 100 mg BP 1027 Piperacillin Assay Standard 100 mg BP 463 Piroxicam Assay Standard 100 mg BP 411 Pizotifen malate Assay Standard 50 mg BP 288 Poldine metisulfate Assay Standard 100 mg BP 1028 Polymyxin B Sulfate 100 mg BP 289 Polythiazide Assay Standard 100 mg BP 510 Potassium trichloroammineplatinate 25 mg BP 1029 Pravastatin 1,1,3,3,-tetramethylbutylamine Assay Standard 100 mg BP 1030 Pravastatin Impurity A 10 mg BP 399 Prazosin hydrochloride Assay Standard 100 mg BP 464 Prednisolone Assay Standard 100 mg BP 292 Prednisolone sodium phosphate Assay Standard 100 mg BP 553 Prednisone Assay Standard 250 mg BP 497 Prilocaine hydrochloride Assay Standard 100 mg BP 293 Primidone Assay Standard 100 mg BP 295 Procaine benzylpenicillin Assay Standard 100 mg BP 638 Prochlorperazine maleate Assay Standard 100 mg BP 493 Prochlorperazine mesilate Assay Standard 100 mg BP 494 Prochlorperazine sulphoxide 25 mg BP 296 Procyclidine hydrochloride Assay Standard 100 mg BP 449 Progesterone Assay Standard 50 mg BP 297 Proguanil hydrochloride Assay Standard 100 mg BP 412 Promethazine hydrochloride Assay Standard 100 mg BP 505 Promethazine sulphoxide 25 mg BP 1031 Propofol Assay Standard 1 mL BP 698 Propofol dimer 25 mg BP 1032 Propofol Impurity J 0.05 mL BP 868 Propylene glycol Assay Standard 100 mg BP 413 Pseudoephedrine hydrochloride Assay Standard Drug Precursor 100 mg BP 717 Pseudomorphine trihydrate 25 mg

178 Visit us at www.lgcstandards.com Edition 2014

British Pharmacopoeia

Code Product Unit BP 906 Pyrazinamide Assay Standard 100 mg BP 1033 Pyridostigmine Bromide 50 mg BP 458 Pyridoxine hydrochloride Assay Standard 100 mg BP 863 Quinidine sulfate 300 mg BP 862 Quinine sulfate 300 mg BP 751 Ramipril Assay Standard 100 mg Ramipril impurity K 25 mg BP 754 Ramipril diketopiperazine acid BP 471 Ranitidine hydrochloride Assay Standard 100 mg BP 593 Ribavirin Assay Standard 100 mg BP 592 Ribavirin impurity standard 50 mg BP 459 Riboflavin sodium phosphate 50 mg BP 400 Rifampicin N-oxide 25 mg BP 586 Ritodrine hydrochloride Assay Standard 200 mg BP 712 Salbutamol aldehyde impurity 25 mg BP 451 Salbutamol Assay Standard 100 mg BP 852 Salbutamol impurity B 10 mg BP 704 Salbutamol ketone impurity 25 mg BP 302 Salbutamol sulphate Assay Standard 100 mg BP 705 Selegiline hydrochloride Assay Standard 100 mg BP 883 Sertraline hydrochloride Assay Standard 100 mg BP 898 Sertraline hydrochloride cis-isomer 20 mg BP 897 Sertraline hydrochloride impurity Standard 20 mg BP 739 Simvastatin Assay Standard 100 mg BP 453 Sodium nitroprusside Assay Standard 200 mg BP 490 Sodium picosulfate Assay Standard 100 mg BP 452 Sodium valproate Assay Standard 500 mg BP 498 Sotalol hydrochloride 100 mg BP 306 Spironolactone 150 mg BP 818 Sucrose Assay Standard 1000 mg BP 312 Sulfadiazine Assay Standard 100 mg BP 310 Sulfadoxine Assay Standard 100 mg BP 314 Sulfamethoxazole Assay Standard 100 mg BP 1039 Sulfapyridine 25 mg BP 779 Sulfasalazine Assay Standard 250 mg BP 1041 Sulindac 50 mg BP 679 Sulpiride Assay Standard 100 mg BP 745 Sumatriptan impurity standard 25 mg BP 950 Sumatriptan Succinate Assay Standard 100 mg BP 876 Tamsulosin hydrochloride Assay Standard 100 mg BP 877 Tamsulosin hydrochloride impurity standard 25 mg BP 455 Temazepam Assay Standard Controlled Substance 100 mg BP 708 Tenoxicam Assay Standard 100 mg BP 709 Tenoxicam degradation impurity standard 25 mg BP 1045 Terbutaline Impurity C 15 mg BP 318 Terbutaline sulfate Assay Standard 100 mg BP 650 Terfenadine Assay Standard 100 mg BP 1076 Testosterone 25 mg BP 319 Testosterone decanoate Controlled Substance 100 mg BP 321 Testosterone isocaproate Controlled Substance 100 mg BP 322 Testosterone phenylpropionate Assay Standard Controlled Substance 100 mg BP 702 Testosterone propionate Assay Standard Controlled Substance 100 mg

Edition 2014 Visit us at www.lgcstandards.com 179

British Pharmacopoeia

Code Product Unit BP 480 Tetracycline hydrochloride Assay Standard 100 mg BP 327 Theophylline Assay Standard 100 mg BP 414 Thiamine mononitrate Assay Standard 100 mg BP 495 Thioridazine Assay Standard 100 mg BP 331 Thiotepa Assay Standard 100 mg BP 848 Tibolone Assay Standard 100 mg BP 849 Tibolone Impurity Standard 10 mg BP 1086 Ticarcillin Impurity A 50 mg BP 1079 Ticarcillin impurity B 25 mg BP 1080 Ticarcillin impurity C 25 mg BP 1087 Ticarcillin monosodium 250 mg BP 1046 Timolol maleate 500 mg BP 645 Tioconazole Assay Standard 100 mg BP 687 Tioconazole impurity standard 100 mg BP 878 Tioguanine Assay Standard 100 mg BP 333 Tobramycin 100 mg BP 744 Tramadol hydrochloride 100 mg BP 893 Tramadol impurity A 15 mg BP 734 Tranexamic acid impurity standard 25 mg BP 565 trans-Clopenthixol acetate dihydrochloride 50 mg BP 566 trans-Clopenthixol decanoate dihydrochloride 25 mg BP 561 trans-Clopenthixol hydrochloride 25 mg BP 556 trans-Flupentixol decanoate dihydrochloride 25 mg BP 544 Transplatin 25 mg BP 590 Trazodone hydrochloride Assay Standard 100 mg BP 591 Trazodone hydrochloride impurity standard 50 mg BP 338 Triamcinolone Assay Standard 100 mg BP 680 Triamcinolone hexacetonide Assay Standard 100 mg BP 340 Triamterene Assay Standard 100 mg BP 034 Trihexyphenidyl hydrochloride Assay Standard 100 mg BP 344 Trimethoprim Assay Standard 100 mg BP 347 Triprolidine hydrochloride 100 mg BP 1047 Tropicamide 50 mg BP 349 Tylosin 50 mg BP 350 Urea Assay Standard 1 g BP 706 Ursodeoxycholic acid Assay Standard 150 mg BP 835 Venlafaxine Hydrochloride Assay Standard 100 mg BP 836 Venlafaxine impurity standard 25 mg BP 563 Vigabatrin Assay Standard 150 mg BP 672 Warfarin Assay Standard 100 mg BP 353 Xylometazoline hydrochloride Assay Standard 100 mg BP 850 Zidovudine and Lamivudine Impurity Standard 50 mg BP 803 Zidovudine Assay Standard 150 mg BP 895 Zidovudine Impurity Standard 25 mg BP 812 Zopiclone Assay Standard 100 mg BP 346 z-Triprolidine hydrochloride 50 mg BP 599 Zuclopenthixol acetate dihydrochloride Assay Standard 100 mg BP 596 Zuclopenthixol decanoate dihydrochloride Assay Standard 100 mg Zuclopenthixol hydrochloride Assay Standard 100 mg BP 558

180 Visit us at www.lgcstandards.com Edition 2014

ATCC microbiology products

ATCC microbiology products As a scientist you know the importance of using the best materials to support your quality control programme. As Europe’s only officially authorized distributor of ATCC cultures, LGC Standards can supply all ATCC organisms specified in the pharmacopoeia. ATCC maintains the highest standards for its biological materials, employing stringent quality control procedures to produce cultures which are well characterized and have low passage numbers. Long-term subculturing of biological materials can have adverse effects on the culture population, including genetic drift, unwanted selection, contamination, and varied cell responses. ATCC quality control cultures sold by LGC Standards are never subcultured or transferred in any way from ATCC’s strains and our European stock- holding means orders are usually filled within 3 - 5 working days. So whether it is quality control strains, genomic DNA, media or growth supplements, antibiotics for selection, or a huge selection of organisms, take the time and guesswork out of ordering your microbiology supplies with authentic, high-quality ATCC materials – exclusively from LGC Standards.

British Pharmacopoeia 2014, volume IV and Addenda

Code Product Unit Appendix XIV A - Biological assay of antibiotics ATCC-6633 Bacillus subtilis amp. ATCC-4617 Bordetella bronchiseptica amp. ATCC-9637 Escherichia coli amp. ATCC-10536 Escherichia coli amp. ATCC-10031 Klebsiella pneumoniae ss. pneumoniae amp. ATCC-10240 Micrococcus luteus amp. ATCC-9763 Saccharomyces cerevisiae amp. ATCC-6538P Staphylococcus aureus subsp. aureus amp. ATCC-9144 Staphylococcus aureus ss. aureus amp. ATCC-9341 Kocuria rhizophila amp. ATCC-12228 Staphylococcus epidermidis amp. ATCC-607 Mycobacterium smegmatis amp. Appendix XVI - Test for absence of Mycoplasma ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp. ATCC-19989 Mycoplasma fermentans; PG18 G Amp. ATCC-19610 Mycoplasma gallisepticum amp. ATCC-17981 Mycoplasma hyorhinis Switzer amp. ATCC-23714 Mycoplasma orale amp. ATCC-15531 Mycoplasma pneumoniae amp. ATCC-25204 Mycoplasma synoviae amp. ATCC-CCL-81 Vero cells amp. Appendix XVI A - Test for sterility ATCC-16404 Aspergillus niger amp. ATCC-6633 Bacillus subtilis amp. ATCC-10231 Candida albicans amp. ATCC-19404 Clostridium sporogenes amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. Appendix XVI B - Tests for microbial contamination ATCC-6633 Bacillus subtilis amp. ATCC-2091 Candida albicans amp. ATCC-10231 Candida albicans amp. ATCC-13124 Clostridium perfringens amp. ATCC-11437 Clostridium sporogenes amp. ATCC-19404 Clostridium sporogenes amp. ATCC-8739 Escherichia coli amp.

Edition 2014 Visit us at www.lgcstandards.com 181

British Pharmacopoeia 2014, volume IV and Addenda

Code Product Unit ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. ATCC-6538P Staphylococcus aureus subsp. aureus amp. Appendix XVI C - Efficacy of antimicrobial preservation ATCC-16404 Aspergillus niger amp. ATCC-10231 Candida albicans amp. ATCC-8739 Escherichia coli amp. ATCC-9027 Pseudomonas aeruginosa amp. ATCC-6538 Staphylococcus aureus ss. aureus amp. Appendix XVIII - Methods of sterilization ATCC-27142** Bacillus pumilus amp. ATCC-7953** Bacillus stearothermophilus amp. ATCC-9372** Bacillus subtilis amp. ATCC-19146 Brevendimonas diminuta (as Pseudomonas diminuta) amp. Appendix XVI (Vet) 3 - Test for absence of mycoplasmas ATCC-23206 Acholeplasma laidlawii (Sabin) Edward and Freundt deposited as Mycoplasma laidlawii amp. ATCC-19610 Mycoplasma gallisepticum amp. ATCC-17981 Mycoplasma hyorhinis Switzer amp. ATCC-23714 Mycoplasma orale amp. ATCC-25204 Mycoplasma synoviae amp. ATCC-CCL-81 Vero cells amp. **=Alternative strain All care has been taken in compiling catalogue numbers, however users should consult the Pharmacopoeia directly to confirm the testing requirements and recommended organisms before ordering or undertaking the testing procedures as described in the Pharmacopoeia.

182 Visit us at www.lgcstandards.com Edition 2014

French Pharmacopoeia

French Pharmacopoeia standards

Code Product Unit FPC0050 Alimémazine tartrate 25 mg FPC0071 Amodiaquine chlorhydrate 25 mg FPC0072 Amprolium chlorhydrate (usage vétérinaire) 25 mg FPC0141 Benzododecinium bromure 1000 mg FPC0190 Bleu patente V 1000 mg FPC0210 Butoformé 150 mg FPC0271 Chlormadinone acetate 100 mg FPC0600 Eosine disodique 200 mg FPC0610 Epivincamine 50 mg FPC0892 Histamine 50 mg FPC0950 Hysope (huile essentielle) 1 mL FPC1222 Linalyle acétate 2 mL FPC2900 Lysine acétylsalicylate Reference Spectrum unit FPC1560 Nifurtimox 250 mg FPC1600 Oxyquinol Reference Spectrum unit FPC3300 Polytetrafluoroethylene Reference Spectrum unit FPC1780 Potassium gluconate 50 mg FPC1785 300 mg FPC2032 sulfate (veterinary usage) 225 mg FPC2034 Suc de papayer 500 mg FPC2036 Sulconazole nitrate 200 mg FPC2044 Sulfadiméthoxine 100mg FPC2120 Sulfogaiacol 100 mg FPC2122 Sulfogaiacol (exempt de gaiacol) 1000 mg FPC2210 Terpine 1000 mg FPC2230 300 mg FPC2520 Vincamine 250 mg Venin d'Abeille PBR unit FPC2530

Edition 2014 Visit us www.lgcstandards.com 183

International Pharmacopoeia standards International Pharmacopoeia standards

Code Product Unit ICRS0191 2-Amino-5-nitrothiazole 25 mg ICRS0193 3-Amino-2,4,6-triiodobenzoic acid 100 mg ICRS0194 3-Aminopyrazole-4-carboxamide hemisulfate 100 mg ICRS1422 Abacavir sulfate 100 mg ICRS1552 Abacavir sulfate for system suitability 10 mg ICRS0201 Acetanilide (116°C) Melting Point Standard 1 g ICRS0202 Acetazolamide 100 mg ICRS0204 Allopurinol 100 mg ICRS0206 Amidotrizoic acid 100 mg ICRS0208 Amitriptyline hydrochloride 100 mg ICRS0209 Amodiaquine hydrochloride 200 mg ICRS1426 Amoxicillin trihydrate 100 mg ICRS0210 Amphotericin B 400 mg ICRS0211 Ampicillin (anhydrous) 200 mg ICRS0212 Ampicillin sodium 200 mg ICRS0213 Ampicillin trihydrate 200 mg ICRS0214 Anhydrotetracycline hydrochloride 25 mg ICRS1408 Artemether 100 mg ICRS1407 Artemotil 100 mg ICRS1410 Artenimol 100 mg ICRS1409 Artesunate 100 mg ICRS46479 Atenolol 100 mg ICRS0215 Atropine sulfate 100 mg ICRS0216 Azathioprine 100 mg ICRS0217 Azobenzene Melting Point Standard 1 g ICRS0218 Bacitracin zinc 200 mg ICRS0221 Benzanilide (165°C) Melting Point Standard 1 g ICRS0222 Benzil (96°C) Melting Point Standard 1 g ICRS0225 Benzylpenicillin potassium 200 mg ICRS0226 Benzylpenicillin sodium 200 mg ICRS0227 Bephenium hydroxynaphthoate 100 mg ICRS0228 Betamethasone 100 mg ICRS0229 Betamethasone sodium phosphate 100 mg ICRS0230 Betamethasone valerate 100 mg ICRS46476 Biperiden hydrochloride 60 mg ICRS0233 Bupivacaine hydrochloride 100 mg ICRS0234 Caffeine 100 mg ICRS0235 Caffeine (237°C) Melting Point Standard 1 g ICRS0236 Calcium folinate (Leucovorin calcium) 100 mg ICRS0237 Captopril 100 mg ICRS0238 Captopril disulfide 25 mg ICRS0239 Carbamazepine 100 mg ICRS0240 Carbenicillin monosodium 200 mg ICRS2132 Carbidopa 100 mg ICRS0190 2-(4-Chloro-3-sulfamoylbenzoyl)benzoic acid 50 mg ICRS0199 5-Chloro-2-methylaminobenzophenone 100 mg ICRS0241 Chloramphenicol 200 mg ICRS0242 Chloramphenicol palmitate 1 g ICRS0243 Chloramphenicol palmitate (Polymorph A) 200 mg ICRS0245 Chloroquine sulfate 200 mg

184 Visit us at www.lgcstandards.com Edition 2014

International Pharmacopoeia

Code Product Unit ICRS0246 Chlorphenamine hydrogen maleate 100 mg ICRS0247 Chlorpromazine hydrochloride 100 mg ICRS0248 Chlortalidone 100 mg ICRS0249 Chlortetracycline hydrochloride 200 mg ICRS0250 Cimetidine 100 mg ICRS46480 Ciprofloxacin 20 mg ICRS0252 Ciprofloxacin by compound A 20 mg ICRS0253 Ciprofloxacin desfluoro-compound 20 mg ICRS0255 Ciprofloxacin fluoroquinolonic acid 20 mg ICRS0256 Ciprofloxacin hydrochloride 400 mg ICRS0258 Cisplatin 100 mg ICRS46474 Clofazimine 150 mg ICRS0259 Clomifene citrate 100 mg ICRS0261 Cloxacillin sodium 200 mg ICRS2130 Colchicine 100 mg ICRS0263 Cortisone acetate 100 mg ICRS46472 Cytarabine 150 mg ICRS46471 Dacarbazine 20 mg ICRS0265 Dapsone 100 mg ICRS0266 Desoxycortone acetate 100 mg ICRS0267 Dexamethasone 100 mg ICRS0268 Dexamethasone acetate 100 mg ICRS0270 Dexamethasone sodium phosphate 100 mg ICRS0282 Diazoxide 100 mg ICRS0283 Dicloxacillin sodium 200 mg ICRS0285 Dicoumarol 100 mg ICRS0286 Dicyanodiamide (210°C) Melting Point Standard 1 g ICRS1413 Didanosine 10 mg ICRS1414 Didanosine for system suitability 10 mg ICRS0287 Diethylcarbamazine dihydrogen citrate 100 mg ICRS0288 Digitoxin 100 mg ICRS0289 Digoxin 100 mg ICRS1549 DL-Methionine 100 mg ICRS0290 Dopamine hydrochloride 100 mg ICRS0292 Doxorubicin hydrochloride 100 mg ICRS1411 Efavirenz 100 mg ICRS0294 Emetine hydrochloride 100 mg ICRS48743 Emtricitabine 100 mg ICRS0197 4-Epianhydrotetracycline hydrochloride 25 mg ICRS0198 4-Epitetracycline hydrochloride 25 mg ICRS0295 Ergocalciferol (Vitamin D2) 500 mg ICRS0296 Ergometrine hydrogen maleate DRUG PRECURSOR 50 mg ICRS0297 Ergotamine tartrate DRUG PRECURSOR 50 mg ICRS0298 Erythromycin 250 mg ICRS0299 Erythromycin B 25 mg ICRS0300 Erythromycin C 25 mg ICRS46470 Erythromycin ethylsuccinate 10 mg ICRS0301 Estradiol benzoate 100 mg ICRS0302 Estrone 100 mg ICRS0304 Ethambutol hydrochloride 100 mg ICRS0305 Ethinylestradiol 100 mg ICRS0306 100 mg

Edition 2014 Visit us at www.lgcstandards.com 185

International Pharmacopoeia standards

Code Product Unit ICRS0307 Ethosuximide 100 mg ICRS0309 Flucloxacillin sodium 200 mg ICRS0310 Flucytosine 100 mg ICRS0311 Fludrocortisone acetate 200 mg ICRS0312 Fluorouracil 100 mg ICRS0315 Fluphenazine hydrochloride 100 mg ICRS0316 Folic acid 100 mg ICRS0195 3-Formylrifamycin 200 mg ICRS0355 Framycetin sulfate (Neomycin B sulfate) 200 mg ICRS0318 Furosemide 100 mg ICRS46481 Gallamine triethiodide 100 mg ICRS0319 Gentamicin sulfate 100 mg ICRS47043 Glibenclamide 100 mg ICRS0322 Griseofulvin 200 mg ICRS0188 (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-hydrazino-2-methylalanine (3-o-Methylcarbidopa) 25 mg ICRS0189 (-)-3-(4-Hydroxy-3-methoxyphenyl)-2-methylalanine (3-o-Methylmethyldopa) 25 mg ICRS0323 Haloperidol 100 mg ICRS0324 Hydrochlorothiazide 100 mg ICRS0325 Hydrocortisone 100 mg ICRS0326 Hydrocortisone acetate 100 mg ICRS0327 Hydrocortisone sodium succinate 200 mg ICRS0328 Ibuprofen 100 mg ICRS0329 Imipramine hydrochloride 100 mg ICRS1415 Indinavir 100 mg ICRS0330 Indometacin 100 mg ICRS0331 Isoniazid 100 mg ICRS1416 Lamivudine 100 mg ICRS1553 Lamivudine for system suitability 10 mg ICRS0333 Lanatoside C 100 mg ICRS0334 Levodopa 100 mg ICRS0335 Levonorgestrel 200 mg ICRS0336 Levothyroxine sodium 2x50 mg ICRS0337 Lidocaine 100 mg ICRS0338 Lidocaine hydrochloride 100 mg ICRS0339 Liothyronine sodium 50 mg ICRS0340 Loperamide hydrochloride 100 mg ICRS2125 Lumefantrine 300 mg ICRS39627 Lumefantrine for system suitability 10 mg ICRS0341 Mebendazole 200 mg ICRS0454 Medroxyprogesterone acetate 100 mg ICRS0345 Methotrexate 100 mg ICRS0346 Methyldopa 100 mg ICRS0347 Methyltestosterone 100 mg ICRS0348 Meticillin sodium 200 mg ICRS0350 Metronidazole 100 mg ICRS0351 Nafcillin sodium 200 mg ICRS2128 Naloxone hydrochloride 100 mg ICRS1417 Nelfinavir mesilate 100 mg ICRS0356 Neostigmine metilsulfate 100 mg ICRS1412 Nevirapine anhydrous 100 mg ICRS1423 Nevirapine impurity B 10 mg ICRS0357 Nicotinamide 100 mg

186 Visit us at www.lgcstandards.com Edition 2014

International Pharmacopoeia

Code Product Unit ICRS0358 Nicotinic acid 100 mg ICRS0360 Niridazole 200 mg ICRS0366 Norethisterone 100 mg ICRS0367 Norethisterone acetate 100 mg ICRS2123 Norethisterone enantate 50 mg ICRS0369 Nystatin 200 mg ICRS0371 Oubain 100 mg ICRS0372 Oxacillin sodium 200 mg ICRS0373 Oxytetracycline dihydrate 200 mg ICRS0374 Oxytetracycline hydrochloride 200 mg ICRS0376 Papaverine hydrochloride 100 mg ICRS0377 Paracetamol 100 mg ICRS0378 Paromomycin sulfate 75 mg ICRS47048 Pentamidine isetionate 30 mg ICRS0380 Phenacetin (136°C) Melting Point Standard 1 g ICRS47049 Phenobarbital - * psy 200 mg ICRS0382 Phenolphthalein (263°C) Melting Point Standard 1 g ICRS0383 Phenoxymethylpenicillin 200 mg ICRS0384 Phenoxymethylpenicillin calcium 200 mg ICRS0385 Phenoxymethylpenicillin potassium 200 mg ICRS0387 Phenytoin 100 mg ICRS0388 Piperazine adipate 100 mg ICRS0389 Piperazine citrate 100 mg ICRS0390 Praziquantel 100 mg ICRS0391 Prednisolone 100 mg ICRS0392 Prednisolone acetate 100 mg ICRS0393 Prednisolone hemisuccinate 200 mg ICRS0394 Prednisolone sodium phosphate 200 mg ICRS0395 Prednisone 100 mg ICRS0396 Prednisone acetate 100 mg ICRS0397 Probenecid 100 mg ICRS0398 Procaine hydrochloride 100 mg ICRS0399 Procarbazine hydrochloride 100 mg ICRS0400 Progesterone 100 mg ICRS0402 Propanolol hydrochlorid 100 mg ICRS0403 Propylthiouracil 100 mg ICRS0404 Pyrantel embonate (Pyrantel pamoate) 500 mg ICRS1424 Pyrazinamide 100 mg ICRS0405 Pyridostigmine bromide 100 mg ICRS47051 Pyrimethamine 250 mg ICRS0406 Reserpine 100 mg ICRS0408 Riboflavin 250 mg ICRS0409 Rifampicin 300 mg ICRS0410 Rifampicin quinone 200 mg ICRS1421 Ritonavir 100 mg ICRS0411 Saccharin (229°C) Melting Point Standard 1 g ICRS1418 Saquinavir mesilate 100 mg ICRS0412 Sodium amidotrizoate 100 mg ICRS0413 Sodium cromoglicate 100 mg ICRS0415 Spectinomycin hydrochloride 200 mg ICRS49241 Spironolactone 150 mg ICRS1419 Stavudine 100 mg

Edition 2014 Visit us at www.lgcstandards.com 187

International Pharmacopoeia standards

Code Product Unit ICRS0416 Streptomycin sulfate 100 mg ICRS0417 Sulfacetamide 100 mg ICRS0419 Sulfamethoxazole 100 mg ICRS0420 Sulfamethoxypyridazine 100 mg ICRS0421 Sulfanilamide 100 mg ICRS0422 Sulfanilamide (166°C) Melting Point Standard 1 g ICRS0423 Sulfapyridine (193°C) Melting Point Standard 1 g ICRS0424 Sulfasalazine 100 mg ICRS0425 Tamoxifen citrate 100 mg ICRS0426 Tamoxifen E-isomer 10 mg ICRS0428 Testosterone propionate 100 mg ICRS0429 Tetracycline hydrochloride 200 mg ICRS0430 Thioacetazone 100 mg ICRS0196 4,4'-Thiodianiline 50 mg ICRS0431 Tolbutamide 100 mg ICRS0432 Tolnaftate 100 mg ICRS0433 Toluene-2-sulfonamide 100 mg ICRS0434 Trimethadione 200 mg ICRS0435 Trimethoprim 100 mg ICRS0438 Vanillin (83°C) Melting Point Standard 1 g ICRS47071 Verapamil hydrochloride 100 mg ICRS0439 Warfarin 100 mg ICRS1420 Zidovudine 100 mg ICRS1554 Zidovudine impurity B 10 mg (Clomifene citrate Z-isomer) 50 mg ICRS0260

188 Visit us at www.lgcstandards.com Edition 2014

With links to all webshop products

Complementary products

@LGCStdsPharma www.lgcstandards.com Follow us on Twitter!

Here’s what you can expect: • Technical tips for your daily work with pharmaceutical reference materials

• Quick answers to your questions on pharmaceutical reference materials

• Information on new pharmacopoeial and impurity standards

• Regulatory news

• Event dates to meet up personally

• Upcoming seminars and webinars

• News from the Pharma world

Visit us at www.lgcstandards.com @LGCStdsPharma

LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043

© LGC Limited, 2014. All rights reserved. LGC Standards is part of the LGC Group. 3970/LB/0614

3970_pharma_twitter_ad_v2.indd 1 6/12/2014 11:37:57 AM Introduction

Pharmaceutical enzymes (see page 193) The Commission on Pharmaceutical Enzymes was formed in 1960, with a remit to establish quantitative methods and an exact definition of enzyme activity for pharmacologically significant enzymes. One consequence of the work of FIP “Federation International Pharmaceutique” has been the production and certification of reference substances for both enzymes and substrates. More recently the work of the commission has been reflected in those monographs of the European Pharmacopoeia which call for enzyme standards. The FIP products marked (EP) in this list are those which are required in certain EP monographs.

European Pharmacopoeia Reagents (from page 194) Chapters 2 and 4 of the European Pharmacopoeia describe the preparation of several hundred reagents and standards used for the testing of pharmaceutical raw materials. LGC Standards offers a large number of these ready-to-use reagents and standard solutions within the spectrum of this new catalogue. The primary solutions for coloration are produced by LGC Standards, the other reagents are manufactured by Reagecon. All are manufactured and tested in compliance with the prescriptions of EP. The products are supplied with certificates of analysis. Lot numbers and expiry dates are stated on all product labels as well. The reagents are always supplied as per the most recently issued EP supplement. Reagents from other pharmacopoeias are also available on request. Please contact your local LGC Standards office for further details.

WHO International Standards for Antibiotics (see page 198) In 2006, the European Directorate for the Quality of Medicines & Healthcare (EDQM) has been designated a WHO Collaborative Centre for the International Standards for Antibiotics (ISA). These standards are essential in the standardisation and quality control of antibiotic material and pharmaceutical products. They are supplied for assays described in the specifications for quality control of antibiotic material. The EDQM is for example responsible for the establishment and storage of the WHO ISA materials. All biological preparations listed in this catalogue are supplied exclusively as WHO ISA materials for use as primary standards in the establishment of national/regional secondary working standards and for no other purpose. You can order the ISA materials directly with your supplies for other reference materials available from LGC Standards. For further information please contact your local LGC Standards office.

Email: [email protected] | Website: www.lgcstandards.com 191

3970_5Pharma_catalogue_internal_comp_prod_v1.indd 191 6/13/2014 11:19:22 AM Refractive index CRM (see page 199) The revised EP general method 2.2.6 replaces CRS reference liquids with certified reference materials available from suppliers of chemical reagents or materials certified for metrology. 9 liquid CRM, certified by the Physical Chemistry Division of the Central Office of Measures (GUM), Warsaw, Poland, cover the wide range of refractive index from 1,333 (water) to 1,657 (1-bromonaphthalene). These CRM are intended for calibration and checking refractive index scales of laboratory refractometers of an uncertainty expected not less than ±0,00005. The n values we determined on a Pulfrich refractometer, previously calibrated with solid class 1 CRM, for which values were established using goniometric procedures. All CRM are supplied with a certificate. Certified values to 5 significant figures for the refractive index at λ = 589.3 nm t = 20°C and associated uncertainties are given. Reference liquids are packed in glass ampoules or plastic drop-bottles.

192 Email: [email protected] | Website: www.lgcstandards.com

3970_5Pharma_catalogue_internal_comp_prod_v1.indd 192 6/13/2014 11:19:22 AM Pharmaceutical enzymes

Pharmaceutical enzymes

Enzymes

Code Product Unit FIP1 Fungal Amylase 2 g FIP2(EP) Amylase (pancreatic) 2 g FIP3 Fungal Protease 2 g FIP4 Bromelain 250 mg FIP5 Endocellulase 1 g FIP6(EP) Chymotrypsin 100 mg FIP7 Fungal Lipase 500 mg FIP8(EP) Lipase (pancreatic) 2 g FIP9 Lysozyme hydrochloride 250 mg FIP10 Papain 2 g FIP11(EP) Pepsin 2 g FIP12(EP) Protease (pancreatic) 2 g FIP13(EP) Trypsin 100 mg FIP14(EP) Hyaluronidase 50 mg Substrates FIP15(EP) Enterokinase 200 mg FIP16 Micrococcus Luteus sp. 1 g FIP17 Starch (EP) 50 g FIP18(EP) Casein 100 g FIP19 Haemoglobin 10 g FIP20 Hydroxyethylcellulose 100 g FIP21 Sodium Taurocholate 10 g Sodium hyaluronate 300 mg FIP22(EP)

Edition 2014 Visit us at www.lgcstandards.com 193

European Pharmacopoeia reagents European Pharmacopoeia reagents

Reagents as outlined in chapter 2

Code Product Unit REAEPPOSO1 Primary opalescence suspension 100 mL Coloration: primary solutions WESEPYS01 Coloration-primary solution yellow 100 mL WESEPRS01 Coloration-primary solution red 100 mL WESEPBS01 Coloration-primary solution blue 100 mL Coloration: standard solutions REAEP703 Standard solution B (brown) 125 mL REAEP704 Standard solution BY (brownish yellow) 125 mL REAEP706 Standard solution Y (yellow) 125 mL REAEP705 Standard solution GY (greenish yellow) 125 mL REAEP707 Standard solution R (red) 125 mL REAHADM1 HCL dilution matrix (10 g/l HCl) 1 L Reference buffer solutions - all @ 25°C REAEP168 pH Buffer Solution 1.68 @ 25 °C 500 mL REAEP401 pH Buffer Solution 4.01 @ 25 °C 500 mL REAEP687 pH Buffer Solution 6.87 @ 25 °C 500 mL REAEP741 pH Buffer Solution 7.41 @ 25 °C 500 mL REAEP918 pH Buffer Solution 9.18 @ 25 °C 500 mL Conductivity & resistivity soutions - @ 20°C Conductivity standard 500 mL Electrolytic conductivity ...... 1330 µS/cm at 20°C Resistivity...... 752 Ω⋅cm REAEP1330 Conductivity standard 500 mL Electrolytic conductivity ...... 133 µS/cm at 20°C Resistivity...... 7519 Ω⋅cm REAEP133 Conductivity standard 500 mL Electrolytic conductivity ...... 26.6 µS/cm at 20°C Resistivity...... 37594 Ω⋅cm REAEP266 Reagents as outlined in chapter 4 (4.1) of Ph. Eur. REA1000401 Acetic acid (30%) 1 L REA1000402 Acetic acid, dilute (12%) 1 L REA1000501 Acetic anhydride solution R1 DRUG PRECURSOR 1 L REA1002501 Alcohol, aldehyde free 1 L REA1004702 Ammonia, dilute R1 1 L REA1004703 Ammonia, dilute R2 1 L REA1005201 Ammonium carbonate solution 1 L REA1007301 Anisaldehyde, solution 100 mL REA1007302 Anisaldehyde, solution R1 100 mL REA1009301 Barium chloride, solution R1 1 L REA1009401 Barium hydroxide, solution 1 L REA1011601 Biuret reagent 1 L REA1012601 Bromocresol green solution 100 mL REA1012602 Bromocresol green-methyl red solution 100 mL REA1012701 Bromocresol purple solution 100 mL REA1012801 Bromophenol blue solution 100 mL REA1012803 Bromophenol blue solution R2 100 mL REA1012901 Bromothymol blue solution R1 100 mL

194 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia reagents

Code Product Unit REA1015201 Calcium sulphate solution 1 L REA1022901 Crystal violet solution 100 mL REA1023100 Cupri-citric solution 1 L REA1023300 Cupri-tartaric (Solution I 500 mL & Solution II 500 mL) 2 x 500 mL REA1031101 Dimidium bromide - sulphan blue mixed solution 1 L REA1032101 Diphenylamine solution 1 L REA1032102 Diphenylamine solution R1 1 L REA1037702 Ferric ammonium sulphate solution R2 1 l REA1038100 Ferroin 100 mL REA1039101 solution 100 mL REA1039401 Fuchsin solution, decolorised 100 mL REA1039402 Fuchsin solution, decolorised R1 100 mL REA1043101 Holmium solution 1 L REA1043501 Hydrochloric acid R1 1 L REA1043503 Hydrochloric acid, dilute 1 L REA1043504 Hydrochloric acid, dilute R1 1 L REA1045901 bromide solution 1 L REA1046300 Iodoplatinate reagent 200 mL REA1048001 nitrate solution 1 L REA1048101 Lead acetate cotton 10 g REA1048102 Lead acetate paper Pck. REA1052101 Mercuric bromide paper Pck. REA1053601 Methoxyphenylacetic reagent 100 mL REA1054801 Methyl orange mixed solution 100 mL REA1054802 Methyl orange solution 100 mL REA1055101 Methyl red mixed solution 100 mL REA1055102 Methyl red solution 100 mL REA1056700 Molybdovanadic reagent 100 mL REA1056801 Mordant black 11 triturate 100 g REA1057601 Naphtobenzein solution 100 mL REA1058303 Ninhydrin, solution 100 mL REA1058304 Ninhydrin solution R1 100 mL REA1058305 Ninhydrin solution R2 100 mL REA1058402 Nitric Acid, Dilute 100 mL REA1062901 Perchloric acid solution 100 mL REA1063601 Phenol red solution 100 mL REA1063603 Phenol red solution R2 500 mL REA1063702 Phenolphthalein solution 100 mL REA1063703 Phenolphthalein solution R1 100 mL REA1065000 Phosphomolybdotungstic reagent 100 mL REA1065200 Phosphomolybdotungstic solution 100 mL REA1065801 Picric acid solution 100 mL REA1065802 Picric acid solution R1 100 mL REA1069101 Potassium chloride, 0.1 M 1 L REA1069201 Potassium chromate, solution 1 L REA1069501 Potassium dichromate, solution 1 L REA1069801 Potassium ferrocyanide, solution 100 mL REA1070001 Potassium hydrogen phthalate, 0.2 M 1 L REA1070302 Potassium hydroxide in alcohol (10% v/v) 1 L REA1070303 Potassium hydroxide solution alcoholic 100 mL REA1070501 Potassium iodide and starch solution 125 mL REA1070502 Potassium iodide solution 1 L

Edition 2014 Visit us at www.lgcstandards.com 195

European Pharmacopoeia reagents

Code Product Unit REA1070600 Potassium iodobismuthate, solution 100 mL REA1070602 Potassium iodobismuthate, solution R2 100 mL REA1070902 Potassium permanganate, solution 1 L REA1071301 Potassium pyroantimonate, solution 125 mL REA1071600-A Potassium tetraiodomercurate solution, alkaline (Part A) 100 mL REA1071600-B Potassium tetraiodomercurate solution, alkaline (Part B) 100 mL REA1075201 solution 100 mL REA1078301 Silver nitrate solution R1 1 L REA1078302 Silver nitrate solution R2 1 L REA1079301 Sodium carbonate solution 1 L REA1081401 Sodium hydroxide solution 1 L REA1081402 Sodium hydroxide solution dilute 1 L REA1081404 Sodium hydroxide solution strong 1 L REA10816005 Sodium hypochlorite solution strong 500 mL REA1083901 Sodium sulfure solution 100 mL REA1085103 Starch, solution 100 mL REA1086804 Sulphuric acid, dilute 1 L REA1089602 Thiocetamide solution 1 L REA1090701 Thymolphthalein solution 100 mL REA1094201 Tris(hydroymethyl) aminomethane solution 100 mL REA1102301 Zinc acetate solution 1 L REA1096601 Zinc chloride formic acid solution 1 L REA1096602 Zinc chloride solution, iodinated 1 L Standard solutions for limit tests as outlined in Chapter 4 (4.1.2) of PH.Eur. REA5000200 standard solution (200 ppm Al) 100 mL REA5000300C Ammonium standard solution (100 ppm NH4) 100 mL REA5000500C Arsenic standard solution (10 ppm As) 100 mL REA5000700C standard solution (0.1% Cd) 100 mL REA5000800C Calcium standard solution (400 ppm Ca) 100 mL REA5000802C Calcium standard solution alcoholic (400 ppm Ca) 1 L REA5000900C Chloride standard solution (8 ppm CI) 100 mL REA5001000 Chromium standard solution (100 ppm Cr) 1 L REA5001100 Copper standard solution (0.1% Cu) 100 mL REA5001200C Ferrocyanide standard solution (100 ppm Fe) 100 mL REA5001400C Fluoride standard solution (10 ppm F) 100 mL REA5001600C Iron standard solution (20 ppm Fe) 100 mL REA5001602C Iron standard solution (8 ppm Fe) 100 mL REA5001701C Lead standard solution (100 ppm Pb) 100 mL REA5001800C Magnesium standard solution (100 ppm Mg) 100 mL REA5002000C Nickel standard solution (10 ppm Ni) 100 mL REA5002100C Nitrate standard solution (100 ppm NO3) 100 mL REA5002200C Phosphate standard solution (5 ppm PO4) 100 mL REA5002400C Potassium standard solution (100 ppm K) 100 mL REA5002700C Sodium standard solution (200 ppm Na) 100 mL REA5002800C Sulphate standard solution (10 ppm SO4) 100 mL REA5003100C Tin standard solution (5 ppm Sn) 1 L REA5003401C Zinc standard solution (100 ppm Zn) 100 mL Buffer solutions as outlined in Chapter 4 (4.1.3) of Ph.Eur. REA4000100 Buffered acetone solution 1 L REA4000600 Buffer solution pH 3.5 1 L REA4001400 Acetate buffer solution pH 4.6 1 L

196 Visit us at www.lgcstandards.com Edition 2014

European Pharmacopoeia reagents

Code Product Unit REA4004800 Phosphate buffer solution pH 7.4 1 L REA4008300 Buffer (phosphate) solution pH 9.0 1 L REA4007200 Ammonium chloride buffer solution pH 9.5 1 L REA4007300 Ammonium chloride buffer solution pH 10.0 1 L Volumetric solutions as outlined in Chapter 4 (4.2.2) of Ph. Eur. REA3000100 0.1M Ammonium and cerium nitrate 1 L REA3000200 0.01M Ammonium and cerium nitrate 1 L REA3000300 0.1M Ammonium and cerium sulphate 1 L REA3000500 0.1M Ammonium 1 L REA3000600 0.1M Barium chloride 1 L REA3000900 0.004M Benzethonium chloride 1 L REA3001100 0.1M Cerium sulphate 1 L REA3008700 1M Cupriethylenediamine hydroxide solution 1 L REA3001300 0.1M Ferric ammonium sulphate 1 L REA3001500 6M Hydrochloric acid 1 L REA3001700 2M Hydrochloric acid 1 L REA3001800 1M Hydrochloric acid 1 L REA3002100 0.1M Hydrochloric acid 1 L REA3008800 0.1M Hydrochloric acid, alcoholic 1 L REA3002700 0.05M Iodine 1 L REA3003100 0.1M Lead nitrate 1 L REA3003300 0.1M Lithium methoxide 1 L REA3003500 0.02M Mercuric nitrate 1 L REA3003900 0.1M Perchloric acid in acetic anhydride 1 L REA3004200 0.033M Potassium bromate 1 L REA3002900 0.01M Iodine 1 L REA3009100 11M Potassium hydroxide 1 L REA3004800 0.1M Potassium hydroxide 1 L REA3004900 0.5M Potassium hydroxide 1 L REA3005000 0.5m Potassium Hydroxide, Alcoholic 1 L REA3005100 0.1M Potassium hydroxide, alcoholic 1 L REA3005300 0.02M Potassium permanganate 1 L REA3005600 0.1M Silver nitrate 1 L REA3009300 0.001M Sodium nitrate 1 L REA3005800 0.1M Sodium arsenite 1 L REA3005900 0.1M Sodium edetate 1 L REA3006300 1M Sodium hydroxide 1 L REA3006600 0.1M Sodium hydroxide 1 L REA3007000 0.1M Sodium hydroxide, ethanolic 1 L REA3007100 0.1M Sodium methoxide 1 L REA3007200 0.1M Sodium nitrate 1 L REA3007300 0.1M Sodium thiosulphate 1 L REA3007800 0.5M Sulphuric acid 1 L REA3008000 0.05M Sulphuric acid 1 L REA3008300 0.1M Tetrabutylammonium hydroxide 1 L REA3008400 0.1M Tetrabutylammonium hydroxide in 2-propanol 1 L 0.1M Zinc sulphate 1 L REA3008600

Edition 2014 Visit us at www.lgcstandards.com 197

WHO International standards for antibiotics WHO International standards for antibiotics

Code Product Unit EPISA_28168 Gramicidin 100 mg EPISA_29078 Amphotericin B 100 mg EPISA_29384 Nystatin 100 mg EPISA_39036 Vancomycin 100 mg EPISA_62_003 Bacitracin 100 mg EPISA_62_008 Spiramycin 50 mg EPISA_62_013 Dihydrostreptomycin 200 mg EPISA_65_062 Colistin 75 mg EPISA_66_231 Rifamycin SV 100 mg EPISA_66_254 Colistin Methane Sulfonate 75 mg EPISA_67_301 Polymoyxin B 75 mg EPISA_68_041 Neomycin B 25 mg EPISA_72_406 Neomycin 50 mg EPISA_76_538 Erythromycin 75 mg EPISA_76_539 Streptomycin 100 mg EPISA_78_547 Bleomycin Complex A2/B2 7 mg EPISA_80_543 Sisomicin 63 mg EPISA_82_510 Tobramycin 11.2 mg EPISA_83_521 Kanamycin 13 mg EPISA_83_577 Netilmicin 7.5 mg EPISA_90_704 Teicoplanin 54 mg EPISA_92_670 Gentamicin 50 mg Tylosin 40 mg EPISA_TYN

198 Visit us at www.lgcstandards.com Edition 2014

Refractive index CRM

Refractive index CRM

Code Product Unit Water 10 mL Refractive index ...... 1.333 at 20 °C PRG 7.21 2,2,4-Trimethylpentane 10 mL Refractive index ...... 1.391 at 20 °C PRG 7.1 Methylsilicone oil 10 mL Refractive index ...... 1.405 at 20 °C PRG 7.11 Methylcyclohexane 10 mL Refractive index ...... 1.423 at 20 °C PRG 7.2 Silicone oil DC 556 10 mL Refractive index ...... 1.462 at 20 °C PRG 7.12 Paraffin oil 10 mL Refractive index ...... 1.475 at 20 °C PRG 7.20 Toluene DRUG PRECURSOR 10 mL Refractive index ...... 1.496 at 20 °C PRG 7.5 Chlorobenzene 10 mL Refractive index ...... 1.524 at 20 °C PRG 7.6 1-Bromonaphthalene 10 mL Refractive index ...... 1.657 at 20 °C PRG 7.8

Edition 2014 Visit us at www.lgcstandards.com 199

Notes

200 Email: [email protected] | Website: www.lgcstandards.com

Notes_pages_v1.indd 200 6/12/2014 12:22:27 PM Notes

Email: [email protected] | Website: www.lgcstandards.com 201

Notes_pages_v1.indd 201 6/12/2014 12:22:27 PM Notes

202 Email: [email protected] | Website: www.lgcstandards.com

Notes_pages_v1.indd 202 6/12/2014 12:22:27 PM Metals standards for the pharmaceutical industry

Regulatory requirements for inorganic impurities are being tightened. Be prepared and get your reference standards for metals from LGC Standards.

The changes finally made official in the USP-NF General Chapters <232> “Elemental Impurities – Limits” and <233> “Elemental Impurities – Procedures” highlight a valid concern that the analytical techniques in place are inadequate for the analysis of inorganic impurities in drug substances and products in the modern world. The former tests in General Chapter <231> are based on an unspecific sulfide precipitation and will be replaced by instrumental analytical methods like ICP-OES and ICP-MS. Limits will be given not only for the single metals, but will also take into account the different specifications of certain elements. LGC Standards provides the perfect range for your metals residues analysis, and will facilitate greater analytical certainty. All products are prepared from high purity raw materials, acids and 18 Mohm Di water, assayed by NIST HP-ICP-AES method, and purity is confirmed by ICP-MS. Furthermore, they are manufactured under ISO 9001 and ISO Guide 34, certified under ISO/IEC 17025 and accompanied by a NISTtraceable COA. LGC Standards can also provide you with single element standards for your specific needs.

VHG-USP1-OI-100 USP Class 1 Oral As @ 1.5 mg/kg, Cd @ 25 mg/kg, Hg @ 15 mg/kg, and Pb @ 5 mg/kg in 5% HNO3. Impurities Standard 100mL bottle

VHG-USP1-PI-100 USP Class 1 Parenteral As @ 1.5 mg/kg, Cd @ 2.5 mg/kg, Hg @ 1.5 mg/kg, and Pb @ 5 mg/kg in 5% HNO3. Impurities Standard 100mL bottle VHG-USP2-OPPM-100 USP Class 2 Oral & Parenteral Ir, Os, Pd, Pt, Rh, Ru @ 100 mg/kg in 20% HCl. Precious Metals Standard 100mL bottle

VHG-USP2-OPI-100 USP Class 2 Oral & Parenteral Cr, Mo, and V @ 10 mg/kg, Ni @ 50 mg/kg, and Cu @ 100 mg/kg in 5% HNO3. Impurities Standard 100mL bottle

VHG-USP1-OPHG-100 USP Class 1 Oral & Parenteral Hg @ 10 mg/kg in 5% HNO3. Mercury Standard 100mL bottle VHG-LSAU-100 Gold Stabilizer for Mercury Au @ 100 μg/mL in 5% HCl. Determination 100mL bottle

Visit us at www.lgcstandards.com @LGCStdsPharma

LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043 For further information, or if you require substances or materials not currently listed please contact one of our local sales offices.

Brazil Hungary Russia Tel: +55 12 3302 5880 Tel: +36 (06) 26 314 891 Tel: +7 812 777 04 88 Email: [email protected] Email: [email protected] Email: [email protected]

Bulgaria India South Africa Tel: +359 (0)2 971 4955 Tel: +91 (0)80 6701 2000 Tel: +27 (0)11 466 4321 Email: [email protected] Email: [email protected] Email: [email protected]

China Ireland Spain Tel: 800 810 4630 (toll-free) Tel: +44 7879556983 Tel: +34 (0)93 308 4181 Email: [email protected] Email: [email protected] Email: [email protected]

Czech Republic Italy Sweden Tel: +420 543 529 205 Tel: +39 02 2412 6830 Tel: +46 (0)33 20 90 60 Email: [email protected] Email: [email protected] Email: [email protected]

Finland Middle East Turkey Tel: +358 (0)2 233 9355 Tel: +49 (0)281 9887 0 Tel: +90 216 360 0870 Email: [email protected] Email: [email protected] Email: [email protected]

France Netherlands United Kingdom Tel: +33 (0)3 88 04 82 82 Tel: +31 (0)643 775 422 Tel: +44 (0)20 8943 8480 Email: [email protected] Email: [email protected] Email: [email protected]

Germany Poland USA + Canada Tel: +49 (0)281 9887 0 Tel: +48 22 751 31 40 Tel: 1-855-LGC-USA1 (toll-free) Email: [email protected] Email: [email protected] Email: [email protected]

Romania Tel: +40 364 116890 Email: [email protected]

www.lgcstandards.com

No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or any retrieval system, without the written permission of the copyright holder. © LGC Limited, 2014. All rights reserved. 3970/LB/0614